Genes in Region
9068581 | DLGAP4-AS1 | DLGAP4 antisense RNA 1 | 20 | 36507702 | 36573275 | Human |
329839210 | LOC130065784 | ATAC-STARR-seq lymphoblastoid silent region 12872 | 20 | 36541340 | 36541539 | Human |
1322585 | MYL9 | myosin light chain 9 | 20 | 36541519 | 36551447 | Human |
155762285 | LOC127893202 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35170723-35171376 | 20 | 36542320 | 36542973 | Human |
155776478 | LOC127893203 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35171377-35172030 | 20 | 36542974 | 36543627 | Human |
155758042 | LOC127893204 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35172031-35172684 | 20 | 36543628 | 36544281 | Human |
155773358 | LOC127893205 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35172685-35173338 | 20 | 36544282 | 36544935 | Human |
155757586 | LOC127893206 | H3K4me1 hESC enhancer GRCh37_chr20:35175959-35176887 | 20 | 36547556 | 36548484 | Human |
155781881 | LOC127893207 | NANOG hESC enhancer GRCh37_chr20:35191013-35191578 | 20 | 36562610 | 36563175 | Human |
155764851 | LOC127893208 | OCT4-H3K27ac hESC enhancer GRCh37_chr20:35199946-35200498 | 20 | 36571543 | 36572095 | Human |
329837570 | LOC130065785 | ATAC-STARR-seq lymphoblastoid active region 17809 | 20 | 36572714 | 36572773 | Human |
329815347 | LOC130065786 | ATAC-STARR-seq lymphoblastoid silent region 12873 | 20 | 36573274 | 36573593 | Human |
1344249 | TGIF2 | TGFB induced factor homeobox 2 | 20 | 36573464 | 36593950 | Human |
329831563 | LOC130065787 | ATAC-STARR-seq lymphoblastoid silent region 12874 | 20 | 36573624 | 36573713 | Human |
329824719 | LOC130065788 | ATAC-STARR-seq lymphoblastoid silent region 12875 | 20 | 36573784 | 36573953 | Human |
7205237 | TGIF2-RAB5IF | TGIF2-RAB5IF readthrough | 20 | 36574515 | 36612557 | Human |
155756031 | LOC127893209 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35213881-35214870 | 20 | 36585478 | 36586467 | Human |
155756992 | LOC127893210 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35217734-35218362 | 20 | 36589331 | 36589959 | Human |
155775714 | LOC127893211 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35219932-35220810 | 20 | 36591529 | 36592407 | Human |
329841372 | LOC130065789 | ATAC-STARR-seq lymphoblastoid active region 17810 | 20 | 36595719 | 36596088 | Human |
329834157 | LOC130065790 | ATAC-STARR-seq lymphoblastoid active region 17811 | 20 | 36600088 | 36600157 | Human |
329818496 | LOC130065791 | ATAC-STARR-seq lymphoblastoid active region 17812 | 20 | 36604653 | 36604702 | Human |
329337555 | LOC129664608 | ReSE screen-validated silencer GRCh37_chr20:35233097-35233496 | 20 | 36604694 | 36605093 | Human |
329822927 | LOC130065792 | ATAC-STARR-seq lymphoblastoid active region 17813 | 20 | 36605433 | 36605572 | Human |
329841728 | LOC130065793 | ATAC-STARR-seq lymphoblastoid silent region 12876 | 20 | 36605773 | 36606082 | Human |
1317125 | RAB5IF | RAB5 interacting factor | 20 | 36605779 | 36612557 | Human |
155230422 | LOC126863023 | MED14-independent group 3 enhancer GRCh37_chr20:35235327-35236526 | 20 | 36606924 | 36608123 | Human |
1320351 | SLA2 | Src like adaptor 2 | 20 | 36612318 | 36646196 | Human |
1603170 | HNRNPA3P2 | heterogeneous nuclear ribonucleoprotein A3 pseudogene 2 | 20 | 36620402 | 36621439 | Human |
329815770 | LOC130065794 | ATAC-STARR-seq lymphoblastoid active region 17814 | 20 | 36630237 | 36630346 | Human |
155764448 | LOC127893212 | H3K4me1 hESC enhancer GRCh37_chr20:35261429-35261930 | 20 | 36633026 | 36633527 | Human |
155778845 | LOC127893213 | OCT4-NANOG hESC enhancer GRCh37_chr20:35271232-35271902 | 20 | 36642829 | 36643499 | Human |
1315300 | NDRG3 | NDRG family member 3 | 20 | 36651771 | 36746090 | Human |
155772782 | LOC127893214 | H3K27ac hESC enhancer GRCh37_chr20:35305009-35305810 | 20 | 36676606 | 36677407 | Human |
155760390 | LOC127893215 | H3K27ac hESC enhancer GRCh37_chr20:35324917-35325417 | 20 | 36696514 | 36697014 | Human |
155758943 | LOC127893216 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35373956-35374922 | 20 | 36745553 | 36746519 | Human |
329340990 | LOC129391171 | MPRA-validated peak4204 silencer | 20 | 36749213 | 36749413 | Human |
1353084 | DSN1 | DSN1 component of MIS12 kinetochore complex | 20 | 36751795 | 36773763 | Human |
155778635 | LOC127893217 | H3K4me1 hESC enhancer GRCh37_chr20:35393973-35394472 | 20 | 36765570 | 36766069 | Human |
329342928 | LOC129664609 | ReSE screen-validated silencer GRCh37_chr20:35399249-35399414 | 20 | 36770846 | 36771011 | Human |
155752469 | LOC127893218 | H3K27ac hESC enhancer GRCh37_chr20:35401925-35402470 | 20 | 36773522 | 36774108 | Human |
155754758 | LOC127893219 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35402471-35403017 | 20 | 36774068 | 36774614 | Human |
151669700 | LOC124904894 | uncharacterized LOC124904894 | 20 | 36775135 | 36777092 | Human |
1352015 | MTCL2 | microtubule crosslinking factor 2 | 20 | 36777447 | 36863538 | Human |
155778438 | LOC127893220 | H3K4me1 hESC enhancer GRCh37_chr20:35410629-35411130 | 20 | 36782226 | 36782727 | Human |
329844930 | LOC130065795 | ATAC-STARR-seq lymphoblastoid active region 17819 | 20 | 36827553 | 36827612 | Human |
329822510 | LOC130065796 | ATAC-STARR-seq lymphoblastoid active region 17820 | 20 | 36828113 | 36828222 | Human |
329821910 | LOC130065797 | ATAC-STARR-seq lymphoblastoid active region 17821 | 20 | 36835413 | 36835472 | Human |
329837184 | LOC130065798 | ATAC-STARR-seq lymphoblastoid silent region 12879 | 20 | 36835703 | 36835992 | Human |
329838197 | LOC130065799 | ATAC-STARR-seq lymphoblastoid active region 17822 | 20 | 36841660 | 36841719 | Human |
329839845 | LOC130065800 | ATAC-STARR-seq lymphoblastoid active region 17823 | 20 | 36845931 | 36846080 | Human |
329832549 | LOC130065801 | ATAC-STARR-seq lymphoblastoid active region 17824 | 20 | 36846251 | 36846300 | Human |
155761717 | LOC127893221 | H3K27ac hESC enhancer GRCh37_chr20:35478413-35478912 | 20 | 36850010 | 36850509 | Human |
155776010 | LOC127893222 | H3K4me1 hESC enhancer GRCh37_chr20:35483021-35483521 | 20 | 36854618 | 36855118 | Human |
155781108 | LOC127893223 | H3K4me1 hESC enhancer GRCh37_chr20:35484024-35484524 | 20 | 36855621 | 36856121 | Human |
155779485 | LOC127893224 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35485529-35486030 | 20 | 36857126 | 36857627 | Human |
155758041 | LOC127893225 | H3K27ac hESC enhancer GRCh37_chr20:35486031-35486531 | 20 | 36857628 | 36858128 | Human |
329821455 | LOC130065802 | ATAC-STARR-seq lymphoblastoid silent region 12880 | 20 | 36863138 | 36863287 | Human |
329821300 | LOC130065803 | ATAC-STARR-seq lymphoblastoid silent region 12881 | 20 | 36863358 | 36864247 | Human |
329819900 | LOC130065804 | ATAC-STARR-seq lymphoblastoid silent region 12882 | 20 | 36867089 | 36867158 | Human |
10412580 | RN7SL156P | RNA, 7SL, cytoplasmic 156, pseudogene | 20 | 36870099 | 36870402 | Human |
155769830 | LOC127893226 | H3K4me1 hESC enhancer GRCh37_chr20:35500385-35500891 | 20 | 36871982 | 36872488 | Human |
1348581 | TLDC2 | TBC/LysM-associated domain containing 2 | 20 | 36876121 | 36894235 | Human |
155776920 | LOC127893227 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35515591-35516313 | 20 | 36887188 | 36887910 | Human |
1318099 | SAMHD1 | SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 | 20 | 36889773 | 36951708 | Human |
155760662 | LOC127893228 | OCT4-NANOG hESC enhancer GRCh37_chr20:35575178-35576013 | 20 | 36946775 | 36947610 | Human |
329827746 | LOC130065805 | ATAC-STARR-seq lymphoblastoid silent region 12883 | 20 | 36951203 | 36951422 | Human |
155780990 | LOC127893229 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:35604082-35604653 | 20 | 36975679 | 36976250 | Human |
155753288 | LOC127893230 | H3K27ac hESC enhancer GRCh37_chr20:35604654-35605224 | 20 | 36976251 | 36976821 | Human |
155754439 | LOC127893231 | H3K4me1 hESC enhancer GRCh37_chr20:35618031-35618532 | 20 | 36989628 | 36990129 | Human |
155755736 | LOC127893232 | H3K4me1 hESC enhancer GRCh37_chr20:35618533-35619032 | 20 | 36990130 | 36990629 | Human |
1313374 | RBL1 | RB transcriptional corepressor like 1 | 20 | 36996349 | 37095997 | Human |
155755611 | LOC127893233 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35628373-35629300 | 20 | 36999970 | 37000897 | Human |
155761137 | LOC127893234 | H3K27ac hESC enhancer GRCh37_chr20:35640175-35641116 | 20 | 37011772 | 37012713 | Human |
1344214 | RPS3AP3 | RPS3A pseudogene 3 | 20 | 37021743 | 37022009 | Human |
329825704 | LOC130065806 | ATAC-STARR-seq lymphoblastoid active region 17825 | 20 | 37043424 | 37043523 | Human |
329824333 | LOC130065807 | ATAC-STARR-seq lymphoblastoid active region 17826 | 20 | 37044264 | 37044433 | Human |
1346749 | RPS27AP3 | RPS27A pseudogene 3 | 20 | 37049238 | 37049745 | Human |
329820993 | LOC130065808 | ATAC-STARR-seq lymphoblastoid active region 17827 | 20 | 37095356 | 37095455 | Human |
155751098 | LOC127893235 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35724092-35724768 | 20 | 37095689 | 37096365 | Human |
329828942 | LOC130065809 | ATAC-STARR-seq lymphoblastoid active region 17829 | 20 | 37096406 | 37096455 | Human |
1352113 | MROH8 | maestro heat like repeat family member 8 | 20 | 37101167 | 37179548 | Human |
16556443 | AL031659.1 | ribosomal protein L13 (RPL13) pseudogene | 20 | 37165782 | 37166319 | Human |
155762892 | LOC127893236 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35807291-35807850 | 20 | 37178888 | 37179447 | Human |
732277 | RPN2 | ribophorin II | 20 | 37179330 | 37241619 | Human |
155756269 | LOC127893237 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35807851-35808408 | 20 | 37179448 | 37180005 | Human |
152975695 | LOC125387267 | Sharpr-MPRA regulatory region 9458 | 20 | 37192306 | 37192600 | Human |
155778590 | LOC127893238 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35821940-35822774 | 20 | 37193537 | 37194371 | Human |
155774714 | LOC127893239 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35858877-35859417 | 20 | 37230474 | 37231014 | Human |
737566 | GHRH | growth hormone releasing hormone | 20 | 37251086 | 37261814 | Human |
329337454 | LOC129664610 | ReSE screen-validated silencer GRCh37_chr20:35886402-35886635 | 20 | 37257999 | 37258232 | Human |
329843201 | LOC130065810 | ATAC-STARR-seq lymphoblastoid silent region 12886 | 20 | 37265146 | 37265265 | Human |
329815746 | LOC130065811 | ATAC-STARR-seq lymphoblastoid silent region 12887 | 20 | 37265406 | 37265455 | Human |
155774052 | LOC127893240 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35896280-35896826 | 20 | 37267877 | 37268423 | Human |
155769336 | LOC127893241 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35896827-35897374 | 20 | 37268424 | 37268971 | Human |
329830334 | LOC130065812 | ATAC-STARR-seq lymphoblastoid active region 17832 | 20 | 37270485 | 37270554 | Human |
329823251 | LOC130065813 | ATAC-STARR-seq lymphoblastoid silent region 12888 | 20 | 37277364 | 37277413 | Human |
329829329 | LOC130065814 | ATAC-STARR-seq lymphoblastoid active region 17833 | 20 | 37289443 | 37289552 | Human |
155772707 | LOC127893242 | H3K27ac hESC enhancer GRCh37_chr20:35918028-35918932 | 20 | 37289625 | 37290529 | Human |
1353788 | MANBAL | mannosidase beta like | 20 | 37289655 | 37317260 | Human |
329836371 | LOC130065815 | ATAC-STARR-seq lymphoblastoid active region 17834 | 20 | 37291758 | 37291867 | Human |
155782279 | LOC127893243 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35943167-35944074 | 20 | 37314764 | 37315671 | Human |
155755157 | LOC127893244 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35944075-35944984 | 20 | 37315672 | 37316581 | Human |
155756361 | LOC127893245 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:35947577-35948274 | 20 | 37319174 | 37319871 | Human |
155761955 | LOC127893246 | H3K4me1 hESC enhancer GRCh37_chr20:35964723-35965222 | 20 | 37336320 | 37336819 | Human |
38610395 | LOC105372606 | uncharacterized LOC105372606 | 20 | 37337440 | 37344595 | Human |
155780823 | LOC127893247 | H3K4me1 hESC enhancer GRCh37_chr20:35968539-35969071 | 20 | 37340136 | 37340668 | Human |
329813473 | LOC130065816 | ATAC-STARR-seq lymphoblastoid active region 17836 | 20 | 37344063 | 37344122 | Human |
1350530 | SRC | SRC proto-oncogene, non-receptor tyrosine kinase | 20 | 37344699 | 37406050 | Human |
329820857 | LOC130065817 | ATAC-STARR-seq lymphoblastoid active region 17837 | 20 | 37345509 | 37345588 | Human |
329833265 | LOC130065818 | ATAC-STARR-seq lymphoblastoid silent region 12889 | 20 | 37345779 | 37346078 | Human |
155772785 | LOC127893248 | H3K4me1 hESC enhancer GRCh37_chr20:35975052-35975552 | 20 | 37346629 | 37347149 | Human |
329826767 | LOC130065819 | ATAC-STARR-seq lymphoblastoid active region 17838 | 20 | 37357100 | 37357149 | Human |
329831372 | LOC130065820 | ATAC-STARR-seq lymphoblastoid active region 17839 | 20 | 37357520 | 37357569 | Human |
155775151 | LOC127893249 | H3K4me1 hESC enhancer GRCh37_chr20:35987177-35987747 | 20 | 37358774 | 37359344 | Human |
329835077 | LOC130065821 | ATAC-STARR-seq lymphoblastoid active region 17840 | 20 | 37365257 | 37365326 | Human |
329837863 | LOC130065822 | ATAC-STARR-seq lymphoblastoid active region 17841 | 20 | 37366643 | 37366742 | Human |
329831113 | LOC130065823 | ATAC-STARR-seq lymphoblastoid active region 17842 | 20 | 37375479 | 37375618 | Human |
329841521 | LOC130065824 | ATAC-STARR-seq lymphoblastoid active region 17843 | 20 | 37377222 | 37377331 | Human |
329817322 | LOC130065825 | ATAC-STARR-seq lymphoblastoid active region 17844 | 20 | 37382732 | 37382821 | Human |
329844283 | LOC130065826 | ATAC-STARR-seq lymphoblastoid silent region 12891 | 20 | 37384677 | 37384966 | Human |
155774783 | LOC127893251 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36022575-36023431 | 20 | 37394172 | 37395028 | Human |
155779279 | LOC127893252 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36023432-36024287 | 20 | 37395029 | 37395884 | Human |
155765596 | LOC127893253 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36024288-36025144 | 20 | 37395885 | 37396741 | Human |
155750416 | LOC127893254 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36025145-36026001 | 20 | 37396742 | 37397598 | Human |
155764569 | LOC127893255 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36026002-36026858 | 20 | 37397599 | 37398455 | Human |
329838965 | LOC130065827 | ATAC-STARR-seq lymphoblastoid silent region 12892 | 20 | 37406363 | 37406752 | Human |
155782093 | LOC127893256 | H3K4me1 hESC enhancer GRCh37_chr20:36035731-36036650 | 20 | 37407328 | 37408247 | Human |
155753719 | LOC127893257 | H3K4me1 hESC enhancer GRCh37_chr20:36040408-36040917 | 20 | 37412005 | 37412514 | Human |
155767142 | LOC127893258 | H3K4me1 hESC enhancer GRCh37_chr20:36040918-36041426 | 20 | 37412515 | 37413023 | Human |
155781806 | LOC127893259 | H3K4me1 hESC enhancer GRCh37_chr20:36049663-36050276 | 20 | 37421260 | 37421873 | Human |
155778692 | LOC127893260 | H3K4me1 hESC enhancer GRCh37_chr20:36054060-36054560 | 20 | 37425657 | 37426157 | Human |
155765330 | LOC127893261 | H3K4me1 hESC enhancer GRCh37_chr20:36054561-36055061 | 20 | 37426158 | 37426658 | Human |
155775057 | LOC127893262 | H3K4me1 hESC enhancer GRCh37_chr20:36070038-36070538 | 20 | 37441636 | 37442136 | Human |
1343860 | RPL7AP14 | ribosomal protein L7a pseudogene 14 | 20 | 37444673 | 37445556 | Human |
155769743 | LOC127893263 | H3K4me1 hESC enhancer GRCh37_chr20:36114871-36115516 | 20 | 37486469 | 37487114 | Human |
155776740 | LOC127893264 | H3K4me1 hESC enhancer GRCh37_chr20:36115517-36116161 | 20 | 37487115 | 37487759 | Human |
329823597 | LOC130065828 | ATAC-STARR-seq lymphoblastoid active region 17845 | 20 | 37507570 | 37507659 | Human |
1347383 | BLCAP | BLCAP apoptosis inducing factor | 20 | 37517417 | 37527876 | Human |
155766755 | LOC127893265 | H3K4me1 hESC enhancer GRCh37_chr20:36146997-36147860 | 20 | 37518595 | 37519458 | Human |
155757096 | LOC127893266 | H3K4me1 hESC enhancer GRCh37_chr20:36147861-36148724 | 20 | 37519459 | 37520322 | Human |
730841 | NNAT | neuronatin | 20 | 37521250 | 37523690 | Human |
155777999 | LOC127893267 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:36154646-36155364 | 20 | 37526244 | 37526962 | Human |
155759014 | LOC127893268 | OCT4-H3K27ac hESC enhancer GRCh37_chr20:36156082-36156799 | 20 | 37527680 | 37528397 | Human |
1345438 | PPIAP3 | peptidylprolyl isomerase A pseudogene 3 | 20 | 37530003 | 37530744 | Human |
155775022 | LOC127893269 | H3K4me1 hESC enhancer GRCh37_chr20:36196423-36196923 | 20 | 37568021 | 37568521 | Human |
11562493 | LINC01746 | long intergenic non-protein coding RNA 1746 | 20 | 37571100 | 37592454 | Human |
329832057 | LOC130065829 | ATAC-STARR-seq lymphoblastoid active region 17848 | 20 | 37576248 | 37576297 | Human |
155774779 | LOC127893270 | H3K4me1 hESC enhancer GRCh37_chr20:36219641-36220140 | 20 | 37591239 | 37591738 | Human |
1346424 | GLRXP1 | glutaredoxin pseudogene 1 | 20 | 37602353 | 37603249 | Human |
5686919 | LINC00489 | long intergenic non-protein coding RNA 489 | 20 | 37619298 | 37623119 | Human |
329823576 | LOC130065830 | ATAC-STARR-seq lymphoblastoid active region 17849 | 20 | 37627182 | 37627281 | Human |
329341832 | LOC129664611 | ReSE screen-validated silencer GRCh37_chr20:36280377-36280529 | 20 | 37651975 | 37652127 | Human |
16551541 | AL162293.1 | novel transcript | 20 | 37676910 | 37683234 | Human |
38659179 | LOC105372609 | uncharacterized LOC105372609 | 20 | 37686042 | 37691276 | Human |
1346196 | CTNNBL1 | catenin beta like 1 | 20 | 37694030 | 37872118 | Human |
329827021 | LOC130065831 | ATAC-STARR-seq lymphoblastoid active region 17850 | 20 | 37694308 | 37694367 | Human |
329839092 | LOC130065832 | ATAC-STARR-seq lymphoblastoid silent region 12893 | 20 | 37697351 | 37697500 | Human |
151672640 | LOC124904895 | uncharacterized LOC124904895 | 20 | 37747397 | 37756386 | Human |
329839499 | LOC130065833 | ATAC-STARR-seq lymphoblastoid silent region 12894 | 20 | 37750264 | 37750313 | Human |
155776321 | LOC127893271 | H3K4me1 hESC enhancer GRCh37_chr20:36414145-36414646 | 20 | 37785743 | 37786244 | Human |
155757959 | LOC127893272 | H3K4me1 hESC enhancer GRCh37_chr20:36414647-36415146 | 20 | 37786245 | 37786744 | Human |
155228802 | LOC126863024 | MED14-independent group 3 enhancer GRCh37_chr20:36416862-36418061 | 20 | 37788460 | 37789659 | Human |
329833772 | LOC130065834 | ATAC-STARR-seq lymphoblastoid active region 17851 | 20 | 37853845 | 37853964 | Human |
155781744 | LOC127893273 | H3K4me1 hESC enhancer GRCh37_chr20:36504902-36505402 | 20 | 37876500 | 37877000 | Human |
155774395 | LOC127893274 | H3K4me1 hESC enhancer GRCh37_chr20:36505403-36505903 | 20 | 37877001 | 37877501 | Human |
329835163 | LOC130065835 | ATAC-STARR-seq lymphoblastoid silent region 12895 | 20 | 37897359 | 37897408 | Human |
151674460 | LOC124904896 | uncharacterized LOC124904896 | 20 | 37898281 | 37918992 | Human |
155769968 | LOC127893275 | H3K4me1 hESC enhancer GRCh37_chr20:36530829-36531792 | 20 | 37902427 | 37903390 | Human |
1313925 | VSTM2L | V-set and transmembrane domain containing 2 like | 20 | 37903127 | 37945350 | Human |
155765278 | LOC127893276 | H3K4me1 hESC enhancer GRCh37_chr20:36537707-36538207 | 20 | 37909305 | 37909805 | Human |
155765995 | LOC127893278 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36543463-36544310 | 20 | 37915061 | 37915908 | Human |
155781960 | LOC127893279 | H3K4me1 hESC enhancer GRCh37_chr20:36545629-36546130 | 20 | 37917227 | 37917728 | Human |
329837869 | LOC130065836 | ATAC-STARR-seq lymphoblastoid active region 17852 | 20 | 37922520 | 37922619 | Human |
155782091 | LOC127893280 | H3K4me1 hESC enhancer GRCh37_chr20:36568310-36568810 | 20 | 37939908 | 37940408 | Human |
155776158 | LOC127893281 | H3K4me1 hESC enhancer GRCh37_chr20:36568811-36569311 | 20 | 37940409 | 37940909 | Human |
329344382 | LOC129391172 | MPRA-validated peak4207 silencer | 20 | 37954713 | 37954913 | Human |
10412388 | RN7SKP185 | RN7SK pseudogene 185 | 20 | 37975156 | 37975481 | Human |
1605708 | TTI1 | TELO2 interacting protein 1 | 20 | 37983021 | 38033456 | Human |
329829884 | LOC130065837 | ATAC-STARR-seq lymphoblastoid active region 17853 | 20 | 37990585 | 37990664 | Human |
155758662 | LOC127893250 | H3K4me1 hESC enhancer GRCh37_chr20:36019051-36019552 | 20 | 37390648 | 37391149 | Human |
155758359 | LOC127893277 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36542615-36543462 | 20 | 37914213 | 37915060 | Human |
155759396 | LOC127893282 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36661589-36662184 | 20 | 38033187 | 38033782 | Human |
1312424 | RPRD1B | regulation of nuclear pre-mRNA domain containing 1B | 20 | 38033746 | 38092364 | Human |
151673584 | LOC124904898 | uncharacterized LOC124904898 | 20 | 38034106 | 38038107 | Human |
329818516 | LOC130065838 | ATAC-STARR-seq lymphoblastoid active region 17855 | 20 | 38073365 | 38073474 | Human |
151668498 | LOC124904897 | uncharacterized LOC124904897 | 20 | 38084891 | 38088420 | Human |
152975770 | LOC125387268 | Sharpr-MPRA regulatory region 13539 | 20 | 38092907 | 38093201 | Human |
329845001 | LOC130065839 | ATAC-STARR-seq lymphoblastoid silent region 12896 | 20 | 38095814 | 38095873 | Human |
10412592 | RN7SL237P | RNA, 7SL, cytoplasmic 237, pseudogene | 20 | 38098414 | 38098700 | Human |
152975697 | LOC125387269 | Sharpr-MPRA regulatory region 2618 | 20 | 38109787 | 38110081 | Human |
151675152 | LOC124904899 | uncharacterized LOC124904899 | 20 | 38110018 | 38114878 | Human |
155750239 | LOC127893284 | H3K27ac hESC enhancer GRCh37_chr20:36740455-36740954 | 20 | 38112053 | 38112552 | Human |
732487 | TGM2 | transglutaminase 2 | 20 | 38127385 | 38168475 | Human |
155757300 | LOC127893286 | H3K4me1 hESC enhancer GRCh37_chr20:36771307-36771975 | 20 | 38142905 | 38143573 | Human |
329815163 | LOC130065840 | ATAC-STARR-seq lymphoblastoid silent region 12897 | 20 | 38165123 | 38165562 | Human |
2289756 | KIAA1755 | KIAA1755 | 20 | 38210503 | 38260735 | Human |
155228472 | LOC126863025 | BRD4-independent group 4 enhancer GRCh37_chr20:36845917-36847116 | 20 | 38217515 | 38218714 | Human |
155779742 | LOC127893287 | H3K4me1 hESC enhancer GRCh37_chr20:36847531-36848032 | 20 | 38219129 | 38219630 | Human |
155780262 | LOC127893283 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36662185-36662780 | 20 | 38033783 | 38034378 | Human |
155762578 | LOC127893285 | H3K4me1 hESC enhancer GRCh37_chr20:36770637-36771306 | 20 | 38142235 | 38142904 | Human |
155753569 | LOC127893288 | H3K4me1 hESC enhancer GRCh37_chr20:36874844-36875344 | 20 | 38246442 | 38246942 | Human |
151673731 | LOC124904900 | uncharacterized LOC124904900 | 20 | 38251963 | 38257861 | Human |
155774445 | LOC127893289 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36881371-36881963 | 20 | 38252969 | 38253561 | Human |
16570690 | AL359555.4 | novel transcript | 20 | 38260175 | 38288947 | Human |
155769112 | LOC127893290 | H3K4me1 hESC enhancer GRCh37_chr20:36888895-36889394 | 20 | 38260493 | 38260992 | Human |
329825145 | LOC130065841 | ATAC-STARR-seq lymphoblastoid silent region 12898 | 20 | 38280158 | 38280267 | Human |
155770267 | LOC127893291 | H3K4me1 hESC enhancer GRCh37_chr20:36915021-36915522 | 20 | 38286619 | 38287120 | Human |
155760336 | LOC127893292 | H3K4me1 hESC enhancer GRCh37_chr20:36926779-36927294 | 20 | 38298377 | 38298892 | Human |
1352137 | BPI | bactericidal permeability increasing protein | 20 | 38304156 | 38337505 | Human |
155229366 | LOC126863026 | BRD4-independent group 4 enhancer GRCh37_chr20:36962737-36963936 | 20 | 38334335 | 38335534 | Human |
155752005 | LOC127893293 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36970603-36971380 | 20 | 38342201 | 38342977 | Human |
155751351 | LOC127893294 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36972161-36972938 | 20 | 38343758 | 38344535 | Human |
1347766 | LBP | lipopolysaccharide binding protein | 20 | 38346482 | 38377013 | Human |
155781587 | LOC127893295 | H3K4me1 hESC enhancer GRCh37_chr20:36982312-36982872 | 20 | 38353912 | 38354472 | Human |
155773195 | LOC127893296 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:36982873-36983432 | 20 | 38354473 | 38355032 | Human |
155758136 | LOC127893297 | H3K27ac hESC enhancer GRCh37_chr20:36986777-36987278 | 20 | 38358123 | 38358624 | Human |
329343270 | LOC129664612 | ReSE screen-validated silencer GRCh37_chr20:36991245-36991414 | 20 | 38362591 | 38362760 | Human |
329340048 | LOC129664613 | ReSE screen-validated silencer GRCh37_chr20:37017902-37018103 | 20 | 38389260 | 38389461 | Human |
151675711 | LOC124904901 | uncharacterized LOC124904901 | 20 | 38412304 | 38417012 | Human |
16568081 | SNORA71 | Small nucleolar RNA SNORA71 | 20 | 38421647 | 38421774 | Human |
1349458 | SNORA71B | small nucleolar RNA, H/ACA box 71B | 20 | 38425195 | 38425330 | Human |
38630372 | LOC112694709 | Sharpr-MPRA regulatory region 13566 | 20 | 38426041 | 38426340 | Human |
1351285 | SNORA71A | small nucleolar RNA, H/ACA box 71A | 20 | 38427306 | 38427443 | Human |
1602558 | SNORA71C | small nucleolar RNA, H/ACA box 71C | 20 | 38429667 | 38429804 | Human |
155751949 | LOC127893298 | H3K4me1 hESC enhancer GRCh37_chr20:37059106-37059606 | 20 | 38430463 | 38430963 | Human |
151673041 | LOC124904958 | uncharacterized LOC124904958 | 20 | 38430793 | 38436716 | Human |
329844006 | LOC130065842 | ATAC-STARR-seq lymphoblastoid active region 17856 | 20 | 38433721 | 38433800 | Human |
1602557 | SNORA71D | small nucleolar RNA, H/ACA box 71D | 20 | 38433862 | 38433999 | Human |
329843752 | LOC130065843 | ATAC-STARR-seq lymphoblastoid active region 17857 | 20 | 38435081 | 38435370 | Human |
329818729 | LOC130065844 | ATAC-STARR-seq lymphoblastoid active region 17858 | 20 | 38435391 | 38435450 | Human |
16551372 | SNORA71 | Small nucleolar RNA SNORA71 | 20 | 38442036 | 38442169 | Human |
329819262 | LOC130065845 | ATAC-STARR-seq lymphoblastoid active region 17859 | 20 | 38446490 | 38446539 | Human |
1601936 | SNHG11 | small nucleolar RNA host gene 11 | 20 | 38446654 | 38450921 | Human |
155760272 | LOC127893299 | H3K4me1 hESC enhancer GRCh37_chr20:37076132-37076686 | 20 | 38447489 | 38448043 | Human |
1602575 | SNORA71E | small nucleolar RNA, H/ACA box 71E | 20 | 38448083 | 38448218 | Human |
1602560 | SNORA60 | small nucleolar RNA, H/ACA box 60 | 20 | 38449369 | 38449504 | Human |
329824287 | LOC130065846 | ATAC-STARR-seq lymphoblastoid active region 17860 | 20 | 38472564 | 38472633 | Human |
1603624 | RALGAPB | Ral GTPase activating protein non-catalytic subunit beta | 20 | 38472843 | 38578858 | Human |
329822872 | LOC130065847 | ATAC-STARR-seq lymphoblastoid silent region 12899 | 20 | 38472924 | 38473123 | Human |
5133986 | MIR548O2 | microRNA 548o-2 | 20 | 38516563 | 38516632 | Human |
1352991 | RPS3P2 | ribosomal protein S3 pseudogene 2 | 20 | 38537750 | 38538459 | Human |
155768621 | LOC127893300 | H3K4me1 hESC enhancer GRCh37_chr20:37189333-37189849 | 20 | 38560690 | 38561206 | Human |
155766976 | LOC127893301 | H3K27ac hESC enhancer GRCh37_chr20:37193517-37194017 | 20 | 38564874 | 38565374 | Human |
329329434 | LOC129391173 | MPRA-validated peak4208 silencer | 20 | 38577732 | 38577932 | Human |
1606699 | ADIG | adipogenin | 20 | 38581197 | 38588463 | Human |
155764950 | LOC127893302 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37229033-37229574 | 20 | 38600390 | 38600931 | Human |
1343259 | ARHGAP40 | Rho GTPase activating protein 40 | 20 | 38601809 | 38650653 | Human |
155771607 | LOC127893303 | H3K27ac hESC enhancer GRCh37_chr20:37236926-37237426 | 20 | 38608283 | 38608783 | Human |
38651018 | LOC391247 | GINS complex subunit 2 (Psf2 homolog) pseudogene | 20 | 38614371 | 38615532 | Human |
329834069 | LOC130065848 | ATAC-STARR-seq lymphoblastoid silent region 12900 | 20 | 38646217 | 38646336 | Human |
38642563 | LOC111365218 | GATA motif-containing MPRA enhancer 112/113 | 20 | 38666473 | 38666617 | Human |
329815869 | LOC130065849 | ATAC-STARR-seq lymphoblastoid silent region 12901 | 20 | 38674457 | 38674566 | Human |
329339761 | LOC129391174 | MPRA-validated peak4211 silencer | 20 | 38685943 | 38686143 | Human |
41410375 | LOC120285842 | VISTA enhancer hs2620 | 20 | 38691862 | 38693085 | Human |
155771751 | LOC127893304 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:37342659-37343160 | 20 | 38714016 | 38714517 | Human |
1346344 | SLC32A1 | solute carrier family 32 member 1 | 20 | 38724486 | 38729372 | Human |
155776706 | LOC127893305 | H3K4me1 hESC enhancer GRCh37_chr20:37354984-37355521 | 20 | 38726341 | 38726878 | Human |
152975719 | LOC125387270 | H3K4me1 hESC enhancer GRCh37_chr20:37355736-37356396 | 20 | 38727093 | 38727753 | Human |
155762748 | LOC127893306 | H3K4me1 hESC enhancer GRCh37_chr20:37357057-37357716 | 20 | 38728414 | 38729073 | Human |
155761825 | LOC127893307 | H3K4me1 hESC enhancer GRCh37_chr20:37360147-37360672 | 20 | 38731504 | 38732029 | Human |
155775449 | LOC127893308 | H3K27ac hESC enhancer GRCh37_chr20:37376699-37377200 | 20 | 38747936 | 38748695 | Human |
1317453 | ACTR5 | actin related protein 5 | 20 | 38748460 | 38772520 | Human |
10401738 | RN7SKP173 | RN7SK pseudogene 173 | 20 | 38761528 | 38761766 | Human |
155774969 | LOC127893309 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37408141-37408805 | 20 | 38779498 | 38780162 | Human |
151672756 | LOC124904902 | uncharacterized LOC124904902 | 20 | 38779498 | 38786836 | Human |
155751407 | LOC127893310 | H3K27ac hESC enhancer GRCh37_chr20:37409138-37409638 | 20 | 38780495 | 38780995 | Human |
155752762 | LOC127893311 | H3K27ac hESC enhancer GRCh37_chr20:37409639-37410139 | 20 | 38780996 | 38781496 | Human |
155762503 | LOC127893312 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37410633-37411244 | 20 | 38781990 | 38782601 | Human |
7244404 | SNHG17 | small nucleolar RNA host gene 17 | 20 | 38420588 | 38435328 | Human |
155775006 | LOC127893313 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37411245-37411854 | 20 | 38782602 | 38783211 | Human |
155755442 | LOC127893315 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37433516-37434377 | 20 | 38804873 | 38805926 | Human |
1322272 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | 20 | 38805697 | 38923024 | Human |
329825356 | LOC130065850 | ATAC-STARR-seq lymphoblastoid silent region 12905 | 20 | 38806117 | 38806336 | Human |
155755521 | LOC127893316 | H3K4me1 hESC enhancer GRCh37_chr20:37434958-37435796 | 20 | 38806315 | 38807153 | Human |
329818070 | LOC130065851 | ATAC-STARR-seq lymphoblastoid active region 17862 | 20 | 38808733 | 38808782 | Human |
329817561 | LOC130065852 | ATAC-STARR-seq lymphoblastoid active region 17863 | 20 | 38808843 | 38808892 | Human |
155761651 | LOC127893317 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37446609-37447156 | 20 | 38817966 | 38818513 | Human |
155765719 | LOC127893318 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:37447157-37447704 | 20 | 38818514 | 38819061 | Human |
329832416 | LOC130065853 | ATAC-STARR-seq lymphoblastoid active region 17864 | 20 | 38833657 | 38833876 | Human |
329845030 | LOC130065854 | ATAC-STARR-seq lymphoblastoid active region 17865 | 20 | 38842763 | 38842872 | Human |
149735381 | LOC121853005 | Sharpr-MPRA regulatory region 4490 | 20 | 38859066 | 38859360 | Human |
329832301 | LOC130065855 | ATAC-STARR-seq lymphoblastoid active region 17866 | 20 | 38859449 | 38859588 | Human |
329816611 | LOC130065856 | ATAC-STARR-seq lymphoblastoid active region 17867 | 20 | 38860465 | 38860714 | Human |
329839732 | LOC130065857 | ATAC-STARR-seq lymphoblastoid active region 17868 | 20 | 38861295 | 38861384 | Human |
329832592 | LOC130065858 | ATAC-STARR-seq lymphoblastoid active region 17869 | 20 | 38863314 | 38863453 | Human |
329842029 | LOC130065859 | ATAC-STARR-seq lymphoblastoid active region 17870 | 20 | 38866571 | 38866670 | Human |
329814553 | LOC130065860 | ATAC-STARR-seq lymphoblastoid active region 17871 | 20 | 38866691 | 38866760 | Human |
155775251 | LOC127893319 | H3K4me1 hESC enhancer GRCh37_chr20:37499114-37499684 | 20 | 38870471 | 38871041 | Human |
329834031 | LOC130065861 | ATAC-STARR-seq lymphoblastoid active region 17872 | 20 | 38871170 | 38871229 | Human |
329820698 | LOC130065862 | ATAC-STARR-seq lymphoblastoid active region 17873 | 20 | 38871250 | 38871339 | Human |
10413320 | RN7SL116P | RNA, 7SL, cytoplasmic 116, pseudogene | 20 | 38872770 | 38873074 | Human |
329830651 | LOC130065863 | ATAC-STARR-seq lymphoblastoid active region 17874 | 20 | 38873288 | 38873607 | Human |
155755573 | LOC127893320 | H3K27ac hESC enhancer GRCh37_chr20:37515241-37515741 | 20 | 38886598 | 38887098 | Human |
329344525 | LOC129391175 | MPRA-validated peak4213 silencer | 20 | 38892602 | 38892802 | Human |
155755242 | LOC127893321 | H3K4me1 hESC enhancer GRCh37_chr20:37521809-37522767 | 20 | 38893166 | 38894124 | Human |
155771873 | LOC127893322 | H3K4me1 hESC enhancer GRCh37_chr20:37536633-37537132 | 20 | 38907990 | 38908489 | Human |
155772816 | LOC127893323 | H3K4me1 hESC enhancer GRCh37_chr20:37548997-37549868 | 20 | 38920354 | 38921225 | Human |
329832970 | LOC130065864 | ATAC-STARR-seq lymphoblastoid silent region 12907 | 20 | 38926035 | 38926394 | Human |
1347604 | FAM83D | family with sequence similarity 83 member D | 20 | 38926417 | 38953106 | Human |
329833103 | LOC130065865 | ATAC-STARR-seq lymphoblastoid active region 17875 | 20 | 38926505 | 38926604 | Human |
329839867 | LOC130065866 | ATAC-STARR-seq lymphoblastoid active region 17876 | 20 | 38927990 | 38928079 | Human |
329823049 | LOC130065867 | ATAC-STARR-seq lymphoblastoid silent region 12908 | 20 | 38962209 | 38962328 | Human |
1322480 | DHX35 | DEAH-box helicase 35 | 20 | 38962344 | 39039721 | Human |
329821993 | LOC130065868 | ATAC-STARR-seq lymphoblastoid active region 17877 | 20 | 38962369 | 38962678 | Human |
1348866 | NPM1P19 | nucleophosmin 1 pseudogene 19 | 20 | 38977514 | 38978514 | Human |
329829089 | LOC130065869 | ATAC-STARR-seq lymphoblastoid active region 17878 | 20 | 38988012 | 38988131 | Human |
329342333 | LOC129391176 | MPRA-validated peak4214 silencer | 20 | 39042612 | 39042812 | Human |
38633658 | LOC112694710 | Sharpr-MPRA regulatory region 15217 | 20 | 39070446 | 39070740 | Human |
155765534 | LOC127893324 | H3K4me1 hESC enhancer GRCh37_chr20:37737834-37738828 | 20 | 39109191 | 39110185 | Human |
155781730 | LOC127893325 | H3K4me1 hESC enhancer GRCh37_chr20:37740853-37741354 | 20 | 39112210 | 39112711 | Human |
38643768 | LOC107985448 | uncharacterized LOC107985448 | 20 | 39130032 | 39220038 | Human |
155777493 | LOC127893326 | H3K4me1 hESC enhancer GRCh37_chr20:37779519-37780019 | 20 | 39150876 | 39151376 | Human |
155768729 | LOC127893327 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37819274-37819952 | 20 | 39190631 | 39191309 | Human |
11562812 | LINC01734 | long intergenic non-protein coding RNA 1734 | 20 | 39213781 | 39224748 | Human |
38613534 | LOC110121317 | VISTA enhancer hs1042 | 20 | 39248171 | 39248957 | Human |
155765300 | LOC127893328 | H3K4me1 hESC enhancer GRCh37_chr20:37898023-37898523 | 20 | 39269380 | 39269880 | Human |
155764820 | LOC127893329 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:37910830-37911508 | 20 | 39282187 | 39282865 | Human |
155781973 | LOC127893330 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:37911509-37912185 | 20 | 39282866 | 39283542 | Human |
155757055 | LOC127893331 | OCT4-NANOG hESC enhancer GRCh37_chr20:37918403-37918981 | 20 | 39289760 | 39290338 | Human |
155755907 | LOC127893332 | OCT4-NANOG hESC enhancer GRCh37_chr20:37919138-37919677 | 20 | 39290495 | 39291034 | Human |
2289735 | ATG3P1 | autophagy related 3 pseudogene 1 | 20 | 39328855 | 39330000 | Human |
10399196 | RN7SL680P | RNA, 7SL, cytoplasmic 680, pseudogene | 20 | 39349094 | 39349392 | Human |
38673977 | LOC102724950 | uncharacterized LOC102724950 | 20 | 39655323 | 39660825 | Human |
155229510 | LOC126863028 | MED14-independent group 3 enhancer GRCh37_chr20:38290050-38291249 | 20 | 39661408 | 39662607 | Human |
38610382 | LOC105372614 | uncharacterized LOC105372614 | 20 | 39757202 | 39816028 | Human |
38625251 | LOC105372613 | uncharacterized LOC105372613 | 20 | 39780900 | 39788283 | Human |
155229264 | LOC126863029 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:38428967-38430166 | 20 | 39800325 | 39801524 | Human |
329836622 | LOC130065870 | ATAC-STARR-seq lymphoblastoid active region 17879 | 20 | 39826024 | 39826153 | Human |
1354138 | HSPE1P1 | heat shock protein family E (Hsp10) member 1 pseudogene 1 | 20 | 39932922 | 39933239 | Human |
8657314 | LINC01370 | long intergenic non-protein coding RNA 1370 | 20 | 40004461 | 40008529 | Human |
38667715 | LOC105372616 | uncharacterized LOC105372616 | 20 | 40116421 | 40121078 | Human |
155755232 | LOC127893334 | H3K4me1 hESC enhancer GRCh37_chr20:38891152-38891652 | 20 | 40262512 | 40263012 | Human |
155774135 | LOC127893335 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:38897457-38897988 | 20 | 40268817 | 40269348 | Human |
155773352 | LOC127893336 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:38897989-38898520 | 20 | 40269349 | 40269880 | Human |
155753158 | LOC127893337 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:38902777-38903308 | 20 | 40274137 | 40274668 | Human |
38614294 | LOC105372617 | uncharacterized LOC105372617 | 20 | 40298148 | 40312797 | Human |
38628017 | LOC105372618 | uncharacterized LOC105372618 | 20 | 40454964 | 40467739 | Human |
155750816 | LOC127893339 | H3K4me1 hESC enhancer GRCh37_chr20:39134803-39135314 | 20 | 40506163 | 40506674 | Human |
38602989 | LOC102724968 | uncharacterized LOC102724968 | 20 | 40568570 | 40644090 | Human |
38607466 | LOC107985435 | uncharacterized LOC107985435 | 20 | 40584688 | 40590478 | Human |
329338185 | LOC129664614 | ReSE screen-validated silencer GRCh37_chr20:39272519-39272668 | 20 | 40643879 | 40644028 | Human |
155776288 | LOC127893341 | H3K4me1 hESC enhancer GRCh37_chr20:39281495-39281994 | 20 | 40652855 | 40653354 | Human |
38628157 | LOC112694711 | Sharpr-MPRA regulatory region 10482 | 20 | 40668669 | 40668963 | Human |
38651412 | LOC105372620 | uncharacterized LOC105372620 | 20 | 40677232 | 40678739 | Human |
329842142 | LOC130065871 | ATAC-STARR-seq lymphoblastoid active region 17880 | 20 | 40680607 | 40680666 | Human |
732545 | MAFB | MAF bZIP transcription factor B | 20 | 40685848 | 40689236 | Human |
329825184 | LOC130065872 | ATAC-STARR-seq lymphoblastoid silent region 12909 | 20 | 40689099 | 40689168 | Human |
329825944 | LOC130065873 | ATAC-STARR-seq lymphoblastoid silent region 12910 | 20 | 40689189 | 40689498 | Human |
155770777 | LOC127893342 | H3K4me1 hESC enhancer GRCh37_chr20:39318089-39319066 | 20 | 40689449 | 40690426 | Human |
155756985 | LOC127893343 | H3K4me1 hESC enhancer GRCh37_chr20:39319067-39320042 | 20 | 40690427 | 40691402 | Human |
38604570 | LOC110121321 | VISTA enhancer hs1086 | 20 | 40705542 | 40706419 | Human |
12743435 | SNORD154 | small nucleolar RNA, C/D box 154 | 20 | 40714572 | 40714623 | Human |
155776114 | LOC127893345 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:39398981-39399542 | 20 | 40770341 | 40770902 | Human |
6481664 | RNA5SP484 | RNA, 5S ribosomal pseudogene 484 | 20 | 40854119 | 40854229 | Human |
329340266 | LOC129664615 | ReSE screen-validated silencer GRCh37_chr20:39502077-39502280 | 20 | 40873437 | 40873640 | Human |
329813194 | LOC130065874 | ATAC-STARR-seq lymphoblastoid silent region 12911 | 20 | 40892903 | 40892962 | Human |
329341324 | LOC129664616 | ReSE screen-validated silencer GRCh37_chr20:39526059-39526232 | 20 | 40897419 | 40897592 | Human |
155752283 | LOC127893346 | H3K4me1 hESC enhancer GRCh37_chr20:39589576-39590207 | 20 | 40960936 | 40961567 | Human |
38629812 | LOC100128988 | uncharacterized LOC100128988 | 20 | 40980713 | 41025396 | Human |
329824507 | LOC130065875 | ATAC-STARR-seq lymphoblastoid active region 17881 | 20 | 40990765 | 40990854 | Human |
329838862 | LOC130065876 | ATAC-STARR-seq lymphoblastoid active region 17882 | 20 | 40990915 | 40991074 | Human |
329814838 | LOC130065877 | ATAC-STARR-seq lymphoblastoid active region 17883 | 20 | 40991095 | 40991144 | Human |
38642990 | LOC105372621 | uncharacterized LOC105372621 | 20 | 40995614 | 41005474 | Human |
155758209 | LOC127893347 | OCT4-NANOG hESC enhancer GRCh37_chr20:39625651-39626225 | 20 | 40997011 | 40997585 | Human |
155229737 | LOC126863030 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:39631901-39633100 | 20 | 41003261 | 41004460 | Human |
329833930 | LOC130065878 | ATAC-STARR-seq lymphoblastoid active region 17884 | 20 | 41011542 | 41011701 | Human |
329843399 | LOC130065879 | ATAC-STARR-seq lymphoblastoid active region 17885 | 20 | 41011842 | 41011891 | Human |
10450688 | RNU2-52P | RNA, U2 small nuclear 52, pseudogene | 20 | 41024205 | 41024391 | Human |
329341422 | LOC129664617 | ReSE screen-validated silencer GRCh37_chr20:39657161-39657512 | 20 | 41028521 | 41028872 | Human |
38672171 | LOC107080552 | origin of replication in promoter of TOP1 | 20 | 41028558 | 41028852 | Human |
733198 | TOP1 | DNA topoisomerase I | 20 | 41028822 | 41124487 | Human |
329827112 | LOC130065880 | ATAC-STARR-seq lymphoblastoid silent region 12912 | 20 | 41029093 | 41029162 | Human |
152975678 | LOC125387271 | Sharpr-MPRA regulatory region 14849 | 20 | 41053129 | 41053423 | Human |
155230286 | LOC126863031 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:39686360-39687559 | 20 | 41057720 | 41058919 | Human |
38600303 | LOC106992256 | t(11;20)(p15;q11) topoisomerase (DNA) I recombination region | 20 | 41082685 | 41084304 | Human |
8662218 | PLCG1-AS1 | PLCG1 antisense RNA 1 | 20 | 41097994 | 41138000 | Human |
329836516 | LOC130065881 | ATAC-STARR-seq lymphoblastoid silent region 12913 | 20 | 41111397 | 41111476 | Human |
329822805 | LOC130065882 | ATAC-STARR-seq lymphoblastoid silent region 12914 | 20 | 41132085 | 41132134 | Human |
151673422 | LOC124904903 | translation initiation factor IF-2-like | 20 | 41133843 | 41137513 | Human |
329832750 | LOC130065883 | ATAC-STARR-seq lymphoblastoid active region 17886 | 20 | 41133998 | 41134177 | Human |
329817872 | LOC130065884 | ATAC-STARR-seq lymphoblastoid active region 17887 | 20 | 41134248 | 41134297 | Human |
155777881 | LOC127893348 | H3K4me1 hESC enhancer GRCh37_chr20:39764698-39765482 | 20 | 41136058 | 41136842 | Human |
155760269 | LOC127893349 | H3K27ac hESC enhancer GRCh37_chr20:39766267-39767051 | 20 | 41136813 | 41138432 | Human |
735936 | PLCG1 | phospholipase C gamma 1 | 20 | 41137543 | 41177626 | Human |
329816765 | LOC130065885 | ATAC-STARR-seq lymphoblastoid active region 17889 | 20 | 41138581 | 41138660 | Human |
155768383 | LOC127893350 | H3K4me1 hESC enhancer GRCh37_chr20:39774494-39774994 | 20 | 41145854 | 41146354 | Human |
155755496 | LOC127893351 | H3K4me1 hESC enhancer GRCh37_chr20:39774995-39775495 | 20 | 41146355 | 41146855 | Human |
329843315 | LOC130065886 | ATAC-STARR-seq lymphoblastoid active region 17890 | 20 | 41157427 | 41157576 | Human |
8550411 | MIR6871 | microRNA 6871 | 20 | 41169023 | 41169078 | Human |
329841820 | LOC130065887 | ATAC-STARR-seq lymphoblastoid active region 17891 | 20 | 41173515 | 41173564 | Human |
1342474 | ZHX3 | zinc fingers and homeoboxes 3 | 20 | 41178455 | 41317731 | Human |
2304450 | RPL23AP81 | ribosomal protein L23a pseudogene 81 | 20 | 41196686 | 41197157 | Human |
10413053 | RN7SL615P | RNA, 7SL, cytoplasmic 615, pseudogene | 20 | 41290280 | 41290577 | Human |
329830995 | LOC130065888 | ATAC-STARR-seq lymphoblastoid silent region 12917 | 20 | 41317251 | 41317540 | Human |
329816946 | LOC130065889 | ATAC-STARR-seq lymphoblastoid silent region 12918 | 20 | 41317551 | 41318000 | Human |
329838555 | LOC130065890 | ATAC-STARR-seq lymphoblastoid active region 17892 | 20 | 41318111 | 41318160 | Human |
329820975 | LOC130065891 | ATAC-STARR-seq lymphoblastoid active region 17893 | 20 | 41329845 | 41329894 | Human |
11520770 | ADI1P1 | acireductone dioxygenase 1 pseudogene 1 | 20 | 41331122 | 41333241 | Human |
329339251 | LOC129664618 | ReSE screen-validated silencer GRCh37_chr20:39962705-39962931 | 20 | 41334065 | 41334291 | Human |
329817301 | LOC130065892 | ATAC-STARR-seq lymphoblastoid active region 17894 | 20 | 41340433 | 41340482 | Human |
329822757 | LOC130065893 | ATAC-STARR-seq lymphoblastoid silent region 12919 | 20 | 41340643 | 41340802 | Human |
1342644 | LPIN3 | lipin 3 | 20 | 41340821 | 41360582 | Human |
155775073 | LOC127893353 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:39975675-39976198 | 20 | 41347035 | 41347558 | Human |
155767003 | LOC127893354 | H3K4me1 hESC enhancer GRCh37_chr20:39986695-39987302 | 20 | 41358055 | 41358662 | Human |
155750306 | LOC127893355 | H3K4me1 hESC enhancer GRCh37_chr20:39987303-39987910 | 20 | 41358663 | 41359270 | Human |
1320036 | EMILIN3 | elastin microfibril interfacer 3 | 20 | 41359962 | 41366818 | Human |
155779347 | LOC127893356 | H3K4me1 hESC enhancer GRCh37_chr20:39994195-39994696 | 20 | 41365555 | 41366056 | Human |
151674106 | LOC124904985 | uncharacterized LOC124904985 | 20 | 41369613 | 41369714 | Human |
16554409 | AL031667.1 | novel pseudogene | 20 | 41382359 | 41383083 | Human |
155756043 | LOC127893357 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:40020313-40020978 | 20 | 41391673 | 41392338 | Human |
1321381 | CHD6 | chromodomain helicase DNA binding protein 6 | 20 | 41402083 | 41618377 | Human |
329341772 | LOC129664619 | ReSE screen-validated silencer GRCh37_chr20:40053627-40053868 | 20 | 41424987 | 41425228 | Human |
329830107 | LOC130065894 | ATAC-STARR-seq lymphoblastoid active region 17895 | 20 | 41432723 | 41432772 | Human |
151671509 | LOC124904904 | uncharacterized LOC124904904 | 20 | 41459742 | 41467560 | Human |
1342774 | RPL12P11 | ribosomal protein L12 pseudogene 11 | 20 | 41547335 | 41547966 | Human |
329338616 | LOC129664620 | ReSE screen-validated silencer GRCh37_chr20:40195885-40196079 | 20 | 41567246 | 41567440 | Human |
329825372 | LOC130065895 | ATAC-STARR-seq lymphoblastoid silent region 12920 | 20 | 41617685 | 41617904 | Human |
329832643 | LOC130065896 | ATAC-STARR-seq lymphoblastoid silent region 12921 | 20 | 41618095 | 41618354 | Human |
329817967 | LOC130065897 | ATAC-STARR-seq lymphoblastoid silent region 12922 | 20 | 41618515 | 41618934 | Human |
155779523 | LOC127893358 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:40278687-40279204 | 20 | 41650048 | 41650565 | Human |
38652813 | LOC111562371 | NFE2L2 motif-containing MPRA enhancer 172 | 20 | 41670115 | 41670259 | Human |
329839159 | LOC130065898 | ATAC-STARR-seq lymphoblastoid active region 17896 | 20 | 41673860 | 41673999 | Human |
10399488 | RNU6-1018P | RNA, U6 small nuclear 1018, pseudogene | 20 | 41684986 | 41685091 | Human |
151674068 | LOC124904905 | uncharacterized LOC124904905 | 20 | 41692535 | 41694175 | Human |
329835635 | LOC130065899 | ATAC-STARR-seq lymphoblastoid active region 17897 | 20 | 41692970 | 41693179 | Human |
329837579 | LOC130065900 | ATAC-STARR-seq lymphoblastoid active region 17898 | 20 | 41693320 | 41693539 | Human |
329826064 | LOC130065901 | ATAC-STARR-seq lymphoblastoid active region 17899 | 20 | 41693760 | 41693999 | Human |
152975779 | LOC125387272 | Sharpr-MPRA regulatory region 13693 | 20 | 41699210 | 41699504 | Human |
16551863 | LOC124900463 | small nucleolar RNA SNORA26 | 20 | 41712479 | 41712600 | Human |
152975760 | LOC125387273 | Sharpr-MPRA regulatory region 432 | 20 | 41769749 | 41770043 | Human |
155757379 | LOC127893359 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:40517268-40517904 | 20 | 41888628 | 41889264 | Human |
38605019 | LOC101927182 | uncharacterized LOC101927182 | 20 | 41903848 | 42108504 | Human |
155781962 | LOC127893360 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:40599959-40600871 | 20 | 41971319 | 41972231 | Human |
155774568 | LOC127893361 | H3K27ac hESC enhancer GRCh37_chr20:40600872-40601783 | 20 | 41972232 | 41973143 | Human |
155754572 | LOC127893362 | H3K4me1 hESC enhancer GRCh37_chr20:40627259-40627760 | 20 | 41998619 | 41999120 | Human |
38642443 | LOC105372622 | uncharacterized LOC105372622 | 20 | 42014541 | 42024127 | Human |
329329797 | LOC129391177 | MPRA-validated peak4218 silencer | 20 | 42024736 | 42024936 | Human |
1320107 | PTPRT | protein tyrosine phosphatase receptor type T | 20 | 42031890 | 43189906 | Human |
329329517 | LOC129391178 | MPRA-validated peak4219 silencer | 20 | 42179866 | 42180066 | Human |
155760585 | LOC127893363 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:40834580-40835212 | 20 | 42205940 | 42206572 | Human |
155753126 | LOC127893364 | OCT4-NANOG hESC enhancer GRCh37_chr20:40937504-40938187 | 20 | 42308864 | 42309547 | Human |
38622399 | LOC105372624 | uncharacterized LOC105372624 | 20 | 42630843 | 42647554 | Human |
16554304 | AL031656.1 | novel transcript, antisense to PTPRT | 20 | 42685483 | 42688562 | Human |
155228192 | LOC126863032 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:41379572-41380771 | 20 | 42750932 | 42752131 | Human |
151671967 | LOC124904981 | uncharacterized LOC124904981 | 20 | 42826554 | 42826702 | Human |
38636583 | LOC105372623 | uncharacterized LOC105372623 | 20 | 42949390 | 42955794 | Human |
21409808 | PTPRT-AS1 | PTPRT antisense RNA 1 | 20 | 42968743 | 42971492 | Human |
10400081 | RN7SKP100 | RN7SK pseudogene 100 | 20 | 43063326 | 43063609 | Human |
155752478 | LOC127893365 | H3K4me1 hESC enhancer GRCh37_chr20:41733081-41733580 | 20 | 43104441 | 43104940 | Human |
155777513 | LOC127893366 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:41804429-41805039 | 20 | 43175789 | 43176399 | Human |
149735422 | PTPRT-DT | PTPRT divergent transcript | 20 | 43190065 | 43202599 | Human |
10399105 | RN7SL666P | RNA, 7SL, cytoplasmic 666, pseudogene | 20 | 43222206 | 43222509 | Human |
1342622 | PPIAP21 | peptidylprolyl isomerase A pseudogene 21 | 20 | 43230733 | 43231461 | Human |
16559428 | LOC124900461 | small Cajal body-specific RNA 15 | 20 | 43304555 | 43304679 | Human |
155773920 | LOC127893367 | NANOG hESC enhancer GRCh37_chr20:41948123-41948641 | 20 | 43319483 | 43320001 | Human |
329843484 | LOC130065902 | ATAC-STARR-seq lymphoblastoid silent region 12923 | 20 | 43383286 | 43383335 | Human |
10399379 | RNU6-743P | RNA, U6 small nuclear 743, pseudogene | 20 | 43405473 | 43405568 | Human |
1350854 | EIF4EBP2P1 | eukaryotic translation initiation factor 4E binding protein 2 pseudogene 1 | 20 | 43422909 | 43423633 | Human |
329815144 | LOC130065903 | ATAC-STARR-seq lymphoblastoid active region 17900 | 20 | 43438953 | 43439102 | Human |
329340109 | LOC129664621 | ReSE screen-validated silencer GRCh37_chr20:42072831-42073022 | 20 | 43444191 | 43444382 | Human |
329342549 | LOC129664622 | ReSE screen-validated silencer GRCh37_chr20:42073753-42073955 | 20 | 43445113 | 43445315 | Human |
329828484 | LOC130065904 | ATAC-STARR-seq lymphoblastoid active region 17901 | 20 | 43457233 | 43457552 | Human |
155770453 | LOC127893368 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42086334-42087281 | 20 | 43457613 | 43458682 | Human |
1342668 | SRSF6 | serine and arginine rich splicing factor 6 | 20 | 43457896 | 43464243 | Human |
10398999 | RNU6-1251P | RNA, U6 small nuclear 1251, pseudogene | 20 | 43473013 | 43473118 | Human |
329830825 | LOC130065905 | ATAC-STARR-seq lymphoblastoid silent region 12926 | 20 | 43507578 | 43507907 | Human |
1344736 | L3MBTL1 | L3MBTL histone methyl-lysine binding protein 1 | 20 | 43507697 | 43550954 | Human |
329821323 | LOC130065906 | ATAC-STARR-seq lymphoblastoid silent region 12927 | 20 | 43514774 | 43514863 | Human |
38658911 | LOC107985380 | transmembrane protein 14C-like | 20 | 43523244 | 43523572 | Human |
329337921 | LOC129664623 | ReSE screen-validated silencer GRCh37_chr20:42173308-42173524 | 20 | 43544668 | 43544884 | Human |
1347154 | SGK2 | serum/glucocorticoid regulated kinase 2 | 20 | 43559027 | 43585627 | Human |
1322228 | IFT52 | intraflagellar transport 52 | 20 | 43590937 | 43647299 | Human |
329822074 | LOC130065907 | ATAC-STARR-seq lymphoblastoid active region 17904 | 20 | 43591059 | 43591128 | Human |
155781526 | LOC127893369 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42236005-42236846 | 20 | 43607365 | 43608206 | Human |
329341375 | LOC129664624 | ReSE screen-validated silencer GRCh37_chr20:42266543-42266756 | 20 | 43637903 | 43638116 | Human |
1347451 | RPL27AP | ribosomal protein L27a pseudogene | 20 | 43652504 | 43653332 | Human |
151669505 | LOC124904906 | uncharacterized LOC124904906 | 20 | 43653923 | 43656426 | Human |
155764361 | LOC127893370 | H3K27ac hESC enhancer GRCh37_chr20:42285347-42285942 | 20 | 43656707 | 43657302 | Human |
329841381 | LOC130065908 | ATAC-STARR-seq lymphoblastoid active region 17905 | 20 | 43657625 | 43657764 | Human |
149735389 | LOC121853006 | Sharpr-MPRA regulatory region 2194 | 20 | 43666909 | 43667319 | Human |
1318263 | MYBL2 | MYB proto-oncogene like 2 | 20 | 43667114 | 43716482 | Human |
329837939 | LOC130065909 | ATAC-STARR-seq lymphoblastoid active region 17906 | 20 | 43667970 | 43668019 | Human |
329820218 | LOC130065910 | ATAC-STARR-seq lymphoblastoid active region 17907 | 20 | 43710112 | 43710241 | Human |
329816630 | LOC130065911 | ATAC-STARR-seq lymphoblastoid active region 17908 | 20 | 43711082 | 43711151 | Human |
329343995 | LOC129391179 | MPRA-validated peak4221 silencer | 20 | 43720415 | 43720615 | Human |
329823000 | LOC130065912 | ATAC-STARR-seq lymphoblastoid active region 17909 | 20 | 43722335 | 43722404 | Human |
1314719 | GTSF1L | gametocyte specific factor 1 like | 20 | 43726164 | 43727002 | Human |
38643355 | LOC101927200 | uncharacterized LOC101927200 | 20 | 43728919 | 43820895 | Human |
155770647 | LOC127893372 | H3K4me1 hESC enhancer GRCh37_chr20:42374309-42375128 | 20 | 43745669 | 43746488 | Human |
329842457 | LOC130065913 | ATAC-STARR-seq lymphoblastoid silent region 12930 | 20 | 43749864 | 43750023 | Human |
329819164 | LOC130065914 | ATAC-STARR-seq lymphoblastoid active region 17910 | 20 | 43751463 | 43751662 | Human |
329830323 | LOC130065915 | ATAC-STARR-seq lymphoblastoid active region 17911 | 20 | 43751853 | 43751922 | Human |
329815206 | LOC130065916 | ATAC-STARR-seq lymphoblastoid active region 17912 | 20 | 43752423 | 43752502 | Human |
155772444 | LOC127893373 | H3K4me1 hESC enhancer GRCh37_chr20:42394850-42395350 | 20 | 43766210 | 43766710 | Human |
155760525 | LOC127893374 | H3K4me1 hESC enhancer GRCh37_chr20:42395351-42395851 | 20 | 43766711 | 43767211 | Human |
10399036 | RNU6-639P | RNA, U6 small nuclear 639, pseudogene | 20 | 43796437 | 43796543 | Human |
329838655 | LOC130065917 | ATAC-STARR-seq lymphoblastoid active region 17913 | 20 | 43799279 | 43799378 | Human |
329827260 | LOC130065918 | ATAC-STARR-seq lymphoblastoid active region 17914 | 20 | 43799389 | 43799528 | Human |
155767896 | LOC127893375 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42443361-42443974 | 20 | 43814721 | 43815334 | Human |
38664198 | LOC105372625 | uncharacterized LOC105372625 | 20 | 43820678 | 43824925 | Human |
329830621 | LOC130065919 | ATAC-STARR-seq lymphoblastoid active region 17915 | 20 | 43825619 | 43825728 | Human |
151676177 | LOC124904907 | uncharacterized LOC124904907 | 20 | 43865640 | 43868815 | Human |
151671399 | LOC124904908 | uncharacterized LOC124904908 | 20 | 43883620 | 43885505 | Human |
11562548 | LINC01728 | long intergenic non-protein coding RNA 1728 | 20 | 43894718 | 43895468 | Human |
155759815 | LOC127893376 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42543229-42543946 | 20 | 43914503 | 43915306 | Human |
1350992 | TOX2 | TOX high mobility group box family member 2 | 20 | 43914852 | 44069616 | Human |
155767700 | LOC127893377 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42543947-42544664 | 20 | 43915307 | 43916024 | Human |
329821982 | LOC130065920 | ATAC-STARR-seq lymphoblastoid silent region 12935 | 20 | 43916163 | 43916222 | Human |
329826924 | LOC130065921 | ATAC-STARR-seq lymphoblastoid silent region 12936 | 20 | 43916283 | 43916332 | Human |
329840572 | LOC130065922 | ATAC-STARR-seq lymphoblastoid active region 17916 | 20 | 43917403 | 43917462 | Human |
155758490 | LOC127893378 | H3K4me1 hESC enhancer GRCh37_chr20:42564724-42565224 | 20 | 43936084 | 43936584 | Human |
152975908 | LOC125387274 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:41614665-41615864 | 20 | 42986025 | 42987224 | Human |
155752459 | LOC127893314 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:37432653-37433515 | 20 | 38804010 | 38804872 | Human |
155227217 | LOC126863027 | BRD4-independent group 4 enhancer GRCh37_chr20:37736157-37737356 | 20 | 39107514 | 39108713 | Human |
155759873 | LOC127893333 | H3K27ac hESC enhancer GRCh37_chr20:38614432-38615135 | 20 | 39985790 | 39986493 | Human |
155755930 | LOC127893338 | H3K4me1 hESC enhancer GRCh37_chr20:39061739-39062240 | 20 | 40433099 | 40433600 | Human |
155772696 | LOC127893340 | H3K4me1 hESC enhancer GRCh37_chr20:39135315-39135826 | 20 | 40506675 | 40507186 | Human |
38635349 | LOC101927098 | uncharacterized LOC101927098 | 20 | 40696849 | 40717430 | Human |
155762923 | LOC127893344 | H3K27ac hESC enhancer GRCh37_chr20:39391384-39391884 | 20 | 40762744 | 40763244 | Human |
155776956 | LOC127893352 | H3K4me1 hESC enhancer GRCh37_chr20:39786713-39787233 | 20 | 41158073 | 41158593 | Human |
16552654 | NEFHP2 | NEFH pseudogene 2 | 20 | 41996935 | 41999447 | Human |
155772244 | LOC127893371 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42306550-42307240 | 20 | 43677910 | 43678600 | Human |
155772617 | LOC127893379 | H3K4me1 hESC enhancer GRCh37_chr20:42565225-42565725 | 20 | 43936585 | 43937085 | Human |
155770061 | LOC127893380 | H3K27ac hESC enhancer GRCh37_chr20:42571264-42571764 | 20 | 43942624 | 43943175 | Human |
329838192 | LOC130065923 | ATAC-STARR-seq lymphoblastoid active region 17918 | 20 | 43950575 | 43950664 | Human |
155227137 | LOC126863033 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:42583279-42584478 | 20 | 43954639 | 43955838 | Human |
155769456 | LOC127893381 | H3K27ac hESC enhancer GRCh37_chr20:42584612-42585246 | 20 | 43955972 | 43956606 | Human |
38670577 | LOC112694714 | Sharpr-MPRA regulatory region 6747 | 20 | 43959269 | 43959563 | Human |
329822308 | LOC130065924 | ATAC-STARR-seq lymphoblastoid active region 17920 | 20 | 43964224 | 43964303 | Human |
329841785 | LOC130065925 | ATAC-STARR-seq lymphoblastoid silent region 12937 | 20 | 43988498 | 43988577 | Human |
155777348 | LOC127893382 | H3K4me1 hESC enhancer GRCh37_chr20:42634840-42635340 | 20 | 44006200 | 44006700 | Human |
10413704 | RN7SL443P | RNA, 7SL, cytoplasmic 443, pseudogene | 20 | 44007248 | 44007537 | Human |
329817541 | LOC130065926 | ATAC-STARR-seq lymphoblastoid silent region 12938 | 20 | 44056167 | 44056276 | Human |
155759271 | LOC127893383 | H3K4me1 hESC enhancer GRCh37_chr20:42696545-42697061 | 20 | 44067905 | 44068421 | Human |
38618815 | LOC112694715 | Sharpr-MPRA regulatory region 7745 | 20 | 44089989 | 44090283 | Human |
1313081 | JPH2 | junctophilin 2 | 20 | 44106590 | 44187188 | Human |
155778943 | LOC127893384 | H3K4me1 hESC enhancer GRCh37_chr20:42739928-42740441 | 20 | 44111288 | 44111801 | Human |
149735385 | LOC121853007 | Sharpr-MPRA regulatory region 3924 | 20 | 44116649 | 44116943 | Human |
151674672 | LOC124904909 | uncharacterized LOC124904909 | 20 | 44151918 | 44158520 | Human |
38666595 | LOC108353820 | JPH2 intron CAGE-defined T cell enhancer | 20 | 44153318 | 44154567 | Human |
329340440 | LOC129664625 | ReSE screen-validated silencer GRCh37_chr20:42795218-42795478 | 20 | 44166578 | 44166838 | Human |
155772356 | LOC127893386 | H3K27ac hESC enhancer GRCh37_chr20:42809003-42809909 | 20 | 44180363 | 44181269 | Human |
155750617 | LOC127893387 | H3K4me1 hESC enhancer GRCh37_chr20:42810816-42811722 | 20 | 44182176 | 44183082 | Human |
1350756 | OSER1 | oxidative stress responsive serine rich 1 | 20 | 44195939 | 44211810 | Human |
155229939 | LOC126863034 | MED14-independent group 3 enhancer GRCh37_chr20:42832370-42833569 | 20 | 44203730 | 44204929 | Human |
155757387 | LOC127893388 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42838821-42839440 | 20 | 44210181 | 44211173 | Human |
329838584 | LOC130065927 | ATAC-STARR-seq lymphoblastoid silent region 12940 | 20 | 44215221 | 44215310 | Human |
155762506 | LOC127893389 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42860439-42861068 | 20 | 44231799 | 44232428 | Human |
155761135 | LOC127893390 | H3K4me1 hESC enhancer GRCh37_chr20:42875650-42876448 | 20 | 44247010 | 44247808 | Human |
1312703 | GDAP1L1 | ganglioside induced differentiation associated protein 1 like 1 | 20 | 44247099 | 44280947 | Human |
38670733 | LOC113960609 | Sharpr-MPRA regulatory region 13448 | 20 | 44248169 | 44248463 | Human |
155771628 | LOC127893391 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:42900885-42901394 | 20 | 44272245 | 44272754 | Human |
152975881 | LOC125387275 | Sharpr-MPRA regulatory region 2613 | 20 | 44274389 | 44274683 | Human |
151671534 | LOC124904910 | uncharacterized LOC124904910 | 20 | 44287726 | 44291355 | Human |
1317034 | FITM2 | fat storage inducing transmembrane protein 2 | 20 | 44302840 | 44311202 | Human |
155761562 | LOC127893392 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42938689-42939418 | 20 | 44310049 | 44310814 | Human |
155756324 | LOC127893393 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42939419-42940148 | 20 | 44310779 | 44311508 | Human |
155763862 | LOC127893394 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:42952746-42953298 | 20 | 44324106 | 44324658 | Human |
155778699 | LOC127893395 | H3K4me1 hESC enhancer GRCh37_chr20:42962599-42963110 | 20 | 44333959 | 44334470 | Human |
155779392 | LOC127893396 | H3K4me1 hESC enhancer GRCh37_chr20:42964365-42965354 | 20 | 44335725 | 44336714 | Human |
1313241 | R3HDML | R3H domain containing like | 20 | 44337043 | 44351238 | Human |
155779323 | LOC127893397 | H3K4me1 hESC enhancer GRCh37_chr20:42981671-42982170 | 20 | 44353031 | 44353530 | Human |
69093 | HNF4A | hepatocyte nuclear factor 4 alpha | 20 | 44355699 | 44434596 | Human |
7778165 | HNF4A-AS1 | HNF4A antisense RNA 1 | 20 | 44356744 | 44395706 | Human |
329822168 | LOC130065928 | ATAC-STARR-seq lymphoblastoid active region 17923 | 20 | 44388450 | 44388539 | Human |
155765141 | LOC127893398 | H3K4me1 hESC enhancer GRCh37_chr20:43017550-43018051 | 20 | 44388910 | 44389411 | Human |
4888851 | MIR3646 | microRNA 3646 | 20 | 44408120 | 44408203 | Human |
8662068 | LINC01430 | long intergenic non-protein coding RNA 1430 | 20 | 44448777 | 44450557 | Human |
1348821 | LINC01620 | long intergenic non-protein coding RNA 1620 | 20 | 44451984 | 44465344 | Human |
1345901 | RPL37AP1 | ribosomal protein L37a pseudogene 1 | 20 | 44466503 | 44466873 | Human |
329820706 | LOC130065929 | ATAC-STARR-seq lymphoblastoid active region 17924 | 20 | 44475670 | 44475759 | Human |
329837331 | LOC130065930 | ATAC-STARR-seq lymphoblastoid silent region 12941 | 20 | 44475850 | 44475979 | Human |
1313976 | TTPAL | alpha tocopherol transfer protein like | 20 | 44475874 | 44494603 | Human |
329820433 | LOC130065931 | ATAC-STARR-seq lymphoblastoid active region 17925 | 20 | 44489995 | 44490104 | Human |
1318130 | SERINC3 | serine incorporator 3 | 20 | 44496221 | 44522070 | Human |
155776589 | LOC127893399 | H3K27ac hESC enhancer GRCh37_chr20:43149922-43150474 | 20 | 44521281 | 44521833 | Human |
38661161 | LOC112694716 | Sharpr-MPRA regulatory region 7879 | 20 | 44521752 | 44522262 | Human |
155767792 | LOC127893400 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:43152936-43153812 | 20 | 44524295 | 44525171 | Human |
155781662 | LOC127893401 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:43154689-43155564 | 20 | 44526048 | 44526923 | Human |
155753770 | LOC127893402 | H3K4me1 hESC enhancer GRCh37_chr20:43160105-43160605 | 20 | 44531464 | 44532202 | Human |
1350390 | PKIG | cAMP-dependent protein kinase inhibitor gamma | 20 | 44531875 | 44619037 | Human |
329835951 | LOC130065932 | ATAC-STARR-seq lymphoblastoid active region 17927 | 20 | 44579520 | 44579659 | Human |
329817476 | LOC130065933 | ATAC-STARR-seq lymphoblastoid active region 17928 | 20 | 44594812 | 44594921 | Human |
329845135 | LOC130065934 | ATAC-STARR-seq lymphoblastoid active region 17929 | 20 | 44594952 | 44595061 | Human |
155777402 | LOC127893403 | H3K4me1 hESC enhancer GRCh37_chr20:43226219-43226966 | 20 | 44597578 | 44598325 | Human |
155753888 | LOC127893405 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:43237694-43238268 | 20 | 44609053 | 44609627 | Human |
329813320 | LOC130065935 | ATAC-STARR-seq lymphoblastoid active region 17930 | 20 | 44610385 | 44610454 | Human |
329817910 | LOC130065936 | ATAC-STARR-seq lymphoblastoid active region 17931 | 20 | 44610505 | 44610604 | Human |
329845136 | LOC130065937 | ATAC-STARR-seq lymphoblastoid active region 17932 | 20 | 44610635 | 44610694 | Human |
329841743 | LOC130065938 | ATAC-STARR-seq lymphoblastoid active region 17933 | 20 | 44615750 | 44615879 | Human |
155751850 | LOC127893406 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:43246415-43247142 | 20 | 44617774 | 44618501 | Human |
736149 | ADA | adenosine deaminase | 20 | 44619522 | 44651699 | Human |
38609683 | LOC107303343 | adenosine deaminase intronic regulatory elements | 20 | 44629004 | 44652471 | Human |
38649790 | LOC108167311 | proximal ADA Alu-mediated recombination region | 20 | 44649731 | 44650034 | Human |
38631417 | LOC108167312 | distal ADA Alu-mediated recombination region | 20 | 44652981 | 44653289 | Human |
9586216 | LINC01260 | long intergenic non-protein coding RNA 1260 | 20 | 44656451 | 44671739 | Human |
155763902 | LOC127893407 | H3K27ac hESC enhancer GRCh37_chr20:43299119-43299620 | 20 | 44670478 | 44670979 | Human |
155773148 | LOC127893408 | H3K27ac hESC enhancer GRCh37_chr20:43299621-43300120 | 20 | 44670980 | 44671479 | Human |
155773558 | LOC127893409 | H3K27ac hESC enhancer GRCh37_chr20:43306608-43307108 | 20 | 44677967 | 44678467 | Human |
155757261 | LOC127893410 | H3K27ac hESC enhancer GRCh37_chr20:43307109-43307609 | 20 | 44678468 | 44678968 | Human |
329825929 | LOC130065939 | ATAC-STARR-seq lymphoblastoid silent region 12945 | 20 | 44683587 | 44683646 | Human |
329814081 | LOC130065940 | ATAC-STARR-seq lymphoblastoid silent region 12946 | 20 | 44685248 | 44685367 | Human |
329823331 | LOC130065941 | ATAC-STARR-seq lymphoblastoid silent region 12947 | 20 | 44696470 | 44696519 | Human |
329820442 | LOC130065942 | ATAC-STARR-seq lymphoblastoid active region 17939 | 20 | 44697210 | 44697259 | Human |
329820502 | LOC130065943 | ATAC-STARR-seq lymphoblastoid active region 17940 | 20 | 44702797 | 44702876 | Human |
151672485 | LOC124904911 | uncharacterized LOC124904911 | 20 | 44708403 | 44714774 | Human |
10059043 | KCNK15-AS1 | KCNK15 and WISP2 antisense RNA 1 | 20 | 44711862 | 44746227 | Human |
152975921 | LOC125387276 | Sharpr-MPRA regulatory region 14821 | 20 | 44714668 | 44714962 | Human |
1351496 | CCN5 | cellular communication network factor 5 | 20 | 44714861 | 44727811 | Human |
155781402 | LOC127893411 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:43355350-43355875 | 20 | 44726709 | 44727234 | Human |
1345243 | KCNK15 | potassium two pore domain channel subfamily K member 15 | 20 | 44745865 | 44752313 | Human |
1350639 | RIMS4 | regulating synaptic membrane exocytosis 4 | 20 | 44751808 | 44810546 | Human |
155750602 | LOC127893412 | H3K4me1 hESC enhancer GRCh37_chr20:43380582-43381129 | 20 | 44751941 | 44752488 | Human |
155227334 | LOC126863036 | BRD4-independent group 4 enhancer GRCh37_chr20:43385377-43386576 | 20 | 44756736 | 44757935 | Human |
155772845 | LOC127893413 | H3K27ac hESC enhancer GRCh37_chr20:43401277-43401777 | 20 | 44772636 | 44773136 | Human |
6769313 | PGBD4P2 | piggyBac transposable element derived 4 pseudogene 2 | 20 | 44841651 | 44842590 | Human |
329843983 | LOC130065944 | ATAC-STARR-seq lymphoblastoid silent region 12948 | 20 | 44885329 | 44885388 | Human |
155775764 | LOC127893414 | H3K27ac hESC enhancer GRCh37_chr20:43514076-43514692 | 20 | 44885435 | 44886051 | Human |
737527 | YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta | 20 | 44885705 | 44908532 | Human |
329828378 | LOC130065945 | ATAC-STARR-seq lymphoblastoid silent region 12950 | 20 | 44909914 | 44910243 | Human |
1346773 | PABPC1L | poly(A) binding protein cytoplasmic 1 like | 20 | 44910060 | 44939316 | Human |
155772099 | LOC127893415 | H3K4me1 hESC enhancer GRCh37_chr20:43545042-43545542 | 20 | 44916401 | 44916901 | Human |
155754397 | LOC127893416 | H3K4me1 hESC enhancer GRCh37_chr20:43545543-43546043 | 20 | 44916902 | 44917402 | Human |
1319142 | TOMM34 | translocase of outer mitochondrial membrane 34 | 20 | 44942130 | 44960397 | Human |
151674327 | LOC124904912 | uncharacterized LOC124904912 | 20 | 44955216 | 44959537 | Human |
329832860 | LOC130065946 | ATAC-STARR-seq lymphoblastoid active region 17941 | 20 | 44959326 | 44959415 | Human |
329822777 | LOC130065947 | ATAC-STARR-seq lymphoblastoid active region 17942 | 20 | 44960196 | 44960245 | Human |
329836946 | LOC130065948 | ATAC-STARR-seq lymphoblastoid active region 17943 | 20 | 44960256 | 44960345 | Human |
329825898 | LOC130065949 | ATAC-STARR-seq lymphoblastoid silent region 12951 | 20 | 44960576 | 44960655 | Human |
6480334 | STK4-DT | STK4 divergent transcript | 20 | 44963794 | 44966458 | Human |
329843843 | LOC130065950 | ATAC-STARR-seq lymphoblastoid silent region 12952 | 20 | 44966337 | 44966586 | Human |
1323808 | STK4 | serine/threonine kinase 4 | 20 | 44966512 | 45080021 | Human |
329817216 | LOC130065951 | ATAC-STARR-seq lymphoblastoid active region 17944 | 20 | 44967727 | 44967806 | Human |
329828034 | LOC130065952 | ATAC-STARR-seq lymphoblastoid silent region 12953 | 20 | 44968267 | 44968396 | Human |
329821749 | LOC130065953 | ATAC-STARR-seq lymphoblastoid silent region 12954 | 20 | 45051830 | 45051899 | Human |
735720 | KCNS1 | potassium voltage-gated channel modifier subfamily S member 1 | 20 | 45091214 | 45101127 | Human |
1312741 | WFDC5 | WAP four-disulfide core domain 5 | 20 | 45109463 | 45116319 | Human |
155758464 | LOC127893417 | H3K4me1 hESC enhancer GRCh37_chr20:43743251-43743752 | 20 | 45114610 | 45115111 | Human |
155777249 | LOC127893418 | H3K4me1 hESC enhancer GRCh37_chr20:43743753-43744252 | 20 | 45115112 | 45115611 | Human |
1349049 | WFDC12 | WAP four-disulfide core domain 12 | 20 | 45123425 | 45124465 | Human |
38613492 | LOC101929863 | uncharacterized LOC101929863 | 20 | 45137438 | 45139029 | Human |
329824472 | LOC130065954 | ATAC-STARR-seq lymphoblastoid active region 17945 | 20 | 45138843 | 45138902 | Human |
155228610 | LOC126863037 | BRD4-independent group 4 enhancer GRCh37_chr20:43803133-43804332 | 20 | 45174492 | 45175691 | Human |
1344308 | PI3 | peptidase inhibitor 3 | 20 | 45174902 | 45176544 | Human |
13708587 | LINC02597 | long intergenic non-protein coding RNA 2597 | 20 | 45179987 | 45190904 | Human |
1349203 | SEMG1 | semenogelin 1 | 20 | 45207033 | 45209768 | Human |
1345967 | SEMG2 | semenogelin 2 | 20 | 45221373 | 45224458 | Human |
38650088 | LOC105372630 | uncharacterized LOC105372630 | 20 | 45230837 | 45290352 | Human |
151669185 | LOC124904913 | uncharacterized LOC124904913 | 20 | 45239368 | 45249048 | Human |
1350976 | SLPI | secretory leukocyte peptidase inhibitor | 20 | 45252239 | 45254564 | Human |
1320229 | MATN4 | matrilin 4 | 20 | 45293450 | 45308684 | Human |
329825670 | LOC130065955 | ATAC-STARR-seq lymphoblastoid silent region 12955 | 20 | 45293828 | 45293887 | Human |
1312429 | RBPJL | recombination signal binding protein for immunoglobulin kappa J region like | 20 | 45306840 | 45317824 | Human |
329827132 | LOC130065956 | ATAC-STARR-seq lymphoblastoid silent region 12956 | 20 | 45311623 | 45311672 | Human |
329826087 | LOC130065957 | ATAC-STARR-seq lymphoblastoid active region 17946 | 20 | 45321281 | 45321330 | Human |
2300500 | TRV-CAC14-1 | tRNA-Val (anticodon CAC) 14-1 | 20 | 45322361 | 45322433 | Human |
730877 | SDC4 | syndecan 4 | 20 | 45325288 | 45348424 | Human |
155782141 | LOC127893419 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:43971073-43971967 | 20 | 45342433 | 45343327 | Human |
1602841 | SYS1 | SYS1 golgi trafficking protein | 20 | 45361949 | 45376798 | Human |
151676256 | LOC124904914 | uncharacterized LOC124904914 | 20 | 45362356 | 45363368 | Human |
329839348 | LOC130065958 | ATAC-STARR-seq lymphoblastoid active region 17947 | 20 | 45362886 | 45363325 | Human |
1642399 | SYS1-DBNDD2 | SYS1-DBNDD2 readthrough (NMD candidate) | 20 | 45363169 | 45410610 | Human |
329814265 | LOC130065959 | ATAC-STARR-seq lymphoblastoid active region 17948 | 20 | 45368218 | 45368267 | Human |
329817852 | LOC130065960 | ATAC-STARR-seq lymphoblastoid silent region 12957 | 20 | 45368768 | 45368857 | Human |
329817945 | LOC130065961 | ATAC-STARR-seq lymphoblastoid active region 17949 | 20 | 45368928 | 45368987 | Human |
1350426 | TP53TG5 | TP53 target 5 | 20 | 45372557 | 45378325 | Human |
329835682 | LOC130065962 | ATAC-STARR-seq lymphoblastoid active region 17950 | 20 | 45373343 | 45373402 | Human |
10450457 | NDUFB4P10 | NADH:ubiquinone oxidoreductase subunit B4 pseudogene 10 | 20 | 45388347 | 45388705 | Human |
38622596 | LOC107985404 | uncharacterized LOC107985404 | 20 | 45394488 | 45407889 | Human |
1313063 | DBNDD2 | dysbindin domain containing 2 | 20 | 45405993 | 45410610 | Human |
155756801 | LOC127893420 | H3K4me1 hESC enhancer GRCh37_chr20:44035517-44036066 | 20 | 45406877 | 45407426 | Human |
38635917 | LOC107985405 | uncharacterized LOC107985405 | 20 | 45410575 | 45418383 | Human |
1316180 | PIGT | phosphatidylinositol glycan anchor biosynthesis class T | 20 | 45416141 | 45426241 | Human |
329834180 | LOC130065963 | ATAC-STARR-seq lymphoblastoid active region 17951 | 20 | 45419610 | 45419669 | Human |
8551171 | MIR6812 | microRNA 6812 | 20 | 45425510 | 45425573 | Human |
38663282 | LOC105372631 | uncharacterized LOC105372631 | 20 | 45427422 | 45448581 | Human |
1344525 | WFDC2 | WAP four-disulfide core domain 2 | 20 | 45469753 | 45481532 | Human |
329817115 | LOC130065964 | ATAC-STARR-seq lymphoblastoid silent region 12958 | 20 | 45470418 | 45470607 | Human |
329824230 | LOC130065965 | ATAC-STARR-seq lymphoblastoid silent region 12959 | 20 | 45470628 | 45470677 | Human |
38606903 | LOC107987282 | uncharacterized LOC107987282 | 20 | 45487612 | 45540387 | Human |
1353947 | RPL5P2 | ribosomal protein L5 pseudogene 2 | 20 | 45490818 | 45491671 | Human |
1353929 | SPINT3 | serine peptidase inhibitor, Kunitz type 3 | 20 | 45512461 | 45515622 | Human |
1352143 | WFDC6 | WAP four-disulfide core domain 6 | 20 | 45534196 | 45539482 | Human |
5013870 | EPPIN-WFDC6 | EPPIN-WFDC6 readthrough | 20 | 45536280 | 45547401 | Human |
3028761 | HSPD1P21 | heat shock protein family D (Hsp60) member 1 pseudogene 21 | 20 | 45539975 | 45540286 | Human |
1315316 | EPPIN | epididymal peptidase inhibitor | 20 | 45540626 | 45547401 | Human |
1347537 | WFDC8 | WAP four-disulfide core domain 8 | 20 | 45551152 | 45579284 | Human |
6481662 | RNA5SP485 | RNA, 5S ribosomal pseudogene 485 | 20 | 45559758 | 45559876 | Human |
5488936 | CCNB1IP1P2 | cyclin B1 interacting protein 1 pseudogene 2 | 20 | 45567804 | 45569007 | Human |
155769126 | LOC127893421 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44206738-44207673 | 20 | 45578099 | 45579034 | Human |
1350341 | WFDC9 | WAP four-disulfide core domain 9 | 20 | 45607939 | 45631284 | Human |
1315782 | WFDC10A | WAP four-disulfide core domain 10A | 20 | 45629739 | 45631196 | Human |
1352846 | RPS2P7 | ribosomal protein S2 pseudogene 7 | 20 | 45640452 | 45641393 | Human |
1351256 | WFDC11 | WAP four-disulfide core domain 11 | 20 | 45648563 | 45670239 | Human |
1343114 | WFDC10B | WAP four-disulfide core domain 10B | 20 | 45684651 | 45705019 | Human |
1352525 | WFDC13 | WAP four-disulfide core domain 13 | 20 | 45702038 | 45708817 | Human |
4888778 | MIR3617 | microRNA 3617 | 20 | 45705102 | 45705180 | Human |
1603467 | SPINT4 | serine peptidase inhibitor, Kunitz type 4 | 20 | 45722347 | 45725830 | Human |
1354354 | HNRNPA1P3 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 3 | 20 | 45745374 | 45746204 | Human |
1343963 | SPINT5P | serine peptidase inhibitor, Kunitz type 5, pseudogene | 20 | 45749920 | 45750074 | Human |
151670289 | LOC124904915 | uncharacterized LOC124904915 | 20 | 45762061 | 45767580 | Human |
155763046 | LOC127893422 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44391506-44392438 | 20 | 45762867 | 45763799 | Human |
155771370 | LOC127893423 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:44393372-44394304 | 20 | 45764733 | 45765665 | Human |
155752977 | LOC127893424 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:44394305-44395236 | 20 | 45765666 | 45766597 | Human |
155768385 | LOC127893425 | H3K27ac hESC enhancer GRCh37_chr20:44399706-44400299 | 20 | 45771067 | 45771660 | Human |
155775607 | LOC127893426 | H3K27ac hESC enhancer GRCh37_chr20:44400300-44400892 | 20 | 45771661 | 45772253 | Human |
1313240 | WFDC3 | WAP four-disulfide core domain 3 | 20 | 45774213 | 45791883 | Human |
401826304 | LOC132090577 | Neanderthal introgressed variant-containing enhancer experimental_60389 | 20 | 45775577 | 45775746 | Human |
127284917 | LOC121627906 | Sharpr-MPRA regulatory region 12827 | 20 | 45777950 | 45778244 | Human |
10399272 | RNU6ATAC38P | RNA, U6atac small nuclear 38, pseudogene | 20 | 45778698 | 45778822 | Human |
155773038 | LOC127893427 | H3K4me1 hESC enhancer GRCh37_chr20:44408579-44409079 | 20 | 45779940 | 45780440 | Human |
152975915 | LOC125387277 | Sharpr-MPRA regulatory region 6194 | 20 | 45781290 | 45781584 | Human |
401824853 | LOC132090578 | Neanderthal introgressed variant-containing enhancer experimental_60411 | 20 | 45783843 | 45784012 | Human |
1322651 | DNTTIP1 | deoxynucleotidyltransferase terminal interacting protein 1 | 20 | 45791954 | 45811418 | Human |
329841789 | LOC130065966 | ATAC-STARR-seq lymphoblastoid silent region 12960 | 20 | 45792037 | 45792306 | Human |
329837452 | LOC130065967 | ATAC-STARR-seq lymphoblastoid silent region 12961 | 20 | 45792517 | 45792656 | Human |
401826415 | LOC132090579 | Neanderthal introgressed variant-containing enhancer experimental_60428 | 20 | 45810250 | 45810419 | Human |
329830479 | LOC130065968 | ATAC-STARR-seq lymphoblastoid silent region 12962 | 20 | 45812447 | 45812636 | Human |
1313378 | UBE2C | ubiquitin conjugating enzyme E2 C | 20 | 45812644 | 45816952 | Human |
155773531 | LOC127893428 | H3K27ac hESC enhancer GRCh37_chr20:44447254-44447902 | 20 | 45818615 | 45819263 | Human |
155765302 | LOC127893429 | H3K27ac hESC enhancer GRCh37_chr20:44449199-44449846 | 20 | 45820560 | 45821207 | Human |
1323707 | TNNC2 | troponin C2, fast skeletal type | 20 | 45823214 | 45833306 | Human |
329823360 | LOC130065969 | ATAC-STARR-seq lymphoblastoid silent region 12963 | 20 | 45833843 | 45834152 | Human |
329820063 | LOC130065970 | ATAC-STARR-seq lymphoblastoid silent region 12964 | 20 | 45834173 | 45834292 | Human |
329833247 | LOC130065971 | ATAC-STARR-seq lymphoblastoid silent region 12965 | 20 | 45834333 | 45834382 | Human |
155758782 | LOC127893430 | H3K4me1 hESC enhancer GRCh37_chr20:44468841-44469394 | 20 | 45840202 | 45840755 | Human |
70372 | ACOT8 | acyl-CoA thioesterase 8 | 20 | 45841721 | 45857392 | Human |
155762201 | LOC127893431 | H3K4me1 hESC enhancer GRCh37_chr20:44470503-44471055 | 20 | 45841864 | 45842416 | Human |
329343675 | LOC129391180 | MPRA-validated peak4224 silencer | 20 | 45849327 | 45849527 | Human |
155760516 | LOC127893432 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44482305-44482834 | 20 | 45853666 | 45854195 | Human |
155754665 | LOC127893433 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44482835-44483364 | 20 | 45854196 | 45854725 | Human |
155760492 | LOC127893434 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44483365-44483894 | 20 | 45854726 | 45855255 | Human |
1320317 | ZSWIM3 | zinc finger SWIM-type containing 3 | 20 | 45857614 | 45879122 | Human |
1313910 | ZSWIM1 | zinc finger SWIM-type containing 1 | 20 | 45880920 | 45885266 | Human |
329843413 | LOC130065972 | ATAC-STARR-seq lymphoblastoid active region 17952 | 20 | 45880937 | 45880986 | Human |
329830500 | LOC130065973 | ATAC-STARR-seq lymphoblastoid active region 17953 | 20 | 45881237 | 45881316 | Human |
155759248 | LOC127893435 | H3K4me1 hESC enhancer GRCh37_chr20:44514972-44515472 | 20 | 45886333 | 45886833 | Human |
1351206 | SPATA25 | spermatogenesis associated 25 | 20 | 45886491 | 45891016 | Human |
155765875 | LOC127893385 | H3K4me1 hESC enhancer GRCh37_chr20:42806021-42806521 | 20 | 44177381 | 44177881 | Human |
7255666 | OSER1-DT | OSER1 divergent transcript | 20 | 44210960 | 44226027 | Human |
329337418 | LOC129664626 | ReSE screen-validated silencer GRCh37_chr20:43405721-43405858 | 20 | 44777080 | 44777217 | Human |
38632365 | R3HDML-AS1 | R3HDML antisense RNA 1 | 20 | 44347552 | 44355242 | Human |
155227921 | LOC126863035 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:43124829-43126028 | 20 | 44496188 | 44497387 | Human |
155766840 | LOC127893404 | H3K4me1 hESC enhancer GRCh37_chr20:43229479-43229980 | 20 | 44600838 | 44601339 | Human |
1322486 | SNX21 | sorting nexin family member 21 | 20 | 45833799 | 45843276 | Human |
1315006 | NEURL2 | neuralized E3 ubiquitin protein ligase 2 | 20 | 45888634 | 45891208 | Human |
155771736 | LOC127893437 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44519312-44520021 | 20 | 45890673 | 45891581 | Human |
1319205 | CTSA | cathepsin A | 20 | 45891335 | 45898820 | Human |
329832722 | LOC130065974 | ATAC-STARR-seq lymphoblastoid active region 17954 | 20 | 45891622 | 45891671 | Human |
1315460 | PLTP | phospholipid transfer protein | 20 | 45898620 | 45912155 | Human |
329340879 | LOC129664627 | ReSE screen-validated silencer GRCh37_chr20:44531171-44531366 | 20 | 45902532 | 45902727 | Human |
152975753 | LOC125387278 | Sharpr-MPRA regulatory region 14031 | 20 | 45924570 | 45924864 | Human |
149735438 | LOC121853008 | Sharpr-MPRA regulatory region 10402 | 20 | 45927310 | 45927604 | Human |
155767533 | LOC127893438 | H3K4me1 hESC enhancer GRCh37_chr20:44561248-44561940 | 20 | 45932609 | 45933301 | Human |
38639652 | LOC107985388 | pre-mRNA-splicing factor cwc22-like | 20 | 45933494 | 45935071 | Human |
329833352 | LOC130065975 | ATAC-STARR-seq lymphoblastoid active region 17955 | 20 | 45933584 | 45933733 | Human |
155763716 | LOC127893439 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44562632-44563323 | 20 | 45933993 | 45934684 | Human |
1321911 | PCIF1 | phosphorylated CTD interacting factor 1 | 20 | 45934683 | 45948020 | Human |
155759284 | LOC127893440 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44563324-44564014 | 20 | 45934685 | 45935375 | Human |
155757537 | LOC127893441 | H3K4me1 hESC enhancer GRCh37_chr20:44567204-44567719 | 20 | 45938565 | 45939080 | Human |
155779029 | LOC127893442 | H3K4me1 hESC enhancer GRCh37_chr20:44567720-44568234 | 20 | 45939081 | 45939595 | Human |
155227207 | LOC126863038 | MED14-independent group 3 enhancer GRCh37_chr20:44572602-44573801 | 20 | 45943963 | 45945162 | Human |
732123 | ZNF335 | zinc finger protein 335 | 20 | 45948660 | 45972203 | Human |
329813762 | LOC130065976 | ATAC-STARR-seq lymphoblastoid silent region 12968 | 20 | 45971715 | 45971834 | Human |
329827758 | LOC130065977 | ATAC-STARR-seq lymphoblastoid active region 17956 | 20 | 45972605 | 45972824 | Human |
1350618 | FTLP1 | ferritin light chain pseudogene 1 | 20 | 45975117 | 45976268 | Human |
155764557 | LOC127893443 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44603922-44604458 | 20 | 45975283 | 45975819 | Human |
155781198 | LOC127893444 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44624055-44624562 | 20 | 45995416 | 45995923 | Human |
155779971 | LOC127893445 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44632651-44633302 | 20 | 46004012 | 46004663 | Human |
155754477 | LOC127893446 | H3K27ac hESC enhancer GRCh37_chr20:44633303-44633954 | 20 | 46004664 | 46005315 | Human |
1348437 | MMP9 | matrix metallopeptidase 9 | 20 | 46008908 | 46016561 | Human |
155758096 | LOC127893447 | H3K4me1 hESC enhancer GRCh37_chr20:44640983-44641493 | 20 | 46012344 | 46012854 | Human |
13210604 | SLC12A5-AS1 | SLC12A5 and MMP9 antisense RNA 1 | 20 | 46013502 | 46022073 | Human |
329841420 | LOC130065978 | ATAC-STARR-seq lymphoblastoid silent region 12969 | 20 | 46014221 | 46014440 | Human |
155763973 | LOC127893436 | H3K4me1 hESC enhancer GRCh37_chr20:44515473-44515973 | 20 | 45886834 | 45887334 | Human |
329831944 | LOC130065979 | ATAC-STARR-seq lymphoblastoid silent region 12970 | 20 | 46021584 | 46021743 | Human |
731044 | SLC12A5 | solute carrier family 12 member 5 | 20 | 46021686 | 46060150 | Human |
329824661 | LOC130065980 | ATAC-STARR-seq lymphoblastoid silent region 12971 | 20 | 46021764 | 46022123 | Human |
38643319 | LOC113960610 | Sharpr-MPRA regulatory region 13245 | 20 | 46040910 | 46041204 | Human |
38623497 | LOC113960611 | Sharpr-MPRA regulatory region 3425 | 20 | 46057330 | 46057624 | Human |
1317043 | NCOA5 | nuclear receptor coactivator 5 | 20 | 46060991 | 46089962 | Human |
329839271 | LOC130065981 | ATAC-STARR-seq lymphoblastoid active region 17957 | 20 | 46064074 | 46064133 | Human |
155752738 | LOC127893448 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:44717073-44717887 | 20 | 46088434 | 46089248 | Human |
155776565 | LOC127893449 | H3K27ac hESC enhancer GRCh37_chr20:44717888-44718701 | 20 | 46089186 | 46090062 | Human |
329821197 | LOC130065982 | ATAC-STARR-seq lymphoblastoid active region 17959 | 20 | 46090076 | 46090125 | Human |
329844377 | LOC130065983 | ATAC-STARR-seq lymphoblastoid active region 17960 | 20 | 46099443 | 46099532 | Human |
1351579 | RPL13P2 | ribosomal protein L13 pseudogene 2 | 20 | 46099475 | 46100194 | Human |
329337758 | LOC129664628 | ReSE screen-validated silencer GRCh37_chr20:44731180-44731415 | 20 | 46102541 | 46102776 | Human |
329827985 | LOC130065984 | ATAC-STARR-seq lymphoblastoid active region 17961 | 20 | 46108396 | 46108715 | Human |
329842924 | LOC130065985 | ATAC-STARR-seq lymphoblastoid active region 17962 | 20 | 46108796 | 46108845 | Human |
155767712 | LOC127893450 | CRISPRi-FlowFISH-validated CD40 regulatory element GRCh37_chr20:44746135-44748232 | 20 | 46117496 | 46119593 | Human |
1604657 | CD40 | CD40 molecule | 20 | 46118314 | 46129858 | Human |
329820365 | LOC130065986 | ATAC-STARR-seq lymphoblastoid active region 17965 | 20 | 46120581 | 46120670 | Human |
329829535 | LOC130065987 | ATAC-STARR-seq lymphoblastoid active region 17966 | 20 | 46129920 | 46130069 | Human |
329835480 | LOC130065988 | ATAC-STARR-seq lymphoblastoid active region 17967 | 20 | 46133068 | 46133117 | Human |
155752064 | LOC127893451 | H3K4me1 hESC enhancer GRCh37_chr20:44781551-44782092 | 20 | 46152912 | 46153453 | Human |
732591 | CDH22 | cadherin 22 | 20 | 46173739 | 46308498 | Human |
329820545 | LOC130065989 | ATAC-STARR-seq lymphoblastoid silent region 12973 | 20 | 46174574 | 46174623 | Human |
151670645 | LOC124904916 | uncharacterized LOC124904916 | 20 | 46201127 | 46212772 | Human |
329818181 | LOC130065990 | ATAC-STARR-seq lymphoblastoid active region 17968 | 20 | 46206110 | 46206189 | Human |
152975873 | LOC125387279 | Sharpr-MPRA regulatory region 13247 | 20 | 46207950 | 46208244 | Human |
155773394 | LOC127893453 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44845561-44846096 | 20 | 46216922 | 46217457 | Human |
329342789 | LOC129391181 | MPRA-validated peak4226 silencer | 20 | 46231037 | 46231237 | Human |
155756847 | LOC127893454 | H3K4me1 hESC enhancer GRCh37_chr20:44886736-44887236 | 20 | 46258097 | 46258597 | Human |
155766426 | LOC127893455 | H3K4me1 hESC enhancer GRCh37_chr20:44928578-44929078 | 20 | 46299939 | 46300439 | Human |
155751816 | LOC127893456 | H3K4me1 hESC enhancer GRCh37_chr20:44929079-44929579 | 20 | 46300440 | 46300940 | Human |
329338993 | LOC129664629 | ReSE screen-validated silencer GRCh37_chr20:44932028-44932246 | 20 | 46303389 | 46303607 | Human |
329337897 | LOC129664630 | ReSE screen-validated silencer GRCh37_chr20:44952422-44952611 | 20 | 46323784 | 46323973 | Human |
155761368 | LOC127893458 | H3K4me1 hESC enhancer GRCh37_chr20:44966161-44966662 | 20 | 46337523 | 46338024 | Human |
1322607 | SLC35C2 | solute carrier family 35 member C2 | 20 | 46345984 | 46364425 | Human |
152975838 | LOC125387280 | Sharpr-MPRA regulatory region 3506 | 20 | 46350870 | 46351164 | Human |
155776150 | LOC127893459 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44979919-44980510 | 20 | 46351280 | 46351871 | Human |
155768512 | LOC127893460 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:44980511-44981101 | 20 | 46351872 | 46352462 | Human |
155781079 | LOC127893461 | H3K4me1 hESC enhancer GRCh37_chr20:44985189-44985688 | 20 | 46356550 | 46357049 | Human |
329830797 | LOC130065991 | ATAC-STARR-seq lymphoblastoid silent region 12974 | 20 | 46364146 | 46364565 | Human |
16567001 | LOC124904917 | uncharacterized LOC124904917 | 20 | 46364539 | 46398019 | Human |
1314023 | ELMO2 | engulfment and cell motility 2 | 20 | 46366050 | 46406615 | Human |
329815883 | LOC130065992 | ATAC-STARR-seq lymphoblastoid active region 17971 | 20 | 46368590 | 46368819 | Human |
155757538 | LOC127893462 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:45022873-45023372 | 20 | 46394234 | 46394733 | Human |
155759309 | LOC127893463 | H3K27ac-H3K4me1 hESC enhancers GRCh37_chr20:45034435-45035064 and GRCh37_chr20:45035065-45035694 | 20 | 46405796 | 46407055 | Human |
38668066 | LOC105372633 | uncharacterized LOC105372633 | 20 | 46406779 | 46444971 | Human |
329831679 | LOC130065993 | ATAC-STARR-seq lymphoblastoid active region 17973 | 20 | 46407323 | 46407482 | Human |
155769397 | LOC127893465 | NANOG hESC enhancer GRCh37_chr20:45052681-45053240 | 20 | 46424042 | 46424601 | Human |
329819779 | LOC130065994 | ATAC-STARR-seq lymphoblastoid active region 17974 | 20 | 46438249 | 46438308 | Human |
4107144 | ZNF663P | zinc finger protein 663, pseudogene | 20 | 46456493 | 46457643 | Human |
155774212 | LOC127893466 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45087277-45087817 | 20 | 46458638 | 46459178 | Human |
155781083 | LOC127893467 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45087818-45088357 | 20 | 46459179 | 46459718 | Human |
1318499 | ZNF334 | zinc finger protein 334 | 20 | 46462313 | 46513559 | Human |
1344748 | MKRN7P | makorin ring finger protein 7, pseudogene | 20 | 46463660 | 46465292 | Human |
2298823 | ZNF840P | zinc finger protein 840, pseudogene | 20 | 46490940 | 46492292 | Human |
329339064 | LOC129664631 | ReSE screen-validated silencer GRCh37_chr20:45142238-45142472 | 20 | 46513599 | 46513833 | Human |
1352743 | OCSTAMP | osteoclast stimulatory transmembrane protein | 20 | 46540946 | 46550654 | Human |
329844554 | LOC130065995 | ATAC-STARR-seq lymphoblastoid active region 17976 | 20 | 46553114 | 46553313 | Human |
69657 | SLC13A3 | solute carrier family 13 member 3 | 20 | 46557828 | 46684485 | Human |
155763590 | LOC127893469 | H3K27ac hESC enhancer GRCh37_chr20:45197011-45197512 | 20 | 46568372 | 46568873 | Human |
155763945 | LOC127893470 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:45211603-45212425 | 20 | 46582964 | 46583786 | Human |
155755730 | LOC127893471 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:45212426-45213247 | 20 | 46583787 | 46584608 | Human |
329819303 | LOC130065996 | ATAC-STARR-seq lymphoblastoid active region 17977 | 20 | 46588984 | 46589073 | Human |
155767631 | LOC127893472 | OCT4-NANOG hESC enhancer GRCh37_chr20:45250755-45251328 | 20 | 46622116 | 46622689 | Human |
155772767 | LOC127893473 | H3K4me1 hESC enhancer GRCh37_chr20:45259736-45260484 | 20 | 46631097 | 46631845 | Human |
155778051 | LOC127893474 | H3K4me1 hESC enhancer GRCh37_chr20:45260485-45261231 | 20 | 46631846 | 46632592 | Human |
329342943 | LOC129664632 | ReSE screen-validated silencer GRCh37_chr20:45302100-45302256 | 20 | 46673461 | 46673617 | Human |
155756152 | LOC127893475 | H3K4me1 hESC enhancer GRCh37_chr20:45303169-45303683 | 20 | 46674530 | 46675044 | Human |
155755244 | LOC127893476 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45311939-45312450 | 20 | 46683300 | 46683811 | Human |
1317644 | TP53RK | TP53 regulating kinase | 20 | 46684365 | 46689444 | Human |
329833146 | LOC130065997 | ATAC-STARR-seq lymphoblastoid silent region 12976 | 20 | 46689023 | 46689072 | Human |
39128308 | TP53RK-DT | TP53RK divergent transcript | 20 | 46689299 | 46690289 | Human |
329829231 | LOC130065998 | ATAC-STARR-seq lymphoblastoid active region 17978 | 20 | 46689303 | 46689892 | Human |
329837119 | LOC130065999 | ATAC-STARR-seq lymphoblastoid active region 17979 | 20 | 46696122 | 46696241 | Human |
155758710 | LOC127893477 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45331499-45332271 | 20 | 46702860 | 46703632 | Human |
1315233 | SLC2A10 | solute carrier family 2 member 10 | 20 | 46708320 | 46736347 | Human |
155774075 | LOC127893478 | H3K4me1 hESC enhancer GRCh37_chr20:45354240-45354740 | 20 | 46725601 | 46726101 | Human |
155750571 | LOC127893479 | H3K4me1 hESC enhancer GRCh37_chr20:45354741-45355241 | 20 | 46726102 | 46726602 | Human |
151673457 | LOC124904918 | uncharacterized LOC124904918 | 20 | 46740062 | 46742275 | Human |
151672721 | LOC124904919 | uncharacterized LOC124904919 | 20 | 46765303 | 46771370 | Human |
155229041 | LOC126863039 | MED14-independent group 3 enhancer GRCh37_chr20:45405530-45406729 | 20 | 46776891 | 46778090 | Human |
155228649 | LOC126863040 | BRD4-independent group 4 enhancer GRCh37_chr20:45431640-45432839 | 20 | 46803001 | 46804200 | Human |
10398974 | RN7SKP33 | RN7SK pseudogene 33 | 20 | 46859333 | 46859672 | Human |
2304348 | RPL13P14 | ribosomal protein L13 pseudogene 14 | 20 | 46863545 | 46864098 | Human |
1350703 | EYA2 | EYA transcriptional coactivator and phosphatase 2 | 20 | 46894843 | 47188844 | Human |
38605054 | EYA2-AS1 | EYA2 antisense RNA 1 | 20 | 46900388 | 46901748 | Human |
155229623 | LOC126863041 | BRD4-independent group 4 enhancer GRCh37_chr20:45529211-45530410 | 20 | 46900572 | 46901771 | Human |
155758696 | LOC127893480 | NANOG hESC enhancer GRCh37_chr20:45548266-45548793 | 20 | 46919627 | 46920154 | Human |
155773032 | LOC127893481 | H3K4me1 hESC enhancer GRCh37_chr20:45572445-45573138 | 20 | 46943806 | 46944499 | Human |
155761837 | LOC127893482 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:45573832-45574524 | 20 | 46945193 | 46945885 | Human |
4110201 | GAPDHP54 | glyceraldehyde 3 phosphate dehydrogenase pseudogene 54 | 20 | 46997711 | 46998477 | Human |
329341749 | LOC129391182 | MPRA-validated peak4229 silencer | 20 | 47049876 | 47050076 | Human |
155759178 | LOC127893484 | H3K4me1 hESC enhancer GRCh37_chr20:45754363-45754876 | 20 | 47125724 | 47126237 | Human |
2304915 | RPS2P54 | ribosomal protein S2 pseudogene 54 | 20 | 47160801 | 47161700 | Human |
4888853 | MIR3616 | microRNA 3616 | 20 | 47166967 | 47167058 | Human |
38619186 | LOC112694717 | Sharpr-MPRA regulatory region 12423 | 20 | 47181341 | 47181635 | Human |
329822668 | LOC130066000 | ATAC-STARR-seq lymphoblastoid active region 17980 | 20 | 47201644 | 47201693 | Human |
38666438 | LOC114004352 | Sharpr-MPRA regulatory region 5760 | 20 | 47207085 | 47207379 | Human |
155763080 | LOC127893485 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45836841-45837466 | 20 | 47208196 | 47208821 | Human |
155761425 | LOC127893486 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45837467-45838090 | 20 | 47208822 | 47209445 | Human |
1319938 | ZMYND8 | zinc finger MYND-type containing 8 | 20 | 47209214 | 47356699 | Human |
329815314 | LOC130066001 | ATAC-STARR-seq lymphoblastoid active region 17981 | 20 | 47232823 | 47232892 | Human |
155775470 | LOC127893487 | H3K4me1 hESC enhancer GRCh37_chr20:45863077-45863577 | 20 | 47234333 | 47234833 | Human |
155762087 | LOC127893488 | H3K27ac hESC enhancer GRCh37_chr20:45881941-45882441 | 20 | 47253197 | 47253697 | Human |
329834762 | LOC130066002 | ATAC-STARR-seq lymphoblastoid active region 17982 | 20 | 47259095 | 47259204 | Human |
329824705 | LOC130066003 | ATAC-STARR-seq lymphoblastoid active region 17983 | 20 | 47259585 | 47259724 | Human |
155761507 | LOC127893489 | H3K4me1 hESC enhancer GRCh37_chr20:45904588-45905088 | 20 | 47275844 | 47276344 | Human |
155764765 | LOC127893490 | H3K4me1 hESC enhancer GRCh37_chr20:45905089-45905589 | 20 | 47276345 | 47276845 | Human |
152975839 | LOC125387281 | Sharpr-MPRA regulatory region 15539 | 20 | 47281465 | 47281759 | Human |
155226994 | LOC126863042 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:45945484-45946683 | 20 | 47316487 | 47318322 | Human |
155752524 | LOC127893491 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45947067-45947983 | 20 | 47318323 | 47319239 | Human |
16564867 | AL031666.2 | novel transcript, antisense to ZMYND8 | 20 | 47318502 | 47320754 | Human |
155776649 | LOC127893492 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45947984-45948902 | 20 | 47319240 | 47320158 | Human |
155778538 | LOC127893493 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45950739-45951656 | 20 | 47321995 | 47322912 | Human |
155773286 | LOC127893494 | H3K27ac hESC enhancer GRCh37_chr20:45957753-45958400 | 20 | 47329009 | 47329656 | Human |
155773945 | LOC127893495 | H3K27ac hESC enhancer GRCh37_chr20:45959988-45960488 | 20 | 47331244 | 47331744 | Human |
155760477 | LOC127893496 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45964446-45965285 | 20 | 47335702 | 47336541 | Human |
155767312 | LOC127893497 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45965286-45966124 | 20 | 47336542 | 47337380 | Human |
155758769 | LOC127893498 | H3K4me1 hESC enhancer GRCh37_chr20:45968129-45968628 | 20 | 47339385 | 47339884 | Human |
155757456 | LOC127893499 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45971039-45971820 | 20 | 47342295 | 47343076 | Human |
155766132 | LOC127893500 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45974595-45975341 | 20 | 47345851 | 47346597 | Human |
16554946 | AL031666.1 | novel transcript, antisense to ZMYND8 | 20 | 47352561 | 47354633 | Human |
329821845 | LOC130066004 | ATAC-STARR-seq lymphoblastoid active region 17984 | 20 | 47352671 | 47352820 | Human |
155767622 | LOC127893501 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45983444-45984051 | 20 | 47354700 | 47355307 | Human |
38600909 | LOC112694718 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45985267-45985874 | 20 | 47356510 | 47357130 | Human |
155760007 | LOC127893502 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:45986483-45987088 | 20 | 47357710 | 47358344 | Human |
38669662 | LOC116286206 | NANOG-H3K27ac-H3K4me1 hESC enhancers GRCh37_chr20:45987089-45987696 and GRCh37_chr20:45987697-45988304 | 20 | 47358345 | 47359560 | Human |
38672763 | LOC116286207 | CRISPRi-validated cis-regulatory element chr20.2033 | 20 | 47360522 | 47361177 | Human |
155781334 | LOC127893503 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46001472-46002090 | 20 | 47372728 | 47373346 | Human |
155764487 | LOC127893504 | H3K27ac hESC enhancer GRCh37_chr20:46004693-46005194 | 20 | 47375949 | 47376450 | Human |
155768179 | LOC127893505 | H3K27ac hESC enhancer GRCh37_chr20:46005195-46005694 | 20 | 47376451 | 47376950 | Human |
155769368 | LOC127893506 | H3K27ac hESC enhancer GRCh37_chr20:46007335-46007835 | 20 | 47378591 | 47379091 | Human |
11562447 | LINC01754 | long intergenic non-protein coding RNA 1754 | 20 | 47382766 | 47412144 | Human |
155771402 | LOC127893507 | H3K27ac hESC enhancer GRCh37_chr20:46012139-46012991 | 20 | 47383395 | 47384247 | Human |
329817228 | LOC130066005 | ATAC-STARR-seq lymphoblastoid active region 17989 | 20 | 47392018 | 47392147 | Human |
329815831 | LOC130066006 | ATAC-STARR-seq lymphoblastoid active region 17990 | 20 | 47392318 | 47392507 | Human |
329816484 | LOC130066007 | ATAC-STARR-seq lymphoblastoid active region 17991 | 20 | 47392768 | 47392817 | Human |
329814973 | LOC130066008 | ATAC-STARR-seq lymphoblastoid active region 17992 | 20 | 47410408 | 47410597 | Human |
329822049 | LOC130066009 | ATAC-STARR-seq lymphoblastoid active region 17993 | 20 | 47412795 | 47412954 | Human |
329839929 | LOC130066010 | ATAC-STARR-seq lymphoblastoid active region 17994 | 20 | 47414688 | 47414737 | Human |
329834827 | LOC130066011 | ATAC-STARR-seq lymphoblastoid silent region 12977 | 20 | 47415779 | 47415828 | Human |
155755092 | LOC127893508 | H3K4me1 hESC enhancer GRCh37_chr20:46044799-46045298 | 20 | 47416055 | 47416554 | Human |
155767717 | LOC127893509 | H3K27ac hESC enhancer GRCh37_chr20:46057414-46057914 | 20 | 47428670 | 47429170 | Human |
329343622 | LOC129391183 | MPRA-validated peak4230 silencer | 20 | 47453152 | 47453352 | Human |
329344129 | LOC129391184 | MPRA-validated peak4231 silencer | 20 | 47453431 | 47453631 | Human |
329834134 | LOC130066012 | ATAC-STARR-seq lymphoblastoid active region 17995 | 20 | 47453848 | 47454057 | Human |
152975811 | LOC125387282 | Sharpr-MPRA regulatory region 10107 | 20 | 47464465 | 47464759 | Human |
329818044 | LOC130066013 | ATAC-STARR-seq lymphoblastoid active region 17996 | 20 | 47468678 | 47468837 | Human |
1349107 | RPL35AP | ribosomal protein L35a pseudogene | 20 | 47478214 | 47479010 | Human |
155756337 | LOC127893510 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:46108400-46108953 | 20 | 47479656 | 47480209 | Human |
155778429 | LOC127893511 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46108954-46109506 | 20 | 47480210 | 47480762 | Human |
10400667 | RNU6-497P | RNA, U6 small nuclear 497, pseudogene | 20 | 47484278 | 47484381 | Human |
329833560 | LOC130066014 | ATAC-STARR-seq lymphoblastoid active region 17997 | 20 | 47486555 | 47486624 | Human |
329838551 | LOC130066015 | ATAC-STARR-seq lymphoblastoid active region 17998 | 20 | 47487225 | 47487554 | Human |
329816027 | LOC130066016 | ATAC-STARR-seq lymphoblastoid active region 17999 | 20 | 47487585 | 47487634 | Human |
329828621 | LOC130066017 | ATAC-STARR-seq lymphoblastoid silent region 12978 | 20 | 47487845 | 47487894 | Human |
329845040 | LOC130066018 | ATAC-STARR-seq lymphoblastoid silent region 12979 | 20 | 47487915 | 47487974 | Human |
10399940 | RNU6-563P | RNA, U6 small nuclear 563, pseudogene | 20 | 47492978 | 47493085 | Human |
38637420 | LOC116286208 | CRISPRi-validated cis-regulatory element chr20.2047 | 20 | 47500803 | 47500875 | Human |
1344181 | NCOA3 | nuclear receptor coactivator 3 | 20 | 47501887 | 47656872 | Human |
329844511 | LOC130066019 | ATAC-STARR-seq lymphoblastoid silent region 12980 | 20 | 47502127 | 47502246 | Human |
155767796 | LOC127893512 | H3K27ac hESC enhancer GRCh37_chr20:46152763-46153530 | 20 | 47524019 | 47524786 | Human |
155752987 | LOC127893513 | H3K4me1 hESC enhancer GRCh37_chr20:46158187-46158687 | 20 | 47529443 | 47529943 | Human |
329339028 | LOC129664633 | ReSE screen-validated silencer GRCh37_chr20:46190110-46190292 | 20 | 47561366 | 47561548 | Human |
329340956 | LOC129391185 | MPRA-validated peak4234 silencer | 20 | 47589692 | 47589892 | Human |
38672263 | LOC100419565 | ribosomal protein S3A pseudogene | 20 | 47630765 | 47631438 | Human |
155778531 | LOC127893514 | H3K27ac hESC enhancer GRCh37_chr20:46276897-46277614 | 20 | 47648153 | 47648870 | Human |
155765087 | LOC127893515 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:46277615-46278332 | 20 | 47648871 | 47649588 | Human |
38625191 | LOC109621227 | nuclear receptor coactivator 3 repeat instability region | 20 | 47651071 | 47651158 | Human |
1312895 | SULF2 | sulfatase 2 | 20 | 47657406 | 47786627 | Human |
329843457 | LOC130066020 | ATAC-STARR-seq lymphoblastoid active region 18000 | 20 | 47663206 | 47663255 | Human |
329828539 | LOC130066021 | ATAC-STARR-seq lymphoblastoid active region 18001 | 20 | 47664066 | 47664205 | Human |
329833118 | LOC130066022 | ATAC-STARR-seq lymphoblastoid active region 18002 | 20 | 47664236 | 47664285 | Human |
155773602 | LOC127893516 | H3K4me1 hESC enhancer GRCh37_chr20:46293563-46294548 | 20 | 47664819 | 47665804 | Human |
155758133 | LOC127893517 | H3K4me1 hESC enhancer GRCh37_chr20:46294549-46295532 | 20 | 47665805 | 47666788 | Human |
329832247 | LOC130066023 | ATAC-STARR-seq lymphoblastoid active region 18003 | 20 | 47667371 | 47667600 | Human |
329826640 | LOC130066024 | ATAC-STARR-seq lymphoblastoid active region 18004 | 20 | 47668581 | 47668750 | Human |
155756159 | LOC127893518 | H3K4me1 hESC enhancer GRCh37_chr20:46303203-46304168 | 20 | 47674459 | 47675424 | Human |
155767389 | LOC127893519 | H3K4me1 hESC enhancer GRCh37_chr20:46307531-46308031 | 20 | 47678787 | 47679287 | Human |
155777239 | LOC127893520 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46316712-46317262 | 20 | 47687968 | 47688518 | Human |
155773270 | LOC127893521 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46317263-46317814 | 20 | 47688519 | 47689070 | Human |
155750575 | LOC127893522 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46326206-46326710 | 20 | 47697462 | 47697966 | Human |
329829205 | LOC130066025 | ATAC-STARR-seq lymphoblastoid active region 18005 | 20 | 47701714 | 47701773 | Human |
155768855 | LOC127893523 | H3K4me1 hESC enhancer GRCh37_chr20:46339340-46339840 | 20 | 47710596 | 47711096 | Human |
155771780 | LOC127893524 | H3K4me1 hESC enhancer GRCh37_chr20:46339841-46340341 | 20 | 47711097 | 47711597 | Human |
329841035 | LOC130066026 | ATAC-STARR-seq lymphoblastoid active region 18006 | 20 | 47712415 | 47712484 | Human |
155765027 | LOC127893525 | H3K4me1 hESC enhancer GRCh37_chr20:46381087-46381588 | 20 | 47752343 | 47752844 | Human |
155779833 | LOC127893527 | H3K4me1 hESC enhancer GRCh37_chr20:46386138-46386895 | 20 | 47757394 | 47758151 | Human |
155769500 | LOC127893528 | H3K4me1 hESC enhancer GRCh37_chr20:46386896-46387654 | 20 | 47758152 | 47758910 | Human |
155782247 | LOC127893529 | H3K4me1 hESC enhancer GRCh37_chr20:46387655-46388411 | 20 | 47758911 | 47759667 | Human |
155753681 | LOC127893530 | NANOG hESC enhancer GRCh37_chr20:46390145-46390683 | 20 | 47761401 | 47761939 | Human |
152975787 | LOC125387283 | Sharpr-MPRA regulatory region 8498 | 20 | 47765660 | 47766599 | Human |
151671457 | LOC124904922 | uncharacterized LOC124904922 | 20 | 47774090 | 47779654 | Human |
329813765 | LOC130066027 | ATAC-STARR-seq lymphoblastoid active region 18007 | 20 | 47782440 | 47782499 | Human |
151673051 | LOC124904920 | uncharacterized LOC124904920 | 20 | 47785754 | 47786885 | Human |
329815349 | LOC130066028 | ATAC-STARR-seq lymphoblastoid active region 18008 | 20 | 47786599 | 47786768 | Human |
151674993 | LOC124904921 | uncharacterized LOC124904921 | 20 | 47787340 | 47797249 | Human |
38640049 | LOC107985401 | uncharacterized LOC107985401 | 20 | 47792135 | 47799871 | Human |
155758027 | LOC127893531 | H3K4me1 hESC enhancer GRCh37_chr20:46428971-46429590 | 20 | 47800227 | 47800846 | Human |
155757053 | LOC127893532 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:46432238-46433192 | 20 | 47803494 | 47804448 | Human |
155763206 | LOC127893533 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:46433193-46434147 | 20 | 47804449 | 47805403 | Human |
155775075 | LOC127893534 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46437768-46438349 | 20 | 47809024 | 47809605 | Human |
155777435 | LOC127893535 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46438350-46438930 | 20 | 47809606 | 47810186 | Human |
155780893 | LOC127893536 | H3K4me1 hESC enhancer GRCh37_chr20:46454838-46455538 | 20 | 47826094 | 47826794 | Human |
10399822 | RNU7-173P | RNA, U7 small nuclear 173 pseudogene | 20 | 47826969 | 47827044 | Human |
155778555 | LOC127893537 | H3K4me1 hESC enhancer GRCh37_chr20:46466833-46467334 | 20 | 47838089 | 47838590 | Human |
38629286 | LOC105372636 | uncharacterized LOC105372636 | 20 | 47840984 | 47843269 | Human |
329338175 | LOC129391186 | MPRA-validated peak4235 silencer | 20 | 47842012 | 47842212 | Human |
329820635 | LOC130066029 | ATAC-STARR-seq lymphoblastoid silent region 12981 | 20 | 47857277 | 47857386 | Human |
329837404 | LOC130066030 | ATAC-STARR-seq lymphoblastoid active region 18009 | 20 | 47857517 | 47857706 | Human |
329813476 | LOC130066031 | ATAC-STARR-seq lymphoblastoid active region 18010 | 20 | 47857977 | 47858036 | Human |
1345441 | SRMP1 | SRM pseudogene 1 | 20 | 47859717 | 47860959 | Human |
155757757 | LOC127893538 | H3K4me1 hESC enhancer GRCh37_chr20:46496687-46497217 | 20 | 47867943 | 47868473 | Human |
6481663 | RNA5SP486 | RNA, 5S ribosomal pseudogene 486 | 20 | 47873191 | 47873273 | Human |
155779502 | LOC127893539 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46523130-46524066 | 20 | 47894386 | 47895322 | Human |
10400702 | RNU7-92P | RNA, U7 small nuclear 92 pseudogene | 20 | 47904348 | 47904423 | Human |
38614922 | LOC105372637 | uncharacterized LOC105372637 | 20 | 47950810 | 47961243 | Human |
155773062 | LOC127893540 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46579981-46580540 | 20 | 47951237 | 47951796 | Human |
155768552 | LOC127893541 | H3K4me1 hESC enhancer GRCh37_chr20:46581153-46581653 | 20 | 47952409 | 47952909 | Human |
155758903 | LOC127893542 | H3K4me1 hESC enhancer GRCh37_chr20:46598923-46599424 | 20 | 47970179 | 47970680 | Human |
155757463 | LOC127893543 | H3K4me1 hESC enhancer GRCh37_chr20:46599425-46599924 | 20 | 47970681 | 47971180 | Human |
329840700 | LOC130066032 | ATAC-STARR-seq lymphoblastoid silent region 12982 | 20 | 47975246 | 47975365 | Human |
155775577 | LOC127893544 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:46607945-46608919 | 20 | 47979201 | 47980175 | Human |
9068480 | LINC01522 | long intergenic non-protein coding RNA 1522 | 20 | 47980093 | 47990117 | Human |
38674002 | LOC107985436 | uncharacterized LOC107985436 | 20 | 47987058 | 48021063 | Human |
155776015 | LOC127893546 | H3K27ac hESC enhancer GRCh37_chr20:46621816-46622316 | 20 | 47993072 | 47993572 | Human |
329831921 | LOC130066033 | ATAC-STARR-seq lymphoblastoid active region 18011 | 20 | 48002759 | 48002928 | Human |
329826050 | LOC130066034 | ATAC-STARR-seq lymphoblastoid active region 18012 | 20 | 48002939 | 48002988 | Human |
155751280 | LOC127893547 | H3K4me1 hESC enhancer GRCh37_chr20:46634734-46635234 | 20 | 48005990 | 48006490 | Human |
38614058 | LOC107985437 | uncharacterized LOC107985437 | 20 | 48015180 | 48024208 | Human |
155770758 | LOC127893548 | H3K4me1 hESC enhancer GRCh37_chr20:46648566-46649066 | 20 | 48019822 | 48020322 | Human |
155781202 | LOC127893549 | H3K4me1 hESC enhancer GRCh37_chr20:46649067-46649567 | 20 | 48020323 | 48020823 | Human |
38651253 | LOC105372639 | uncharacterized LOC105372639 | 20 | 48025219 | 48066291 | Human |
329822370 | LOC130066035 | ATAC-STARR-seq lymphoblastoid active region 18013 | 20 | 48027319 | 48027368 | Human |
151675201 | LOC124904923 | uncharacterized LOC124904923 | 20 | 48057362 | 48065887 | Human |
329343028 | LOC129664634 | ReSE screen-validated silencer GRCh37_chr20:46704990-46705175 | 20 | 48076247 | 48076432 | Human |
155778854 | LOC127893550 | H3K4me1 hESC enhancer GRCh37_chr20:46720958-46721466 | 20 | 48092215 | 48092723 | Human |
155754710 | LOC127893551 | H3K4me1 hESC enhancer GRCh37_chr20:46721467-46721975 | 20 | 48092724 | 48093232 | Human |
401825136 | LOC132090581 | Neanderthal introgressed variant-containing enhancer experimental_60566 | 20 | 48094463 | 48094632 | Human |
38667109 | LOC105372640 | uncharacterized LOC105372640 | 20 | 48120276 | 48126814 | Human |
155781911 | LOC127893552 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46754717-46755602 | 20 | 48125974 | 48126859 | Human |
155750462 | LOC127893553 | H3K27ac hESC enhancer GRCh37_chr20:46803778-46804278 | 20 | 48175035 | 48175535 | Human |
155777587 | LOC127893554 | H3K27ac hESC enhancer GRCh37_chr20:46804279-46804779 | 20 | 48175536 | 48176036 | Human |
155752565 | LOC127893555 | H3K4me1 hESC enhancer GRCh37_chr20:46833156-46833688 | 20 | 48204413 | 48204945 | Human |
155774237 | LOC127893556 | H3K4me1 hESC enhancer GRCh37_chr20:46834755-46835286 | 20 | 48206012 | 48206543 | Human |
155772119 | LOC127893557 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:46842063-46842887 | 20 | 48213320 | 48214144 | Human |
9068793 | LINC01523 | long intergenic non-protein coding RNA 1523 | 20 | 47983226 | 47984313 | Human |
401826301 | LOC132090580 | Neanderthal introgressed variant-containing enhancer experimental_60555 | 20 | 48063326 | 48063495 | Human |
38662587 | LOC105372641 | uncharacterized LOC105372641 | 20 | 48192322 | 48202756 | Human |
155766201 | LOC127893452 | H3K4me1 hESC enhancer GRCh37_chr20:44844486-44845022 | 20 | 46215847 | 46216383 | Human |
155758895 | LOC127893457 | H3K4me1 hESC enhancer GRCh37_chr20:44941853-44942801 | 20 | 46313215 | 46314163 | Human |
155758376 | LOC127893468 | H3K4me1 hESC enhancer GRCh37_chr20:45173599-45174450 | 20 | 46544960 | 46545811 | Human |
155779365 | LOC127893483 | H3K27ac hESC enhancer GRCh37_chr20:45663821-45664320 | 20 | 47035182 | 47035681 | Human |
155782257 | LOC127893526 | H3K4me1 hESC enhancer GRCh37_chr20:46381589-46382088 | 20 | 47752845 | 47753344 | Human |
155768139 | LOC127893545 | H3K4me1 hESC enhancer GRCh37_chr20:46611853-46612352 | 20 | 47983109 | 47983608 | Human |
329340335 | LOC129664635 | ReSE screen-validated silencer GRCh37_chr20:46857183-46857312 | 20 | 48228440 | 48228569 | Human |
155752554 | LOC127893558 | H3K4me1 hESC enhancer GRCh37_chr20:46870479-46870978 | 20 | 48241736 | 48242235 | Human |
155760080 | LOC127893559 | H3K4me1 hESC enhancer GRCh37_chr20:46888828-46889328 | 20 | 48260085 | 48260585 | Human |
155227849 | LOC126863043 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:46893650-46894849 | 20 | 48264907 | 48266106 | Human |
155773895 | LOC127893560 | NANOG hESC enhancer GRCh37_chr20:46895251-46895778 | 20 | 48266508 | 48267035 | Human |
151674231 | LOC124904924 | uncharacterized LOC124904924 | 20 | 48275847 | 48282197 | Human |
155777170 | LOC127893561 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46921157-46921901 | 20 | 48292414 | 48293158 | Human |
155776780 | LOC127893562 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:46923391-46924136 | 20 | 48294648 | 48295393 | Human |
155778718 | LOC127893563 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:46924137-46924880 | 20 | 48295394 | 48296137 | Human |
155778043 | LOC127893564 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:46924881-46925625 | 20 | 48296138 | 48296882 | Human |
155770346 | LOC127893565 | H3K4me1 hESC enhancer GRCh37_chr20:46948811-46949389 | 20 | 48320068 | 48320646 | Human |
329817003 | LOC130066036 | ATAC-STARR-seq lymphoblastoid active region 18014 | 20 | 48339416 | 48339465 | Human |
329827603 | LOC130066037 | ATAC-STARR-seq lymphoblastoid active region 18015 | 20 | 48339576 | 48339685 | Human |
329817495 | LOC130066038 | ATAC-STARR-seq lymphoblastoid active region 18016 | 20 | 48339996 | 48340085 | Human |
329844834 | LOC130066039 | ATAC-STARR-seq lymphoblastoid active region 18017 | 20 | 48340146 | 48340195 | Human |
329340095 | LOC129664636 | ReSE screen-validated silencer GRCh37_chr20:46979410-46979659 | 20 | 48350667 | 48350916 | Human |
5552963 | LINC00494 | long intergenic non-protein coding RNA 494 | 20 | 48359911 | 48370638 | Human |
38630933 | LOC105372643 | uncharacterized LOC105372643 | 20 | 48394181 | 48399963 | Human |
155754694 | LOC127893566 | H3K4me1 hESC enhancer GRCh37_chr20:47034597-47035373 | 20 | 48405854 | 48406630 | Human |
155753556 | LOC127893567 | H3K4me1 hESC enhancer GRCh37_chr20:47054573-47055079 | 20 | 48425830 | 48426336 | Human |
155782120 | LOC127893568 | H3K4me1 hESC enhancer GRCh37_chr20:47083129-47083690 | 20 | 48454883 | 48455444 | Human |
329844978 | LOC130066040 | ATAC-STARR-seq lymphoblastoid active region 18018 | 20 | 48460742 | 48460881 | Human |
38609773 | LOC105372645 | uncharacterized LOC105372645 | 20 | 48471342 | 48473330 | Human |
38649099 | LOC107985439 | uncharacterized LOC107985439 | 20 | 48475951 | 48482965 | Human |
329834700 | LOC130066041 | ATAC-STARR-seq lymphoblastoid active region 18019 | 20 | 48482647 | 48482716 | Human |
329816074 | LOC130066042 | ATAC-STARR-seq lymphoblastoid active region 18020 | 20 | 48488710 | 48488839 | Human |
329821406 | LOC130066043 | ATAC-STARR-seq lymphoblastoid active region 18021 | 20 | 48489240 | 48489339 | Human |
329341024 | LOC129391187 | MPRA-validated peak4239 silencer | 20 | 48489350 | 48489550 | Human |
10399067 | RNU7-144P | RNA, U7 small nuclear 144 pseudogene | 20 | 48494234 | 48494309 | Human |
38602477 | LOC105372647 | uncharacterized LOC105372647 | 20 | 48498065 | 48499973 | Human |
38648508 | LOC114004353 | NANOG hESC enhancer GRCh37_chr20:47139607-47140108 | 20 | 48523069 | 48523570 | Human |
38672392 | LOC105372646 | uncharacterized LOC105372646 | 20 | 48526354 | 48563624 | Human |
329835926 | LOC130066044 | ATAC-STARR-seq lymphoblastoid active region 18022 | 20 | 48541542 | 48541621 | Human |
155776623 | LOC127893570 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47215027-47215985 | 20 | 48598489 | 48599447 | Human |
152975755 | LOC125387284 | Sharpr-MPRA regulatory region 8803 | 20 | 48603751 | 48604045 | Human |
401825296 | LOC132090582 | Neanderthal introgressed variant-containing enhancer experimental_60582 | 20 | 48617194 | 48617363 | Human |
155753310 | LOC127893571 | H3K4me1 hESC enhancer GRCh37_chr20:47235455-47235955 | 20 | 48618917 | 48619417 | Human |
155782773 | LOC127893572 | H3K4me1 hESC enhancer GRCh37_chr20:47235991-47236699 | 20 | 48619453 | 48620161 | Human |
329833447 | LOC130066045 | ATAC-STARR-seq lymphoblastoid silent region 12983 | 20 | 48620554 | 48620683 | Human |
329822264 | LOC130066046 | ATAC-STARR-seq lymphoblastoid active region 18023 | 20 | 48620984 | 48621043 | Human |
1603014 | PREX1 | phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 | 20 | 48624252 | 48888185 | Human |
329832259 | LOC130066047 | ATAC-STARR-seq lymphoblastoid active region 18024 | 20 | 48636038 | 48636177 | Human |
149735459 | LOC121853010 | Sharpr-MPRA regulatory region 6651 | 20 | 48638551 | 48638845 | Human |
329343986 | LOC129664637 | ReSE screen-validated silencer GRCh37_chr20:47259130-47259274 | 20 | 48642592 | 48642736 | Human |
329842219 | LOC130066048 | ATAC-STARR-seq lymphoblastoid silent region 12984 | 20 | 48679750 | 48679919 | Human |
155764461 | LOC127893573 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47299567-47300316 | 20 | 48683029 | 48683778 | Human |
155750686 | LOC127893574 | H3K27ac hESC enhancer GRCh37_chr20:47310619-47311119 | 20 | 48694081 | 48694581 | Human |
401825276 | LOC132090583 | Neanderthal introgressed variant-containing enhancer experimental_60598 | 20 | 48694740 | 48694909 | Human |
401825831 | LOC132090584 | Neanderthal introgressed variant-containing enhancer experimental_60600 | 20 | 48697894 | 48698063 | Human |
155758926 | LOC127893575 | H3K4me1 hESC enhancer GRCh37_chr20:47319614-47320114 | 20 | 48703076 | 48703576 | Human |
401825847 | LOC132090585 | Neanderthal introgressed variant-containing enhancer experimental_60606 | 20 | 48707646 | 48707815 | Human |
329843406 | LOC130066049 | ATAC-STARR-seq lymphoblastoid active region 18025 | 20 | 48712793 | 48712902 | Human |
329823890 | LOC130066050 | ATAC-STARR-seq lymphoblastoid active region 18026 | 20 | 48712943 | 48712992 | Human |
329815035 | LOC130066051 | ATAC-STARR-seq lymphoblastoid active region 18027 | 20 | 48716079 | 48716288 | Human |
329832518 | LOC130066052 | ATAC-STARR-seq lymphoblastoid active region 18028 | 20 | 48717124 | 48717183 | Human |
329827384 | LOC130066053 | ATAC-STARR-seq lymphoblastoid silent region 12985 | 20 | 48718084 | 48718143 | Human |
329815293 | LOC130066054 | ATAC-STARR-seq lymphoblastoid active region 18029 | 20 | 48719150 | 48719329 | Human |
329829817 | LOC130066055 | ATAC-STARR-seq lymphoblastoid active region 18030 | 20 | 48719520 | 48719789 | Human |
329829003 | LOC130066056 | ATAC-STARR-seq lymphoblastoid active region 18031 | 20 | 48720931 | 48721030 | Human |
329827589 | LOC130066057 | ATAC-STARR-seq lymphoblastoid active region 18032 | 20 | 48721503 | 48721612 | Human |
329821557 | LOC130066058 | ATAC-STARR-seq lymphoblastoid active region 18033 | 20 | 48722433 | 48722482 | Human |
329819251 | LOC130066059 | ATAC-STARR-seq lymphoblastoid active region 18034 | 20 | 48722573 | 48722642 | Human |
155757302 | LOC127893576 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47339203-47340102 | 20 | 48722665 | 48723615 | Human |
329819995 | LOC130066060 | ATAC-STARR-seq lymphoblastoid active region 18036 | 20 | 48740592 | 48740701 | Human |
155771972 | LOC127893577 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47364075-47364807 | 20 | 48747538 | 48748270 | Human |
155764939 | LOC127893578 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47365963-47366558 | 20 | 48749426 | 48750021 | Human |
329818192 | LOC130066061 | ATAC-STARR-seq lymphoblastoid active region 18037 | 20 | 48751624 | 48751753 | Human |
155782334 | LOC127893579 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47374563-47375557 | 20 | 48758026 | 48759020 | Human |
329840143 | LOC130066062 | ATAC-STARR-seq lymphoblastoid silent region 12986 | 20 | 48760821 | 48760870 | Human |
329841607 | LOC130066063 | ATAC-STARR-seq lymphoblastoid active region 18039 | 20 | 48761401 | 48761450 | Human |
329338648 | LOC129664638 | ReSE screen-validated silencer GRCh37_chr20:47381423-47381601 | 20 | 48764886 | 48765064 | Human |
329341891 | LOC129664639 | ReSE screen-validated silencer GRCh37_chr20:47388421-47388642 | 20 | 48771884 | 48772105 | Human |
329839756 | LOC130066064 | ATAC-STARR-seq lymphoblastoid active region 18040 | 20 | 48781785 | 48781834 | Human |
329827875 | LOC130066065 | ATAC-STARR-seq lymphoblastoid active region 18041 | 20 | 48783255 | 48783344 | Human |
329842820 | LOC130066066 | ATAC-STARR-seq lymphoblastoid active region 18042 | 20 | 48784045 | 48784094 | Human |
329824136 | LOC130066067 | ATAC-STARR-seq lymphoblastoid active region 18043 | 20 | 48788419 | 48788478 | Human |
329813531 | LOC130066068 | ATAC-STARR-seq lymphoblastoid active region 18044 | 20 | 48789059 | 48789118 | Human |
329825227 | LOC130066069 | ATAC-STARR-seq lymphoblastoid active region 18045 | 20 | 48789219 | 48789318 | Human |
329825634 | LOC130066070 | ATAC-STARR-seq lymphoblastoid silent region 12987 | 20 | 48790198 | 48790297 | Human |
155768826 | LOC127893581 | H3K4me1 hESC enhancer GRCh37_chr20:47410381-47411036 | 20 | 48793844 | 48794499 | Human |
155759075 | LOC127893582 | H3K4me1 hESC enhancer GRCh37_chr20:47411037-47411690 | 20 | 48794500 | 48795153 | Human |
155778139 | LOC127893583 | H3K4me1 hESC enhancer GRCh37_chr20:47414263-47414873 | 20 | 48797726 | 48798336 | Human |
155779086 | LOC127893584 | H3K4me1 hESC enhancer GRCh37_chr20:47415894-47416394 | 20 | 48799357 | 48799857 | Human |
155760775 | LOC127893585 | H3K4me1 hESC enhancer GRCh37_chr20:47435997-47436994 | 20 | 48819460 | 48820457 | Human |
329832425 | LOC130066071 | ATAC-STARR-seq lymphoblastoid active region 18046 | 20 | 48823817 | 48823866 | Human |
329840092 | LOC130066072 | ATAC-STARR-seq lymphoblastoid active region 18047 | 20 | 48824157 | 48824246 | Human |
329833355 | LOC130066073 | ATAC-STARR-seq lymphoblastoid silent region 12988 | 20 | 48827493 | 48827562 | Human |
329835005 | LOC130066074 | ATAC-STARR-seq lymphoblastoid silent region 12989 | 20 | 48827973 | 48828652 | Human |
329824281 | LOC130066075 | ATAC-STARR-seq lymphoblastoid active region 18048 | 20 | 48839269 | 48839378 | Human |
329819807 | LOC130066076 | ATAC-STARR-seq lymphoblastoid active region 18049 | 20 | 48839759 | 48839818 | Human |
329831846 | LOC130066077 | ATAC-STARR-seq lymphoblastoid active region 18050 | 20 | 48846714 | 48846993 | Human |
155778233 | LOC127893586 | H3K4me1 hESC enhancer GRCh37_chr20:47474509-47475009 | 20 | 48857972 | 48858472 | Human |
329835346 | LOC130066078 | ATAC-STARR-seq lymphoblastoid active region 18051 | 20 | 48872798 | 48872877 | Human |
329835454 | LOC130066079 | ATAC-STARR-seq lymphoblastoid silent region 12990 | 20 | 48921472 | 48921551 | Human |
736641 | ARFGEF2 | ARF guanine nucleotide exchange factor 2 | 20 | 48921711 | 49036693 | Human |
329826693 | LOC130066080 | ATAC-STARR-seq lymphoblastoid silent region 12991 | 20 | 48921782 | 48921881 | Human |
329824149 | LOC130066081 | ATAC-STARR-seq lymphoblastoid silent region 12992 | 20 | 48921922 | 48921971 | Human |
329824127 | LOC130066082 | ATAC-STARR-seq lymphoblastoid active region 18052 | 20 | 48922342 | 48922421 | Human |
1351785 | SNAP23P1 | synaptosome associated protein 23 pseudogene 1 | 20 | 49038358 | 49038609 | Human |
9068646 | CSE1L-DT | CSE1L divergent transcript | 20 | 49040463 | 49046056 | Human |
329823072 | LOC130066083 | ATAC-STARR-seq lymphoblastoid active region 18053 | 20 | 49045935 | 49046084 | Human |
1316788 | CSE1L | chromosome segregation 1 like | 20 | 49046312 | 49096949 | Human |
155754523 | LOC127893587 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47663207-47663847 | 20 | 49046635 | 49047310 | Human |
734025 | STAU1 | staufen double-stranded RNA binding protein 1 | 20 | 49113339 | 49219295 | Human |
329341759 | LOC129664640 | ReSE screen-validated silencer GRCh37_chr20:47734294-47734451 | 20 | 49117757 | 49117914 | Human |
1353664 | ARPC3P1 | actin related protein 2/3 complex subunit 3 pseudogene 1 | 20 | 49134451 | 49135297 | Human |
155752000 | LOC127893588 | H3K4me1 hESC enhancer GRCh37_chr20:47797000-47797528 | 20 | 49180463 | 49180991 | Human |
329822746 | LOC130066084 | ATAC-STARR-seq lymphoblastoid active region 18055 | 20 | 49187078 | 49187147 | Human |
329815202 | LOC130066085 | ATAC-STARR-seq lymphoblastoid silent region 12993 | 20 | 49187548 | 49187707 | Human |
329828141 | LOC130066086 | ATAC-STARR-seq lymphoblastoid silent region 12994 | 20 | 49187938 | 49188607 | Human |
1313779 | DDX27 | DEAD-box helicase 27 | 20 | 49219416 | 49244073 | Human |
1603622 | ZNFX1 | zinc finger NFX1-type containing 1 | 20 | 49245900 | 49278057 | Human |
329841691 | LOC130066087 | ATAC-STARR-seq lymphoblastoid active region 18056 | 20 | 49272853 | 49272932 | Human |
329835211 | LOC130066088 | ATAC-STARR-seq lymphoblastoid active region 18057 | 20 | 49277232 | 49277291 | Human |
155756486 | LOC127893590 | H3K27ac hESC enhancer GRCh37_chr20:47894170-47894670 | 20 | 49277633 | 49278133 | Human |
38638445 | LOC112694720 | Sharpr-MPRA regulatory region 13855 | 20 | 49278112 | 49278761 | Human |
1603447 | ZFAS1 | ZNFX1 antisense RNA 1 | 20 | 49278178 | 49289260 | Human |
1602330 | SNORD12C | small nucleolar RNA, C/D box 12C | 20 | 49278945 | 49279023 | Human |
1626522 | SNORD12B | small nucleolar RNA, C/D box 12B | 20 | 49280313 | 49280415 | Human |
1602749 | SNORD12 | small nucleolar RNA, C/D box 12 | 20 | 49280683 | 49280772 | Human |
155765223 | LOC127893591 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:47900044-47900976 | 20 | 49283507 | 49284439 | Human |
155758240 | LOC127893592 | H3K27ac hESC enhancer GRCh37_chr20:47902841-47903772 | 20 | 49286304 | 49287235 | Human |
155773818 | LOC127893593 | H3K27ac hESC enhancer GRCh37_chr20:47903773-47904704 | 20 | 49287236 | 49288167 | Human |
329820762 | LOC130066089 | ATAC-STARR-seq lymphoblastoid active region 18059 | 20 | 49290337 | 49290446 | Human |
329824128 | LOC130066090 | ATAC-STARR-seq lymphoblastoid active region 18060 | 20 | 49291482 | 49291581 | Human |
155766850 | LOC127893594 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47909763-47910696 | 20 | 49293226 | 49294159 | Human |
155769094 | LOC127893596 | H3K27ac hESC enhancer GRCh37_chr20:47911631-47912563 | 20 | 49295094 | 49296026 | Human |
155762927 | LOC127893597 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47913664-47914226 | 20 | 49297127 | 49297689 | Human |
151672975 | LOC124904925 | uncharacterized LOC124904925 | 20 | 49310517 | 49311285 | Human |
155780625 | LOC127893598 | H3K4me1 hESC enhancer GRCh37_chr20:47934991-47935572 | 20 | 49318454 | 49319035 | Human |
155771765 | LOC127893599 | H3K4me1 hESC enhancer GRCh37_chr20:47935573-47936154 | 20 | 49319036 | 49319617 | Human |
155757279 | LOC127893600 | H3K27ac hESC enhancer GRCh37_chr20:47940265-47940766 | 20 | 49323728 | 49324229 | Human |
155772424 | LOC127893601 | H3K27ac hESC enhancer GRCh37_chr20:47940767-47941266 | 20 | 49324230 | 49324729 | Human |
38667213 | LOC105372649 | uncharacterized LOC105372649 | 20 | 49330334 | 49439020 | Human |
329837249 | LOC130066091 | ATAC-STARR-seq lymphoblastoid active region 18061 | 20 | 49334178 | 49334237 | Human |
732211 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 20 | 49363877 | 49483362 | Human |
155781761 | LOC127893602 | NANOG hESC enhancer GRCh37_chr20:47985158-47985711 | 20 | 49368621 | 49369174 | Human |
329337900 | LOC129664641 | ReSE screen-validated silencer GRCh37_chr20:47990213-47990475 | 20 | 49373676 | 49373938 | Human |
155754968 | LOC127893603 | H3K4me1 hESC enhancer GRCh37_chr20:48040793-48041316 | 20 | 49424256 | 49424779 | Human |
155781710 | LOC127893604 | H3K4me1 hESC enhancer GRCh37_chr20:48041317-48041840 | 20 | 49424780 | 49425303 | Human |
155777161 | LOC127893605 | H3K4me1 hESC enhancer GRCh37_chr20:48063137-48063648 | 20 | 49446600 | 49447111 | Human |
155772515 | LOC127893606 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48063649-48064158 | 20 | 49447112 | 49447621 | Human |
155778065 | LOC127893607 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48064159-48064670 | 20 | 49447622 | 49448133 | Human |
329830931 | LOC130066092 | ATAC-STARR-seq lymphoblastoid silent region 12997 | 20 | 49484301 | 49484440 | Human |
329838849 | LOC130066093 | ATAC-STARR-seq lymphoblastoid silent region 12998 | 20 | 49484531 | 49484590 | Human |
736622 | PTGIS | prostaglandin I2 synthase | 20 | 49503874 | 49568137 | Human |
155766344 | LOC127893608 | H3K4me1 hESC enhancer GRCh37_chr20:48121719-48122220 | 20 | 49505182 | 49505683 | Human |
329814837 | LOC130066094 | ATAC-STARR-seq lymphoblastoid active region 18062 | 20 | 49541801 | 49541850 | Human |
329342081 | LOC129664642 | ReSE screen-validated silencer GRCh37_chr20:48158843-48159119 | 20 | 49542306 | 49542582 | Human |
38640165 | LOC101927486 | uncharacterized LOC101927486 | 20 | 49568044 | 49571934 | Human |
155762330 | LOC127893609 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48184974-48185590 | 20 | 49568437 | 49569053 | Human |
155762534 | LOC127893610 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48185591-48186205 | 20 | 49569054 | 49569668 | Human |
155752394 | LOC127893611 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48196657-48197231 | 20 | 49580120 | 49580694 | Human |
38649328 | LOC105372651 | uncharacterized LOC105372651 | 20 | 49594570 | 49603638 | Human |
155765153 | LOC127893612 | H3K4me1 hESC enhancer GRCh37_chr20:48212298-48212798 | 20 | 49595761 | 49596261 | Human |
155771816 | LOC127893613 | H3K4me1 hESC enhancer GRCh37_chr20:48227493-48227993 | 20 | 49610956 | 49611456 | Human |
329827064 | LOC130066095 | ATAC-STARR-seq lymphoblastoid silent region 13000 | 20 | 49620647 | 49620696 | Human |
329820845 | LOC130066096 | ATAC-STARR-seq lymphoblastoid active region 18063 | 20 | 49620827 | 49620896 | Human |
329825163 | LOC130066097 | ATAC-STARR-seq lymphoblastoid active region 18064 | 20 | 49627223 | 49627292 | Human |
151668944 | LOC124904926 | uncharacterized LOC124904926 | 20 | 49629784 | 49632196 | Human |
329839488 | LOC130066098 | ATAC-STARR-seq lymphoblastoid active region 18065 | 20 | 49630611 | 49630660 | Human |
329836440 | LOC130066099 | ATAC-STARR-seq lymphoblastoid active region 18066 | 20 | 49630891 | 49631210 | Human |
155774380 | LOC127893614 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48247798-48248480 | 20 | 49631261 | 49631943 | Human |
1320747 | B4GALT5 | beta-1,4-galactosyltransferase 5 | 20 | 49632945 | 49713878 | Human |
155759244 | LOC127893615 | H3K27ac hESC enhancer GRCh37_chr20:48253041-48253541 | 20 | 49636504 | 49637004 | Human |
149735405 | LOC121853011 | Sharpr-MPRA regulatory region 2374 | 20 | 49661932 | 49662226 | Human |
329842749 | LOC130066100 | ATAC-STARR-seq lymphoblastoid active region 18067 | 20 | 49676598 | 49676677 | Human |
155754250 | LOC127893616 | H3K4me1 hESC enhancer GRCh37_chr20:48299818-48300523 | 20 | 49683281 | 49683986 | Human |
329843492 | LOC130066101 | ATAC-STARR-seq lymphoblastoid silent region 13001 | 20 | 49687733 | 49687832 | Human |
329815088 | LOC130066102 | ATAC-STARR-seq lymphoblastoid silent region 13002 | 20 | 49713351 | 49713470 | Human |
329825158 | LOC130066103 | ATAC-STARR-seq lymphoblastoid silent region 13003 | 20 | 49713761 | 49714090 | Human |
10400064 | RN7SL197P | RNA, 7SL, cytoplasmic 197, pseudogene | 20 | 49721949 | 49722247 | Human |
152975870 | LOC125387285 | Sharpr-MPRA regulatory region 10962 | 20 | 49727712 | 49728006 | Human |
1342723 | SNRPFP1 | small nuclear ribonucleoprotein polypeptide F pseudogene 1 | 20 | 49729572 | 49729939 | Human |
329816856 | LOC130066104 | ATAC-STARR-seq lymphoblastoid active region 18068 | 20 | 49750833 | 49750922 | Human |
155768849 | LOC127893618 | H3K27ac hESC enhancer GRCh37_chr20:48376629-48377128 | 20 | 49760092 | 49760591 | Human |
38671181 | LOC105372652 | uncharacterized LOC105372652 | 20 | 49764657 | 49775371 | Human |
155754448 | LOC127893619 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48385061-48385910 | 20 | 49768524 | 49769373 | Human |
155763478 | LOC127893620 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48385911-48386759 | 20 | 49769374 | 49770222 | Human |
155775819 | LOC127893621 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48388387-48389025 | 20 | 49771850 | 49772488 | Human |
329343062 | LOC129664643 | ReSE screen-validated silencer GRCh37_chr20:48391876-48392024 | 20 | 49775339 | 49775487 | Human |
155767427 | LOC127893622 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48400170-48400693 | 20 | 49783633 | 49784156 | Human |
329824645 | LOC130066105 | ATAC-STARR-seq lymphoblastoid active region 18069 | 20 | 49785683 | 49785922 | Human |
10399125 | RNU6-919P | RNA, U6 small nuclear 919, pseudogene | 20 | 49794811 | 49794914 | Human |
329836285 | LOC130066106 | ATAC-STARR-seq lymphoblastoid active region 18070 | 20 | 49802941 | 49803070 | Human |
329819105 | LOC130066107 | ATAC-STARR-seq lymphoblastoid active region 18071 | 20 | 49805109 | 49805168 | Human |
329823396 | LOC130066108 | ATAC-STARR-seq lymphoblastoid active region 18072 | 20 | 49805249 | 49805298 | Human |
329819001 | LOC130066109 | ATAC-STARR-seq lymphoblastoid active region 18073 | 20 | 49805399 | 49805488 | Human |
329845338 | LOC130066110 | ATAC-STARR-seq lymphoblastoid active region 18074 | 20 | 49812507 | 49812646 | Human |
329822892 | LOC130066111 | ATAC-STARR-seq lymphoblastoid silent region 13004 | 20 | 49812797 | 49813076 | Human |
1317829 | SLC9A8 | solute carrier family 9 member A8 | 20 | 49812828 | 49892242 | Human |
2293227 | RNU7-72P | RNA, U7 small nuclear 72 pseudogene | 20 | 49827996 | 49828052 | Human |
38647306 | GLYR1P1 | GLYR1 pseudogene 1 | 20 | 49829102 | 49831365 | Human |
155764926 | LOC127893623 | H3K4me1 hESC enhancer GRCh37_chr20:48452608-48453108 | 20 | 49836071 | 49836571 | Human |
155776616 | LOC127893624 | H3K4me1 hESC enhancer GRCh37_chr20:48453109-48453609 | 20 | 49836572 | 49837072 | Human |
14398547 | MIR12122 | microRNA 12122 | 20 | 49863859 | 49863953 | Human |
329837030 | LOC130066112 | ATAC-STARR-seq lymphoblastoid active region 18075 | 20 | 49867750 | 49867859 | Human |
329828266 | LOC130066113 | ATAC-STARR-seq lymphoblastoid active region 18076 | 20 | 49868100 | 49868149 | Human |
155764872 | LOC127893625 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48504605-48505416 | 20 | 49888068 | 49888879 | Human |
155755865 | LOC127893626 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48505417-48506228 | 20 | 49888880 | 49889691 | Human |
401825907 | LOC132090586 | Neanderthal introgressed variant-containing enhancer experimental_60689 | 20 | 49890766 | 49890935 | Human |
401825144 | LOC132090587 | Neanderthal introgressed variant-containing enhancer experimental_60693 | 20 | 49894567 | 49894736 | Human |
731260 | SPATA2 | spermatogenesis associated 2 | 20 | 49903391 | 49915529 | Human |
149735417 | LOC121853012 | Sharpr-MPRA regulatory region 10189 | 20 | 49909912 | 49910206 | Human |
401824847 | LOC132090588 | Neanderthal introgressed variant-containing enhancer experimental_60705 | 20 | 49914547 | 49914716 | Human |
329815898 | LOC130066114 | ATAC-STARR-seq lymphoblastoid silent region 13006 | 20 | 49915231 | 49915480 | Human |
329824370 | LOC130066115 | ATAC-STARR-seq lymphoblastoid active region 18077 | 20 | 49915511 | 49915570 | Human |
38664652 | LOC105372653 | uncharacterized LOC105372653 | 20 | 49915822 | 49928821 | Human |
401826544 | LOC132090589 | Neanderthal introgressed variant-containing enhancer experimental_60723 | 20 | 49925611 | 49925780 | Human |
152975798 | LOC125387286 | Sharpr-MPRA regulatory region 9917 | 20 | 49928692 | 49928986 | Human |
329338547 | LOC129391188 | MPRA-validated peak4247 silencer | 20 | 49933959 | 49934159 | Human |
329821909 | LOC130066116 | ATAC-STARR-seq lymphoblastoid silent region 13007 | 20 | 49935598 | 49935677 | Human |
155768920 | LOC127893627 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48552583-48553188 | 20 | 49936046 | 49936651 | Human |
1349716 | RNF114 | ring finger protein 114 | 20 | 49936397 | 49953885 | Human |
152975756 | LOC125387287 | Sharpr-MPRA regulatory region 103 | 20 | 49936892 | 49937186 | Human |
152975916 | LOC125387288 | Sharpr-MPRA regulatory region 7979 | 20 | 49937472 | 49937766 | Human |
152975857 | LOC125387289 | Sharpr-MPRA regulatory region 5689 | 20 | 49939392 | 49939686 | Human |
151675702 | LOC124904976 | small nucleolar RNA U13 | 20 | 49940296 | 49940400 | Human |
401825913 | LOC132090590 | Neanderthal introgressed variant-containing enhancer experimental_60738 | 20 | 49942765 | 49942934 | Human |
1351868 | KRT18P4 | keratin 18 pseudogene 4 | 20 | 49956699 | 49958087 | Human |
152975703 | LOC125387290 | Sharpr-MPRA regulatory region 11781 | 20 | 49957032 | 49957444 | Human |
401825048 | LOC132090591 | Neanderthal introgressed variant-containing enhancer experimental_60755 | 20 | 49965132 | 49965301 | Human |
155763540 | LOC127893628 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48582740-48583331 | 20 | 49966203 | 49966794 | Human |
155769052 | LOC127893629 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48583332-48583922 | 20 | 49966795 | 49967385 | Human |
10398886 | RNU6-147P | RNA, U6 small nuclear 147, pseudogene | 20 | 49972106 | 49972212 | Human |
329824811 | LOC130066117 | ATAC-STARR-seq lymphoblastoid silent region 13009 | 20 | 49979154 | 49979213 | Human |
329822990 | LOC130066118 | ATAC-STARR-seq lymphoblastoid silent region 13010 | 20 | 49979314 | 49979413 | Human |
155778910 | LOC127893630 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48597922-48598859 | 20 | 49981385 | 49982322 | Human |
329815714 | LOC130066119 | ATAC-STARR-seq lymphoblastoid silent region 13011 | 20 | 49982475 | 49982994 | Human |
1347076 | SNAI1 | snail family transcriptional repressor 1 | 20 | 49982980 | 49988886 | Human |
155779755 | LOC127893631 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48606199-48606951 | 20 | 49989662 | 49990414 | Human |
329833795 | LOC130066120 | ATAC-STARR-seq lymphoblastoid active region 18079 | 20 | 49999266 | 49999385 | Human |
329817949 | LOC130066121 | ATAC-STARR-seq lymphoblastoid active region 18080 | 20 | 49999436 | 49999815 | Human |
155775321 | LOC127893632 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48632321-48633048 | 20 | 50015784 | 50016511 | Human |
155758954 | LOC127893633 | H3K4me1 hESC enhancer GRCh37_chr20:48643875-48644714 | 20 | 50027338 | 50028177 | Human |
155759880 | LOC127893634 | H3K4me1 hESC enhancer GRCh37_chr20:48644715-48645552 | 20 | 50028178 | 50029015 | Human |
38657269 | SCREEM1 | SNAI1 cis-regulatory eRNA expressed in monocytes 1 | 20 | 50029091 | 50030477 | Human |
155759077 | LOC127893635 | H3K4me1 hESC enhancer GRCh37_chr20:48646392-48647229 | 20 | 50029855 | 50030692 | Human |
6893025 | TRERNA1 | translation regulatory long non-coding RNA 1 | 20 | 50040707 | 50041629 | Human |
329815833 | LOC130066122 | ATAC-STARR-seq lymphoblastoid active region 18081 | 20 | 50041395 | 50041594 | Human |
155767657 | LOC127893636 | H3K4me1 hESC enhancer GRCh37_chr20:48660109-48661056 | 20 | 50043572 | 50044519 | Human |
155773879 | LOC127893637 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48666284-48667078 | 20 | 50049747 | 50050541 | Human |
38618020 | LOC105372655 | uncharacterized LOC105372655 | 20 | 50053015 | 50057564 | Human |
155781060 | LOC127893638 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48671143-48671728 | 20 | 50054606 | 50055191 | Human |
329838449 | LOC130066123 | ATAC-STARR-seq lymphoblastoid active region 18082 | 20 | 50056889 | 50056978 | Human |
329338887 | LOC129664644 | ReSE screen-validated silencer GRCh37_chr20:48681498-48681675 | 20 | 50064961 | 50065138 | Human |
329828665 | LOC130066124 | ATAC-STARR-seq lymphoblastoid silent region 13012 | 20 | 50071320 | 50071559 | Human |
155770090 | LOC127893639 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48689593-48690102 | 20 | 50073056 | 50073565 | Human |
155779299 | LOC127893640 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48690103-48690612 | 20 | 50073566 | 50074075 | Human |
1346082 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 20 | 50081124 | 50115957 | Human |
1603241 | PEDS1-UBE2V1 | PEDS1-UBE2V1 readthrough | 20 | 50081124 | 50153723 | Human |
155779530 | LOC127893641 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:48715799-48716462 | 20 | 50099262 | 50099925 | Human |
329819874 | LOC130066125 | ATAC-STARR-seq lymphoblastoid silent region 13013 | 20 | 50112678 | 50113217 | Human |
329820333 | LOC130066126 | ATAC-STARR-seq lymphoblastoid active region 18083 | 20 | 50113388 | 50113497 | Human |
155775082 | LOC127893642 | H3K27ac hESC enhancer GRCh37_chr20:48730039-48730606 | 20 | 50113502 | 50114069 | Human |
329344250 | LOC129664645 | ReSE screen-validated silencer GRCh37_chr20:48732458-48732614 | 20 | 50115921 | 50116077 | Human |
1603242 | PEDS1 | plasmanylethanolamine desaturase 1 | 20 | 50118254 | 50153723 | Human |
155781137 | LOC127893643 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48754882-48755569 | 20 | 50138345 | 50139032 | Human |
151670247 | LOC124904927 | putative uncharacterized protein CCDC28A-AS1 | 20 | 50143729 | 50143893 | Human |
155772765 | LOC127893644 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48760275-48760910 | 20 | 50143738 | 50144373 | Human |
329833813 | LOC130066127 | ATAC-STARR-seq lymphoblastoid silent region 13014 | 20 | 50153477 | 50154156 | Human |
155229682 | LOC126863044 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:48782079-48783278 | 20 | 50165542 | 50166741 | Human |
155773664 | LOC127893645 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48788805-48789306 | 20 | 50172268 | 50172769 | Human |
8552573 | LINC01273 | long intergenic non-protein coding RNA 1273 | 20 | 50172570 | 50176671 | Human |
155767360 | LOC127893646 | H3K4me1 hESC enhancer GRCh37_chr20:48795707-48796206 | 20 | 50179170 | 50179669 | Human |
8699406 | CEBPB-AS1 | CEBPB antisense RNA 1 | 20 | 50184603 | 50192069 | Human |
329833556 | LOC130066128 | ATAC-STARR-seq lymphoblastoid active region 18084 | 20 | 50186595 | 50186684 | Human |
329826716 | LOC130066129 | ATAC-STARR-seq lymphoblastoid silent region 13015 | 20 | 50190363 | 50190772 | Human |
736208 | CEBPB | CCAAT enhancer binding protein beta | 20 | 50190583 | 50192690 | Human |
152975730 | LOC125387291 | Sharpr-MPRA regulatory region 92 | 20 | 50190732 | 50191062 | Human |
329817313 | LOC130066130 | ATAC-STARR-seq lymphoblastoid silent region 13017 | 20 | 50191203 | 50191642 | Human |
329828542 | LOC130066131 | ATAC-STARR-seq lymphoblastoid silent region 13018 | 20 | 50192063 | 50192172 | Human |
155762258 | LOC127893647 | H3K4me1 hESC enhancer GRCh37_chr20:48810074-48810635 | 20 | 50193537 | 50194098 | Human |
155764184 | LOC127893648 | H3K4me1 hESC enhancer GRCh37_chr20:48814475-48814992 | 20 | 50197938 | 50198455 | Human |
155775720 | LOC127893649 | H3K4me1 hESC enhancer GRCh37_chr20:48814993-48815508 | 20 | 50198456 | 50198971 | Human |
155759652 | LOC127893650 | H3K4me1 hESC enhancer GRCh37_chr20:48840734-48841234 | 20 | 50224197 | 50224697 | Human |
155762161 | LOC127893651 | H3K4me1 hESC enhancer GRCh37_chr20:48841235-48841735 | 20 | 50224698 | 50225198 | Human |
127284914 | LOC121627907 | Sharpr-MPRA regulatory region 4966 | 20 | 50226552 | 50226846 | Human |
38604758 | LOC107985386 | uncharacterized LOC107985386 | 20 | 50238454 | 50247491 | Human |
38674892 | LOC105372656 | uncharacterized LOC105372656 | 20 | 50252674 | 50264246 | Human |
329329633 | LOC129391189 | MPRA-validated peak4248 silencer | 20 | 50262218 | 50262418 | Human |
8552421 | PELATON | plaque enriched lncRNA in atherosclerotic and inflammatory bowel macrophage regulation | 20 | 50267478 | 50279788 | Human |
155781437 | LOC127893652 | H3K4me1 hESC enhancer GRCh37_chr20:48891163-48891664 | 20 | 50274626 | 50275127 | Human |
155760976 | LOC127893653 | H3K4me1 hESC enhancer GRCh37_chr20:48891665-48892164 | 20 | 50275128 | 50275627 | Human |
155778848 | LOC127893654 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48894009-48894546 | 20 | 50277472 | 50278009 | Human |
127284963 | LOC121627908 | Sharpr-MPRA regulatory region 10045 | 20 | 50279012 | 50279306 | Human |
329817619 | LOC130066132 | ATAC-STARR-seq lymphoblastoid silent region 13019 | 20 | 50285867 | 50285916 | Human |
155780231 | LOC127893655 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48908810-48909546 | 20 | 50292273 | 50293009 | Human |
4108149 | LINC01270 | long intergenic non-protein coding RNA 1270 | 20 | 50292720 | 50314919 | Human |
155763919 | LOC127893656 | H3K4me1 hESC enhancer GRCh37_chr20:48910660-48911160 | 20 | 50294123 | 50294623 | Human |
155757904 | LOC127893657 | H3K4me1 hESC enhancer GRCh37_chr20:48921517-48922292 | 20 | 50304980 | 50305755 | Human |
152975802 | LOC125387293 | Sharpr-MPRA regulatory region 5066 | 20 | 50306052 | 50306346 | Human |
155770117 | LOC127893658 | H3K4me1 hESC enhancer GRCh37_chr20:48925071-48925582 | 20 | 50308534 | 50309045 | Human |
155767634 | LOC127893659 | H3K4me1 hESC enhancer GRCh37_chr20:48925583-48926093 | 20 | 50309046 | 50309556 | Human |
8552501 | LINC01271 | long intergenic non-protein coding RNA 1271 | 20 | 50310711 | 50321342 | Human |
155781050 | LOC127893660 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48937461-48938045 | 20 | 50320924 | 50321508 | Human |
155750564 | LOC127893661 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48938046-48938631 | 20 | 50321509 | 50322094 | Human |
155755058 | LOC127893662 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:48938632-48939216 | 20 | 50322095 | 50322679 | Human |
329813743 | LOC130066133 | ATAC-STARR-seq lymphoblastoid active region 18085 | 20 | 50339114 | 50339313 | Human |
329816306 | LOC130066134 | ATAC-STARR-seq lymphoblastoid active region 18086 | 20 | 50350455 | 50350504 | Human |
38622962 | LOC105372657 | uncharacterized LOC105372657 | 20 | 50350698 | 50368866 | Human |
329338852 | LOC129664646 | ReSE screen-validated silencer GRCh37_chr20:48971862-48972074 | 20 | 50355325 | 50355537 | Human |
329342815 | LOC129391190 | MPRA-validated peak4249 silencer | 20 | 50372179 | 50372379 | Human |
155778570 | LOC127893663 | H3K27ac hESC enhancer GRCh37_chr20:48990074-48990574 | 20 | 50373537 | 50374037 | Human |
329344039 | LOC129664647 | ReSE screen-validated silencer GRCh37_chr20:48995605-48996033 | 20 | 50379068 | 50379496 | Human |
151675861 | LOC124904928 | uncharacterized LOC124904928 | 20 | 50385626 | 50387670 | Human |
152975889 | LOC125387294 | Sharpr-MPRA regulatory region 2765 | 20 | 50413132 | 50413426 | Human |
329343116 | LOC129391191 | MPRA-validated peak4252 silencer | 20 | 50417859 | 50418059 | Human |
10399569 | RN7SL636P | RNA, 7SL, cytoplasmic 636, pseudogene | 20 | 50429190 | 50429483 | Human |
152975883 | LOC125387295 | Sharpr-MPRA regulatory region 10608 | 20 | 50435632 | 50435926 | Human |
155229611 | LOC126863045 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:49056367-49057566 | 20 | 50439830 | 50441029 | Human |
155777943 | LOC127893664 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49065061-49066026 | 20 | 50448524 | 50449489 | Human |
155773000 | LOC127893665 | H3K4me1 hESC enhancer GRCh37_chr20:49074250-49074778 | 20 | 50457713 | 50458241 | Human |
155757987 | LOC127893666 | H3K4me1 hESC enhancer GRCh37_chr20:49076728-49077228 | 20 | 50460191 | 50460691 | Human |
329829699 | LOC130066135 | ATAC-STARR-seq lymphoblastoid silent region 13020 | 20 | 50460903 | 50461022 | Human |
1352296 | COX6CP2 | cytochrome c oxidase subunit 6C pseudogene 2 | 20 | 50479693 | 50480105 | Human |
329838959 | LOC130066136 | ATAC-STARR-seq lymphoblastoid active region 18087 | 20 | 50483782 | 50483831 | Human |
329833164 | LOC130066137 | ATAC-STARR-seq lymphoblastoid active region 18088 | 20 | 50483872 | 50483981 | Human |
329815979 | LOC130066138 | ATAC-STARR-seq lymphoblastoid active region 18089 | 20 | 50498451 | 50498520 | Human |
329832359 | LOC130066139 | ATAC-STARR-seq lymphoblastoid active region 18090 | 20 | 50499683 | 50499912 | Human |
127284915 | LOC121627909 | Sharpr-MPRA regulatory region 4283 | 20 | 50504292 | 50504586 | Human |
155761609 | LOC127893667 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49126094-49126681 | 20 | 50509557 | 50510246 | Human |
329825482 | LOC130066140 | ATAC-STARR-seq lymphoblastoid active region 18091 | 20 | 50510357 | 50510456 | Human |
1343639 | PTPN1 | protein tyrosine phosphatase non-receptor type 1 | 20 | 50510383 | 50585241 | Human |
329824580 | LOC130066141 | ATAC-STARR-seq lymphoblastoid silent region 13022 | 20 | 50520626 | 50520675 | Human |
155227983 | LOC126863046 | BRD4-independent group 4 enhancer GRCh37_chr20:49157072-49158271 | 20 | 50540535 | 50542082 | Human |
152975938 | LOC125387296 | Sharpr-MPRA regulatory region 13607 | 20 | 50554212 | 50554506 | Human |
10399688 | RN7SL672P | RNA, 7SL, cytoplasmic 672, pseudogene | 20 | 50557682 | 50557997 | Human |
155229007 | LOC126863047 | MED14-independent group 3 enhancer GRCh37_chr20:49177610-49178809 | 20 | 50561073 | 50562272 | Human |
1602910 | MIR645 | microRNA 645 | 20 | 50585786 | 50585879 | Human |
1313101 | RIPOR3 | RIPOR family member 3 | 20 | 50586108 | 50691542 | Human |
155752625 | LOC127893668 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49202858-49203371 | 20 | 50586321 | 50586834 | Human |
155750933 | LOC127893669 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49203372-49203884 | 20 | 50586835 | 50587347 | Human |
152975957 | LOC125387297 | Sharpr-MPRA regulatory region 3633 | 20 | 50588132 | 50588426 | Human |
155773086 | LOC127893670 | H3K4me1 hESC enhancer GRCh37_chr20:49218491-49218991 | 20 | 50601954 | 50602454 | Human |
155778451 | LOC127893671 | H3K4me1 hESC enhancer GRCh37_chr20:49227064-49227564 | 20 | 50610527 | 50611027 | Human |
2312973 | MIR1302-5 | microRNA 1302-5 | 20 | 50614636 | 50614785 | Human |
155770236 | LOC127893672 | H3K4me1 hESC enhancer GRCh37_chr20:49233537-49234037 | 20 | 50617000 | 50617500 | Human |
1350263 | RPL36P2 | ribosomal protein L36 pseudogene 2 | 20 | 50620726 | 50621124 | Human |
155751450 | LOC127893673 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49241541-49242502 | 20 | 50625004 | 50625965 | Human |
155768147 | LOC127893674 | H3K4me1 hESC enhancer GRCh37_chr20:49245378-49245975 | 20 | 50628841 | 50629438 | Human |
155782618 | LOC127893675 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49256745-49257440 | 20 | 50640208 | 50640903 | Human |
155760026 | LOC127893676 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49261035-49261616 | 20 | 50644498 | 50645079 | Human |
21410121 | RIPOR3-AS1 | RIPOR3 antisense RNA 1 | 20 | 50645471 | 50660291 | Human |
155779408 | LOC127893677 | H3K4me1 hESC enhancer GRCh37_chr20:49282430-49282930 | 20 | 50665893 | 50666393 | Human |
155766541 | LOC127893678 | H3K4me1 hESC enhancer GRCh37_chr20:49282931-49283431 | 20 | 50666394 | 50666894 | Human |
38636619 | LOC105372659 | uncharacterized LOC105372659 | 20 | 50667213 | 50674420 | Human |
38630855 | LOC110121454 | VISTA enhancer hs1860 | 20 | 50689770 | 50692625 | Human |
329340404 | LOC129664648 | ReSE screen-validated silencer GRCh37_chr20:49313764-49313925 | 20 | 50697227 | 50697388 | Human |
155779205 | LOC127893679 | H3K4me1 hESC enhancer GRCh37_chr20:49320243-49320744 | 20 | 50703706 | 50704207 | Human |
155773138 | LOC127893680 | H3K4me1 hESC enhancer GRCh37_chr20:49320745-49321244 | 20 | 50704208 | 50704707 | Human |
38658322 | LOC116286209 | CRISPRi-validated cis-regulatory element chr20.2420 | 20 | 50711196 | 50711384 | Human |
329819668 | LOC130066142 | ATAC-STARR-seq lymphoblastoid silent region 13023 | 20 | 50727465 | 50727574 | Human |
329815399 | LOC130066143 | ATAC-STARR-seq lymphoblastoid active region 18094 | 20 | 50730683 | 50730732 | Human |
329814088 | LOC130066144 | ATAC-STARR-seq lymphoblastoid silent region 13024 | 20 | 50730923 | 50731132 | Human |
329844282 | LOC130066145 | ATAC-STARR-seq lymphoblastoid silent region 13025 | 20 | 50731233 | 50732022 | Human |
1317848 | PARD6B | par-6 family cell polarity regulator beta | 20 | 50731580 | 50753741 | Human |
155777130 | LOC127893681 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:49353859-49354534 | 20 | 50737322 | 50737997 | Human |
155770280 | LOC127893682 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49406827-49407512 | 20 | 50790290 | 50790975 | Human |
329817479 | LOC130066146 | ATAC-STARR-seq lymphoblastoid silent region 13026 | 20 | 50794794 | 50795613 | Human |
1352594 | BCAS4 | breast carcinoma amplified sequence 4 | 20 | 50794894 | 50882676 | Human |
329820716 | LOC130066147 | ATAC-STARR-seq lymphoblastoid active region 18095 | 20 | 50798911 | 50798990 | Human |
329835447 | LOC130066148 | ATAC-STARR-seq lymphoblastoid active region 18096 | 20 | 50799491 | 50799600 | Human |
329816158 | LOC130066149 | ATAC-STARR-seq lymphoblastoid active region 18097 | 20 | 50799621 | 50799680 | Human |
329826875 | LOC130066150 | ATAC-STARR-seq lymphoblastoid active region 18098 | 20 | 50800221 | 50800330 | Human |
329836223 | LOC130066151 | ATAC-STARR-seq lymphoblastoid active region 18099 | 20 | 50810273 | 50810332 | Human |
329831694 | LOC130066152 | ATAC-STARR-seq lymphoblastoid silent region 13027 | 20 | 50812348 | 50812397 | Human |
329842986 | LOC130066153 | ATAC-STARR-seq lymphoblastoid silent region 13028 | 20 | 50813931 | 50813980 | Human |
329834205 | LOC130066154 | ATAC-STARR-seq lymphoblastoid active region 18100 | 20 | 50815045 | 50815094 | Human |
329833354 | LOC130066155 | ATAC-STARR-seq lymphoblastoid active region 18101 | 20 | 50815155 | 50815324 | Human |
329824671 | LOC130066156 | ATAC-STARR-seq lymphoblastoid active region 18102 | 20 | 50818726 | 50818775 | Human |
329841643 | LOC130066157 | ATAC-STARR-seq lymphoblastoid active region 18103 | 20 | 50818786 | 50818835 | Human |
329826476 | LOC130066158 | ATAC-STARR-seq lymphoblastoid active region 18104 | 20 | 50819323 | 50819372 | Human |
155771037 | LOC127893683 | H3K4me1 hESC enhancer GRCh37_chr20:49436893-49437394 | 20 | 50820356 | 50820857 | Human |
329828271 | LOC130066159 | ATAC-STARR-seq lymphoblastoid active region 18105 | 20 | 50821922 | 50822251 | Human |
155780566 | LOC127893684 | H3K4me1 hESC enhancer GRCh37_chr20:49450347-49450846 | 20 | 50833810 | 50834309 | Human |
155764785 | LOC127893685 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49453840-49454668 | 20 | 50837303 | 50838131 | Human |
1605429 | TMSB4XP6 | TMSB4X pseudogene 6 | 20 | 50840219 | 50840824 | Human |
329839725 | LOC130066160 | ATAC-STARR-seq lymphoblastoid active region 18106 | 20 | 50844701 | 50845180 | Human |
155772624 | LOC127893686 | H3K4me1 hESC enhancer GRCh37_chr20:49464983-49465591 | 20 | 50848446 | 50849054 | Human |
155773407 | LOC127893687 | H3K4me1 hESC enhancer GRCh37_chr20:49465592-49466199 | 20 | 50849055 | 50849662 | Human |
155771610 | LOC127893688 | H3K4me1 hESC enhancer GRCh37_chr20:49477383-49477904 | 20 | 50860846 | 50861367 | Human |
155774877 | LOC127893689 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49479088-49479680 | 20 | 50862551 | 50863143 | Human |
155758841 | LOC127893690 | H3K4me1 hESC enhancer GRCh37_chr20:49480032-49480778 | 20 | 50863495 | 50864241 | Human |
151671493 | LOC124904929 | uncharacterized LOC124904929 | 20 | 50866492 | 50876011 | Human |
155780510 | LOC127893691 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49486444-49487157 | 20 | 50869907 | 50870620 | Human |
155777564 | LOC127893692 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49487158-49487870 | 20 | 50870621 | 50871333 | Human |
155777374 | LOC127893693 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49488585-49489297 | 20 | 50872048 | 50872760 | Human |
155761536 | LOC127893694 | H3K4me1 hESC enhancer GRCh37_chr20:49491439-49492150 | 20 | 50874902 | 50875613 | Human |
155774339 | LOC127893695 | H3K4me1 hESC enhancer GRCh37_chr20:49492678-49493258 | 20 | 50876141 | 50876721 | Human |
155782053 | LOC127893696 | H3K4me1 hESC enhancer GRCh37_chr20:49495917-49496418 | 20 | 50879380 | 50879881 | Human |
155771846 | LOC127893697 | H3K4me1 hESC enhancer GRCh37_chr20:49496419-49496918 | 20 | 50879882 | 50880381 | Human |
737453 | ADNP | activity dependent neuroprotector homeobox | 20 | 50888918 | 50931437 | Human |
329839643 | LOC130066161 | ATAC-STARR-seq lymphoblastoid silent region 13031 | 20 | 50911978 | 50912137 | Human |
1343089 | PSMD10P1 | proteasome 26S subunit, non-ATPase, 10 pseudogene 1 | 20 | 50913715 | 50914595 | Human |
155750301 | LOC127893698 | H3K4me1 hESC enhancer GRCh37_chr20:49541986-49542486 | 20 | 50925449 | 50925949 | Human |
155774497 | LOC127893699 | H3K4me1 hESC enhancer GRCh37_chr20:49542487-49542987 | 20 | 50925950 | 50926450 | Human |
329834983 | LOC130066162 | ATAC-STARR-seq lymphoblastoid silent region 13032 | 20 | 50929572 | 50929621 | Human |
329814338 | LOC130066163 | ATAC-STARR-seq lymphoblastoid silent region 13033 | 20 | 50929652 | 50929701 | Human |
155751749 | LOC127893700 | H3K27ac hESC enhancer GRCh37_chr20:49546803-49547593 | 20 | 50930266 | 50931056 | Human |
9068737 | ADNP-AS1 | ADNP antisense RNA 1 | 20 | 50930984 | 50945134 | Human |
329818703 | LOC130066164 | ATAC-STARR-seq lymphoblastoid silent region 13036 | 20 | 50931176 | 50931395 | Human |
329822767 | LOC130066165 | ATAC-STARR-seq lymphoblastoid active region 18107 | 20 | 50931476 | 50931595 | Human |
329338151 | LOC129664649 | ReSE screen-validated silencer GRCh37_chr20:49548232-49548419 | 20 | 50931695 | 50931925 | Human |
1320840 | DPM1 | dolichyl-phosphate mannosyltransferase subunit 1, catalytic | 20 | 50934855 | 50958564 | Human |
329841389 | LOC130066166 | ATAC-STARR-seq lymphoblastoid active region 18108 | 20 | 50958289 | 50958778 | Human |
1316006 | MOCS3 | molybdenum cofactor synthesis 3 | 20 | 50958818 | 50963929 | Human |
155780154 | LOC127893701 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49575528-49576138 | 20 | 50958991 | 50959601 | Human |
155782082 | LOC127893702 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49606180-49607142 | 20 | 50989643 | 50990605 | Human |
38645725 | LOC112694721 | Sharpr-MPRA regulatory region 8647 | 20 | 50993112 | 50993406 | Human |
1604067 | KCNG1 | potassium voltage-gated channel modifier subfamily G member 1 | 20 | 51003656 | 51023107 | Human |
155772715 | LOC127893703 | H3K4me1 hESC enhancer GRCh37_chr20:49620535-49621036 | 20 | 51003998 | 51004499 | Human |
155776927 | LOC127893704 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49637285-49637848 | 20 | 51020748 | 51021311 | Human |
329836149 | LOC130066167 | ATAC-STARR-seq lymphoblastoid silent region 13038 | 20 | 51023036 | 51023205 | Human |
155763985 | LOC127893705 | H3K27ac hESC enhancer GRCh37_chr20:49651184-49652168 | 20 | 51034647 | 51035631 | Human |
155765948 | LOC127893707 | H3K4me1 hESC enhancer GRCh37_chr20:49693483-49693982 | 20 | 51076946 | 51077445 | Human |
155759887 | LOC127893708 | NANOG hESC enhancer GRCh37_chr20:49703630-49704209 | 20 | 51087093 | 51087672 | Human |
155764085 | LOC127893709 | H3K27ac hESC enhancer GRCh37_chr20:49709053-49710038 | 20 | 51092516 | 51093501 | Human |
38601173 | LOC105372661 | uncharacterized LOC105372661 | 20 | 51117390 | 51143022 | Human |
155781011 | LOC127893710 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:49735490-49736325 | 20 | 51118953 | 51119788 | Human |
38627147 | LOC105372662 | uncharacterized LOC105372662 | 20 | 51119642 | 51124876 | Human |
155763526 | LOC127893711 | H3K4me1 hESC enhancer GRCh37_chr20:49737507-49738012 | 20 | 51120970 | 51121475 | Human |
1346846 | RPSAP1 | ribosomal protein SA pseudogene 1 | 20 | 51130704 | 51131743 | Human |
329844130 | LOC130066168 | ATAC-STARR-seq lymphoblastoid silent region 13039 | 20 | 51220309 | 51220368 | Human |
329841912 | LOC130066169 | ATAC-STARR-seq lymphoblastoid silent region 13040 | 20 | 51220429 | 51220478 | Human |
155757668 | LOC127893712 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49838165-49838839 | 20 | 51221628 | 51222302 | Human |
155775892 | LOC127893713 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49838840-49839513 | 20 | 51222303 | 51222976 | Human |
155778035 | LOC127893714 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49853584-49854170 | 20 | 51237047 | 51237633 | Human |
155228200 | LOC126863049 | BRD4-independent group 4 enhancer GRCh37_chr20:49874837-49876036 | 20 | 51258300 | 51259499 | Human |
155752062 | LOC127893715 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:49922777-49923737 | 20 | 51306240 | 51307200 | Human |
155759578 | LOC127893716 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:49927461-49928450 | 20 | 51310924 | 51311913 | Human |
155774873 | LOC127893717 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:49928451-49929439 | 20 | 51311914 | 51312902 | Human |
155770839 | LOC127893718 | H3K4me1 hESC enhancer GRCh37_chr20:49938175-49938676 | 20 | 51321638 | 51322139 | Human |
155768098 | LOC127893719 | H3K4me1 hESC enhancer GRCh37_chr20:49944615-49945493 | 20 | 51328078 | 51328956 | Human |
151674716 | LOC124904930 | uncharacterized LOC124904930 | 20 | 51345798 | 51354226 | Human |
127284947 | LOC121627910 | Sharpr-MPRA regulatory region 14118 | 20 | 51366212 | 51366506 | Human |
38656060 | LOC105372663 | uncharacterized LOC105372663 | 20 | 51366435 | 51396989 | Human |
1317023 | NFATC2 | nuclear factor of activated T cells 2 | 20 | 51386963 | 51562839 | Human |
329839070 | LOC130066170 | ATAC-STARR-seq lymphoblastoid active region 18109 | 20 | 51400446 | 51400915 | Human |
329818588 | LOC130066171 | ATAC-STARR-seq lymphoblastoid active region 18110 | 20 | 51404887 | 51405046 | Human |
152975701 | LOC125387298 | Sharpr-MPRA regulatory region 9422 | 20 | 51418192 | 51418486 | Human |
155767841 | LOC127893720 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50039818-50040650 | 20 | 51423281 | 51424113 | Human |
155753917 | LOC127893721 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50041537-50042129 | 20 | 51425000 | 51425592 | Human |
329817330 | LOC130066172 | ATAC-STARR-seq lymphoblastoid active region 18111 | 20 | 51425585 | 51425634 | Human |
155229232 | LOC126863050 | MED14-independent group 3 enhancer GRCh37_chr20:50051304-50052503 | 20 | 51434767 | 51435966 | Human |
127284969 | LOC121627911 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:50063011-50064210 | 20 | 51446474 | 51447673 | Human |
155781347 | LOC127893722 | H3K4me1 hESC enhancer GRCh37_chr20:50067417-50067918 | 20 | 51450880 | 51451381 | Human |
4109018 | MIR3194 | microRNA 3194 | 20 | 51452905 | 51452977 | Human |
155776179 | LOC127893723 | H3K4me1 hESC enhancer GRCh37_chr20:50072771-50073376 | 20 | 51456234 | 51456839 | Human |
155769613 | LOC127893724 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50079139-50080099 | 20 | 51462602 | 51463562 | Human |
155228890 | LOC126863051 | MED14-independent group 3 enhancer GRCh37_chr20:50103914-50105113 | 20 | 51487377 | 51488576 | Human |
155755864 | LOC127882580 | H3K4me1 hESC enhancer GRCh37_chr20:50105077-50105578 | 20 | 51488540 | 51489040 | Human |
329831072 | LOC130066173 | ATAC-STARR-seq lymphoblastoid active region 18112 | 20 | 51497572 | 51497701 | Human |
329843890 | LOC130066174 | ATAC-STARR-seq lymphoblastoid active region 18113 | 20 | 51531211 | 51531260 | Human |
329813387 | LOC130066175 | ATAC-STARR-seq lymphoblastoid active region 18114 | 20 | 51531301 | 51531470 | Human |
155226977 | LOC126863052 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:50149441-50150640 | 20 | 51532902 | 51534101 | Human |
155756966 | LOC127893725 | H3K4me1 hESC enhancer GRCh37_chr20:50157559-50158228 | 20 | 51541020 | 51541689 | Human |
329817638 | LOC130066176 | ATAC-STARR-seq lymphoblastoid silent region 13041 | 20 | 51542454 | 51542563 | Human |
329844984 | LOC130066177 | ATAC-STARR-seq lymphoblastoid silent region 13042 | 20 | 51542574 | 51542733 | Human |
155765220 | LOC127893726 | H3K4me1 hESC enhancer GRCh37_chr20:50186888-50187388 | 20 | 51570349 | 51570849 | Human |
735480 | ATP9A | ATPase phospholipid transporting 9A (putative) | 20 | 51596514 | 51768390 | Human |
155230371 | LOC126863053 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:50224727-50225926 | 20 | 51608188 | 51609387 | Human |
329338295 | LOC129664650 | ReSE screen-validated silencer GRCh37_chr20:50226387-50226540 | 20 | 51609848 | 51610001 | Human |
155766294 | LOC127893727 | H3K4me1 hESC enhancer GRCh37_chr20:50240809-50241341 | 20 | 51624270 | 51624802 | Human |
155229627 | LOC126863054 | BRD4-independent group 4 enhancer GRCh37_chr20:50247413-50248612 | 20 | 51630874 | 51632073 | Human |
149735416 | LOC121853013 | Sharpr-MPRA regulatory region 9373 | 20 | 51639270 | 51639564 | Human |
155775791 | LOC127893569 | H3K4me1 hESC enhancer GRCh37_chr20:47118417-47119102 | 20 | 48490171 | 48490856 | Human |
13825391 | LINC01275 | long intergenic non-protein coding RNA 1275 | 20 | 50162767 | 50166200 | Human |
155752781 | LOC127893580 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47379434-47380209 | 20 | 48762897 | 48763672 | Human |
155782477 | LOC127893589 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:47835541-47836266 | 20 | 49219004 | 49219729 | Human |
155761662 | LOC127893595 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:47910697-47911630 | 20 | 49294160 | 49295093 | Human |
155756181 | LOC127893617 | H3K27ac hESC enhancer GRCh37_chr20:48376127-48376628 | 20 | 49759590 | 49760091 | Human |
155227364 | LOC126863048 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:49345068-49346267 | 20 | 50728531 | 50729730 | Human |
155758221 | LOC127893706 | H3K4me1 hESC enhancer GRCh37_chr20:49674148-49674648 | 20 | 51057611 | 51058111 | Human |
152975884 | LOC125387299 | Sharpr-MPRA regulatory region 11561 | 20 | 51695550 | 51695844 | Human |
155780300 | LOC127893728 | H3K27ac hESC enhancer GRCh37_chr20:50315099-50315599 | 20 | 51698560 | 51699060 | Human |
152975864 | LOC125387300 | Sharpr-MPRA regulatory region 2244 | 20 | 51701470 | 51701975 | Human |
155768955 | LOC127893729 | H3K4me1 hESC enhancer GRCh37_chr20:50318515-50319015 | 20 | 51701976 | 51702476 | Human |
155759794 | LOC127893730 | OCT4-NANOG hESC enhancer GRCh37_chr20:50321824-50322382 | 20 | 51705285 | 51705843 | Human |
155760503 | LOC127893731 | H3K4me1 hESC enhancer GRCh37_chr20:50323455-50323954 | 20 | 51706916 | 51707415 | Human |
155752568 | LOC127893732 | NANOG hESC enhancer GRCh37_chr20:50327032-50327577 | 20 | 51710493 | 51711038 | Human |
155773799 | LOC127893733 | H3K4me1 hESC enhancer GRCh37_chr20:50329473-50329983 | 20 | 51712934 | 51713444 | Human |
16552208 | RPL29P35 | ribosomal protein L29 pseudogene 35 | 20 | 51734540 | 51735064 | Human |
152975887 | LOC125387301 | Sharpr-MPRA regulatory region 2265 | 20 | 51738970 | 51739264 | Human |
152975861 | LOC125387302 | Sharpr-MPRA regulatory region 2507 | 20 | 51742990 | 51743284 | Human |
155753075 | LOC127893734 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50366388-50366998 | 20 | 51749849 | 51750459 | Human |
155781746 | LOC127893735 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50378781-50379465 | 20 | 51762242 | 51762926 | Human |
1351271 | SALL4 | spalt like transcription factor 4 | 20 | 51782331 | 51802521 | Human |
155752242 | LOC127893736 | H3K27ac hESC enhancer GRCh37_chr20:50405009-50405510 | 20 | 51788470 | 51788971 | Human |
155779776 | LOC127893737 | H3K27ac hESC enhancer GRCh37_chr20:50405511-50406010 | 20 | 51788972 | 51789471 | Human |
155764247 | LOC127893738 | H3K4me1 hESC enhancer GRCh37_chr20:50406470-50407036 | 20 | 51789931 | 51790497 | Human |
155762310 | LOC127893739 | H3K4me1 hESC enhancer GRCh37_chr20:50407037-50407602 | 20 | 51790498 | 51791063 | Human |
155767104 | LOC127893740 | H3K4me1 hESC enhancer GRCh37_chr20:50411851-50412350 | 20 | 51795312 | 51795811 | Human |
155767814 | LOC127893741 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50415843-50416766 | 20 | 51799304 | 51800227 | Human |
329823889 | LOC130066178 | ATAC-STARR-seq lymphoblastoid active region 18116 | 20 | 51800375 | 51800424 | Human |
155764327 | LOC127893742 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50417479-50418121 | 20 | 51800940 | 51801582 | Human |
155762408 | LOC127893743 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:50418765-50419406 | 20 | 51802226 | 51802867 | Human |
155774960 | LOC127893744 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50427387-50428259 | 20 | 51810848 | 51811720 | Human |
8661825 | LINC01429 | long intergenic non-protein coding RNA 1429 | 20 | 51831797 | 51862913 | Human |
155770687 | LOC127893745 | H3K4me1 hESC enhancer GRCh37_chr20:50463018-50463518 | 20 | 51846479 | 51846979 | Human |
155778903 | LOC127893746 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50478941-50479507 | 20 | 51862402 | 51862968 | Human |
155776890 | LOC127893747 | H3K4me1 hESC enhancer GRCh37_chr20:50503748-50504248 | 20 | 51887209 | 51887709 | Human |
155758370 | LOC127893748 | H3K4me1 hESC enhancer GRCh37_chr20:50504249-50504749 | 20 | 51887710 | 51888210 | Human |
155752313 | LOC127893749 | H3K4me1 hESC enhancer GRCh37_chr20:50509256-50509756 | 20 | 51892717 | 51893217 | Human |
155780786 | LOC127893750 | H3K4me1 hESC enhancer GRCh37_chr20:50509757-50510257 | 20 | 51893218 | 51893718 | Human |
10399077 | RNU6-347P | RNA, U6 small nuclear 347, pseudogene | 20 | 51902291 | 51902395 | Human |
2293169 | RNU7-6P | RNA, U7 small nuclear 6 pseudogene | 20 | 51904969 | 51905030 | Human |
329344596 | LOC129664651 | ReSE screen-validated silencer GRCh37_chr20:50523831-50524007 | 20 | 51907292 | 51907468 | Human |
155757281 | LOC127893751 | H3K27ac hESC enhancer GRCh37_chr20:50573503-50574010 | 20 | 51956964 | 51957471 | Human |
155756573 | LOC127893752 | H3K27ac hESC enhancer GRCh37_chr20:50576428-50577262 | 20 | 51959889 | 51960723 | Human |
155777015 | LOC127893753 | H3K27ac hESC enhancer GRCh37_chr20:50577263-50578095 | 20 | 51960724 | 51961556 | Human |
155759019 | LOC127893754 | H3K27ac hESC enhancer GRCh37_chr20:50585067-50585568 | 20 | 51968528 | 51969029 | Human |
155778307 | LOC127893755 | H3K27ac hESC enhancer GRCh37_chr20:50585569-50586068 | 20 | 51969030 | 51969529 | Human |
155781032 | LOC127893756 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50664393-50664912 | 20 | 52047854 | 52048373 | Human |
155777977 | LOC127893757 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50664913-50665430 | 20 | 52048374 | 52048891 | Human |
155777641 | LOC127893758 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50665431-50665949 | 20 | 52048892 | 52049410 | Human |
155760034 | LOC127893759 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:50665950-50666467 | 20 | 52049411 | 52049928 | Human |
38671069 | LOC105372664 | uncharacterized LOC105372664 | 20 | 52076709 | 52096481 | Human |
1317439 | ZFP64 | ZFP64 zinc finger protein | 20 | 52084011 | 52191779 | Human |
155776492 | LOC127893760 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50721212-50722180 | 20 | 52104673 | 52105641 | Human |
155760265 | LOC127893761 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:50722181-50723147 | 20 | 52105642 | 52106608 | Human |
4144670 | ERP29P1 | endoplasmic reticulum lumenal protein 29 pseudogene 1 | 20 | 52110147 | 52111196 | Human |
329815649 | LOC130066179 | ATAC-STARR-seq lymphoblastoid silent region 13043 | 20 | 52179095 | 52179144 | Human |
329835647 | LOC130066180 | ATAC-STARR-seq lymphoblastoid active region 18117 | 20 | 52179765 | 52179944 | Human |
155765022 | LOC127893762 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:50803075-50803576 | 20 | 52186536 | 52187037 | Human |
155753338 | LOC127893763 | H3K27ac hESC enhancer GRCh37_chr20:50807173-50808029 | 20 | 52190634 | 52191490 | Human |
329825052 | LOC130066181 | ATAC-STARR-seq lymphoblastoid silent region 13045 | 20 | 52191851 | 52192120 | Human |
329839357 | LOC130066182 | ATAC-STARR-seq lymphoblastoid active region 18118 | 20 | 52192531 | 52192660 | Human |
329341305 | LOC129664652 | ReSE screen-validated silencer GRCh37_chr20:50820158-50820351 | 20 | 52203619 | 52203812 | Human |
155771158 | LOC127893764 | OCT4-NANOG hESC enhancer GRCh37_chr20:50825698-50826328 | 20 | 52209159 | 52209789 | Human |
155780174 | LOC127893765 | H3K4me1 hESC enhancer GRCh37_chr20:50826513-50827047 | 20 | 52209974 | 52210508 | Human |
38628051 | LOC105372666 | uncharacterized LOC105372666 | 20 | 52210643 | 52694155 | Human |
38608913 | LOC107985427 | uncharacterized LOC107985427 | 20 | 52443362 | 52444568 | Human |
38672972 | LOC105372667 | uncharacterized LOC105372667 | 20 | 52469241 | 52471659 | Human |
151676195 | LOC124904931 | uncharacterized LOC124904931 | 20 | 52488059 | 52500591 | Human |
4144448 | MRPS33P4 | mitochondrial ribosomal protein S33 pseudogene 4 | 20 | 52511299 | 52511550 | Human |
155778405 | LOC127893766 | OCT4-NANOG hESC enhancer GRCh37_chr20:51168644-51169208 | 20 | 52552105 | 52552669 | Human |
2300496 | TRI-AAT12-1 | tRNA-Ile (anticodon AAT) 12-1 | 20 | 52601799 | 52601876 | Human |
38630404 | LOC105372665 | uncharacterized LOC105372665 | 20 | 52610066 | 52619168 | Human |
9068686 | LINC01524 | long intergenic non-protein coding RNA 1524 | 20 | 52620838 | 52650426 | Human |
1345831 | RPL36P1 | ribosomal protein L36 pseudogene 1 | 20 | 52890157 | 52890384 | Human |
151671613 | LOC124904932 | uncharacterized LOC124904932 | 20 | 52954562 | 52957239 | Human |
1353516 | TSHZ2 | teashirt zinc finger homeobox 2 | 20 | 52972358 | 53495330 | Human |
155230661 | LOC126863055 | MED14-independent group 3 enhancer GRCh37_chr20:51664301-51665500 | 20 | 53047762 | 53048961 | Human |
155227336 | LOC126863056 | BRD4-independent group 4 enhancer GRCh37_chr20:51681690-51682889 | 20 | 53065151 | 53066350 | Human |
329341760 | LOC129664653 | ReSE screen-validated silencer GRCh37_chr20:51705255-51705481 | 20 | 53088716 | 53088942 | Human |
10413091 | RN7SKP184 | RN7SK pseudogene 184 | 20 | 53097653 | 53097897 | Human |
329343645 | LOC129391192 | MPRA-validated peak4263 silencer | 20 | 53149216 | 53149416 | Human |
329818016 | LOC130066183 | ATAC-STARR-seq lymphoblastoid silent region 13046 | 20 | 53157420 | 53157539 | Human |
152975850 | LOC125387303 | Sharpr-MPRA regulatory region 1604 | 20 | 53176270 | 53176564 | Human |
152975960 | LOC125387304 | Sharpr-MPRA regulatory region 9561 | 20 | 53194930 | 53195224 | Human |
155771690 | LOC127893768 | OCT4-NANOG hESC enhancer GRCh37_chr20:51898656-51899211 | 20 | 53282117 | 53282672 | Human |
155780113 | LOC127893769 | NANOG hESC enhancer GRCh37_chr20:51899474-51900080 | 20 | 53282935 | 53283541 | Human |
38624646 | LOC112694722 | Sharpr-MPRA regulatory region 12391 | 20 | 53331550 | 53331844 | Human |
38619412 | LOC105372670 | uncharacterized LOC105372670 | 20 | 53397668 | 53401319 | Human |
152975832 | LOC125387305 | Sharpr-MPRA regulatory region 11508 | 20 | 53407951 | 53408245 | Human |
329818030 | LOC130066184 | ATAC-STARR-seq lymphoblastoid silent region 13047 | 20 | 53413191 | 53413240 | Human |
1350778 | PPIAP10 | peptidylprolyl isomerase A pseudogene 10 | 20 | 53421192 | 53421678 | Human |
38644480 | TSHZ2-AS1 | TSHZ2 antisense RNA 1 | 20 | 53431971 | 53473113 | Human |
155765078 | LOC127893770 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52077141-52077719 | 20 | 53460602 | 53461180 | Human |
155782207 | LOC127893771 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52077720-52078297 | 20 | 53461181 | 53461758 | Human |
155761264 | LOC127893772 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52089451-52090068 | 20 | 53472912 | 53473529 | Human |
155772873 | LOC127893773 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52120609-52121259 | 20 | 53504070 | 53504720 | Human |
155752800 | LOC127893774 | H3K4me1 hESC enhancer GRCh37_chr20:52126933-52127434 | 20 | 53510394 | 53510895 | Human |
155774345 | LOC127893775 | H3K4me1 hESC enhancer GRCh37_chr20:52127435-52127934 | 20 | 53510896 | 53511395 | Human |
38648184 | LOC105372671 | uncharacterized LOC105372671 | 20 | 53516918 | 53525310 | Human |
329339458 | LOC129456124 | reporter assay-validated silencer 6 | 20 | 53535246 | 53535546 | Human |
155776888 | LOC127893776 | H3K27ac hESC enhancer GRCh37_chr20:52173455-52173955 | 20 | 53556916 | 53557416 | Human |
329341974 | LOC129664654 | ReSE screen-validated silencer GRCh37_chr20:52175886-52176069 | 20 | 53559347 | 53559530 | Human |
1318226 | ZNF217 | zinc finger protein 217 | 20 | 53567071 | 53597702 | Human |
329342404 | LOC129664655 | ReSE screen-validated silencer GRCh37_chr20:52189693-52189843 | 20 | 53573154 | 53573304 | Human |
155761549 | LOC127893777 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52198379-52199170 | 20 | 53581840 | 53582631 | Human |
329819158 | LOC130066185 | ATAC-STARR-seq lymphoblastoid silent region 13048 | 20 | 53592550 | 53592789 | Human |
329842319 | LOC130066186 | ATAC-STARR-seq lymphoblastoid silent region 13049 | 20 | 53593210 | 53593359 | Human |
329843769 | LOC130066187 | ATAC-STARR-seq lymphoblastoid silent region 13050 | 20 | 53593850 | 53593929 | Human |
329827491 | LOC130066188 | ATAC-STARR-seq lymphoblastoid silent region 13051 | 20 | 53594020 | 53594859 | Human |
329827457 | LOC130066189 | ATAC-STARR-seq lymphoblastoid active region 18121 | 20 | 53596660 | 53596709 | Human |
155777929 | LOC127893778 | H3K4me1 hESC enhancer GRCh37_chr20:52214839-52215339 | 20 | 53598300 | 53598800 | Human |
16556218 | AC005808.1 | novel transcript | 20 | 53608354 | 53634590 | Human |
329831989 | LOC130066190 | ATAC-STARR-seq lymphoblastoid active region 18122 | 20 | 53608510 | 53608829 | Human |
329829975 | LOC130066191 | ATAC-STARR-seq lymphoblastoid active region 18123 | 20 | 53610770 | 53610819 | Human |
155782584 | LOC127893779 | H3K27ac hESC enhancer GRCh37_chr20:52238084-52238848 | 20 | 53621545 | 53622309 | Human |
329342553 | LOC129664656 | ReSE screen-validated silencer GRCh37_chr20:52243436-52243628 | 20 | 53626897 | 53627089 | Human |
329825939 | LOC130066192 | ATAC-STARR-seq lymphoblastoid active region 18124 | 20 | 53643279 | 53643328 | Human |
329821584 | LOC130066193 | ATAC-STARR-seq lymphoblastoid active region 18125 | 20 | 53643369 | 53643418 | Human |
329837598 | LOC130066194 | ATAC-STARR-seq lymphoblastoid active region 18126 | 20 | 53653202 | 53653251 | Human |
329830215 | LOC130066195 | ATAC-STARR-seq lymphoblastoid active region 18127 | 20 | 53655024 | 53655143 | Human |
329817363 | LOC130066196 | ATAC-STARR-seq lymphoblastoid active region 18128 | 20 | 53660212 | 53660271 | Human |
329830409 | LOC130066197 | ATAC-STARR-seq lymphoblastoid active region 18129 | 20 | 53660282 | 53660341 | Human |
329814197 | LOC130066198 | ATAC-STARR-seq lymphoblastoid active region 18130 | 20 | 53661262 | 53661321 | Human |
2293285 | RNU7-14P | RNA, U7 small nuclear 14 pseudogene | 20 | 53668698 | 53668757 | Human |
155762951 | LOC127893780 | H3K4me1 hESC enhancer GRCh37_chr20:52307857-52308356 | 20 | 53691318 | 53691817 | Human |
329338550 | LOC129391193 | MPRA-validated peak4269 silencer | 20 | 53698576 | 53698776 | Human |
329822254 | LOC130066199 | ATAC-STARR-seq lymphoblastoid active region 18131 | 20 | 53708003 | 53708052 | Human |
155775967 | LOC127893781 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52327852-52328753 | 20 | 53711313 | 53712214 | Human |
155765239 | LOC127893782 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52328754-52329654 | 20 | 53712215 | 53713115 | Human |
155769409 | LOC127893783 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52329655-52330556 | 20 | 53713116 | 53714017 | Human |
329338211 | LOC129391194 | MPRA-validated peak4270 silencer | 20 | 53715536 | 53715736 | Human |
155756065 | LOC127893784 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52340879-52341878 | 20 | 53724340 | 53725339 | Human |
155750616 | LOC127893785 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52341879-52342876 | 20 | 53725340 | 53726337 | Human |
155770834 | LOC127893786 | H3K27ac hESC enhancer GRCh37_chr20:52345091-52345591 | 20 | 53728552 | 53729052 | Human |
329818575 | LOC130066200 | ATAC-STARR-seq lymphoblastoid active region 18132 | 20 | 53729453 | 53729502 | Human |
329838771 | LOC130066201 | ATAC-STARR-seq lymphoblastoid active region 18133 | 20 | 53729783 | 53729882 | Human |
329340496 | LOC129391195 | MPRA-validated peak4271 silencer | 20 | 53734116 | 53734316 | Human |
155755213 | LOC127893787 | H3K27ac hESC enhancer GRCh37_chr20:52352121-52353026 | 20 | 53735582 | 53736487 | Human |
151671712 | LOC124904933 | uncharacterized LOC124904933 | 20 | 53736763 | 53741800 | Human |
155766327 | LOC127893789 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52353931-52354834 | 20 | 53737392 | 53738295 | Human |
152975840 | LOC125387306 | Sharpr-MPRA regulatory region 8160 | 20 | 53740570 | 53740864 | Human |
155760322 | LOC127893790 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52364790-52365383 | 20 | 53748251 | 53748844 | Human |
155756501 | LOC127893791 | H3K27ac hESC enhancer GRCh37_chr20:52367327-52367828 | 20 | 53750788 | 53751289 | Human |
329831132 | LOC130066202 | ATAC-STARR-seq lymphoblastoid active region 18134 | 20 | 53754578 | 53754627 | Human |
329817848 | LOC130066203 | ATAC-STARR-seq lymphoblastoid active region 18135 | 20 | 53754658 | 53754737 | Human |
155776068 | LOC127893792 | H3K27ac hESC enhancer GRCh37_chr20:52379320-52379986 | 20 | 53762781 | 53763447 | Human |
329844027 | LOC130066204 | ATAC-STARR-seq lymphoblastoid active region 18136 | 20 | 53767649 | 53767818 | Human |
155756921 | LOC127893793 | OCT4-NANOG hESC enhancer GRCh37_chr20:52384680-52385276 | 20 | 53768141 | 53768737 | Human |
329339875 | LOC129391196 | MPRA-validated peak4272 silencer | 20 | 53779796 | 53779996 | Human |
329329717 | LOC129391197 | MPRA-validated peak4274 silencer | 20 | 53799116 | 53799316 | Human |
155757772 | LOC127893794 | H3K4me1 hESC enhancer GRCh37_chr20:52417835-52418336 | 20 | 53801296 | 53801797 | Human |
329814358 | LOC130066205 | ATAC-STARR-seq lymphoblastoid active region 18137 | 20 | 53828724 | 53828833 | Human |
38652809 | LOC111413042 | HNF4 motif-containing MPRA enhancer 186 | 20 | 53830100 | 53830244 | Human |
155780015 | LOC127893795 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52456215-52456785 | 20 | 53839676 | 53840246 | Human |
151670524 | LOC124904934 | uncharacterized LOC124904934 | 20 | 53845483 | 53853705 | Human |
329821447 | LOC130066206 | ATAC-STARR-seq lymphoblastoid silent region 13052 | 20 | 53847314 | 53847373 | Human |
151669008 | LOC124904935 | uncharacterized LOC124904935 | 20 | 53863577 | 53866164 | Human |
1601685 | SUMO1P1 | SUMO1 pseudogene 1 | 20 | 53874498 | 53875709 | Human |
155227970 | LOC126863058 | BRD4-independent group 4 enhancer GRCh37_chr20:52491437-52492636 | 20 | 53874898 | 53876097 | Human |
329339704 | LOC129391198 | MPRA-validated peak4276 silencer | 20 | 53885216 | 53885416 | Human |
155229181 | LOC126863059 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:52522628-52523827 | 20 | 53906089 | 53907288 | Human |
329819896 | LOC130066207 | ATAC-STARR-seq lymphoblastoid active region 18138 | 20 | 53930973 | 53931072 | Human |
152975786 | LOC125387307 | Sharpr-MPRA regulatory region 3819 | 20 | 53938770 | 53939064 | Human |
151668085 | LOC124904936 | uncharacterized LOC124904936 | 20 | 53940385 | 53943581 | Human |
1351231 | BCAS1 | brain enriched myelin associated protein 1 | 20 | 53943541 | 54070594 | Human |
329832560 | LOC130066208 | ATAC-STARR-seq lymphoblastoid active region 18139 | 20 | 53949097 | 53949196 | Human |
5134152 | MIR4756 | microRNA 4756 | 20 | 54068408 | 54068485 | Human |
155755923 | LOC127893797 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52685852-52686726 | 20 | 54069313 | 54070187 | Human |
329842257 | LOC130066209 | ATAC-STARR-seq lymphoblastoid silent region 13053 | 20 | 54079705 | 54079764 | Human |
155778129 | LOC127893798 | NANOG hESC enhancer GRCh37_chr20:52697269-52697770 | 20 | 54080730 | 54081231 | Human |
155755928 | LOC127893799 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:52740093-52740898 | 20 | 54123554 | 54124359 | Human |
155227602 | LOC126863060 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:52755491-52756690 | 20 | 54138952 | 54140151 | Human |
1606586 | CYP24A1 | cytochrome P450 family 24 subfamily A member 1 | 20 | 54143538 | 54173986 | Human |
155762035 | LOC127893800 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52790155-52790748 | 20 | 54173616 | 54174209 | Human |
38657286 | LOC105372675 | uncharacterized LOC105372675 | 20 | 54178294 | 54189852 | Human |
329836598 | LOC130066210 | ATAC-STARR-seq lymphoblastoid active region 18140 | 20 | 54205407 | 54205636 | Human |
151670984 | LOC124904937 | uncharacterized LOC124904937 | 20 | 54206946 | 54208041 | Human |
155768041 | LOC127893801 | NANOG-H3K27ac-H3K4me1 hESC enhancers GRCh37_chr20:52824023-52824840 and GRCh37_chr20:52824841-52825657 | 20 | 54207484 | 54209118 | Human |
1347549 | PFDN4 | prefoldin subunit 4 | 20 | 54208087 | 54219961 | Human |
329815173 | LOC130066211 | ATAC-STARR-seq lymphoblastoid silent region 13055 | 20 | 54227425 | 54227474 | Human |
38659928 | LOC107985385 | uncharacterized LOC107985385 | 20 | 54228905 | 54232911 | Human |
155763368 | LOC127893803 | NANOG hESC enhancer GRCh37_chr20:52976162-52976663 | 20 | 54359623 | 54360124 | Human |
1343098 | DOK5 | docking protein 5 | 20 | 54475593 | 54651169 | Human |
155760489 | LOC127893804 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:53278465-53278969 | 20 | 54661926 | 54662430 | Human |
10399524 | RNU4ATAC7P | RNA, U4atac small nuclear 7, pseudogene | 20 | 54859688 | 54859812 | Human |
1351204 | RPL12P4 | ribosomal protein L12 pseudogene 4 | 20 | 55074556 | 55075178 | Human |
155765233 | LOC127893806 | H3K4me1 hESC enhancer GRCh37_chr20:53700573-53701073 | 20 | 55084034 | 55084534 | Human |
155763389 | LOC127893807 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:53719034-53719938 | 20 | 55102495 | 55103399 | Human |
155758721 | LOC127893808 | NANOG hESC enhancer GRCh37_chr20:53746218-53746719 | 20 | 55129679 | 55130180 | Human |
329339348 | LOC129391199 | MPRA-validated peak4279 silencer | 20 | 55132516 | 55132716 | Human |
8662798 | LINC01441 | long intergenic non-protein coding RNA 1441 | 20 | 55420336 | 55427197 | Human |
155760804 | LOC127893809 | OCT4-NANOG hESC enhancer GRCh37_chr20:54039521-54040195 | 20 | 55422983 | 55423657 | Human |
8662785 | LINC01440 | long intergenic non-protein coding RNA 1440 | 20 | 55423043 | 55426791 | Human |
38668039 | LOC112694723 | Sharpr-MPRA regulatory region 10667 | 20 | 55471411 | 55471705 | Human |
38664097 | LOC105372676 | uncharacterized LOC105372676 | 20 | 55577460 | 55637463 | Human |
38656781 | LOC107984001 | uncharacterized LOC107984001 | 20 | 55664777 | 55745031 | Human |
38626754 | LOC110121370 | VISTA enhancer hs1448 | 20 | 55666588 | 55669614 | Human |
38607268 | LOC105372677 | uncharacterized LOC105372677 | 20 | 55803900 | 55829691 | Human |
38624213 | LOC105372678 | uncharacterized LOC105372678 | 20 | 55852508 | 55858371 | Human |
155776985 | LOC127893811 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:54434810-54435348 | 20 | 55859754 | 55860292 | Human |
1346675 | CBLN4 | cerebellin 4 precursor | 20 | 55997357 | 56005519 | Human |
38666810 | LOC105376989 | uncharacterized LOC105376989 | 20 | 56101774 | 56103602 | Human |
38674678 | LOC105372680 | uncharacterized LOC105372680 | 20 | 56142463 | 56169781 | Human |
6481661 | RNA5SP487 | RNA, 5S ribosomal pseudogene 487 | 20 | 56205052 | 56205173 | Human |
155779506 | LOC127893812 | NANOG hESC enhancer GRCh37_chr20:54792881-54793405 | 20 | 56217825 | 56218349 | Human |
329820371 | LOC130066212 | ATAC-STARR-seq lymphoblastoid silent region 13056 | 20 | 56248133 | 56248202 | Human |
1345990 | MC3R | melanocortin 3 receptor | 20 | 56248732 | 56249815 | Human |
155226941 | LOC126863063 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:54834703-54835902 | 20 | 56259647 | 56260846 | Human |
152975894 | LOC125387308 | Sharpr-MPRA regulatory region 10041 | 20 | 56343953 | 56344247 | Human |
329841698 | LOC130066213 | ATAC-STARR-seq lymphoblastoid silent region 13057 | 20 | 56358651 | 56359250 | Human |
1322807 | FAM210B | family with sequence similarity 210 member B | 20 | 56358974 | 56368663 | Human |
329341763 | LOC129664657 | ReSE screen-validated silencer GRCh37_chr20:54937273-54937462 | 20 | 56362217 | 56362406 | Human |
155756616 | LOC127893813 | H3K4me1 hESC enhancer GRCh37_chr20:54938029-54938529 | 20 | 56362973 | 56363473 | Human |
1353168 | AURKA | aurora kinase A | 20 | 56369390 | 56392215 | Human |
155229800 | LOC126863064 | BRD4-independent group 4 enhancer GRCh37_chr20:54961142-54962341 | 20 | 56386086 | 56387285 | Human |
329814147 | LOC130066214 | ATAC-STARR-seq lymphoblastoid active region 18142 | 20 | 56392361 | 56392600 | Human |
1319516 | CSTF1 | cleavage stimulation factor subunit 1 | 20 | 56392379 | 56406362 | Human |
1321668 | CASS4 | Cas scaffold protein family member 4 | 20 | 56412036 | 56460382 | Human |
1342999 | RPL39P | ribosomal protein L39 pseudogene | 20 | 56459235 | 56459632 | Human |
1322335 | RTF2 | replication termination factor 2 | 20 | 56468627 | 56519449 | Human |
151674009 | LOC124904979 | small nucleolar RNA U13 | 20 | 56475643 | 56475745 | Human |
1354424 | GCNT7 | glucosaminyl (N-acetyl) transferase family member 7 | 20 | 56491492 | 56525925 | Human |
329329696 | LOC129391200 | MPRA-validated peak4281 silencer | 20 | 56500720 | 56500920 | Human |
155751008 | LOC127893814 | H3K4me1 hESC enhancer GRCh37_chr20:55086509-55087317 | 20 | 56511453 | 56512261 | Human |
155771810 | LOC127893815 | H3K4me1 hESC enhancer GRCh37_chr20:55087318-55088125 | 20 | 56512262 | 56513069 | Human |
1317211 | FAM209A | family with sequence similarity 209 member A | 20 | 56524744 | 56533590 | Human |
1342812 | FAM209B | family with sequence similarity 209 member B | 20 | 56533246 | 56536520 | Human |
151670563 | LOC124904971 | uncharacterized LOC124904971 | 20 | 56553918 | 56555611 | Human |
329814339 | LOC130066215 | ATAC-STARR-seq lymphoblastoid active region 18143 | 20 | 56554836 | 56554885 | Human |
11562073 | LINC01716 | long intergenic non-protein coding RNA 1716 | 20 | 56577563 | 56596126 | Human |
155777185 | LOC127893816 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55159734-55160366 | 20 | 56584678 | 56585310 | Human |
155778913 | LOC127893817 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55170612-55171203 | 20 | 56595556 | 56596147 | Human |
155750852 | LOC127893818 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55171204-55171796 | 20 | 56596148 | 56596740 | Human |
1342924 | RPS4XP3 | ribosomal protein S4X pseudogene 3 | 20 | 56601648 | 56602114 | Human |
155229233 | LOC126863065 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:55181331-55182530 | 20 | 56606275 | 56607474 | Human |
155771930 | LOC127893819 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55199862-55200624 | 20 | 56624806 | 56625568 | Human |
155766441 | LOC127893820 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55202149-55202909 | 20 | 56627093 | 56627853 | Human |
329831395 | LOC130066216 | ATAC-STARR-seq lymphoblastoid silent region 13058 | 20 | 56629217 | 56629276 | Human |
1346626 | TFAP2C | transcription factor AP-2 gamma | 20 | 56629306 | 56639283 | Human |
152975751 | LOC125387309 | Sharpr-MPRA regulatory region 3831 | 20 | 56629333 | 56629627 | Human |
155771825 | LOC127893821 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:55211854-55212614 | 20 | 56636798 | 56637558 | Human |
10399833 | RNU6-1146P | RNA, U6 small nuclear 1146, pseudogene | 20 | 56667430 | 56667531 | Human |
155753508 | LOC127893822 | H3K4me1 hESC enhancer GRCh37_chr20:55252755-55253256 | 20 | 56677699 | 56678200 | Human |
10399385 | RN7SL170P | RNA, 7SL, cytoplasmic 170, pseudogene | 20 | 56688401 | 56688695 | Human |
155769938 | LOC127893823 | H3K4me1 hESC enhancer GRCh37_chr20:55265347-55265942 | 20 | 56690291 | 56690886 | Human |
1343132 | PTMAP6 | prothymosin alpha pseudogene 6 | 20 | 56701345 | 56701514 | Human |
155754332 | LOC127893824 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55286729-55287342 | 20 | 56711673 | 56712286 | Human |
155779223 | LOC127893825 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55287343-55287956 | 20 | 56712287 | 56712900 | Human |
329817158 | LOC130066217 | ATAC-STARR-seq lymphoblastoid active region 18144 | 20 | 56722115 | 56722184 | Human |
155754428 | LOC127893826 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55311142-55311780 | 20 | 56736086 | 56736724 | Human |
155760372 | LOC127893827 | H3K4me1 hESC enhancer GRCh37_chr20:55317881-55318380 | 20 | 56742825 | 56743324 | Human |
155766613 | LOC127893828 | H3K4me1 hESC enhancer GRCh37_chr20:55334559-55335162 | 20 | 56759503 | 56760106 | Human |
155750576 | LOC127893829 | H3K4me1 hESC enhancer GRCh37_chr20:55335163-55335765 | 20 | 56760107 | 56760709 | Human |
155757553 | LOC127893830 | H3K4me1 hESC enhancer GRCh37_chr20:55350371-55351220 | 20 | 56775315 | 56776164 | Human |
10399256 | RNU6-929P | RNA, U6 small nuclear 929, pseudogene | 20 | 56785982 | 56786087 | Human |
155771351 | LOC127893831 | H3K27ac hESC enhancer GRCh37_chr20:55363417-55364176 | 20 | 56788361 | 56789120 | Human |
155773434 | LOC127893832 | H3K27ac hESC enhancer GRCh37_chr20:55364177-55364935 | 20 | 56789121 | 56789879 | Human |
152975743 | LOC125387310 | Sharpr-MPRA regulatory region 537 | 20 | 56804633 | 56805512 | Human |
155780435 | LOC127893834 | H3K4me1 hESC enhancer GRCh37_chr20:55382452-55383081 | 20 | 56807396 | 56808025 | Human |
155758392 | LOC127893835 | H3K4me1 hESC enhancer GRCh37_chr20:55383713-55384341 | 20 | 56808657 | 56809285 | Human |
155768906 | LOC127893836 | H3K27ac hESC enhancer GRCh37_chr20:55406913-55407706 | 20 | 56831857 | 56832650 | Human |
155771977 | LOC127893837 | H3K27ac hESC enhancer GRCh37_chr20:55407707-55408500 | 20 | 56832651 | 56833444 | Human |
329341074 | LOC129664658 | ReSE screen-validated silencer GRCh37_chr20:55423625-55423770 | 20 | 56848569 | 56848714 | Human |
155781383 | LOC127893838 | H3K4me1 hESC enhancer GRCh37_chr20:55447159-55447691 | 20 | 56872103 | 56872635 | Human |
155771080 | LOC127893839 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55450301-55450946 | 20 | 56875245 | 56875890 | Human |
155764300 | LOC127893840 | H3K4me1 hESC enhancer GRCh37_chr20:55468204-55468808 | 20 | 56893148 | 56893752 | Human |
155763813 | LOC127893841 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55472313-55472844 | 20 | 56897257 | 56897788 | Human |
155751775 | LOC127893842 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55499864-55500713 | 20 | 56924808 | 56925657 | Human |
155780935 | LOC127893843 | H3K4me1 hESC enhancer GRCh37_chr20:55533349-55533974 | 20 | 56958293 | 56958918 | Human |
155763131 | LOC127893844 | H3K4me1 hESC enhancer GRCh37_chr20:55543166-55543675 | 20 | 56968110 | 56968619 | Human |
38623652 | LOC105376985 | uncharacterized LOC105376985 | 20 | 52660097 | 52661792 | Human |
38650507 | LOC105372668 | uncharacterized LOC105372668 | 20 | 52840944 | 52895426 | Human |
38632034 | ZNF217-AS1 | ZNF217 antisense RNA 1 | 20 | 53552770 | 53575308 | Human |
155774622 | LOC127893767 | NANOG hESC enhancer GRCh37_chr20:51683526-51684027 | 20 | 53066987 | 53067488 | Human |
155774150 | LOC127893788 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:52353027-52353930 | 20 | 53736488 | 53737391 | Human |
155230103 | LOC126863057 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:52390627-52391826 | 20 | 53774088 | 53775287 | Human |
155764118 | LOC127893796 | H3K4me1 hESC enhancer GRCh37_chr20:52551551-52552052 | 20 | 53935012 | 53935513 | Human |
155229029 | LOC126863061 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:52901007-52902206 | 20 | 54284468 | 54285667 | Human |
155755219 | LOC127893805 | H3K4me1 hESC enhancer GRCh37_chr20:53530679-53531178 | 20 | 54914140 | 54914639 | Human |
155227581 | LOC126863062 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:54153167-54154366 | 20 | 55578109 | 55579308 | Human |
155760171 | LOC127893810 | H3K4me1 hESC enhancer GRCh37_chr20:54207780-54208291 | 20 | 55632722 | 55633233 | Human |
155758656 | LOC127893833 | H3K4me1 hESC enhancer GRCh37_chr20:55381821-55382451 | 20 | 56806765 | 56807395 | Human |
38651379 | LOC105372683 | uncharacterized LOC105372683 | 20 | 56974635 | 56985804 | Human |
155761976 | LOC127893845 | H3K4me1 hESC enhancer GRCh37_chr20:55570502-55571030 | 20 | 56995446 | 56995974 | Human |
155762938 | LOC127893846 | H3K4me1 hESC enhancer GRCh37_chr20:55578655-55579522 | 20 | 57003599 | 57004466 | Human |
329339815 | LOC129664659 | ReSE screen-validated silencer GRCh37_chr20:55589742-55589905 | 20 | 57014686 | 57014849 | Human |
155759918 | LOC127893847 | H3K4me1 hESC enhancer GRCh37_chr20:55604837-55605336 | 20 | 57029781 | 57030280 | Human |
155756636 | LOC127893848 | H3K4me1 hESC enhancer GRCh37_chr20:55619775-55620276 | 20 | 57044719 | 57045220 | Human |
155781919 | LOC127893849 | H3K4me1 hESC enhancer GRCh37_chr20:55640151-55640652 | 20 | 57065095 | 57065596 | Human |
155775840 | LOC127893850 | OCT4-NANOG hESC enhancer GRCh37_chr20:55646149-55646712 | 20 | 57071093 | 57071656 | Human |
38653405 | LOC105372685 | uncharacterized LOC105372685 | 20 | 57115424 | 57135988 | Human |
155758289 | LOC127893851 | H3K4me1 hESC enhancer GRCh37_chr20:55707263-55707764 | 20 | 57132207 | 57132708 | Human |
38662788 | LOC114827864 | VISTA enhancer hs2565 | 20 | 57155027 | 57159433 | Human |
38652356 | LOC105372686 | uncharacterized LOC105372686 | 20 | 57158786 | 57162379 | Human |
155778420 | LOC127893852 | H3K4me1 hESC enhancer GRCh37_chr20:55736368-55736868 | 20 | 57161312 | 57161812 | Human |
1344234 | BMP7 | bone morphogenetic protein 7 | 20 | 57168753 | 57266641 | Human |
155775348 | LOC127893853 | H3K4me1 hESC enhancer GRCh37_chr20:55747859-55748360 | 20 | 57172803 | 57173304 | Human |
155770604 | LOC127893854 | H3K4me1 hESC enhancer GRCh37_chr20:55758285-55758807 | 20 | 57183229 | 57183751 | Human |
155759038 | LOC127893855 | H3K4me1 hESC enhancer GRCh37_chr20:55758808-55759329 | 20 | 57183752 | 57184273 | Human |
155771703 | LOC127893856 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55773380-55774038 | 20 | 57198324 | 57198982 | Human |
155768474 | LOC127893857 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55774039-55774698 | 20 | 57198983 | 57199642 | Human |
155229060 | LOC126863066 | BRD4-independent group 4 enhancer GRCh37_chr20:55780300-55781499 | 20 | 57205244 | 57206443 | Human |
9068492 | BMP7-AS1 | BMP7 antisense RNA 1 | 20 | 57213696 | 57215866 | Human |
155759810 | LOC127893858 | H3K4me1 hESC enhancer GRCh37_chr20:55798567-55799068 | 20 | 57223511 | 57224012 | Human |
155779103 | LOC127893859 | H3K4me1 hESC enhancer GRCh37_chr20:55801141-55801641 | 20 | 57226085 | 57226585 | Human |
155752434 | LOC127893860 | OCT4-NANOG hESC enhancer GRCh37_chr20:55806824-55807357 | 20 | 57231768 | 57232301 | Human |
155768933 | LOC127893861 | OCT4-NANOG hESC enhancer GRCh37_chr20:55807358-55807890 | 20 | 57232302 | 57232834 | Human |
155777823 | LOC127893862 | H3K4me1 hESC enhancer GRCh37_chr20:55819232-55820156 | 20 | 57244176 | 57245100 | Human |
155773501 | LOC127893863 | H3K4me1 hESC enhancer GRCh37_chr20:55834429-55834991 | 20 | 57259373 | 57259935 | Human |
155769018 | LOC127893864 | H3K4me1 hESC enhancer GRCh37_chr20:55837926-55838642 | 20 | 57262870 | 57263586 | Human |
155781423 | LOC127893865 | H3K4me1 hESC enhancer GRCh37_chr20:55839361-55840076 | 20 | 57264305 | 57265020 | Human |
38636458 | LOC109461473 | BMP7 promoter region | 20 | 57266129 | 57269490 | Human |
38622753 | LOC112268270 | translation initiation factor IF-2-like | 20 | 57266440 | 57267287 | Human |
38628927 | LOC105372687 | uncharacterized LOC105372687 | 20 | 57274358 | 57329664 | Human |
155776516 | LOC127893866 | H3K4me1 hESC enhancer GRCh37_chr20:55861989-55862490 | 20 | 57286933 | 57287434 | Human |
155780171 | LOC127893867 | H3K4me1 hESC enhancer GRCh37_chr20:55862491-55862990 | 20 | 57287435 | 57287934 | Human |
155772964 | LOC127893868 | H3K4me1 hESC enhancer GRCh37_chr20:55865617-55866584 | 20 | 57290561 | 57291528 | Human |
155756973 | LOC127893869 | H3K4me1 hESC enhancer GRCh37_chr20:55867403-55867902 | 20 | 57292347 | 57292846 | Human |
155761376 | LOC127893870 | H3K4me1 hESC enhancer GRCh37_chr20:55876343-55876878 | 20 | 57301287 | 57301822 | Human |
155760696 | LOC127893871 | H3K4me1 hESC enhancer GRCh37_chr20:55892097-55892598 | 20 | 57317041 | 57317542 | Human |
4109024 | MIR4325 | microRNA 4325 | 20 | 57321502 | 57321591 | Human |
155776255 | LOC127893872 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:55901391-55901894 | 20 | 57326335 | 57326838 | Human |
155777222 | LOC127893873 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:55901895-55902397 | 20 | 57326839 | 57327341 | Human |
2304574 | RPL39P39 | ribosomal protein L39 pseudogene 39 | 20 | 57328500 | 57328893 | Human |
1315081 | SPO11 | SPO11 initiator of meiotic double strand breaks | 20 | 57329803 | 57343993 | Human |
155764181 | LOC127893874 | H3K27ac hESC enhancer GRCh37_chr20:55925942-55926510 | 20 | 57350886 | 57351454 | Human |
1323051 | RAE1 | ribonucleic acid export 1 | 20 | 57351255 | 57379202 | Human |
329816232 | LOC130066218 | ATAC-STARR-seq lymphoblastoid active region 18145 | 20 | 57351645 | 57351724 | Human |
6482133 | MTND1P9 | MT-ND1 pseudogene 9 | 20 | 57357429 | 57358369 | Human |
2300511 | NMTRL-TAA5-1 | nuclear-encoded mitochondrial tRNA-Leu (TAA) 5-1 | 20 | 57358372 | 57358446 | Human |
155765028 | LOC127893875 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55949536-55950533 | 20 | 57374480 | 57375477 | Human |
151670014 | LOC124904938 | uncharacterized LOC124904938 | 20 | 57376240 | 57382604 | Human |
127284973 | LOC121627912 | Sharpr-MPRA regulatory region 7479 | 20 | 57381773 | 57382067 | Human |
21409836 | RBM38-AS1 | RBM38 antisense RNA 1 | 20 | 57384160 | 57393056 | Human |
329842543 | LOC130066219 | ATAC-STARR-seq lymphoblastoid silent region 13059 | 20 | 57389089 | 57389468 | Human |
155757821 | LOC127893876 | H3K27ac hESC enhancer GRCh37_chr20:55966169-55966670 | 20 | 57391079 | 57391614 | Human |
1318308 | RBM38 | RNA binding motif protein 38 | 20 | 57391396 | 57409333 | Human |
155782023 | LOC127893877 | H3K27ac hESC enhancer GRCh37_chr20:55966671-55967170 | 20 | 57391615 | 57392114 | Human |
329829902 | LOC130066220 | ATAC-STARR-seq lymphoblastoid active region 18146 | 20 | 57392869 | 57393058 | Human |
155780611 | LOC127893879 | H3K4me1 hESC enhancer GRCh37_chr20:55973481-55973980 | 20 | 57398425 | 57398991 | Human |
155782110 | LOC127893880 | H3K4me1 hESC enhancer GRCh37_chr20:55975022-55975885 | 20 | 57399966 | 57400829 | Human |
329830402 | LOC130066221 | ATAC-STARR-seq lymphoblastoid active region 18148 | 20 | 57400812 | 57400911 | Human |
155755331 | LOC127893881 | H3K4me1 hESC enhancer GRCh37_chr20:55984023-55984528 | 20 | 57408967 | 57409472 | Human |
329842956 | LOC130066222 | ATAC-STARR-seq lymphoblastoid active region 18149 | 20 | 57409640 | 57409799 | Human |
329338760 | LOC129664660 | ReSE screen-validated silencer GRCh37_chr20:55985201-55985370 | 20 | 57410145 | 57410314 | Human |
329835344 | LOC130066223 | ATAC-STARR-seq lymphoblastoid active region 18150 | 20 | 57410510 | 57410639 | Human |
329840755 | LOC130066224 | ATAC-STARR-seq lymphoblastoid active region 18151 | 20 | 57412119 | 57412248 | Human |
329819013 | LOC130066225 | ATAC-STARR-seq lymphoblastoid active region 18152 | 20 | 57412349 | 57412398 | Human |
155777280 | LOC127893882 | H3K4me1 hESC enhancer GRCh37_chr20:55988977-55989746 | 20 | 57413921 | 57414690 | Human |
149735503 | LOC121853014 | H3K4me1 hESC enhancer GRCh37_chr20:55989747-55990514 | 20 | 57414691 | 57415458 | Human |
155762898 | LOC127893883 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:55990515-55991283 | 20 | 57415459 | 57416227 | Human |
329820659 | LOC130066226 | ATAC-STARR-seq lymphoblastoid active region 18153 | 20 | 57432741 | 57432790 | Human |
329828780 | LOC130066227 | ATAC-STARR-seq lymphoblastoid active region 18154 | 20 | 57433652 | 57433731 | Human |
151673929 | LOC124904939 | uncharacterized LOC124904939 | 20 | 57434661 | 57439646 | Human |
329824048 | LOC130066228 | ATAC-STARR-seq lymphoblastoid active region 18155 | 20 | 57435865 | 57435924 | Human |
329341280 | LOC129664661 | ReSE screen-validated silencer GRCh37_chr20:56012611-56012842 | 20 | 57437555 | 57437786 | Human |
155663511 | LOC127663534 | H3K4me1 hESC enhancer GRCh37_chr20:56014209-56014710 | 20 | 57439153 | 57439654 | Human |
38625596 | LOC110121469 | VISTA enhancer hs1971 | 20 | 57439654 | 57444237 | Human |
329822836 | LOC130066229 | ATAC-STARR-seq lymphoblastoid active region 18156 | 20 | 57450687 | 57450976 | Human |
38619370 | LOC111365159 | H3K4me1 hESC enhancers GRCh37_chr20:56026537-56027036 and GRCh37_chr20:56027096-56027596 | 20 | 57451481 | 57452540 | Human |
38644119 | LOC105372688 | uncharacterized LOC105372688 | 20 | 57460260 | 57463226 | Human |
149735401 | LOC121853015 | Sharpr-MPRA regulatory region 5175 | 20 | 57461113 | 57461407 | Human |
155780287 | LOC127893884 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56039390-56040220 | 20 | 57464334 | 57465164 | Human |
155772891 | LOC127893885 | H3K4me1 hESC enhancer GRCh37_chr20:56042501-56043002 | 20 | 57467445 | 57467946 | Human |
155778061 | LOC127893886 | H3K4me1 hESC enhancer GRCh37_chr20:56045653-56046391 | 20 | 57470597 | 57471335 | Human |
155765691 | LOC127893887 | H3K4me1 hESC enhancer GRCh37_chr20:56048063-56048564 | 20 | 57473007 | 57473508 | Human |
155770366 | LOC127893888 | H3K4me1 hESC enhancer GRCh37_chr20:56048565-56049064 | 20 | 57473509 | 57474008 | Human |
329823381 | LOC130066230 | ATAC-STARR-seq lymphoblastoid active region 18158 | 20 | 57475019 | 57475088 | Human |
155780420 | LOC127893889 | H3K4me1 hESC enhancer GRCh37_chr20:56051358-56051858 | 20 | 57476302 | 57476802 | Human |
329830317 | LOC130066231 | ATAC-STARR-seq lymphoblastoid active region 18159 | 20 | 57480968 | 57481087 | Human |
329840093 | LOC130066232 | ATAC-STARR-seq lymphoblastoid active region 18160 | 20 | 57481098 | 57481147 | Human |
329829497 | LOC130066233 | ATAC-STARR-seq lymphoblastoid active region 18161 | 20 | 57481358 | 57481577 | Human |
329817033 | LOC130066234 | ATAC-STARR-seq lymphoblastoid active region 18162 | 20 | 57483340 | 57483539 | Human |
329815572 | LOC130066235 | ATAC-STARR-seq lymphoblastoid silent region 13063 | 20 | 57483830 | 57483929 | Human |
1345595 | HMGB1P1 | high mobility group box 1 pseudogene 1 | 20 | 57487941 | 57489130 | Human |
329343532 | LOC129391201 | MPRA-validated peak4284 silencer | 20 | 57492940 | 57493140 | Human |
1313529 | CTCFL | CCCTC-binding factor like | 20 | 57495965 | 57525652 | Human |
329822441 | LOC130066236 | ATAC-STARR-seq lymphoblastoid active region 18163 | 20 | 57498861 | 57498910 | Human |
155765187 | LOC127893890 | H3K4me1 hESC enhancer GRCh37_chr20:56074415-56074974 | 20 | 57499359 | 57499918 | Human |
329329858 | LOC129391202 | MPRA-validated peak4285 silencer | 20 | 57499900 | 57500100 | Human |
329828668 | LOC130066237 | ATAC-STARR-seq lymphoblastoid active region 18164 | 20 | 57503217 | 57503306 | Human |
155758377 | LOC127893891 | H3K4me1 hESC enhancer GRCh37_chr20:56098387-56099325 | 20 | 57523331 | 57524269 | Human |
151673842 | LOC124904940 | uncharacterized LOC124904940 | 20 | 57528643 | 57529900 | Human |
151675855 | LOC124904941 | uncharacterized LOC124904941 | 20 | 57546237 | 57548897 | Human |
1347922 | PCK1 | phosphoenolpyruvate carboxykinase 1 | 20 | 57561110 | 57568121 | Human |
155767678 | LOC127893892 | H3K4me1 hESC enhancer GRCh37_chr20:56143743-56144243 | 20 | 57568687 | 57569187 | Human |
149735452 | LOC121853016 | Sharpr-MPRA regulatory region 2062 | 20 | 57586333 | 57586627 | Human |
155772004 | LOC127893893 | H3K4me1 hESC enhancer GRCh37_chr20:56165049-56165804 | 20 | 57589993 | 57590748 | Human |
329835434 | LOC130066238 | ATAC-STARR-seq lymphoblastoid silent region 13064 | 20 | 57596992 | 57597051 | Human |
329341402 | LOC129664662 | ReSE screen-validated silencer GRCh37_chr20:56172128-56172301 | 20 | 57597072 | 57597245 | Human |
1351033 | ZBP1 | Z-DNA binding protein 1 | 20 | 57603852 | 57620426 | Human |
155758936 | LOC127893894 | H3K4me1 hESC enhancer GRCh37_chr20:56193035-56193894 | 20 | 57617979 | 57618838 | Human |
329814598 | LOC130066239 | ATAC-STARR-seq lymphoblastoid active region 18165 | 20 | 57619016 | 57619125 | Human |
329830901 | LOC130066240 | ATAC-STARR-seq lymphoblastoid active region 18166 | 20 | 57620206 | 57620255 | Human |
329834794 | LOC130066241 | ATAC-STARR-seq lymphoblastoid active region 18167 | 20 | 57620386 | 57620675 | Human |
1317924 | PMEPA1 | prostate transmembrane protein, androgen induced 1 | 20 | 57648396 | 57711472 | Human |
329819747 | LOC130066242 | ATAC-STARR-seq lymphoblastoid silent region 13065 | 20 | 57654430 | 57654509 | Human |
155760624 | LOC127893895 | H3K4me1 hESC enhancer GRCh37_chr20:56229759-56230358 | 20 | 57654703 | 57655302 | Human |
155761074 | LOC127893896 | H3K4me1 hESC enhancer GRCh37_chr20:56230359-56230956 | 20 | 57655303 | 57655900 | Human |
329830894 | LOC130066243 | ATAC-STARR-seq lymphoblastoid active region 18168 | 20 | 57657736 | 57657865 | Human |
155763314 | LOC127893897 | H3K4me1 hESC enhancer GRCh37_chr20:56236773-56237645 | 20 | 57661717 | 57662589 | Human |
155770211 | LOC127893898 | H3K4me1 hESC enhancer GRCh37_chr20:56238905-56239419 | 20 | 57663849 | 57664363 | Human |
155773846 | LOC127893899 | H3K4me1 hESC enhancer GRCh37_chr20:56241925-56242541 | 20 | 57666869 | 57667485 | Human |
155776063 | LOC127893900 | H3K4me1 hESC enhancer GRCh37_chr20:56251833-56252416 | 20 | 57676777 | 57677360 | Human |
155779014 | LOC127893901 | H3K4me1 hESC enhancer GRCh37_chr20:56253071-56253587 | 20 | 57678015 | 57678531 | Human |
155769445 | LOC127893902 | H3K4me1 hESC enhancer GRCh37_chr20:56253588-56254103 | 20 | 57678532 | 57679047 | Human |
155756464 | LOC127893903 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56254668-56255192 | 20 | 57679612 | 57680136 | Human |
155763023 | LOC127893904 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56255193-56255716 | 20 | 57680137 | 57680660 | Human |
329824013 | LOC130066244 | ATAC-STARR-seq lymphoblastoid active region 18170 | 20 | 57680937 | 57681046 | Human |
329820232 | LOC130066245 | ATAC-STARR-seq lymphoblastoid active region 18171 | 20 | 57681457 | 57681516 | Human |
329829681 | LOC130066246 | ATAC-STARR-seq lymphoblastoid active region 18172 | 20 | 57681607 | 57681656 | Human |
155770450 | LOC127893905 | H3K4me1 hESC enhancer GRCh37_chr20:56257022-56257522 | 20 | 57681875 | 57682466 | Human |
155773443 | LOC127893906 | H3K4me1 hESC enhancer GRCh37_chr20:56267863-56268682 | 20 | 57692807 | 57693626 | Human |
155782797 | LOC127893907 | H3K4me1 hESC enhancer GRCh37_chr20:56271371-56271903 | 20 | 57696315 | 57696847 | Human |
155229168 | LOC126863067 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:56272784-56273983 | 20 | 57697728 | 57698927 | Human |
155770173 | LOC127893908 | H3K4me1 hESC enhancer GRCh37_chr20:56279768-56280362 | 20 | 57704712 | 57705306 | Human |
155764151 | LOC127893909 | H3K27ac hESC enhancer GRCh37_chr20:56283453-56284064 | 20 | 57708397 | 57709008 | Human |
329824921 | LOC130066247 | ATAC-STARR-seq lymphoblastoid silent region 13066 | 20 | 57709847 | 57710276 | Human |
9835337 | NKILA | NF-kappaB interacting lncRNA | 20 | 57710183 | 57712780 | Human |
329814945 | LOC130066248 | ATAC-STARR-seq lymphoblastoid silent region 13067 | 20 | 57710297 | 57710416 | Human |
155771978 | LOC127893910 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56287125-56287736 | 20 | 57712069 | 57712680 | Human |
155780467 | LOC127893911 | H3K4me1 hESC enhancer GRCh37_chr20:56290116-56290644 | 20 | 57715060 | 57715588 | Human |
155774265 | LOC127893912 | H3K4me1 hESC enhancer GRCh37_chr20:56299854-56300354 | 20 | 57724798 | 57725298 | Human |
155759995 | LOC127893913 | H3K4me1 hESC enhancer GRCh37_chr20:56300355-56300855 | 20 | 57725299 | 57725799 | Human |
155771384 | LOC127893914 | H3K4me1 hESC enhancer GRCh37_chr20:56319851-56320352 | 20 | 57744795 | 57745296 | Human |
155759548 | LOC127893915 | H3K4me1 hESC enhancer GRCh37_chr20:56320353-56320852 | 20 | 57745297 | 57745796 | Human |
155765275 | LOC127893916 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56322729-56323588 | 20 | 57747673 | 57748532 | Human |
155782531 | LOC127893917 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56323589-56324446 | 20 | 57748533 | 57749390 | Human |
155778054 | LOC127893918 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56346807-56347450 | 20 | 57771751 | 57772394 | Human |
155759435 | LOC127893920 | H3K4me1 hESC enhancer GRCh37_chr20:56358085-56358678 | 20 | 57783029 | 57783622 | Human |
155777640 | LOC127893921 | H3K4me1 hESC enhancer GRCh37_chr20:56369354-56369854 | 20 | 57794298 | 57794798 | Human |
155767816 | LOC127893922 | H3K4me1 hESC enhancer GRCh37_chr20:56410252-56410913 | 20 | 57835196 | 57835857 | Human |
155763025 | LOC127893923 | H3K4me1 hESC enhancer GRCh37_chr20:56410914-56411574 | 20 | 57835858 | 57836518 | Human |
155780184 | LOC127893924 | H3K4me1 hESC enhancer GRCh37_chr20:56474981-56475610 | 20 | 57899925 | 57900554 | Human |
155760621 | LOC127893925 | H3K4me1 hESC enhancer GRCh37_chr20:56475611-56476238 | 20 | 57900555 | 57901182 | Human |
155781957 | LOC127893926 | H3K27ac hESC enhancer GRCh37_chr20:56496341-56496840 | 20 | 57921285 | 57921784 | Human |
155773795 | LOC127893927 | H3K4me1 hESC enhancer GRCh37_chr20:56527975-56528475 | 20 | 57952919 | 57953419 | Human |
38623340 | LOC105372693 | uncharacterized LOC105372693 | 20 | 57985899 | 57999562 | Human |
11563955 | LINC01742 | long intergenic non-protein coding RNA 1742 | 20 | 58003904 | 58004648 | Human |
155767713 | LOC127893928 | H3K4me1 hESC enhancer GRCh37_chr20:56585301-56585802 | 20 | 58010245 | 58010746 | Human |
329344683 | LOC129664663 | ReSE screen-validated silencer GRCh37_chr20:56596630-56596799 | 20 | 58021574 | 58021743 | Human |
155767751 | LOC127893929 | H3K4me1 hESC enhancer GRCh37_chr20:56612905-56613406 | 20 | 58037849 | 58038350 | Human |
155776855 | LOC127893930 | H3K4me1 hESC enhancer GRCh37_chr20:56613407-56613906 | 20 | 58038351 | 58038850 | Human |
38670659 | LOC114004356 | Sharpr-MPRA regulatory region 7266 | 20 | 58048133 | 58048427 | Human |
2946602 | HSPD1P19 | heat shock protein family D (Hsp60) member 1 pseudogene 19 | 20 | 58097222 | 58100274 | Human |
38608105 | LOC107987284 | uncharacterized LOC107987284 | 20 | 58129530 | 58133827 | Human |
38673014 | LOC107985434 | uncharacterized LOC107985434 | 20 | 58129599 | 58159431 | Human |
1342910 | CIMIP1 | ciliary microtubule inner protein 1 | 20 | 58150902 | 58161150 | Human |
38645231 | LOC105372694 | uncharacterized LOC105372694 | 20 | 58164461 | 58179679 | Human |
155769913 | LOC127893931 | H3K4me1 hESC enhancer GRCh37_chr20:56750743-56751243 | 20 | 58175687 | 58176187 | Human |
329832822 | LOC130066249 | ATAC-STARR-seq lymphoblastoid silent region 13068 | 20 | 58179782 | 58179841 | Human |
1315900 | ANKRD60 | ankyrin repeat domain 60 | 20 | 58216126 | 58228653 | Human |
1354233 | PPP4R1L | protein phosphatase 4 regulatory subunit 1 like (pseudogene) | 20 | 58232777 | 58309439 | Human |
329818530 | LOC130066250 | ATAC-STARR-seq lymphoblastoid silent region 13069 | 20 | 58237125 | 58237174 | Human |
155768226 | LOC127893932 | H3K27ac hESC enhancer GRCh37_chr20:56816520-56817020 | 20 | 58241464 | 58241964 | Human |
155778996 | LOC127893933 | H3K4me1 hESC enhancer GRCh37_chr20:56877500-56878000 | 20 | 58302444 | 58302944 | Human |
329839476 | LOC130066251 | ATAC-STARR-seq lymphoblastoid silent region 13070 | 20 | 58309184 | 58309743 | Human |
1323682 | RAB22A | RAB22A, member RAS oncogene family | 20 | 58309715 | 58367507 | Human |
329832386 | LOC130066252 | ATAC-STARR-seq lymphoblastoid silent region 13071 | 20 | 58309784 | 58310113 | Human |
155758916 | LOC127893934 | NANOG hESC enhancer GRCh37_chr20:56947914-56948415 | 20 | 58372858 | 58373359 | Human |
329829446 | LOC130066253 | ATAC-STARR-seq lymphoblastoid silent region 13072 | 20 | 58388938 | 58389377 | Human |
68452 | VAPB | VAMP associated protein B and C | 20 | 58389229 | 58451101 | Human |
329829796 | LOC130066254 | ATAC-STARR-seq lymphoblastoid silent region 13073 | 20 | 58389638 | 58389757 | Human |
155758412 | LOC127893935 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56988153-56988944 | 20 | 58413097 | 58413888 | Human |
155781292 | LOC127893936 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56988945-56989734 | 20 | 58413889 | 58414678 | Human |
155776868 | LOC127893937 | OCT4-NANOG hESC enhancer GRCh37_chr20:57002581-57003275 | 20 | 58427525 | 58428219 | Human |
155779099 | LOC127893938 | H3K27ac hESC enhancer GRCh37_chr20:57021533-57022034 | 20 | 58446477 | 58446978 | Human |
329828838 | LOC130066255 | ATAC-STARR-seq lymphoblastoid active region 18173 | 20 | 58458655 | 58458794 | Human |
329837852 | LOC130066256 | ATAC-STARR-seq lymphoblastoid active region 18174 | 20 | 58458925 | 58459034 | Human |
1605849 | APCDD1L | APC down-regulated 1 like | 20 | 58459101 | 58515399 | Human |
329338786 | LOC129664664 | ReSE screen-validated silencer GRCh37_chr20:57035877-57036065 | 20 | 58460821 | 58461009 | Human |
6892856 | APCDD1L-DT | APCDD1L divergent transcript | 20 | 58515379 | 58619892 | Human |
155227673 | LOC126863068 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:57116639-57117838 | 20 | 58541583 | 58542782 | Human |
155756575 | LOC127893940 | H3K4me1 hESC enhancer GRCh37_chr20:57121117-57121618 | 20 | 58546061 | 58546562 | Human |
155758231 | LOC127893942 | H3K4me1 hESC enhancer GRCh37_chr20:57169387-57170169 | 20 | 58594331 | 58595113 | Human |
155764378 | LOC127893943 | H3K4me1 hESC enhancer GRCh37_chr20:57185055-57185556 | 20 | 58609999 | 58610500 | Human |
155771548 | LOC127893944 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57193651-57194322 | 20 | 58618595 | 58619266 | Human |
155766972 | LOC127893945 | H3K4me1 hESC enhancer GRCh37_chr20:57194995-57195666 | 20 | 58619939 | 58620610 | Human |
38631959 | LOC112694724 | Sharpr-MPRA regulatory region 4326 | 20 | 58623913 | 58624207 | Human |
11563796 | LINC01711 | long intergenic non-protein coding RNA 1711 | 20 | 58634772 | 58635738 | Human |
329829593 | LOC130066257 | ATAC-STARR-seq lymphoblastoid active region 18175 | 20 | 58634776 | 58634905 | Human |
329816228 | LOC130066258 | ATAC-STARR-seq lymphoblastoid active region 18176 | 20 | 58634926 | 58634995 | Human |
155774338 | LOC127893947 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57212955-57213590 | 20 | 58637899 | 58638534 | Human |
38648579 | LOC107985410 | uncharacterized LOC107985410 | 20 | 58640123 | 58649635 | Human |
152975940 | LOC125387311 | Sharpr-MPRA regulatory region 5631 | 20 | 58647493 | 58647787 | Human |
155756684 | LOC127893948 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57223531-57224068 | 20 | 58648475 | 58649012 | Human |
329839812 | LOC130066259 | ATAC-STARR-seq lymphoblastoid silent region 13074 | 20 | 58650186 | 58650545 | Human |
5133079 | STX16-NPEPL1 | STX16-NPEPL1 readthrough (NMD candidate) | 20 | 58651253 | 58715844 | Human |
1319758 | STX16 | syntaxin 16 | 20 | 58651283 | 58679526 | Human |
155781880 | LOC127893949 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:57227205-57227708 | 20 | 58652042 | 58652652 | Human |
155766536 | LOC127893950 | H3K27ac hESC enhancer GRCh37_chr20:57236323-57236822 | 20 | 58661267 | 58661766 | Human |
155774055 | LOC127893951 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57244387-57245042 | 20 | 58669331 | 58669986 | Human |
155779853 | LOC127893952 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57245043-57245700 | 20 | 58669987 | 58670644 | Human |
155759409 | LOC127893953 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57245701-57246356 | 20 | 58670645 | 58671300 | Human |
155782185 | LOC127893954 | H3K4me1 hESC enhancer GRCh37_chr20:57250883-57251408 | 20 | 58675827 | 58676352 | Human |
155750613 | LOC127893955 | H3K4me1 hESC enhancer GRCh37_chr20:57251409-57251933 | 20 | 58676353 | 58676877 | Human |
151931291 | NPEPL1 | aminopeptidase like 1 | 20 | 58689131 | 58715844 | Human |
155768168 | LOC127893956 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57267289-57267994 | 20 | 58692233 | 58692938 | Human |
329827113 | LOC130066260 | ATAC-STARR-seq lymphoblastoid silent region 13077 | 20 | 58692936 | 58693095 | Human |
329821542 | LOC130066261 | ATAC-STARR-seq lymphoblastoid silent region 13078 | 20 | 58693126 | 58693205 | Human |
329838123 | LOC130066262 | ATAC-STARR-seq lymphoblastoid silent region 13079 | 20 | 58693226 | 58693315 | Human |
155778478 | LOC127893957 | H3K4me1 hESC enhancer GRCh37_chr20:57269435-57270042 | 20 | 58694379 | 58694986 | Human |
155762492 | LOC127893958 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57276557-57277089 | 20 | 58701501 | 58702033 | Human |
155755148 | LOC127893959 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57277090-57277621 | 20 | 58702034 | 58702565 | Human |
155758992 | LOC127893960 | H3K4me1 hESC enhancer GRCh37_chr20:57290235-57291042 | 20 | 58715179 | 58715986 | Human |
1322762 | NPEPL1 | aminopeptidase like 1 | 20 | 58717595 | 58719231 | Human |
6480932 | PIEZO1P2 | piezo type mechanosensitive ion channel component 1 pseudogene 2 | 20 | 58741189 | 58766333 | Human |
155757386 | LOC127893961 | H3K4me1 hESC enhancer GRCh37_chr20:57320681-57321180 | 20 | 58745625 | 58746124 | Human |
155767458 | LOC127893962 | H3K4me1 hESC enhancer GRCh37_chr20:57327629-57328292 | 20 | 58752573 | 58753236 | Human |
155755466 | LOC127893963 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:57328293-57328958 | 20 | 58753237 | 58753902 | Human |
155757291 | LOC127893964 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:57328959-57329622 | 20 | 58753903 | 58754566 | Human |
38619248 | LOC105372695 | uncharacterized LOC105372695 | 20 | 58773425 | 58774811 | Human |
155760218 | LOC127893965 | H3K4me1 hESC enhancer GRCh37_chr20:57362050-57362726 | 20 | 58786994 | 58787671 | Human |
155752500 | LOC127893966 | H3K4me1 hESC enhancer GRCh37_chr20:57378241-57378944 | 20 | 58803186 | 58803889 | Human |
155756114 | LOC127893967 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57380351-57381052 | 20 | 58805296 | 58805997 | Human |
155772128 | LOC127893968 | H3K4me1 hESC enhancer GRCh37_chr20:57388251-57388750 | 20 | 58813196 | 58813695 | Human |
1349952 | MIR296 | microRNA 296 | 20 | 58817615 | 58817694 | Human |
2290256 | MIR298 | microRNA 298 | 20 | 58818226 | 58818313 | Human |
2300358 | GNAS-AS1 | GNAS antisense RNA 1 | 20 | 58818918 | 58850902 | Human |
736916 | GNAS | GNAS complex locus | 20 | 58839748 | 58911192 | Human |
329820605 | LOC130066263 | ATAC-STARR-seq lymphoblastoid active region 18178 | 20 | 58852558 | 58852657 | Human |
155778219 | LOC127893969 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57429646-57430522 | 20 | 58854591 | 58855467 | Human |
155753369 | LOC127893970 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57430523-57431398 | 20 | 58855468 | 58856343 | Human |
38636795 | LOC101927932 | uncharacterized LOC101927932 | 20 | 58863756 | 58888810 | Human |
329829645 | LOC130066264 | ATAC-STARR-seq lymphoblastoid active region 18179 | 20 | 58888539 | 58888758 | Human |
329826696 | LOC130066265 | ATAC-STARR-seq lymphoblastoid silent region 13080 | 20 | 58889199 | 58889478 | Human |
329836703 | LOC130066266 | ATAC-STARR-seq lymphoblastoid silent region 13081 | 20 | 58890679 | 58890828 | Human |
329827869 | LOC130066267 | ATAC-STARR-seq lymphoblastoid silent region 13082 | 20 | 58890889 | 58891388 | Human |
329822500 | LOC130066268 | ATAC-STARR-seq lymphoblastoid silent region 13083 | 20 | 58891399 | 58891618 | Human |
329840057 | LOC130066269 | ATAC-STARR-seq lymphoblastoid silent region 13084 | 20 | 58892489 | 58892578 | Human |
155761815 | LOC127893971 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:57470438-57471032 | 20 | 58895383 | 58895977 | Human |
155781415 | LOC127893972 | H3K4me1 hESC enhancer GRCh37_chr20:57471033-57471626 | 20 | 58895978 | 58896571 | Human |
155771971 | LOC127893973 | H3K4me1 hESC enhancer GRCh37_chr20:57474225-57474776 | 20 | 58899170 | 58899721 | Human |
329841321 | LOC130066270 | ATAC-STARR-seq lymphoblastoid active region 18180 | 20 | 58907643 | 58908122 | Human |
38652027 | LOC107985382 | uncharacterized LOC107985382 | 20 | 58944946 | 58967854 | Human |
38607798 | LOC112268264 | small integral membrane protein 30-like | 20 | 58948089 | 58948388 | Human |
155755855 | LOC127893974 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr20:57540701-57541253 | 20 | 58965646 | 58966198 | Human |
155767860 | LOC127893975 | H3K27ac hESC enhancer GRCh37_chr20:57556569-57557069 | 20 | 58981112 | 58982014 | Human |
1346942 | NELFCD | negative elongation factor complex member C/D | 20 | 58981256 | 58995113 | Human |
1352898 | CTSZ | cathepsin Z | 20 | 58995185 | 59007254 | Human |
329823784 | LOC130066271 | ATAC-STARR-seq lymphoblastoid active region 18181 | 20 | 59004688 | 59004737 | Human |
329819397 | LOC130066272 | ATAC-STARR-seq lymphoblastoid active region 18182 | 20 | 59004748 | 59004807 | Human |
329841306 | LOC130066273 | ATAC-STARR-seq lymphoblastoid active region 18183 | 20 | 59005048 | 59005357 | Human |
155760240 | LOC127893976 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:57581561-57582372 | 20 | 59006506 | 59007537 | Human |
329832795 | LOC130066274 | ATAC-STARR-seq lymphoblastoid active region 18184 | 20 | 59007998 | 59008157 | Human |
329841960 | LOC130066275 | ATAC-STARR-seq lymphoblastoid active region 18185 | 20 | 59008178 | 59008287 | Human |
329824055 | LOC130066276 | ATAC-STARR-seq lymphoblastoid active region 18186 | 20 | 59008428 | 59008507 | Human |
1345439 | TUBB1 | tubulin beta 1 class VI | 20 | 59016438 | 59026654 | Human |
1346801 | ATP5F1E | ATP synthase F1 subunit epsilon | 20 | 59025475 | 59032335 | Human |
38647372 | SLMO2-ATP5E | SLMO2-ATP5E readthrough | 20 | 59028678 | 59042846 | Human |
155753828 | LOC127893977 | NANOG hESC enhancer GRCh37_chr20:57603869-57604399 | 20 | 59028814 | 59029344 | Human |
329830049 | LOC130066277 | ATAC-STARR-seq lymphoblastoid active region 18187 | 20 | 59032129 | 59032268 | Human |
329842345 | LOC130066278 | ATAC-STARR-seq lymphoblastoid silent region 13087 | 20 | 59032289 | 59032578 | Human |
1345443 | PRELID3B | PRELI domain containing 3B | 20 | 59033145 | 59042786 | Human |
329836561 | LOC130066279 | ATAC-STARR-seq lymphoblastoid silent region 13088 | 20 | 59042704 | 59043103 | Human |
155228826 | LOC126863069 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:57638504-57639703 | 20 | 59063449 | 59064648 | Human |
151674869 | LOC124904943 | uncharacterized LOC124904943 | 20 | 59063450 | 59064206 | Human |
155762138 | LOC127893978 | NANOG hESC enhancer GRCh37_chr20:57681118-57681619 | 20 | 59106063 | 59106564 | Human |
1349830 | MRPS16P2 | mitochondrial ribosomal protein S16 pseudogene 2 | 20 | 59113075 | 59113932 | Human |
155763939 | LOC127893979 | OCT4-NANOG hESC enhancer GRCh37_chr20:57697082-57697631 | 20 | 59122027 | 59122576 | Human |
1316121 | ZNF831 | zinc finger protein 831 | 20 | 59123388 | 59259113 | Human |
329339001 | LOC129664665 | ReSE screen-validated silencer GRCh37_chr20:57724967-57725189 | 20 | 59149912 | 59150134 | Human |
155759968 | LOC127893980 | H3K4me1 hESC enhancer GRCh37_chr20:57734401-57735226 | 20 | 59159346 | 59160171 | Human |
155230197 | LOC126863070 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:57770614-57771813 | 20 | 59195559 | 59196758 | Human |
329844079 | LOC130066280 | ATAC-STARR-seq lymphoblastoid silent region 13089 | 20 | 59222592 | 59222661 | Human |
1344952 | EDN3 | endothelin 3 | 20 | 59300611 | 59325992 | Human |
155763996 | LOC127893981 | H3K4me1 hESC enhancer GRCh37_chr20:57893004-57893504 | 20 | 59317949 | 59318449 | Human |
152975749 | LOC125387312 | Sharpr-MPRA regulatory region 9189 | 20 | 59318994 | 59319288 | Human |
155763537 | LOC127893982 | H3K4me1 hESC enhancer GRCh37_chr20:57950919-57951420 | 20 | 59375864 | 59376365 | Human |
155750930 | LOC127893983 | H3K4me1 hESC enhancer GRCh37_chr20:57979490-57979990 | 20 | 59404435 | 59404935 | Human |
155753251 | LOC127893984 | NANOG hESC enhancer GRCh37_chr20:58013205-58013760 | 20 | 59438150 | 59438705 | Human |
1351580 | PIEZO1P1 | piezo type mechanosensitive ion channel component 1 pseudogene 1 | 20 | 59460619 | 59460837 | Human |
329340844 | LOC129664666 | ReSE screen-validated silencer GRCh37_chr20:58051005-58051166 | 20 | 59475950 | 59476111 | Human |
155776463 | LOC127893985 | H3K4me1 hESC enhancer GRCh37_chr20:58070963-58071463 | 20 | 59495908 | 59496408 | Human |
155767862 | LOC127893986 | H3K4me1 hESC enhancer GRCh37_chr20:58089356-58090192 | 20 | 59514301 | 59515137 | Human |
155780682 | LOC127893987 | H3K4me1 hESC enhancer GRCh37_chr20:58090193-58091028 | 20 | 59515138 | 59515973 | Human |
329341726 | LOC129664667 | ReSE screen-validated silencer GRCh37_chr20:58133017-58133222 | 20 | 59557962 | 59558167 | Human |
155770800 | LOC127893988 | H3K4me1 hESC enhancer GRCh37_chr20:58143003-58143837 | 20 | 59567948 | 59568782 | Human |
155777712 | LOC127893989 | H3K4me1 hESC enhancer GRCh37_chr20:58147145-58147686 | 20 | 59572090 | 59572631 | Human |
1605886 | PHACTR3 | phosphatase and actin regulator 3 | 20 | 59577509 | 59847711 | Human |
329342289 | LOC129391203 | MPRA-validated peak4290 silencer | 20 | 59604161 | 59604361 | Human |
329833242 | LOC130066281 | ATAC-STARR-seq lymphoblastoid active region 18189 | 20 | 59722750 | 59722799 | Human |
329838369 | LOC130066282 | ATAC-STARR-seq lymphoblastoid active region 18190 | 20 | 59744190 | 59744259 | Human |
155764794 | LOC127893990 | H3K4me1 hESC enhancer GRCh37_chr20:58325659-58326160 | 20 | 59750604 | 59751105 | Human |
329835636 | LOC130066283 | ATAC-STARR-seq lymphoblastoid active region 18191 | 20 | 59752328 | 59752657 | Human |
155227665 | LOC126863071 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:58345121-58346320 | 20 | 59770066 | 59771265 | Human |
10399369 | RNU7-141P | RNA, U7 small nuclear 141 pseudogene | 20 | 59852667 | 59852728 | Human |
69483 | SYCP2 | synaptonemal complex protein 2 | 20 | 59863571 | 59933637 | Human |
1323673 | FAM217B | family with sequence similarity 217 member B | 20 | 59933779 | 59948680 | Human |
329825009 | LOC130066284 | ATAC-STARR-seq lymphoblastoid silent region 13090 | 20 | 59933928 | 59934327 | Human |
1315049 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | 20 | 59936663 | 59940305 | Human |
329833119 | LOC130066285 | ATAC-STARR-seq lymphoblastoid silent region 13091 | 20 | 59939767 | 59939896 | Human |
127284982 | LOC121627913 | Sharpr-MPRA regulatory region 25 | 20 | 59940194 | 59940626 | Human |
155779008 | LOC127893991 | H3K27ac hESC enhancer GRCh37_chr20:58529519-58530020 | 20 | 59954464 | 59954965 | Human |
1323191 | CDH26 | cadherin 26 | 20 | 59958423 | 60035934 | Human |
155777440 | LOC127893992 | NANOG-H3K27ac hESC enhancer GRCh37_chr20:58569287-58569819 | 20 | 59994232 | 59994764 | Human |
155779763 | LOC127893993 | H3K4me1 hESC enhancer GRCh37_chr20:58611565-58612066 | 20 | 60036510 | 60037011 | Human |
155757403 | LOC127893994 | H3K4me1 hESC enhancer GRCh37_chr20:58612067-58612566 | 20 | 60037012 | 60037511 | Human |
1606918 | LINC02910 | long intergenic non-protein coding RNA 2910 | 20 | 60055925 | 60072953 | Human |
329818231 | LOC130066286 | ATAC-STARR-seq lymphoblastoid active region 18192 | 20 | 60057613 | 60057662 | Human |
329816181 | LOC130066287 | ATAC-STARR-seq lymphoblastoid active region 18193 | 20 | 60057673 | 60057852 | Human |
155762223 | LOC127893995 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:58633003-58633804 | 20 | 60057948 | 60058749 | Human |
1603345 | MIR646HG | MIR646 host gene | 20 | 60087686 | 60101387 | Human |
329341165 | LOC129664668 | ReSE screen-validated silencer GRCh37_chr20:58677553-58677708 | 20 | 60102498 | 60102653 | Human |
155755909 | LOC127893996 | H3K4me1 hESC enhancer GRCh37_chr20:58686253-58686792 | 20 | 60111197 | 60111736 | Human |
329342648 | LOC129664669 | ReSE screen-validated silencer GRCh37_chr20:58786198-58786437 | 20 | 60211140 | 60211379 | Human |
155758104 | LOC127893997 | H3K4me1 hESC enhancer GRCh37_chr20:58788309-58788809 | 20 | 60213251 | 60213751 | Human |
38606285 | LOC105372698 | uncharacterized LOC105372698 | 20 | 60255791 | 60287274 | Human |
1602909 | MIR646 | microRNA 646 | 20 | 60308474 | 60308567 | Human |
38625079 | LOC105372697 | uncharacterized LOC105372697 | 20 | 60332692 | 60344117 | Human |
1347360 | MTCO2P1 | MT-CO2 pseudogene 1 | 20 | 60414396 | 60414872 | Human |
38633087 | LOC101928048 | uncharacterized LOC101928048 | 20 | 60469609 | 60472976 | Human |
151668552 | LOC124904944 | uncharacterized LOC124904944 | 20 | 60473130 | 60485858 | Human |
5133919 | MIR4533 | microRNA 4533 | 20 | 60478111 | 60478181 | Human |
155766374 | LOC127893999 | H3K4me1 hESC enhancer GRCh37_chr20:59059838-59060338 | 20 | 60484780 | 60485280 | Human |
155754159 | LOC127894000 | H3K4me1 hESC enhancer GRCh37_chr20:59060339-59060839 | 20 | 60485281 | 60485781 | Human |
401826167 | LOC132090592 | Neanderthal introgressed variant-containing enhancer experimental_60818 | 20 | 60496017 | 60496186 | Human |
155779198 | LOC127894001 | OCT4-NANOG hESC enhancer GRCh37_chr20:59087400-59088072 | 20 | 60512342 | 60513014 | Human |
151675752 | LOC124904945 | uncharacterized LOC124904945 | 20 | 60549284 | 60555660 | Human |
5133896 | MIR548AG2 | microRNA 548ag-2 | 20 | 60564562 | 60564625 | Human |
155782062 | LOC127894002 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:59154177-59155084 | 20 | 60579119 | 60580026 | Human |
329339096 | LOC129391204 | MPRA-validated peak4292 silencer | 20 | 60589698 | 60589898 | Human |
155227992 | LOC126863072 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:59251235-59252434 | 20 | 60676177 | 60677376 | Human |
155769518 | LOC127894003 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:59266538-59267215 | 20 | 60691480 | 60692157 | Human |
155775401 | LOC127894004 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:59267216-59267892 | 20 | 60692158 | 60692834 | Human |
155755546 | LOC127894005 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:59267893-59268569 | 20 | 60692835 | 60693511 | Human |
155769988 | LOC127894006 | H3K4me1 hESC enhancer GRCh37_chr20:59289824-59290424 | 20 | 60714766 | 60715366 | Human |
155780053 | LOC127894007 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr20:59303390-59304068 | 20 | 60728332 | 60729010 | Human |
38624564 | LOC105372699 | uncharacterized LOC105372699 | 20 | 60750432 | 60775630 | Human |
401826314 | LOC132090593 | Neanderthal introgressed variant-containing enhancer experimental_60829 | 20 | 60775147 | 60775316 | Human |
38637119 | LOC105372700 | uncharacterized LOC105372700 | 20 | 60804498 | 60809373 | Human |
155227385 | LOC126863073 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:59381122-59382321 | 20 | 60806066 | 60807265 | Human |
155771926 | LOC127894008 | H3K4me1 hESC enhancer GRCh37_chr20:59443414-59443929 | 20 | 60868358 | 60868873 | Human |
155761937 | LOC127894009 | H3K4me1 hESC enhancer GRCh37_chr20:59443930-59444444 | 20 | 60868874 | 60869388 | Human |
329338232 | LOC129391205 | MPRA-validated peak4294 silencer | 20 | 60921120 | 60921320 | Human |
155750496 | LOC127894010 | H3K4me1 hESC enhancer GRCh37_chr20:59632462-59633382 | 20 | 61057406 | 61058326 | Human |
11562377 | LINC01718 | long intergenic non-protein coding RNA 1718 | 20 | 61079064 | 61080179 | Human |
155229063 | LOC126863074 | MED14-independent group 3 enhancer GRCh37_chr20:59676211-59677410 | 20 | 61101155 | 61102354 | Human |
155777189 | LOC127894011 | H3K4me1 hESC enhancer GRCh37_chr20:59688891-59689390 | 20 | 61113835 | 61114334 | Human |
155753313 | LOC127894012 | NANOG-H3K4me1 hESC enhancer GRCh37_chr20:59698201-59698846 | 20 | 61123145 | 61123790 | Human |
155227596 | LOC126863075 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:59738200-59739399 | 20 | 61163144 | 61164343 | Human |
38670377 | LOC105372701 | uncharacterized LOC105372701 | 20 | 61179144 | 61185188 | Human |
155230056 | LOC126863076 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:59794837-59796036 | 20 | 61219781 | 61220980 | Human |
1343938 | CDH4 | cadherin 4 | 20 | 61252261 | 61940617 | Human |
155751872 | LOC127894013 | H3K4me1 hESC enhancer GRCh37_chr20:59829421-59830113 | 20 | 61254365 | 61255057 | Human |
155765920 | LOC127894014 | H3K4me1 hESC enhancer GRCh37_chr20:59837300-59837811 | 20 | 61262244 | 61262755 | Human |
155780238 | LOC127894015 | H3K4me1 hESC enhancer GRCh37_chr20:59842714-59843244 | 20 | 61267658 | 61268188 | Human |
155753142 | LOC127894016 | H3K4me1 hESC enhancer GRCh37_chr20:59843245-59843775 | 20 | 61268189 | 61268719 | Human |
155780571 | LOC127894017 | OCT4-H3K4me1 hESC enhancer GRCh37_chr20:59881901-59882407 | 20 | 61306845 | 61307351 | Human |
155770096 | LOC127894018 | H3K4me1 hESC enhancer GRCh37_chr20:59892319-59893194 | 20 | 61317263 | 61318138 | Human |
155772214 | LOC127894019 | H3K4me1 hESC enhancer GRCh37_chr20:59928779-59929522 | 20 | 61353723 | 61354466 | Human |
152975871 | LOC125387313 | Sharpr-MPRA regulatory region 1887 | 20 | 61361753 | 61362047 | Human |
155228022 | LOC126863077 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:59964898-59966097 | 20 | 61389842 | 61391041 | Human |
155772097 | LOC127894020 | H3K4me1 hESC enhancer GRCh37_chr20:59966867-59967466 | 20 | 61391811 | 61392410 | Human |
155777611 | LOC127894021 | H3K4me1 hESC enhancer GRCh37_chr20:59971133-59971634 | 20 | 61396077 | 61396578 | Human |
155758521 | LOC127894022 | H3K4me1 hESC enhancer GRCh37_chr20:59971635-59972134 | 20 | 61396579 | 61397078 | Human |
155773071 | LOC127894023 | H3K4me1 hESC enhancer GRCh37_chr20:59981242-59981742 | 20 | 61406186 | 61406686 | Human |
155755460 | LOC127894024 | H3K4me1 hESC enhancer GRCh37_chr20:59981743-59982243 | 20 | 61406687 | 61407187 | Human |
155771330 | LOC127894025 | H3K4me1 hESC enhancer GRCh37_chr20:59999531-60000423 | 20 | 61424475 | 61425367 | Human |
155760600 | LOC127894026 | H3K4me1 hESC enhancer GRCh37_chr20:60000424-60001315 | 20 | 61425368 | 61426259 | Human |
38606007 | LOC105372703 | uncharacterized LOC105372703 | 20 | 61433064 | 61437425 | Human |
155761489 | LOC127894027 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60008559-60009148 | 20 | 61433503 | 61434092 | Human |
155751258 | LOC127894028 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60009149-60009738 | 20 | 61434093 | 61434682 | Human |
155227409 | LOC126863078 | MED14-independent group 3 enhancer GRCh37_chr20:60011920-60013119 | 20 | 61436452 | 61438063 | Human |
155768842 | LOC127894029 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60023738-60024298 | 20 | 61448682 | 61449242 | Human |
155781920 | LOC127894030 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60024299-60024857 | 20 | 61449243 | 61449801 | Human |
155759905 | LOC127894031 | H3K4me1 hESC enhancer GRCh37_chr20:60073706-60074206 | 20 | 61498650 | 61499150 | Human |
155228698 | LOC126863079 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:60075832-60077031 | 20 | 61500776 | 61501975 | Human |
155769062 | LOC127894032 | H3K4me1 hESC enhancer GRCh37_chr20:60088606-60089115 | 20 | 61513550 | 61514059 | Human |
155772720 | LOC127894033 | H3K4me1 hESC enhancer GRCh37_chr20:60106507-60107008 | 20 | 61531451 | 61531952 | Human |
155774067 | LOC127894034 | H3K4me1 hESC enhancer GRCh37_chr20:60113444-60114423 | 20 | 61538388 | 61539367 | Human |
155776974 | LOC127894035 | H3K4me1 hESC enhancer GRCh37_chr20:60131355-60131856 | 20 | 61556299 | 61556800 | Human |
155775138 | LOC127894036 | H3K4me1 hESC enhancer GRCh37_chr20:60131857-60132356 | 20 | 61556801 | 61557300 | Human |
155761856 | LOC127894037 | H3K4me1 hESC enhancer GRCh37_chr20:60137997-60138897 | 20 | 61562941 | 61563841 | Human |
155774435 | LOC127894038 | H3K4me1 hESC enhancer GRCh37_chr20:60164799-60165300 | 20 | 61589743 | 61590244 | Human |
155759772 | LOC127894039 | H3K4me1 hESC enhancer GRCh37_chr20:60173673-60174405 | 20 | 61598617 | 61599349 | Human |
329342099 | LOC129391206 | MPRA-validated peak4296 silencer | 20 | 61608380 | 61608580 | Human |
155769106 | LOC127894040 | NANOG hESC enhancer GRCh37_chr20:60193522-60194023 | 20 | 61618466 | 61618967 | Human |
155754348 | LOC127894041 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60203424-60204083 | 20 | 61628368 | 61629027 | Human |
155770986 | LOC127894042 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60204084-60204742 | 20 | 61629028 | 61629686 | Human |
329338279 | LOC129664670 | ReSE screen-validated silencer GRCh37_chr20:60231445-60231625 | 20 | 61656389 | 61656569 | Human |
155774151 | LOC127894043 | H3K4me1 hESC enhancer GRCh37_chr20:60237181-60237694 | 20 | 61662125 | 61662638 | Human |
155773349 | LOC127894044 | H3K4me1 hESC enhancer GRCh37_chr20:60237695-60238208 | 20 | 61662639 | 61663152 | Human |
155769699 | LOC127894045 | H3K4me1 hESC enhancer GRCh37_chr20:60263433-60263932 | 20 | 61688377 | 61688876 | Human |
155761120 | LOC127894046 | H3K4me1 hESC enhancer GRCh37_chr20:60274679-60275179 | 20 | 61699623 | 61700123 | Human |
329338351 | LOC129664671 | ReSE screen-validated silencer GRCh37_chr20:60284281-60284449 | 20 | 61709225 | 61709393 | Human |
16550858 | AL162457.1 | novel transcript, antisense to CDH4 | 20 | 61717506 | 61719748 | Human |
155772458 | LOC127894047 | H3K4me1 hESC enhancer GRCh37_chr20:60321424-60321924 | 20 | 61746368 | 61746868 | Human |
155758682 | LOC127894048 | H3K4me1 hESC enhancer GRCh37_chr20:60321925-60322425 | 20 | 61746869 | 61747369 | Human |
155776486 | LOC127894049 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60328223-60329209 | 20 | 61753167 | 61754153 | Human |
155752190 | LOC127894050 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60329210-60330195 | 20 | 61754154 | 61755139 | Human |
155774981 | LOC127894051 | H3K4me1 hESC enhancer GRCh37_chr20:60332068-60332568 | 20 | 61757012 | 61757512 | Human |
155758702 | LOC127894052 | H3K4me1 hESC enhancer GRCh37_chr20:60332569-60333069 | 20 | 61757513 | 61758013 | Human |
155750471 | LOC127894053 | H3K4me1 hESC enhancer GRCh37_chr20:60340987-60341560 | 20 | 61765931 | 61766504 | Human |
155781025 | LOC127894054 | H3K4me1 hESC enhancer GRCh37_chr20:60342316-60342816 | 20 | 61767260 | 61767760 | Human |
155757885 | LOC127894055 | H3K4me1 hESC enhancer GRCh37_chr20:60344183-60344683 | 20 | 61769127 | 61769627 | Human |
38649408 | LOC112694725 | Sharpr-MPRA regulatory region 10002 | 20 | 61771773 | 61772067 | Human |
155775662 | LOC127894056 | H3K4me1 hESC enhancer GRCh37_chr20:60377656-60378176 | 20 | 61802600 | 61803120 | Human |
155764290 | LOC127894057 | H3K4me1 hESC enhancer GRCh37_chr20:60378177-60378697 | 20 | 61803121 | 61803641 | Human |
155755979 | LOC127894058 | H3K4me1 hESC enhancer GRCh37_chr20:60383971-60384684 | 20 | 61808915 | 61809628 | Human |
155755582 | LOC127894059 | H3K4me1 hESC enhancer GRCh37_chr20:60410329-60410830 | 20 | 61835273 | 61835774 | Human |
155764713 | LOC127894060 | H3K4me1 hESC enhancer GRCh37_chr20:60434505-60435006 | 20 | 61859449 | 61859950 | Human |
155774621 | LOC127894061 | H3K4me1 hESC enhancer GRCh37_chr20:60453666-60454166 | 20 | 61878610 | 61879110 | Human |
155770149 | LOC127894062 | H3K4me1 hESC enhancer GRCh37_chr20:60454167-60454667 | 20 | 61879111 | 61879611 | Human |
155776183 | LOC127894063 | H3K4me1 hESC enhancer GRCh37_chr20:60466559-60467058 | 20 | 61891503 | 61892002 | Human |
155782719 | LOC127894064 | H3K4me1 hESC enhancer GRCh37_chr20:60476138-60477031 | 20 | 61901082 | 61901975 | Human |
149735406 | LOC121853017 | Sharpr-MPRA regulatory region 9437 | 20 | 61918593 | 61918887 | Human |
155229583 | LOC126863080 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr20:60501357-60502556 | 20 | 61926299 | 61927856 | Human |
155764017 | LOC127894065 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60507695-60508426 | 20 | 61932637 | 61933368 | Human |
155751173 | LOC127894066 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60509158-60509888 | 20 | 61934100 | 61934830 | Human |
155763627 | LOC127894067 | H3K4me1 hESC enhancer GRCh37_chr20:60523619-60524118 | 20 | 61948563 | 61949062 | Human |
329337559 | LOC129391207 | MPRA-validated peak4298 silencer | 20 | 61952100 | 61952300 | Human |
155780686 | LOC127894068 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60527344-60527916 | 20 | 61952288 | 61952860 | Human |
2312957 | MIR1257 | microRNA 1257 | 20 | 61953546 | 61953662 | Human |
155753101 | LOC127894069 | H3K4me1 hESC enhancer GRCh37_chr20:60528727-60529226 | 20 | 61953671 | 61954170 | Human |
155229826 | LOC126863081 | BRD4-independent group 4 enhancer GRCh37_chr20:60538354-60539553 | 20 | 61963298 | 61964497 | Human |
155765311 | LOC127894070 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60540456-60541084 | 20 | 61965400 | 61966028 | Human |
155774266 | LOC127894071 | H3K4me1 hESC enhancer GRCh37_chr20:60541085-60541714 | 20 | 61966029 | 61966658 | Human |
1345040 | TAF4 | TATA-box binding protein associated factor 4 | 20 | 61974798 | 62065881 | Human |
155761779 | LOC127894072 | H3K4me1 hESC enhancer GRCh37_chr20:60551058-60551558 | 20 | 61976002 | 61976502 | Human |
155755336 | LOC127894073 | H3K4me1 hESC enhancer GRCh37_chr20:60551559-60552059 | 20 | 61976503 | 61977003 | Human |
155757474 | LOC127894074 | H3K4me1 hESC enhancer GRCh37_chr20:60564347-60565309 | 20 | 61989291 | 61990253 | Human |
155778778 | LOC127894075 | H3K4me1 hESC enhancer GRCh37_chr20:60578426-60578926 | 20 | 62003370 | 62003870 | Human |
155763782 | LOC127894076 | H3K4me1 hESC enhancer GRCh37_chr20:60578927-60579427 | 20 | 62003871 | 62004371 | Human |
155778441 | LOC127894077 | H3K4me1 hESC enhancer GRCh37_chr20:60589023-60589524 | 20 | 62013967 | 62014468 | Human |
155782824 | LOC127894078 | H3K4me1 hESC enhancer GRCh37_chr20:60596697-60597476 | 20 | 62021641 | 62022420 | Human |
155772130 | LOC127894080 | H3K4me1 hESC enhancer GRCh37_chr20:60603061-60603696 | 20 | 62028005 | 62028640 | Human |
329816528 | LOC130066288 | ATAC-STARR-seq lymphoblastoid active region 18195 | 20 | 62031176 | 62031235 | Human |
329815775 | LOC130066289 | ATAC-STARR-seq lymphoblastoid active region 18196 | 20 | 62031276 | 62031345 | Human |
2304716 | RPL17P48 | ribosomal protein L17 pseudogene 48 | 20 | 62037392 | 62037976 | Human |
155773474 | LOC127894081 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60622502-60623100 | 20 | 62047446 | 62048044 | Human |
155760554 | LOC127894082 | H3K4me1 hESC enhancer GRCh37_chr20:60629188-60629688 | 20 | 62054132 | 62054632 | Human |
155761492 | LOC127894083 | H3K4me1 hESC enhancer GRCh37_chr20:60629689-60630189 | 20 | 62054633 | 62055133 | Human |
155772151 | LOC127894084 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60638627-60639140 | 20 | 62063571 | 62064084 | Human |
155776518 | LOC127894085 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60639141-60639655 | 20 | 62064085 | 62064599 | Human |
155781914 | LOC127894086 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60639656-60640169 | 20 | 62064600 | 62065113 | Human |
9685641 | MIR3195 | microRNA 3195 | 20 | 62064802 | 62064885 | Human |
155752053 | LOC127894087 | H3K27ac hESC enhancer GRCh37_chr20:60640170-60640684 | 20 | 62065114 | 62065651 | Human |
329827043 | LOC130066290 | ATAC-STARR-seq lymphoblastoid silent region 13094 | 20 | 62065912 | 62066021 | Human |
329841322 | LOC130066291 | ATAC-STARR-seq lymphoblastoid silent region 13095 | 20 | 62066282 | 62066661 | Human |
38673364 | LOC105372705 | uncharacterized LOC105372705 | 20 | 62066454 | 62068535 | Human |
155757466 | LOC127894088 | H3K27ac hESC enhancer GRCh37_chr20:60641713-60642226 | 20 | 62066657 | 62067170 | Human |
155755673 | LOC127894089 | H3K4me1 hESC enhancer GRCh37_chr20:60662279-60662835 | 20 | 62087223 | 62087779 | Human |
155771698 | LOC127894090 | H3K4me1 hESC enhancer GRCh37_chr20:60662836-60663391 | 20 | 62087780 | 62088335 | Human |
38618432 | LOC105372706 | uncharacterized LOC105372706 | 20 | 62101143 | 62123684 | Human |
155760328 | LOC127894091 | H3K4me1 hESC enhancer GRCh37_chr20:60687696-60688502 | 20 | 62112640 | 62113446 | Human |
155770557 | LOC127894092 | H3K27ac hESC enhancer GRCh37_chr20:60697043-60697730 | 20 | 62121534 | 62122674 | Human |
1351489 | LSM14B | LSM family member 14B | 20 | 62122475 | 62135374 | Human |
155774998 | LOC127894093 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60697731-60698419 | 20 | 62122675 | 62123363 | Human |
155772860 | LOC127894094 | H3K4me1 hESC enhancer GRCh37_chr20:60698420-60699107 | 20 | 62123364 | 62124051 | Human |
155761254 | LOC127894095 | H3K4me1 hESC enhancer GRCh37_chr20:60708899-60709398 | 20 | 62133843 | 62134342 | Human |
737158 | PSMA7 | proteasome 20S subunit alpha 7 | 20 | 62136733 | 62143394 | Human |
329820109 | LOC130066292 | ATAC-STARR-seq lymphoblastoid silent region 13098 | 20 | 62142596 | 62143235 | Human |
329842671 | LOC130066293 | ATAC-STARR-seq lymphoblastoid silent region 13099 | 20 | 62143276 | 62143985 | Human |
1345361 | SS18L1 | SS18L1 subunit of BAF chromatin remodeling complex | 20 | 62143769 | 62182514 | Human |
329844386 | LOC130066294 | ATAC-STARR-seq lymphoblastoid silent region 13100 | 20 | 62144106 | 62144165 | Human |
329823734 | LOC130066295 | ATAC-STARR-seq lymphoblastoid silent region 13101 | 20 | 62144196 | 62144245 | Human |
149735466 | LOC121853018 | Sharpr-MPRA regulatory region 1753 | 20 | 62149493 | 62150454 | Human |
155228600 | LOC126863082 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr20:60735092-60736291 | 20 | 62160036 | 62161530 | Human |
155760295 | LOC127894096 | H3K4me1 hESC enhancer GRCh37_chr20:60736587-60737199 | 20 | 62161531 | 62162143 | Human |
329824851 | LOC130066296 | ATAC-STARR-seq lymphoblastoid silent region 13102 | 20 | 62182657 | 62182846 | Human |
329338800 | LOC129664672 | ReSE screen-validated silencer GRCh37_chr20:60757942-60758126 | 20 | 62182886 | 62183070 | Human |
1344224 | MTG2 | mitochondrial ribosome associated GTPase 2 | 20 | 62183028 | 62203568 | Human |
329828615 | LOC130066297 | ATAC-STARR-seq lymphoblastoid silent region 13103 | 20 | 62183077 | 62183246 | Human |
155781779 | LOC127894097 | H3K4me1 hESC enhancer GRCh37_chr20:60789379-60789879 | 20 | 62214323 | 62214823 | Human |
732356 | HRH3 | histamine receptor H3 | 20 | 62214960 | 62220278 | Human |
329816305 | LOC130066298 | ATAC-STARR-seq lymphoblastoid silent region 13104 | 20 | 62220383 | 62220492 | Human |
155781758 | LOC127894098 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60803162-60804062 | 20 | 62228106 | 62229006 | Human |
1322699 | OSBPL2 | oxysterol binding protein like 2 | 20 | 62228243 | 62236301 | Human |
329833682 | LOC130066299 | ATAC-STARR-seq lymphoblastoid silent region 13105 | 20 | 62238249 | 62238648 | Human |
35315983 | OSBPL2 | oxysterol binding protein like 2 | 20 | 62238521 | 62296183 | Human |
155758583 | LOC127894099 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60814402-60815326 | 20 | 62239346 | 62240270 | Human |
155754162 | LOC127894100 | H3K4me1 hESC enhancer GRCh37_chr20:60818849-60819457 | 20 | 62243793 | 62244401 | Human |
155751670 | LOC127894101 | H3K4me1 hESC enhancer GRCh37_chr20:60819458-60820065 | 20 | 62244402 | 62245009 | Human |
155756560 | LOC127894102 | H3K4me1 hESC enhancer GRCh37_chr20:60831784-60832284 | 20 | 62256728 | 62257228 | Human |
155768261 | LOC127894103 | H3K4me1 hESC enhancer GRCh37_chr20:60853989-60854489 | 20 | 62278933 | 62279433 | Human |
329819140 | LOC130066300 | ATAC-STARR-seq lymphoblastoid silent region 13106 | 20 | 62302507 | 62302626 | Human |
329833852 | LOC130066301 | ATAC-STARR-seq lymphoblastoid silent region 13107 | 20 | 62302647 | 62303106 | Human |
736707 | ADRM1 | ADRM1 26S proteasome ubiquitin receptor | 20 | 62302896 | 62308862 | Human |
155766038 | LOC127894104 | H3K4me1 hESC enhancer GRCh37_chr20:60880842-60881345 | 20 | 62305786 | 62306289 | Human |
1354079 | LAMA5 | laminin subunit alpha 5 | 20 | 62309065 | 62367312 | Human |
329821198 | LOC130066302 | ATAC-STARR-seq lymphoblastoid silent region 13108 | 20 | 62321251 | 62321310 | Human |
38629406 | LOC112694726 | Sharpr-MPRA regulatory region 11098 | 20 | 62321453 | 62321747 | Human |
5134096 | MIR4758 | microRNA 4758 | 20 | 62332487 | 62332557 | Human |
151673890 | LOC124904946 | uncharacterized LOC124904946 | 20 | 62339974 | 62348303 | Human |
329816154 | LOC130066303 | ATAC-STARR-seq lymphoblastoid active region 18197 | 20 | 62340034 | 62340163 | Human |
8662009 | LAMA5-AS1 | LAMA5 antisense RNA 1 | 20 | 62353010 | 62356480 | Human |
155772091 | LOC127894105 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60929780-60930720 | 20 | 62354724 | 62355664 | Human |
155750735 | LOC127894106 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60930721-60931659 | 20 | 62355665 | 62356603 | Human |
155761362 | LOC127894107 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60935576-60936276 | 20 | 62360520 | 62361220 | Human |
155777632 | LOC127894108 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60936277-60936975 | 20 | 62361221 | 62361919 | Human |
155761274 | LOC127894109 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60936976-60937675 | 20 | 62361920 | 62362619 | Human |
155779476 | LOC127894110 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60937676-60938374 | 20 | 62362620 | 62363318 | Human |
329833765 | LOC130066304 | ATAC-STARR-seq lymphoblastoid active region 18198 | 20 | 62363457 | 62363506 | Human |
152975927 | LOC125387314 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60939075-60939774 | 20 | 62364019 | 62364718 | Human |
155763611 | LOC127894111 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60939775-60940474 | 20 | 62364719 | 62365418 | Human |
155756796 | LOC127894112 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60941173-60941872 | 20 | 62366117 | 62366816 | Human |
329841250 | LOC130066305 | ATAC-STARR-seq lymphoblastoid silent region 13109 | 20 | 62366996 | 62367435 | Human |
155770720 | LOC127894114 | H3K4me1 hESC enhancer GRCh37_chr20:60946071-60946768 | 20 | 62371015 | 62371712 | Human |
38617750 | LOC105372708 | uncharacterized LOC105372708 | 20 | 62373815 | 62378827 | Human |
155782065 | LOC127894115 | H3K4me1 hESC enhancer GRCh37_chr20:60949451-60950054 | 20 | 62374395 | 62374998 | Human |
155770850 | LOC127894116 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60950055-60950656 | 20 | 62374999 | 62375600 | Human |
155757203 | LOC127894117 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60953065-60953666 | 20 | 62378009 | 62378610 | Human |
155759050 | LOC127894118 | H3K4me1 hESC enhancer GRCh37_chr20:60956340-60957020 | 20 | 62381284 | 62381964 | Human |
329844524 | LOC130066306 | ATAC-STARR-seq lymphoblastoid active region 18199 | 20 | 62383017 | 62383196 | Human |
329829802 | LOC130066307 | ATAC-STARR-seq lymphoblastoid active region 18200 | 20 | 62386241 | 62386290 | Human |
156430117 | RPS21-DT | RPS21 divergent transcript | 20 | 62386303 | 62386989 | Human |
155777441 | LOC127894119 | H3K27ac hESC enhancer GRCh37_chr20:60961625-60962316 | 20 | 62386569 | 62387260 | Human |
1348628 | RPS21 | ribosomal protein S21 | 20 | 62387103 | 62388520 | Human |
155776239 | LOC127894120 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60962317-60963008 | 20 | 62387191 | 62387952 | Human |
1345026 | CABLES2 | Cdk5 and Abl enzyme substrate 2 | 20 | 62388634 | 62407285 | Human |
155756524 | LOC127894121 | H3K4me1 hESC enhancer GRCh37_chr20:60967444-60967944 | 20 | 62392388 | 62392888 | Human |
155774996 | LOC127894122 | H3K4me1 hESC enhancer GRCh37_chr20:60967945-60968445 | 20 | 62392889 | 62393389 | Human |
155769120 | LOC127894123 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60968662-60969186 | 20 | 62393606 | 62394130 | Human |
38675388 | LOC105372709 | uncharacterized LOC105372709 | 20 | 62402232 | 62406894 | Human |
329813958 | LOC130066308 | ATAC-STARR-seq lymphoblastoid silent region 13112 | 20 | 62407202 | 62407451 | Human |
1353930 | RBBP8NL | RBBP8 N-terminal like | 20 | 62410237 | 62427539 | Human |
329834444 | LOC130066309 | ATAC-STARR-seq lymphoblastoid active region 18201 | 20 | 62410684 | 62410743 | Human |
155773678 | LOC127894124 | H3K4me1 hESC enhancer GRCh37_chr20:60998065-60998856 | 20 | 62423009 | 62423800 | Human |
152975772 | LOC125387315 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:61001435-61002194 | 20 | 62426379 | 62427138 | Human |
38659943 | LOC105372710 | uncharacterized LOC105372710 | 20 | 62427830 | 62431509 | Human |
155778162 | LOC127894125 | H3K4me1 hESC enhancer GRCh37_chr20:61012716-61013216 | 20 | 62437660 | 62438160 | Human |
329820596 | LOC130066310 | ATAC-STARR-seq lymphoblastoid active region 18202 | 20 | 62439455 | 62439504 | Human |
155779936 | LOC127894126 | H3K4me1 hESC enhancer GRCh37_chr20:61016724-61017224 | 20 | 62441668 | 62442168 | Human |
155750719 | LOC127894127 | H3K4me1 hESC enhancer GRCh37_chr20:61017225-61017725 | 20 | 62442169 | 62442669 | Human |
152975687 | LOC125387316 | Sharpr-MPRA regulatory region 3586 | 20 | 62449933 | 62450227 | Human |
1354270 | GATA5 | GATA binding protein 5 | 20 | 62463497 | 62475995 | Human |
155770264 | LOC127894128 | H3K4me1 hESC enhancer GRCh37_chr20:61048659-61049319 | 20 | 62473603 | 62474263 | Human |
38659112 | LOC105372711 | uncharacterized LOC105372711 | 20 | 62480452 | 62491198 | Human |
155750464 | LOC127894129 | H3K4me1 hESC enhancer GRCh37_chr20:61059580-61060461 | 20 | 62484524 | 62485405 | Human |
155779077 | LOC127894130 | H3K4me1 hESC enhancer GRCh37_chr20:61060462-61061342 | 20 | 62485406 | 62486286 | Human |
329339266 | LOC129664673 | ReSE screen-validated silencer GRCh37_chr20:61065697-61065904 | 20 | 62490641 | 62490848 | Human |
151673153 | LOC124904947 | uncharacterized LOC124904947 | 20 | 62494825 | 62496014 | Human |
329826126 | LOC130066311 | ATAC-STARR-seq lymphoblastoid active region 18203 | 20 | 62494926 | 62494995 | Human |
155751354 | LOC127894131 | H3K4me1 hESC enhancer GRCh37_chr20:61071135-61071640 | 20 | 62496079 | 62496584 | Human |
155765334 | LOC127894133 | H3K4me1 hESC enhancer GRCh37_chr20:61075123-61075623 | 20 | 62500067 | 62500567 | Human |
329819193 | LOC130066312 | ATAC-STARR-seq lymphoblastoid active region 18204 | 20 | 62502033 | 62502262 | Human |
155762770 | LOC127894134 | H3K4me1 hESC enhancer GRCh37_chr20:61086501-61087310 | 20 | 62511445 | 62512254 | Human |
38644393 | LOC105376995 | uncharacterized LOC105376995 | 20 | 62534008 | 62536708 | Human |
155772012 | LOC127894132 | H3K4me1 hESC enhancer GRCh37_chr20:61071641-61072147 | 20 | 62496585 | 62497091 | Human |
4105736 | MTRNR2L3 | MT-RNR2 like 3 (pseudogene) | 20 | 57358433 | 57359039 | Human |
38617012 | LOC105372692 | uncharacterized LOC105372692 | 20 | 57718674 | 57729224 | Human |
14974414 | PHACTR3-AS1 | PHACTR3 antisense RNA 1 | 20 | 59626464 | 59628289 | Human |
30305568 | MIR646HG | MIR646 host gene | 20 | 60138492 | 60322256 | Human |
38638610 | LOC105372704 | uncharacterized LOC105372704 | 20 | 62000728 | 62002628 | Human |
155782508 | LOC127893878 | H3K4me1 hESC enhancer GRCh37_chr20:55970944-55971905 | 20 | 57395888 | 57396849 | Human |
155775971 | LOC127893919 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:56347451-56348092 | 20 | 57772395 | 57773036 | Human |
155770847 | LOC127893939 | H3K4me1 hESC enhancer GRCh37_chr20:57089058-57090056 | 20 | 58514002 | 58515000 | Human |
155765045 | LOC127893941 | H3K4me1 hESC enhancer GRCh37_chr20:57134321-57134821 | 20 | 58559265 | 58559765 | Human |
155781663 | LOC127893946 | H3K4me1 hESC enhancer GRCh37_chr20:57195667-57196336 | 20 | 58620611 | 58621280 | Human |
155765032 | LOC127893998 | NANOG hESC enhancer GRCh37_chr20:58847405-58847906 | 20 | 60272347 | 60272848 | Human |
155760251 | LOC127894079 | H3K4me1 hESC enhancer GRCh37_chr20:60597477-60598254 | 20 | 62022421 | 62023198 | Human |
155760500 | LOC127894113 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr20:60943971-60944670 | 20 | 62368915 | 62369614 | Human |
QTLs in Region (GRCh38)
407230532 | GWAS879508_H | response to carboplatin QTL GWAS879508 (human) | | 0.000009 | response to carboplatin | | 20 | 38323940 | 38323941 | Human |
407033924 | GWAS682900_H | alcohol consumption measurement QTL GWAS682900 (human) | | 2e-09 | alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 51204108 | 51204109 | Human |
407148621 | GWAS797597_H | neutrophil percentage of leukocytes QTL GWAS797597 (human) | | 1e-12 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 44413724 | 44413725 | Human |
407132232 | GWAS781208_H | triglyceride:HDL cholesterol ratio QTL GWAS781208 (human) | | 1e-10 | triglyceride:HDL cholesterol ratio | | 20 | 57260984 | 57260985 | Human |
407230544 | GWAS879520_H | Cleft palate QTL GWAS879520 (human) | | 0.000003 | Cleft palate | | 20 | 48172924 | 48172925 | Human |
407165010 | GWAS813986_H | alkaline phosphatase measurement QTL GWAS813986 (human) | | 1e-26 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 20 | 46010872 | 46010873 | Human |
406984792 | GWAS633768_H | depressive symptom measurement QTL GWAS633768 (human) | | 8e-09 | depressive symptom measurement | | 20 | 45651255 | 45651256 | Human |
407132249 | GWAS781225_H | triglyceride:HDL cholesterol ratio QTL GWAS781225 (human) | | 4e-12 | triglyceride:HDL cholesterol ratio | | 20 | 46970451 | 46970452 | Human |
407230566 | GWAS879542_H | bone density QTL GWAS879542 (human) | | 5e-11 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 51909166 | 51909167 | Human |
406919273 | GWAS568249_H | malate measurement QTL GWAS568249 (human) | | 2e-13 | malate measurement | | 20 | 46612739 | 46612740 | Human |
407361647 | GWAS1010623_H | erythrocyte count QTL GWAS1010623 (human) | | 9e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 62455524 | 62455525 | Human |
407066730 | GWAS715706_H | gut microbiome measurement QTL GWAS715706 (human) | | 0.000005 | gut microbiome measurement | | 20 | 36544154 | 36544155 | Human |
407132269 | GWAS781245_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS781245 (human) | | 2e-58 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407361645 | GWAS1010621_H | erythrocyte count QTL GWAS1010621 (human) | | 6e-32 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 57415349 | 57415350 | Human |
407230575 | GWAS879551_H | reticulocyte count QTL GWAS879551 (human) | | 1e-13 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 57437932 | 57437933 | Human |
406952043 | GWAS601019_H | diastolic blood pressure QTL GWAS601019 (human) | | 5e-24 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 59170760 | 59170761 | Human |
407361644 | GWAS1010620_H | erythrocyte count QTL GWAS1010620 (human) | | 8e-20 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 53613491 | 53613492 | Human |
407361643 | GWAS1010619_H | erythrocyte count QTL GWAS1010619 (human) | | 1e-49 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 50485053 | 50485054 | Human |
407361642 | GWAS1010618_H | erythrocyte count QTL GWAS1010618 (human) | | 3e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 45956781 | 45956782 | Human |
406935666 | GWAS584642_H | blood protein measurement QTL GWAS584642 (human) | | 4e-31 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 44624007 | 44624008 | Human |
406935669 | GWAS584645_H | CD40 measurement QTL GWAS584645 (human) | | 7e-15 | CD40 measurement | | 20 | 46120612 | 46120613 | Human |
406968446 | GWAS617422_H | left ventricular structural measurement QTL GWAS617422 (human) | | 0.0000004 | left ventricular structural measurement | heart left ventricle morphological measurement (CMO:0000951) | 20 | 41253766 | 41253767 | Human |
407394318 | GWAS1043294_H | vaginal microbiome measurement QTL GWAS1043294 (human) | | 0.000003 | vaginal microbiome measurement | | 20 | 49811259 | 49811260 | Human |
407214089 | GWAS863065_H | alkaline phosphatase measurement QTL GWAS863065 (human) | | 4e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 20 | 57565383 | 57565384 | Human |
407214088 | GWAS863064_H | alkaline phosphatase measurement QTL GWAS863064 (human) | | 2e-17 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 20 | 57561418 | 57561419 | Human |
407410704 | GWAS1059680_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS1059680 (human) | | 4e-102 | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407246874 | GWAS895850_H | cataract QTL GWAS895850 (human) | | 1e-11 | cataract | | 20 | 41081398 | 41081399 | Human |
406902822 | GWAS551798_H | COVID-19 QTL GWAS551798 (human) | | 0.000001 | COVID-19 | | 20 | 58221330 | 58221331 | Human |
407115811 | GWAS764787_H | polyunsaturated fatty acids to monounsaturated fatty acids ratio QTL GWAS764787 (human) | | 6e-23 | polyunsaturated fatty acids to monounsaturated fatty acids ratio | | 20 | 45947863 | 45947864 | Human |
407066667 | GWAS715643_H | heel bone mineral density QTL GWAS715643 (human) | | 3e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 40118090 | 40118091 | Human |
407345195 | GWAS994171_H | calcium measurement QTL GWAS994171 (human) | | 4e-82 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 54115823 | 54115824 | Human |
407345194 | GWAS994170_H | calcium measurement QTL GWAS994170 (human) | | 7e-09 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 43932782 | 43932783 | Human |
407230516 | GWAS879492_H | bone density QTL GWAS879492 (human) | | 8e-09 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 51908815 | 51908816 | Human |
407066679 | GWAS715655_H | high density lipoprotein cholesterol measurement QTL GWAS715655 (human) | | 7e-143 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407033912 | GWAS682888_H | alcohol consumption measurement QTL GWAS682888 (human) | | 5e-09 | alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 52619074 | 52619075 | Human |
407033913 | GWAS682889_H | alcohol consumption measurement QTL GWAS682889 (human) | | 3e-09 | alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 61274058 | 61274059 | Human |
407279674 | GWAS928650_H | idiopathic osteonecrosis of the femoral head QTL GWAS928650 (human) | | 7e-14 | idiopathic osteonecrosis of the femoral head | | 20 | 39920335 | 39920336 | Human |
407164984 | GWAS813960_H | apolipoprotein B measurement QTL GWAS813960 (human) | | 2e-11 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 20 | 41152318 | 41152319 | Human |
406984899 | GWAS633875_H | hemoglobin measurement QTL GWAS633875 (human) | | 2e-10 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood cholesterol level (CMO:0002280) | 20 | 41049649 | 41049650 | Human |
407328963 | GWAS977939_H | sphingomyelin measurement QTL GWAS977939 (human) | | 6e-21 | sphingomyelin measurement | | 20 | 45934368 | 45934369 | Human |
406984902 | GWAS633878_H | hemoglobin measurement QTL GWAS633878 (human) | | 3e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 57343878 | 57343879 | Human |
406919364 | GWAS568340_H | cancer QTL GWAS568340 (human) | | 6e-08 | cancer | | 20 | 48723580 | 48723581 | Human |
406984903 | GWAS633879_H | hemoglobin measurement QTL GWAS633879 (human) | | 1e-24 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 57562778 | 57562779 | Human |
406984901 | GWAS633877_H | hemoglobin measurement QTL GWAS633877 (human) | | 9e-23 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 50485053 | 50485054 | Human |
407312589 | GWAS961565_H | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement QTL GWAS961565 (human) | | 1e-11 | blood lipid amount (VT:0003949) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 41049649 | 41049650 | Human |
407378118 | GWAS1027094_H | triglyceride measurement, alcohol consumption measurement QTL GWAS1027094 (human) | | 5e-11 | triglyceride measurement, alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 45923216 | 45923217 | Human |
406952143 | GWAS601119_H | response to trastuzumab, left ventricular diastolic function measurement, trait in response to paclitaxel QTL GWAS601119 (human) | | 0.000006 | response to trastuzumab, left ventricular diastolic function measurement, trait in response to paclitaxel | | 20 | 58367256 | 58367257 | Human |
407148756 | GWAS797732_H | response to serotonin-norephinephrine reuptake inhibitor QTL GWAS797732 (human) | | 0.000004 | response to serotonin-norephinephrine reuptake inhibitor | | 20 | 51482170 | 51482171 | Human |
407132375 | GWAS781351_H | triglyceride:HDL cholesterol ratio QTL GWAS781351 (human) | | 0.000001 | triglyceride:HDL cholesterol ratio | | 20 | 57260984 | 57260985 | Human |
407083226 | GWAS732202_H | BMI-adjusted waist-hip ratio QTL GWAS732202 (human) | | 4e-43 | BMI-adjusted waist-hip ratio | | 20 | 46907424 | 46907425 | Human |
406903002 | GWAS551978_H | high density lipoprotein cholesterol measurement QTL GWAS551978 (human) | | 1e-15 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 46057452 | 46057453 | Human |
406919391 | GWAS568367_H | total cholesterol measurement QTL GWAS568367 (human) | | 6e-11 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40462847 | 40462848 | Human |
407410922 | GWAS1059898_H | bactericidal permeability-increasing protein measurement QTL GWAS1059898 (human) | | 1e-67 | neutrophil phagocytosis trait (VT:0002467) | | 20 | 38345754 | 38345755 | Human |
407034086 | GWAS683062_H | waist circumference QTL GWAS683062 (human) | | 2e-09 | waist circumference | waist circumference (CMO:0000242) | 20 | 52365406 | 52365407 | Human |
407230688 | GWAS879664_H | asthma, response to diisocyanate QTL GWAS879664 (human) | | 0.000002 | asthma, response to diisocyanate | | 20 | 42321191 | 42321192 | Human |
407116001 | GWAS764977_H | high density lipoprotein cholesterol measurement QTL GWAS764977 (human) | | 4e-90 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45947863 | 45947864 | Human |
407083238 | GWAS732214_H | glomerular filtration rate QTL GWAS732214 (human) | | 4e-13 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 20 | 62283702 | 62283703 | Human |
407247090 | GWAS896066_H | complement factor H-related protein 3 measurement QTL GWAS896066 (human) | | 0.000008 | complement factor H-related protein 3 measurement | | 20 | 45460393 | 45460394 | Human |
407410940 | GWAS1059916_H | free cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1059916 (human) | | 3e-31 | free cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407410942 | GWAS1059918_H | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS1059918 (human) | | 2e-97 | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407279754 | GWAS928730_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS928730 (human) | | 3e-37 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45947863 | 45947864 | Human |
407050383 | GWAS699359_H | 5-HIAA measurement QTL GWAS699359 (human) | | 0.000004 | 5-HIAA measurement | cervical spinal cord 5-HIAA level (CMO:0003127) | 20 | 51865839 | 51865840 | Human |
407378053 | GWAS1027029_H | adenosine deaminase measurement QTL GWAS1027029 (human) | | 2e-470 | adenosine deaminase measurement | | 20 | 44626579 | 44626580 | Human |
407115925 | GWAS764901_H | triglyceride measurement, alcohol consumption measurement QTL GWAS764901 (human) | | 5e-08 | triglyceride measurement, alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 46975601 | 46975602 | Human |
407230621 | GWAS879597_H | bone density QTL GWAS879597 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 45409402 | 45409403 | Human |
407230620 | GWAS879596_H | bone density QTL GWAS879596 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 44246607 | 44246608 | Human |
407230623 | GWAS879599_H | bone density QTL GWAS879599 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 55769817 | 55769818 | Human |
406968474 | GWAS617450_H | resting heart rate QTL GWAS617450 (human) | | 7e-72 | resting heart rate | heart rate (CMO:0000002) | 20 | 38211754 | 38211755 | Human |
407230622 | GWAS879598_H | bone density QTL GWAS879598 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 49688863 | 49688864 | Human |
407230617 | GWAS879593_H | bone density QTL GWAS879593 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 41883084 | 41883085 | Human |
406984860 | GWAS633836_H | colon carcinoma QTL GWAS633836 (human) | | 0.0000001 | colon carcinoma | | 20 | 48723580 | 48723581 | Human |
407230618 | GWAS879594_H | bone density QTL GWAS879594 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 42724271 | 42724272 | Human |
407410856 | GWAS1059832_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1059832 (human) | | 4e-13 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
406935715 | GWAS584691_H | uric acid measurement QTL GWAS584691 (human) | | 0.000004 | uric acid measurement | blood uric acid level (CMO:0000501) | 20 | 51447684 | 51447685 | Human |
407230627 | GWAS879603_H | bone density QTL GWAS879603 (human) | | 1e-300 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 59473829 | 59473830 | Human |
406919334 | GWAS568310_H | neutrophil percentage of leukocytes QTL GWAS568310 (human) | | 1e-10 | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 20 | 44413724 | 44413725 | Human |
407034026 | GWAS683002_H | mean reticulocyte volume QTL GWAS683002 (human) | | 8e-14 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 20 | 37047109 | 37047110 | Human |
407197869 | GWAS846845_H | 7-methylguanine measurement QTL GWAS846845 (human) | | 0.00001 | 7-methylguanine measurement | | 20 | 55279499 | 55279500 | Human |
407312557 | GWAS961533_H | sex hormone-binding globulin measurement QTL GWAS961533 (human) | | 2e-12 | sex hormone-binding globulin measurement | | 20 | 44425801 | 44425802 | Human |
407345325 | GWAS994301_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS994301 (human) | | 1e-41 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45934368 | 45934369 | Human |
407083185 | GWAS732161_H | blood protein measurement QTL GWAS732161 (human) | | 1e-291 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38162912 | 38162913 | Human |
407099568 | GWAS748544_H | chronotype measurement QTL GWAS748544 (human) | | 4e-09 | chronotype measurement | | 20 | 44910092 | 44910093 | Human |
407410876 | GWAS1059852_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS1059852 (human) | | 1e-13 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407378109 | GWAS1027085_H | high density lipoprotein cholesterol measurement QTL GWAS1027085 (human) | | 0.0000001 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
406952123 | GWAS601099_H | celiac disease QTL GWAS601099 (human) | | 5e-08 | celiac disease | | 20 | 45967568 | 45967569 | Human |
407378249 | GWAS1027225_H | triglyceride measurement, alcohol consumption measurement QTL GWAS1027225 (human) | | 5e-27 | triglyceride measurement, alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 45923216 | 45923217 | Human |
407132486 | GWAS781462_H | triglyceride:HDL cholesterol ratio QTL GWAS781462 (human) | | 1e-10 | triglyceride:HDL cholesterol ratio | | 20 | 47712230 | 47712231 | Human |
407132480 | GWAS781456_H | triglyceride:HDL cholesterol ratio QTL GWAS781456 (human) | | 2e-10 | triglyceride:HDL cholesterol ratio | | 20 | 57561480 | 57561481 | Human |
407066949 | GWAS715925_H | triglycerides in very small VLDL measurement QTL GWAS715925 (human) | | 9e-16 | sphingomyelin measurement | blood very low density lipoprotein triglyceride level (CMO:0002688) | 20 | 45923216 | 45923217 | Human |
407066954 | GWAS715930_H | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement QTL GWAS715930 (human) | | 8e-25 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407345485 | GWAS994461_H | total cholesterol measurement QTL GWAS994461 (human) | | 6e-14 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41018876 | 41018877 | Human |
407132488 | GWAS781464_H | triglyceride:HDL cholesterol ratio QTL GWAS781464 (human) | | 4e-09 | triglyceride:HDL cholesterol ratio | | 20 | 52619074 | 52619075 | Human |
407034203 | GWAS683179_H | vital capacity QTL GWAS683179 (human) | | 9e-22 | vital capacity | | 20 | 48940477 | 48940478 | Human |
407165292 | GWAS814268_H | alkaline phosphatase measurement QTL GWAS814268 (human) | | 2e-13 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 20 | 46033306 | 46033307 | Human |
407345513 | GWAS994489_H | very low density lipoprotein particle size measurement QTL GWAS994489 (human) | | 1e-41 | very low density lipoprotein particle size measurement | blood very low density lipoprotein particle diameter (CMO:0002694) | 20 | 45947863 | 45947864 | Human |
407345527 | GWAS994503_H | elafin measurement QTL GWAS994503 (human) | | 2e-14 | elafin measurement | | 20 | 45165428 | 45165429 | Human |
407378297 | GWAS1027273_H | balding measurement QTL GWAS1027273 (human) | | 1e-12 | balding measurement | coat/hair morphological measurement (CMO:0001807) | 20 | 56813700 | 56813701 | Human |
407329138 | GWAS978114_H | neuroimaging measurement QTL GWAS978114 (human) | | 3e-13 | neuroimaging measurement | | 20 | 41203988 | 41203989 | Human |
406968699 | GWAS617675_H | kunitz-type protease inhibitor 3 measurement QTL GWAS617675 (human) | | 1e-155 | kunitz-type protease inhibitor 3 measurement | | 20 | 45512691 | 45512692 | Human |
407378290 | GWAS1027266_H | balding measurement QTL GWAS1027266 (human) | | 4e-12 | balding measurement | coat/hair morphological measurement (CMO:0001807) | 20 | 56826683 | 56826684 | Human |
407378293 | GWAS1027269_H | balding measurement QTL GWAS1027269 (human) | | 4e-12 | balding measurement | coat/hair morphological measurement (CMO:0001807) | 20 | 46844797 | 46844798 | Human |
407263611 | GWAS912587_H | basal cell carcinoma QTL GWAS912587 (human) | | 4e-17 | basal cell carcinoma | | 20 | 50782249 | 50782250 | Human |
407067004 | GWAS715980_H | schizophrenia, anorexia nervosa QTL GWAS715980 (human) | | 4e-08 | schizophrenia, anorexia nervosa | | 20 | 38746749 | 38746750 | Human |
407165188 | GWAS814164_H | brain measurement QTL GWAS814164 (human) | | 4e-16 | brain measurement | brain measurement (CMO:0000911) | 20 | 41560277 | 41560278 | Human |
407312647 | GWAS961623_H | serum gamma-glutamyl transferase measurement QTL GWAS961623 (human) | | 1e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 20 | 62072779 | 62072780 | Human |
407165189 | GWAS814165_H | brain measurement QTL GWAS814165 (human) | | 3e-09 | brain measurement | brain measurement (CMO:0000911) | 20 | 53832397 | 53832398 | Human |
407050497 | GWAS699473_H | triacylglycerol 54:1 measurement QTL GWAS699473 (human) | | 0.000004 | blood triglyceride amount (VT:0002644) | | 20 | 36936286 | 36936287 | Human |
407410954 | GWAS1059930_H | cholesteryl ester measurement, low density lipoprotein cholesterol measurement QTL GWAS1059930 (human) | | 5e-20 | blood lipid amount (VT:0003949) | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 45923216 | 45923217 | Human |
407083268 | GWAS732244_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS732244 (human) | | 6e-12 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 40537052 | 40537053 | Human |
407034117 | GWAS683093_H | free cholesterol in large VLDL measurement QTL GWAS683093 (human) | | 3e-24 | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 45923216 | 45923217 | Human |
407083277 | GWAS732253_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS732253 (human) | | 2e-138 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45916821 | 45916822 | Human |
407230740 | GWAS879716_H | alcohol drinking QTL GWAS879716 (human) | | 0.000005 | alcohol drinking | | 20 | 57483299 | 57483300 | Human |
407214352 | GWAS863328_H | Myopia QTL GWAS863328 (human) | | 0.000003 | Myopia | | 20 | 58859245 | 58859246 | Human |
407361822 | GWAS1010798_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1010798 (human) | | 4e-27 | Agents acting on the renin-angiotensin system use measurement | | 20 | 59140743 | 59140744 | Human |
407361821 | GWAS1010797_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1010797 (human) | | 2e-09 | Agents acting on the renin-angiotensin system use measurement | | 20 | 52271789 | 52271790 | Human |
407247140 | GWAS896116_H | cholesterol in chylomicrons and extremely large VLDL measurement QTL GWAS896116 (human) | | 6e-11 | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 40551182 | 40551183 | Human |
407329061 | GWAS978037_H | non-high density lipoprotein cholesterol measurement QTL GWAS978037 (human) | | 1e-60 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 20 | 41131808 | 41131809 | Human |
406968615 | GWAS617591_H | Abdominal Aortic Aneurysm QTL GWAS617591 (human) | | 2e-17 | Abdominal Aortic Aneurysm | | 20 | 45942678 | 45942679 | Human |
407099699 | GWAS748675_H | triglycerides to total lipids in IDL percentage QTL GWAS748675 (human) | | 2e-25 | triglycerides to total lipids in IDL percentage | | 20 | 45947863 | 45947864 | Human |
407296306 | GWAS945282_H | frontotemporal dementia QTL GWAS945282 (human) | | 4e-09 | frontotemporal dementia | | 20 | 49944619 | 49944620 | Human |
406952246 | GWAS601222_H | systolic blood pressure QTL GWAS601222 (human) | | 3e-22 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 59170760 | 59170761 | Human |
407312701 | GWAS961677_H | high density lipoprotein cholesterol measurement QTL GWAS961677 (human) | | 3e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45950322 | 45950323 | Human |
407312700 | GWAS961676_H | high density lipoprotein cholesterol measurement QTL GWAS961676 (human) | | 1e-10 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45716137 | 45716138 | Human |
407165247 | GWAS814223_H | FEV/FVC ratio, response to bronchodilator QTL GWAS814223 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 47707282 | 47707283 | Human |
407181625 | GWAS830601_H | executive function measurement QTL GWAS830601 (human) | | 0.0000005 | executive function measurement | | 20 | 55448302 | 55448303 | Human |
407279928 | GWAS928904_H | lipid measurement, high density lipoprotein cholesterol measurement QTL GWAS928904 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47847399 | 47847400 | Human |
407034173 | GWAS683149_H | triglycerides in medium LDL measurement QTL GWAS683149 (human) | | 1e-36 | triglycerides in medium LDL measurement | | 20 | 45947863 | 45947864 | Human |
407067074 | GWAS716050_H | N-acetylaspartate (NAA) measurement QTL GWAS716050 (human) | | 5e-24 | N-acetylaspartate (NAA) measurement | | 20 | 46607483 | 46607484 | Human |
407263683 | GWAS912659_H | asparaginase hypersensitivity QTL GWAS912659 (human) | | 0.0000003 | asparaginase hypersensitivity | | 20 | 57815282 | 57815283 | Human |
407394766 | GWAS1043742_H | heel bone mineral density, urate measurement QTL GWAS1043742 (human) | | 3e-12 | heel bone mineral density, urate measurement | blood uric acid level (CMO:0000501) | 20 | 58995189 | 58995190 | Human |
407280074 | GWAS929050_H | vaginal microbiome measurement QTL GWAS929050 (human) | | 0.000004 | vaginal microbiome measurement | | 20 | 43886610 | 43886611 | Human |
406919641 | GWAS568617_H | eye morphology measurement QTL GWAS568617 (human) | | 2e-09 | eye morphology measurement | eye morphological measurement (CMO:0003080) | 20 | 39390491 | 39390492 | Human |
407083483 | GWAS732459_H | esterified cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS732459 (human) | | 2e-77 | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45947863 | 45947864 | Human |
407329247 | GWAS978223_H | serum alanine aminotransferase measurement QTL GWAS978223 (human) | | 5e-08 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 20 | 62364779 | 62364780 | Human |
407132633 | GWAS781609_H | triglyceride:HDL cholesterol ratio QTL GWAS781609 (human) | | 6e-09 | triglyceride:HDL cholesterol ratio | | 20 | 57561480 | 57561481 | Human |
406919657 | GWAS568633_H | myeloid white cell count QTL GWAS568633 (human) | | 7e-10 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 44413724 | 44413725 | Human |
406952425 | GWAS601401_H | pancreatic carcinoma QTL GWAS601401 (human) | | 0.0000009 | pancreatic carcinoma | | 20 | 44458008 | 44458009 | Human |
407165419 | GWAS814395_H | lipid measurement QTL GWAS814395 (human) | | 0.000002 | lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 55348825 | 55348826 | Human |
407296500 | GWAS945476_H | creatinine measurement QTL GWAS945476 (human) | | 1e-08 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 54174247 | 54174248 | Human |
407181815 | GWAS830791_H | erythrocyte measurement QTL GWAS830791 (human) | | 4e-26 | erythrocyte measurement | red blood cell measurement (CMO:0001356) | 20 | 57415349 | 57415350 | Human |
407329267 | GWAS978243_H | sex hormone-binding globulin measurement QTL GWAS978243 (human) | | 4e-16 | sex hormone-binding globulin measurement | | 20 | 46928426 | 46928427 | Human |
407345662 | GWAS994638_H | schizophrenia QTL GWAS994638 (human) | | 0.000004 | schizophrenia | | 20 | 49498698 | 49498699 | Human |
407411186 | GWAS1060162_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1060162 (human) | | 2e-10 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45484646 | 45484647 | Human |
407411187 | GWAS1060163_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1060163 (human) | | 3e-237 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45925376 | 45925377 | Human |
407329273 | GWAS978249_H | heart rate QTL GWAS978249 (human) | | 2e-19 | heart rate | heart rate (CMO:0000002) | 20 | 38241114 | 38241115 | Human |
407050634 | GWAS699610_H | sexual dimorphism measurement QTL GWAS699610 (human) | | 2e-11 | sexual dimorphism measurement | | 20 | 45934578 | 45934579 | Human |
407214485 | GWAS863461_H | Alzheimer disease, gastroesophageal reflux disease QTL GWAS863461 (human) | | 0.0000001 | Alzheimer disease, gastroesophageal reflux disease | | 20 | 37611619 | 37611620 | Human |
407345557 | GWAS994533_H | urate measurement QTL GWAS994533 (human) | | 4e-11 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 44410897 | 44410898 | Human |
407230870 | GWAS879846_H | hemoglobin measurement QTL GWAS879846 (human) | | 7e-10 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 57544460 | 57544461 | Human |
407296405 | GWAS945381_H | schizophrenia QTL GWAS945381 (human) | | 0.000008 | schizophrenia | | 20 | 59678449 | 59678450 | Human |
407181713 | GWAS830689_H | coronary artery disease QTL GWAS830689 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 20 | 41295639 | 41295640 | Human |
407181712 | GWAS830688_H | coronary artery disease QTL GWAS830688 (human) | | 7e-10 | familial hyperlipidemia | | 20 | 40513876 | 40513877 | Human |
407411102 | GWAS1060078_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1060078 (human) | | 6e-129 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407165330 | GWAS814306_H | high density lipoprotein cholesterol measurement QTL GWAS814306 (human) | | 7e-17 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47736892 | 47736893 | Human |
407181715 | GWAS830691_H | coronary artery disease QTL GWAS830691 (human) | | 1e-10 | coronary artery disease | | 20 | 59164414 | 59164415 | Human |
407181714 | GWAS830690_H | coronary artery disease QTL GWAS830690 (human) | | 1e-09 | coronary artery disease | | 20 | 48816613 | 48816614 | Human |
407067035 | GWAS716011_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS716011 (human) | | 7e-13 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 40537052 | 40537053 | Human |
407411089 | GWAS1060065_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS1060065 (human) | | 1e-19 | very low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 45923216 | 45923217 | Human |
407165356 | GWAS814332_H | sex hormone-binding globulin measurement QTL GWAS814332 (human) | | 8e-08 | sex hormone-binding globulin measurement | | 20 | 52532117 | 52532118 | Human |
407132591 | GWAS781567_H | mean corpuscular volume QTL GWAS781567 (human) | | 0.0000002 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 57415349 | 57415350 | Human |
406886831 | GWAS535807_H | nose morphology measurement QTL GWAS535807 (human) | | 2e-09 | nose morphology measurement | nose measurement (CMO:0003147) | 20 | 39364098 | 39364099 | Human |
407247287 | GWAS896263_H | cholesteryl ester measurement QTL GWAS896263 (human) | | 2e-19 | blood lipid amount (VT:0003949) | serum alanine aminotransferase activity level (CMO:0000575) | 20 | 40551182 | 40551183 | Human |
407067058 | GWAS716034_H | systolic blood pressure QTL GWAS716034 (human) | | 0.000002 | systolic blood pressure | mean arterial blood pressure (CMO:0000009) | 20 | 44168718 | 44168719 | Human |
407148977 | GWAS797953_H | mean platelet volume QTL GWAS797953 (human) | | 2e-10 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 54078416 | 54078417 | Human |
407132593 | GWAS781569_H | mean corpuscular volume QTL GWAS781569 (human) | | 2e-19 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 57415349 | 57415350 | Human |
407230899 | GWAS879875_H | reticulocyte count QTL GWAS879875 (human) | | 8e-10 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 57425586 | 57425587 | Human |
407230898 | GWAS879874_H | reticulocyte count QTL GWAS879874 (human) | | 3e-14 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 53613491 | 53613492 | Human |
407148979 | GWAS797955_H | mean platelet volume QTL GWAS797955 (human) | | 6e-30 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 59047403 | 59047404 | Human |
407050682 | GWAS699658_H | osteoarthritis, knee, body mass index QTL GWAS699658 (human) | | 4e-11 | osteoarthritis, knee, body mass index | body mass index (BMI) (CMO:0000105) | 20 | 40603657 | 40603658 | Human |
406886984 | GWAS535960_H | colorectal cancer, colorectal adenoma QTL GWAS535960 (human) | | 7e-09 | colorectal cancer, colorectal adenoma | | 20 | 44037835 | 44037836 | Human |
407247436 | GWAS896412_H | vitamin D deficiency QTL GWAS896412 (human) | | 3e-08 | vitamin D deficiency | | 20 | 54102016 | 54102017 | Human |
407247437 | GWAS896413_H | vitamin D deficiency QTL GWAS896413 (human) | | 5e-16 | vitamin D deficiency | | 20 | 54126051 | 54126052 | Human |
407132744 | GWAS781720_H | triglyceride:HDL cholesterol ratio QTL GWAS781720 (human) | | 1e-08 | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 40513876 | 40513877 | Human |
407050830 | GWAS699806_H | body mass index QTL GWAS699806 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 55867410 | 55867411 | Human |
407018066 | GWAS667042_H | mean platelet volume QTL GWAS667042 (human) | | 2e-09 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 59022590 | 59022591 | Human |
407050832 | GWAS699808_H | body mass index QTL GWAS699808 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 59032308 | 59032309 | Human |
407034452 | GWAS683428_H | cognitive function measurement, self reported educational attainment QTL GWAS683428 (human) | | 1e-20 | cognitive function measurement, self reported educational attainment | | 20 | 49106590 | 49106591 | Human |
407329375 | GWAS978351_H | non-high density lipoprotein cholesterol measurement QTL GWAS978351 (human) | | 5e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 20 | 53919886 | 53919887 | Human |
407116381 | GWAS765357_H | protein measurement QTL GWAS765357 (human) | | 1e-08 | protein measurement | | 20 | 44189199 | 44189200 | Human |
407329374 | GWAS978350_H | non-high density lipoprotein cholesterol measurement QTL GWAS978350 (human) | | 5e-10 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 20 | 48986704 | 48986705 | Human |
407198303 | GWAS847279_H | lipid measurement QTL GWAS847279 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 42627651 | 42627652 | Human |
407329373 | GWAS978349_H | non-high density lipoprotein cholesterol measurement QTL GWAS978349 (human) | | 3e-09 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 20 | 45337263 | 45337264 | Human |
406985314 | GWAS634290_H | deoxycholate measurement QTL GWAS634290 (human) | | 0.000004 | deoxycholate measurement | | 20 | 41725176 | 41725177 | Human |
407034466 | GWAS683442_H | thyroid stimulating hormone measurement QTL GWAS683442 (human) | | 1e-09 | thyroid stimulating hormone measurement | blood thyroid stimulating hormone level (CMO:0001247) | 20 | 58890223 | 58890224 | Human |
407034467 | GWAS683443_H | thyroid stimulating hormone measurement QTL GWAS683443 (human) | | 5e-16 | thyroid stimulating hormone measurement | blood thyroid stimulating hormone level (CMO:0001247) | 20 | 58890888 | 58890889 | Human |
407034465 | GWAS683441_H | thyroid stimulating hormone measurement QTL GWAS683441 (human) | | 0.0000009 | thyroid stimulating hormone measurement | blood thyroid stimulating hormone level (CMO:0001247) | 20 | 45465735 | 45465736 | Human |
406952548 | GWAS601524_H | wellbeing measurement QTL GWAS601524 (human) | | 2e-08 | wellbeing measurement | | 20 | 49084487 | 49084488 | Human |
407296609 | GWAS945585_H | systolic blood pressure QTL GWAS945585 (human) | | 4e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 51492442 | 51492443 | Human |
407296628 | GWAS945604_H | cortical thickness QTL GWAS945604 (human) | | 3e-18 | cortical thickness | | 20 | 41203988 | 41203989 | Human |
407394938 | GWAS1043914_H | vaginal microbiome measurement QTL GWAS1043914 (human) | | 0.000008 | vaginal microbiome measurement | | 20 | 48197134 | 48197135 | Human |
407362165 | GWAS1011141_H | mathematical ability QTL GWAS1011141 (human) | | 1e-12 | mathematical ability | | 20 | 48877357 | 48877358 | Human |
407329396 | GWAS978372_H | alpha fetoprotein measurement QTL GWAS978372 (human) | | 4e-12 | blood alpha-fetoprotein amount (VT:0010776) | | 20 | 40556638 | 40556639 | Human |
407034488 | GWAS683464_H | cholesterol in medium LDL measurement QTL GWAS683464 (human) | | 3e-26 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407050878 | GWAS699854_H | lysophosphatidylcholine 20:4 measurement QTL GWAS699854 (human) | | 0.000003 | glycerophosphocholine amount (VT:0011004) | | 20 | 47044574 | 47044575 | Human |
407018108 | GWAS667084_H | body height QTL GWAS667084 (human) | | 1e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 43630996 | 43630997 | Human |
407018109 | GWAS667085_H | body height QTL GWAS667085 (human) | | 9e-14 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 45804240 | 45804241 | Human |
407362055 | GWAS1011031_H | neuroticism measurement QTL GWAS1011031 (human) | | 0.000005 | neuroticism measurement | | 20 | 47211814 | 47211815 | Human |
407312897 | GWAS961873_H | total cholesterol measurement, very low density lipoprotein cholesterol measurement QTL GWAS961873 (human) | | 3e-38 | total cholesterol measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45934368 | 45934369 | Human |
407230994 | GWAS879970_H | BMI-adjusted waist-hip ratio QTL GWAS879970 (human) | | 5e-12 | BMI-adjusted waist-hip ratio | | 20 | 46874575 | 46874576 | Human |
407247398 | GWAS896374_H | type 2 diabetes mellitus QTL GWAS896374 (human) | | 3e-12 | type 2 diabetes mellitus | | 20 | 44376375 | 44376376 | Human |
406903328 | GWAS552304_H | triglyceride measurement QTL GWAS552304 (human) | | 9e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 46057452 | 46057453 | Human |
406952480 | GWAS601456_H | wellbeing measurement QTL GWAS601456 (human) | | 0.000002 | wellbeing measurement | | 20 | 47199054 | 47199055 | Human |
407034406 | GWAS683382_H | linoleic acid measurement QTL GWAS683382 (human) | | 8e-15 | linoleic acid measurement | blood free fatty acids level (CMO:0000117) | 20 | 45961659 | 45961660 | Human |
407116333 | GWAS765309_H | body fat percentage QTL GWAS765309 (human) | | 3e-10 | body fat percentage | body fat percentage (CMO:0000302) | 20 | 49088959 | 49088960 | Human |
407198255 | GWAS847231_H | serum alanine aminotransferase measurement QTL GWAS847231 (human) | | 8e-11 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 20 | 40513876 | 40513877 | Human |
407263789 | GWAS912765_H | total cortical area measurement QTL GWAS912765 (human) | | 3e-10 | total cortical area measurement | | 20 | 53825322 | 53825323 | Human |
407362090 | GWAS1011066_H | leukocyte count QTL GWAS1011066 (human) | | 9e-25 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 20 | 40630638 | 40630639 | Human |
407312938 | GWAS961914_H | high density lipoprotein cholesterol measurement QTL GWAS961914 (human) | | 2e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 46031013 | 46031014 | Human |
407362089 | GWAS1011065_H | leukocyte count QTL GWAS1011065 (human) | | 3e-09 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 20 | 38159027 | 38159028 | Human |
407312937 | GWAS961913_H | high density lipoprotein cholesterol measurement QTL GWAS961913 (human) | | 4e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45966613 | 45966614 | Human |
407329320 | GWAS978296_H | phosphatidylcholine measurement QTL GWAS978296 (human) | | 2e-08 | phosphatidylcholine measurement | | 20 | 55688773 | 55688774 | Human |
407018034 | GWAS667010_H | body height QTL GWAS667010 (human) | | 0.0000003 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 39913927 | 39913928 | Human |
407018035 | GWAS667011_H | body height QTL GWAS667011 (human) | | 2e-08 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 40200605 | 40200606 | Human |
407018032 | GWAS667008_H | body height QTL GWAS667008 (human) | | 1e-32 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 37044679 | 37044680 | Human |
407018033 | GWAS667009_H | body height QTL GWAS667009 (human) | | 0.0000004 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 39260860 | 39260861 | Human |
406919730 | GWAS568706_H | triglyceride measurement QTL GWAS568706 (human) | | 5e-18 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45925376 | 45925377 | Human |
407099957 | GWAS748933_H | cognitive function measurement QTL GWAS748933 (human) | | 3e-12 | cognitive function measurement | | 20 | 42588817 | 42588818 | Human |
406919737 | GWAS568713_H | low density lipoprotein cholesterol measurement QTL GWAS568713 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40462847 | 40462848 | Human |
406952507 | GWAS601483_H | proactivator polypeptide-like 1 measurement QTL GWAS601483 (human) | | 2e-16 | proactivator polypeptide-like 1 measurement | | 20 | 45919331 | 45919332 | Human |
407165497 | GWAS814473_H | FEV/FVC ratio, response to bronchodilator QTL GWAS814473 (human) | | 0.0000006 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 43991952 | 43991953 | Human |
407083581 | GWAS732557_H | total cholesterol in large LDL QTL GWAS732557 (human) | | 4e-29 | total cholesterol in large LDL | | 20 | 40537052 | 40537053 | Human |
407181883 | GWAS830859_H | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement QTL GWAS830859 (human) | | 2e-19 | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 45947863 | 45947864 | Human |
407034562 | GWAS683538_H | myeloid white cell count QTL GWAS683538 (human) | | 3e-22 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 48767764 | 48767765 | Human |
407182021 | GWAS830997_H | thyroid stimulating hormone measurement QTL GWAS830997 (human) | | 6e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 58891038 | 58891039 | Human |
407034563 | GWAS683539_H | myeloid white cell count QTL GWAS683539 (human) | | 1e-16 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 50568735 | 50568736 | Human |
407247552 | GWAS896528_H | myeloid white cell count QTL GWAS896528 (human) | | 8e-37 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 40630638 | 40630639 | Human |
407378638 | GWAS1027614_H | blood protein measurement QTL GWAS1027614 (human) | | 5e-26 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 46113425 | 46113426 | Human |
407182019 | GWAS830995_H | cup-to-disc ratio measurement QTL GWAS830995 (human) | | 1e-10 | cup-to-disc ratio measurement | | 20 | 47168611 | 47168612 | Human |
407345869 | GWAS994845_H | total cholesterol measurement QTL GWAS994845 (human) | | 1e-127 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41131808 | 41131809 | Human |
407247563 | GWAS896539_H | cataract QTL GWAS896539 (human) | | 1e-10 | cataract | | 20 | 41108082 | 41108083 | Human |
407083731 | GWAS732707_H | blood protein measurement QTL GWAS732707 (human) | | 4e-268 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38162912 | 38162913 | Human |
407214805 | GWAS863781_H | blood protein measurement QTL GWAS863781 (human) | | 0.000001 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38368705 | 38368706 | Human |
407345877 | GWAS994853_H | systolic blood pressure QTL GWAS994853 (human) | | 4e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 48794296 | 48794297 | Human |
407214806 | GWAS863782_H | blood protein measurement QTL GWAS863782 (human) | | 7e-13 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 39709522 | 39709523 | Human |
406985431 | GWAS634407_H | aging, epigenetic status QTL GWAS634407 (human) | | 4e-08 | aging, epigenetic status | | 20 | 41718727 | 41718728 | Human |
407001821 | GWAS650797_H | intraocular pressure measurement QTL GWAS650797 (human) | | 8e-09 | intraocular pressure measurement | | 20 | 50443654 | 50443655 | Human |
407280356 | GWAS929332_H | vaginal microbiome measurement QTL GWAS929332 (human) | | 0.000004 | vaginal microbiome measurement | | 20 | 56835357 | 56835358 | Human |
407001830 | GWAS650806_H | body mass index QTL GWAS650806 (human) | | 2e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 55845940 | 55845941 | Human |
407001831 | GWAS650807_H | body mass index QTL GWAS650807 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 58852896 | 58852897 | Human |
407001828 | GWAS650804_H | body mass index QTL GWAS650804 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 55570176 | 55570177 | Human |
407395043 | GWAS1044019_H | BMI-adjusted waist-hip ratio QTL GWAS1044019 (human) | | 4e-23 | BMI-adjusted waist-hip ratio | | 20 | 40551182 | 40551183 | Human |
407378661 | GWAS1027637_H | body mass index QTL GWAS1027637 (human) | | 6e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 43362121 | 43362122 | Human |
407378662 | GWAS1027638_H | body mass index QTL GWAS1027638 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 54854044 | 54854045 | Human |
407362289 | GWAS1011265_H | reticulocyte count QTL GWAS1011265 (human) | | 9e-36 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 53613491 | 53613492 | Human |
407345915 | GWAS994891_H | high density lipoprotein cholesterol measurement QTL GWAS994891 (human) | | 4e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47661506 | 47661507 | Human |
407345914 | GWAS994890_H | high density lipoprotein cholesterol measurement QTL GWAS994890 (human) | | 9e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45953796 | 45953797 | Human |
407231226 | GWAS880202_H | Testicular Germ Cell Tumor QTL GWAS880202 (human) | | 3e-12 | Testicular Germ Cell Tumor | | 20 | 52091515 | 52091516 | Human |
407100033 | GWAS749009_H | phospholipids:total lipids ratio QTL GWAS749009 (human) | | 2e-23 | phospholipids:total lipids ratio | | 20 | 45956781 | 45956782 | Human |
407198342 | GWAS847318_H | body height QTL GWAS847318 (human) | | 3e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 39251590 | 39251591 | Human |
407018113 | GWAS667089_H | body height QTL GWAS667089 (human) | | 7e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 48687768 | 48687769 | Human |
406887050 | GWAS536026_H | blood protein measurement QTL GWAS536026 (human) | | 5e-12 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 45064043 | 45064044 | Human |
407116425 | GWAS765401_H | mean corpuscular volume QTL GWAS765401 (human) | | 2e-13 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 43702817 | 43702818 | Human |
407214741 | GWAS863717_H | type 2 diabetes mellitus QTL GWAS863717 (human) | | 2e-08 | type 2 diabetes mellitus | | 20 | 44373081 | 44373082 | Human |
407018128 | GWAS667104_H | body height QTL GWAS667104 (human) | | 2e-11 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 41357445 | 41357446 | Human |
407411356 | GWAS1060332_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS1060332 (human) | | 8e-32 | very low density lipoprotein cholesterol measurement, phospholipid measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407050900 | GWAS699876_H | post-traumatic stress disorder symptom measurement QTL GWAS699876 (human) | | 5e-08 | post-traumatic stress disorder symptom measurement | | 20 | 43645820 | 43645821 | Human |
407411346 | GWAS1060322_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS1060322 (human) | | 9e-37 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
406968986 | GWAS617962_H | low affinity immunoglobulin epsilon Fc receptor measurement QTL GWAS617962 (human) | | 2e-13 | low affinity immunoglobulin epsilon Fc receptor measurement | | 20 | 46120612 | 46120613 | Human |
407247514 | GWAS896490_H | monocyte count QTL GWAS896490 (human) | | 5e-31 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 20 | 50338887 | 50338888 | Human |
407149209 | GWAS798185_H | lipid measurement, high density lipoprotein cholesterol measurement QTL GWAS798185 (human) | | 5e-13 | free cholesterol measurement, intermediate density lipoprotein measurement | blood intermediate density lipoprotein cholesterol level (CMO:0001562) | 20 | 45941553 | 45941554 | Human |
407067293 | GWAS716269_H | BMI-adjusted waist-hip ratio QTL GWAS716269 (human) | | 0.0000005 | BMI-adjusted waist-hip ratio | | 20 | 52972308 | 52972309 | Human |
407247533 | GWAS896509_H | sex hormone-binding globulin measurement QTL GWAS896509 (human) | | 7e-13 | sex hormone-binding globulin measurement | | 20 | 48915103 | 48915108 | Human |
407132840 | GWAS781816_H | triglyceride:HDL cholesterol ratio QTL GWAS781816 (human) | | 0.0000008 | triglyceride:HDL cholesterol ratio | | 20 | 52619074 | 52619075 | Human |
406969007 | GWAS617983_H | basophil count, eosinophil count QTL GWAS617983 (human) | | 4e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 20 | 51524602 | 51524603 | Human |
407378598 | GWAS1027574_H | susceptibility to infectious disease measurement QTL GWAS1027574 (human) | | 0.000002 | susceptibility to infectious disease measurement | infection incidence/prevalence measurement (CMO:0002025) | 20 | 55948459 | 55948460 | Human |
407247551 | GWAS896527_H | myeloid white cell count QTL GWAS896527 (human) | | 1e-11 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 38265947 | 38265948 | Human |
406887100 | GWAS536076_H | blood protein measurement QTL GWAS536076 (human) | | 1e-69 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38345754 | 38345755 | Human |
407182149 | GWAS831125_H | Drugs used in diabetes use measurement QTL GWAS831125 (human) | | 9e-10 | Drugs used in diabetes use measurement | | 20 | 44355723 | 44355724 | Human |
407116615 | GWAS765591_H | mean corpuscular volume QTL GWAS765591 (human) | | 3e-15 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 37047109 | 37047110 | Human |
407182150 | GWAS831126_H | Drugs used in diabetes use measurement QTL GWAS831126 (human) | | 2e-08 | Drugs used in diabetes use measurement | | 20 | 51538847 | 51538848 | Human |
406920005 | GWAS568981_H | neuroimaging measurement QTL GWAS568981 (human) | | 0.000006 | neuroimaging measurement | | 20 | 53815912 | 53815913 | Human |
407296832 | GWAS945808_H | brain measurement QTL GWAS945808 (human) | | 2e-10 | bilirubin measurement | serum total bilirubin level (CMO:0000376) | 20 | 41203988 | 41203989 | Human |
407313228 | GWAS962204_H | C-reactive protein measurement QTL GWAS962204 (human) | | 6e-19 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 44413724 | 44413725 | Human |
407378755 | GWAS1027731_H | high density lipoprotein cholesterol measurement QTL GWAS1027731 (human) | | 4e-14 | low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 45923216 | 45923217 | Human |
407116616 | GWAS765592_H | mean corpuscular volume QTL GWAS765592 (human) | | 8e-10 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 44035026 | 44035027 | Human |
407116617 | GWAS765593_H | mean corpuscular volume QTL GWAS765593 (human) | | 2e-11 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 44210764 | 44210765 | Human |
406969164 | GWAS618140_H | brain connectivity measurement QTL GWAS618140 (human) | | 4e-10 | brain connectivity measurement | | 20 | 56958090 | 56958091 | Human |
407116618 | GWAS765594_H | mean corpuscular volume QTL GWAS765594 (human) | | 6e-17 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 44310786 | 44310787 | Human |
407362388 | GWAS1011364_H | leukocyte count QTL GWAS1011364 (human) | | 4e-09 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 20 | 50594098 | 50594099 | Human |
407149399 | GWAS798375_H | HbA1c measurement QTL GWAS798375 (human) | | 4e-16 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 20 | 57415349 | 57415350 | Human |
407362387 | GWAS1011363_H | leukocyte count QTL GWAS1011363 (human) | | 2e-11 | leukocyte quantity (VT:0000217) | white blood cell count (CMO:0000027) | 20 | 48767764 | 48767765 | Human |
407001943 | GWAS650919_H | systolic blood pressure QTL GWAS650919 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 44168718 | 44168719 | Human |
407165779 | GWAS814755_H | motor function measurement QTL GWAS814755 (human) | | 0.000008 | motor coordination/balance trait (VT:0001516) | | 20 | 52960487 | 52960488 | Human |
407001941 | GWAS650917_H | systolic blood pressure QTL GWAS650917 (human) | | 7e-20 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 59176062 | 59176063 | Human |
407001950 | GWAS650926_H | systolic blood pressure QTL GWAS650926 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 41623190 | 41623191 | Human |
407280472 | GWAS929448_H | memory performance QTL GWAS929448 (human) | | 0.000004 | memory performance | | 20 | 56187362 | 56187363 | Human |
407100259 | GWAS749235_H | erythrocyte count QTL GWAS749235 (human) | | 3e-11 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 44210821 | 44210822 | Human |
407296871 | GWAS945847_H | creatinine measurement QTL GWAS945847 (human) | | 2e-13 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 58883049 | 58883050 | Human |
407329638 | GWAS978614_H | blood urea nitrogen measurement QTL GWAS978614 (human) | | 9e-21 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 20 | 58901754 | 58901755 | Human |
407100263 | GWAS749239_H | erythrocyte count QTL GWAS749239 (human) | | 5e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 51536805 | 51536806 | Human |
407100262 | GWAS749238_H | erythrocyte count QTL GWAS749238 (human) | | 2e-55 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 50485053 | 50485054 | Human |
407100261 | GWAS749237_H | erythrocyte count QTL GWAS749237 (human) | | 1e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 46083536 | 46083537 | Human |
407100260 | GWAS749236_H | erythrocyte count QTL GWAS749236 (human) | | 3e-19 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 45961659 | 45961660 | Human |
407034730 | GWAS683706_H | phospholipids in large VLDL measurement QTL GWAS683706 (human) | | 1e-24 | phospholipids in large VLDL measurement | blood very low density lipoprotein phospholipid level (CMO:0001571) | 20 | 45923216 | 45923217 | Human |
407247727 | GWAS896703_H | lymphocyte count QTL GWAS896703 (human) | | 2e-15 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 20 | 40642366 | 40642367 | Human |
407100265 | GWAS749241_H | erythrocyte count QTL GWAS749241 (human) | | 3e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 53943587 | 53943588 | Human |
407100264 | GWAS749240_H | erythrocyte count QTL GWAS749240 (human) | | 9e-26 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 53605567 | 53605568 | Human |
407346039 | GWAS995015_H | BMI-adjusted waist circumference QTL GWAS995015 (human) | | 4e-14 | BMI-adjusted waist circumference | | 20 | 46921850 | 46921851 | Human |
407100275 | GWAS749251_H | cognitive function measurement QTL GWAS749251 (human) | | 9e-10 | cognitive function measurement | | 20 | 48796542 | 48796543 | Human |
407346038 | GWAS995014_H | BMI-adjusted waist circumference QTL GWAS995014 (human) | | 7e-15 | BMI-adjusted waist circumference | | 20 | 46893463 | 46893464 | Human |
407100273 | GWAS749249_H | cognitive function measurement QTL GWAS749249 (human) | | 2e-10 | cognitive function measurement | | 20 | 45967010 | 45967011 | Human |
407346037 | GWAS995013_H | BMI-adjusted waist circumference QTL GWAS995013 (human) | | 5e-16 | BMI-adjusted waist circumference | | 20 | 46891513 | 46891514 | Human |
407346036 | GWAS995012_H | BMI-adjusted waist circumference QTL GWAS995012 (human) | | 2e-16 | BMI-adjusted waist circumference | | 20 | 46874226 | 46874227 | Human |
407346035 | GWAS995011_H | BMI-adjusted waist circumference QTL GWAS995011 (human) | | 4e-19 | BMI-adjusted waist circumference | | 20 | 40550283 | 40550284 | Human |
407001974 | GWAS650950_H | vital capacity QTL GWAS650950 (human) | | 9e-10 | vital capacity | | 20 | 46844375 | 46844376 | Human |
407100279 | GWAS749255_H | cognitive function measurement QTL GWAS749255 (human) | | 2e-11 | cognitive function measurement | | 20 | 59644709 | 59644710 | Human |
407100278 | GWAS749254_H | cognitive function measurement QTL GWAS749254 (human) | | 7e-11 | cognitive function measurement | | 20 | 50477089 | 50477090 | Human |
407346033 | GWAS995009_H | Inguinal hernia QTL GWAS995009 (human) | | 6e-14 | Inguinal hernia | | 20 | 57260984 | 57260985 | Human |
407100276 | GWAS749252_H | cognitive function measurement QTL GWAS749252 (human) | | 5e-22 | cognitive function measurement | | 20 | 49106590 | 49106591 | Human |
407083896 | GWAS732872_H | free cholesterol in medium HDL measurement QTL GWAS732872 (human) | | 2e-78 | free cholesterol in medium HDL measurement | | 20 | 45947863 | 45947864 | Human |
407346043 | GWAS995019_H | BMI-adjusted waist circumference QTL GWAS995019 (human) | | 2e-17 | BMI-adjusted waist circumference | | 20 | 53079553 | 53079554 | Human |
407346042 | GWAS995018_H | BMI-adjusted waist circumference QTL GWAS995018 (human) | | 3e-14 | BMI-adjusted waist circumference | | 20 | 53096139 | 53096140 | Human |
407346041 | GWAS995017_H | BMI-adjusted waist circumference QTL GWAS995017 (human) | | 5e-08 | BMI-adjusted waist circumference | | 20 | 51397244 | 51397245 | Human |
407346040 | GWAS995016_H | BMI-adjusted waist circumference QTL GWAS995016 (human) | | 1e-11 | BMI-adjusted waist circumference | | 20 | 46944571 | 46944575 | Human |
407280390 | GWAS929366_H | vaginal microbiome measurement QTL GWAS929366 (human) | | 0.000006 | vaginal microbiome measurement | | 20 | 60953660 | 60953661 | Human |
407116556 | GWAS765532_H | myeloid white cell count QTL GWAS765532 (human) | | 3e-19 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 48767764 | 48767765 | Human |
407083786 | GWAS732762_H | phospholipids in medium LDL measurement QTL GWAS732762 (human) | | 2e-29 | cholesterol esters in large LDL measurement | blood low density lipoprotein phospholipid level (CMO:0001568) | 20 | 40537052 | 40537053 | Human |
407116557 | GWAS765533_H | myeloid white cell count QTL GWAS765533 (human) | | 2e-14 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 50568735 | 50568736 | Human |
407001865 | GWAS650841_H | colonic neoplasm, overall survival QTL GWAS650841 (human) | | 0.0000007 | colonic neoplasm, overall survival | | 20 | 60847915 | 60847916 | Human |
407116555 | GWAS765531_H | myeloid white cell count QTL GWAS765531 (human) | | 1e-10 | myeloid white cell count | white blood cell count (CMO:0000027) | 20 | 38159027 | 38159028 | Human |
407149332 | GWAS798308_H | schizophrenia QTL GWAS798308 (human) | | 2e-09 | schizophrenia | | 20 | 38738094 | 38738095 | Human |
407280406 | GWAS929382_H | vaginal microbiome measurement QTL GWAS929382 (human) | | 0.000001 | vaginal microbiome measurement | | 20 | 59926203 | 59926204 | Human |
407149333 | GWAS798309_H | schizophrenia QTL GWAS798309 (human) | | 3e-08 | schizophrenia | | 20 | 49512632 | 49512633 | Human |
407280407 | GWAS929383_H | vaginal microbiome measurement QTL GWAS929383 (human) | | 0.0000008 | vaginal microbiome measurement | | 20 | 59965927 | 59965928 | Human |
407149331 | GWAS798307_H | schizophrenia QTL GWAS798307 (human) | | 4e-09 | schizophrenia | | 20 | 38718108 | 38718109 | Human |
406985497 | GWAS634473_H | breakfast skipping measurement QTL GWAS634473 (human) | | 3e-08 | breakfast skipping measurement | | 20 | 44838739 | 44838740 | Human |
407329563 | GWAS978539_H | cortical thickness QTL GWAS978539 (human) | | 3e-22 | cortical thickness | | 20 | 38214481 | 38214482 | Human |
406903581 | GWAS552557_H | total cholesterol measurement QTL GWAS552557 (human) | | 0.000006 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40561719 | 40561720 | Human |
406903582 | GWAS552558_H | total cholesterol measurement QTL GWAS552558 (human) | | 0.000006 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41407325 | 41407326 | Human |
406919973 | GWAS568949_H | systolic blood pressure QTL GWAS568949 (human) | | 6e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 44166512 | 44166513 | Human |
407411503 | GWAS1060479_H | sexual dimorphism measurement QTL GWAS1060479 (human) | | 2e-09 | sexual dimorphism measurement | | 20 | 36995890 | 36995891 | Human |
406919974 | GWAS568950_H | systolic blood pressure QTL GWAS568950 (human) | | 2e-15 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 59164414 | 59164415 | Human |
407345966 | GWAS994942_H | mathematical ability QTL GWAS994942 (human) | | 1e-09 | mathematical ability | | 20 | 48877357 | 48877358 | Human |
407067439 | GWAS716415_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa QTL GWAS716415 (human) | | 1e-09 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | | 20 | 38797315 | 38797316 | Human |
407182133 | GWAS831109_H | Stuttering QTL GWAS831109 (human) | | 0.000002 | Stuttering | | 20 | 44060870 | 44060871 | Human |
407182134 | GWAS831110_H | Stuttering QTL GWAS831110 (human) | | 0.000002 | Stuttering | | 20 | 57032873 | 57032874 | Human |
407149375 | GWAS798351_H | brain volume measurement QTL GWAS798351 (human) | | 9e-11 | brain volume measurement | brain morphological measurement (CMO:0000136) | 20 | 53832397 | 53832398 | Human |
407378741 | GWAS1027717_H | prostate carcinoma QTL GWAS1027717 (human) | | 0.000006 | prostate carcinoma | | 20 | 53838666 | 53838667 | Human |
407313209 | GWAS962185_H | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS962185 (human) | | 9e-32 | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45947863 | 45947864 | Human |
407296964 | GWAS945940_H | rheumatoid arthritis QTL GWAS945940 (human) | | 4e-13 | rheumatoid arthritis | | 20 | 37423443 | 37423444 | Human |
407215052 | GWAS864028_H | low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS864028 (human) | | 3e-11 | low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 41049649 | 41049650 | Human |
407002064 | GWAS651040_H | sex hormone-binding globulin measurement QTL GWAS651040 (human) | | 5e-92 | sex hormone-binding globulin measurement | | 20 | 44411929 | 44411930 | Human |
407378909 | GWAS1027885_H | atrial fibrillation QTL GWAS1027885 (human) | | 2e-11 | pulse pressure measurement | pulse pressure (CMO:0000292) | 20 | 38213512 | 38213513 | Human |
406952916 | GWAS601892_H | stathmin-2 measurement QTL GWAS601892 (human) | | 3e-13 | stathmin-2 measurement | | 20 | 59022916 | 59022917 | Human |
407198684 | GWAS847660_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS847660 (human) | | 3e-14 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47711852 | 47711853 | Human |
407198683 | GWAS847659_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS847659 (human) | | 3e-312 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45934368 | 45934369 | Human |
407247844 | GWAS896820_H | phosphoglycerides measurement QTL GWAS896820 (human) | | 6e-14 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 20 | 44413724 | 44413725 | Human |
407231459 | GWAS880435_H | low density lipoprotein cholesterol measurement QTL GWAS880435 (human) | | 0.000003 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 41095698 | 41095699 | Human |
407329775 | GWAS978751_H | very low density lipoprotein cholesterol measurement, phospholipid measurement QTL GWAS978751 (human) | | 8e-12 | very low density lipoprotein cholesterol measurement, phospholipid measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 41284992 | 41284993 | Human |
407084010 | GWAS732986_H | diastolic blood pressure QTL GWAS732986 (human) | | 6e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 58897119 | 58897120 | Human |
407231465 | GWAS880441_H | high density lipoprotein cholesterol measurement QTL GWAS880441 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45948343 | 45948344 | Human |
407067630 | GWAS716606_H | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS716606 (human) | | 4e-12 | phospholipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407133175 | GWAS782151_H | hemoglobin measurement, hemoglobin A2 measurement QTL GWAS782151 (human) | | 0.000007 | hemoglobin measurement, hemoglobin A2 measurement | hemoglobin measurement (CMO:0000508) | 20 | 45919033 | 45919034 | Human |
407182320 | GWAS831296_H | erythrocyte measurement QTL GWAS831296 (human) | | 1e-21 | erythrocyte measurement | red blood cell measurement (CMO:0001356) | 20 | 57415349 | 57415350 | Human |
407231485 | GWAS880461_H | lipoprotein measurement QTL GWAS880461 (human) | | 1e-23 | total cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 44413724 | 44413725 | Human |
407395312 | GWAS1044288_H | high density lipoprotein cholesterol measurement QTL GWAS1044288 (human) | | 4e-240 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407002104 | GWAS651080_H | monocyte count QTL GWAS651080 (human) | | 2e-30 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 20 | 44210072 | 44210073 | Human |
406969339 | GWAS618315_H | parathyroid hormone measurement QTL GWAS618315 (human) | | 2e-10 | parathyroid hormone measurement | blood parathyroid hormone level (CMO:0002961) | 20 | 54125508 | 54125509 | Human |
407002105 | GWAS651081_H | monocyte count QTL GWAS651081 (human) | | 2e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 20 | 48704911 | 48704912 | Human |
407198713 | GWAS847689_H | apolipoprotein B measurement QTL GWAS847689 (human) | | 3e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40697511 | 40697512 | Human |
406969340 | GWAS618316_H | parathyroid hormone measurement QTL GWAS618316 (human) | | 2e-72 | parathyroid hormone measurement | blood parathyroid hormone level (CMO:0002961) | 20 | 54114863 | 54114864 | Human |
407313401 | GWAS962377_H | high density lipoprotein cholesterol measurement QTL GWAS962377 (human) | | 2e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 52611648 | 52611649 | Human |
407198714 | GWAS847690_H | apolipoprotein B measurement QTL GWAS847690 (human) | | 2e-09 | apolipoprotein B measurement | blood apoliprotein B level (CMO:0000522) | 20 | 41012331 | 41012332 | Human |
407133179 | GWAS782155_H | esterified cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS782155 (human) | | 1e-225 | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407313400 | GWAS962376_H | high density lipoprotein cholesterol measurement QTL GWAS962376 (human) | | 5e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47784419 | 47784420 | Human |
407067525 | GWAS716501_H | waist-hip ratio QTL GWAS716501 (human) | | 2e-27 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 20 | 52366331 | 52366332 | Human |
407378817 | GWAS1027793_H | alcohol consumption measurement, high density lipoprotein cholesterol measurement QTL GWAS1027793 (human) | | 8e-56 | alcohol consumption measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407362446 | GWAS1011422_H | resting heart rate QTL GWAS1011422 (human) | | 2e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 58888417 | 58888418 | Human |
407067533 | GWAS716509_H | mean arterial pressure, alcohol drinking QTL GWAS716509 (human) | | 4e-15 | mean arterial pressure, alcohol drinking | mean arterial blood pressure (CMO:0000009) | 20 | 59165293 | 59165294 | Human |
407002002 | GWAS650978_H | open-angle glaucoma QTL GWAS650978 (human) | | 1e-09 | open-angle glaucoma | | 20 | 47159504 | 47159505 | Human |
407002003 | GWAS650979_H | open-angle glaucoma QTL GWAS650979 (human) | | 2e-11 | open-angle glaucoma | | 20 | 50441252 | 50441253 | Human |
407198615 | GWAS847591_H | lymphocyte:monocyte ratio QTL GWAS847591 (human) | | 5e-08 | lymphocyte:monocyte ratio | | 20 | 50302232 | 50302233 | Human |
407346069 | GWAS995045_H | total cholesterol measurement QTL GWAS995045 (human) | | 1e-18 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 53918748 | 53918749 | Human |
407002001 | GWAS650977_H | open-angle glaucoma QTL GWAS650977 (human) | | 6e-11 | open-angle glaucoma | | 20 | 39920335 | 39920336 | Human |
407346068 | GWAS995044_H | total cholesterol measurement QTL GWAS995044 (human) | | 8e-15 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 48924980 | 48924981 | Human |
407362459 | GWAS1011435_H | resting heart rate QTL GWAS1011435 (human) | | 4e-22 | resting heart rate | heart rate (CMO:0000002) | 20 | 38213512 | 38213513 | Human |
407215001 | GWAS863977_H | cystatin C measurement QTL GWAS863977 (human) | | 3e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 62475466 | 62475467 | Human |
407002016 | GWAS650992_H | sex hormone-binding globulin measurement QTL GWAS650992 (human) | | 4e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 57260984 | 57260985 | Human |
407116716 | GWAS765692_H | triglyceride measurement QTL GWAS765692 (human) | | 2e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 57565383 | 57565384 | Human |
407133102 | GWAS782078_H | triglyceride:HDL cholesterol ratio QTL GWAS782078 (human) | | 7e-11 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 20 | 40513876 | 40513877 | Human |
407133109 | GWAS782085_H | triglyceride:HDL cholesterol ratio QTL GWAS782085 (human) | | 4e-26 | triglyceride:HDL cholesterol ratio | | 20 | 45909845 | 45909846 | Human |
407083965 | GWAS732941_H | cholesterol to total lipids in medium LDL percentage QTL GWAS732941 (human) | | 3e-18 | cholesterol to total lipids in medium LDL percentage | | 20 | 45923216 | 45923217 | Human |
407280717 | GWAS929693_H | Alzheimer disease, gastroesophageal reflux disease QTL GWAS929693 (human) | | 0.000004 | Alzheimer disease, gastroesophageal reflux disease | | 20 | 37642954 | 37642955 | Human |
407116873 | GWAS765849_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS765849 (human) | | 1e-12 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45916409 | 45916410 | Human |
407411781 | GWAS1060757_H | anemia (phenotype), response to ribavirin QTL GWAS1060757 (human) | | 0.000002 | anemia (phenotype), response to ribavirin | | 20 | 54205061 | 54205062 | Human |
407379032 | GWAS1028008_H | blood protein measurement QTL GWAS1028008 (human) | | 2e-1206 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 45123141 | 45123142 | Human |
406920272 | GWAS569248_H | N1-methyladenosine measurement QTL GWAS569248 (human) | | 1e-15 | N1-methyladenosine measurement | | 20 | 44642751 | 44642752 | Human |
407379035 | GWAS1028011_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1028011 (human) | | 6e-13 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407116887 | GWAS765863_H | mean corpuscular volume QTL GWAS765863 (human) | | 1e-14 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 50483272 | 50483273 | Human |
406969431 | GWAS618407_H | lipopolysaccharide-binding protein measurement QTL GWAS618407 (human) | | 5e-93 | lipopolysaccharide-binding protein measurement | | 20 | 38371808 | 38371810 | Human |
407018580 | GWAS667556_H | body height QTL GWAS667556 (human) | | 2e-11 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 49235382 | 49235383 | Human |
406969430 | GWAS618406_H | lipopolysaccharide-binding protein measurement QTL GWAS618406 (human) | | 9e-33 | lipopolysaccharide-binding protein measurement | | 20 | 38354411 | 38354412 | Human |
407018586 | GWAS667562_H | body height QTL GWAS667562 (human) | | 8e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 56382507 | 56382508 | Human |
407018587 | GWAS667563_H | body height QTL GWAS667563 (human) | | 2e-48 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 58790600 | 58790601 | Human |
407018585 | GWAS667561_H | body height QTL GWAS667561 (human) | | 5e-10 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 49986787 | 49986788 | Human |
407362649 | GWAS1011625_H | Fuchs endothelial corneal dystrophy QTL GWAS1011625 (human) | | 1e-08 | Fuchs endothelial corneal dystrophy | | 20 | 62322048 | 62322049 | Human |
407051364 | GWAS700340_H | sexual dimorphism measurement QTL GWAS700340 (human) | | 3e-10 | sexual dimorphism measurement | | 20 | 44380341 | 44380342 | Human |
407329888 | GWAS978864_H | uric acid measurement QTL GWAS978864 (human) | | 1e-09 | uric acid measurement | blood uric acid level (CMO:0000501) | 20 | 58901754 | 58901755 | Human |
407297132 | GWAS946108_H | vaginal microbiome measurement QTL GWAS946108 (human) | | 0.000006 | vaginal microbiome measurement | | 20 | 46073481 | 46073482 | Human |
407411810 | GWAS1060786_H | diastolic blood pressure QTL GWAS1060786 (human) | | 8e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 59032894 | 59032895 | Human |
407149672 | GWAS798648_H | heel bone mineral density QTL GWAS798648 (human) | | 3e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46002657 | 46002658 | Human |
407297130 | GWAS946106_H | vaginal microbiome measurement QTL GWAS946106 (human) | | 0.000006 | vaginal microbiome measurement | | 20 | 46060026 | 46060027 | Human |
407297131 | GWAS946107_H | vaginal microbiome measurement QTL GWAS946107 (human) | | 0.000006 | vaginal microbiome measurement | | 20 | 46063959 | 46063960 | Human |
406903918 | GWAS552894_H | facial morphology measurement QTL GWAS552894 (human) | | 0.000004 | facial morphology measurement | | 20 | 47086598 | 47086599 | Human |
407297129 | GWAS946105_H | vaginal microbiome measurement QTL GWAS946105 (human) | | 0.000002 | vaginal microbiome measurement | | 20 | 46052214 | 46052215 | Human |
407379065 | GWAS1028041_H | intraocular pressure measurement QTL GWAS1028041 (human) | | 5e-10 | intraocular pressure measurement | | 20 | 39910126 | 39910127 | Human |
407313520 | GWAS962496_H | cortical surface area measurement QTL GWAS962496 (human) | | 1e-09 | cerebral cortex morphology trait (VT:0000788) | tibia-fibula cortical bone total cross-sectional area (CMO:0001721) | 20 | 56953359 | 56953360 | Human |
407149693 | GWAS798669_H | fasting blood glucose measurement QTL GWAS798669 (human) | | 1e-10 | fasting blood glucose measurement | blood glucose level (CMO:0000046) | 20 | 51538847 | 51538848 | Human |
407133190 | GWAS782166_H | lipid measurement QTL GWAS782166 (human) | | 2e-31 | lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 45906012 | 45906013 | Human |
407264261 | GWAS913237_H | total cortical area measurement QTL GWAS913237 (human) | | 5e-09 | total cortical area measurement | | 20 | 53825322 | 53825323 | Human |
407002123 | GWAS651099_H | open-angle glaucoma QTL GWAS651099 (human) | | 1e-08 | open-angle glaucoma | | 20 | 61981337 | 61981338 | Human |
406903819 | GWAS552795_H | total cholesterol measurement QTL GWAS552795 (human) | | 0.000002 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40546240 | 40546241 | Human |
407067661 | GWAS716637_H | blood protein measurement QTL GWAS716637 (human) | | 3e-13 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 40282057 | 40282058 | Human |
406887438 | GWAS536414_H | body mass index QTL GWAS536414 (human) | | 0.0000005 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 51209643 | 51209644 | Human |
406936590 | GWAS585566_H | calcium measurement QTL GWAS585566 (human) | | 1e-08 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 54115823 | 54115824 | Human |
406887439 | GWAS536415_H | body mass index QTL GWAS536415 (human) | | 8e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 55820112 | 55820113 | Human |
407362585 | GWAS1011561_H | reticulocyte count QTL GWAS1011561 (human) | | 3e-49 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 57416581 | 57416582 | Human |
407362584 | GWAS1011560_H | reticulocyte count QTL GWAS1011560 (human) | | 2e-59 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 57415314 | 57415315 | Human |
407313442 | GWAS962418_H | clinical and behavioural ideal cardiovascular health QTL GWAS962418 (human) | | 1e-10 | clinical and behavioural ideal cardiovascular health | | 20 | 41131808 | 41131809 | Human |
407346219 | GWAS995195_H | systolic blood pressure QTL GWAS995195 (human) | | 7e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 41534816 | 41534817 | Human |
407411749 | GWAS1060725_H | triglyceride measurement QTL GWAS1060725 (human) | | 5e-108 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45923216 | 45923217 | Human |
407198773 | GWAS847749_H | mean platelet volume QTL GWAS847749 (human) | | 2e-09 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 57410043 | 57410044 | Human |
407182389 | GWAS831365_H | Calcium channel blocker use measurement QTL GWAS831365 (human) | | 6e-09 | Calcium channel blocker use measurement | | 20 | 58888938 | 58888939 | Human |
407198772 | GWAS847748_H | mean platelet volume QTL GWAS847748 (human) | | 1e-09 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 53564091 | 53564092 | Human |
407034928 | GWAS683904_H | triglycerides in small LDL measurement QTL GWAS683904 (human) | | 7e-12 | blood lipid amount (VT:0003949) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
406969395 | GWAS618371_H | protein measurement QTL GWAS618371 (human) | | 2e-08 | protein measurement | | 20 | 62002148 | 62002149 | Human |
407198774 | GWAS847750_H | mean platelet volume QTL GWAS847750 (human) | | 5e-24 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 57441016 | 57441017 | Human |
407002167 | GWAS651143_H | hemoglobin measurement QTL GWAS651143 (human) | | 5e-44 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 44413724 | 44413725 | Human |
407198771 | GWAS847747_H | mean platelet volume QTL GWAS847747 (human) | | 2e-30 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 44885696 | 44885697 | Human |
406903866 | GWAS552842_H | wellbeing measurement QTL GWAS552842 (human) | | 6e-11 | wellbeing measurement | | 20 | 47211814 | 47211815 | Human |
407116994 | GWAS765970_H | coronary artery calcification QTL GWAS765970 (human) | | 2e-42 | coronary artery calcification | | 20 | 45916409 | 45916410 | Human |
407215298 | GWAS864274_H | white matter hyperintensity measurement QTL GWAS864274 (human) | | 0.000005 | white matter hyperintensity measurement | | 20 | 58699388 | 58699389 | Human |
407133387 | GWAS782363_H | blood protein measurement QTL GWAS782363 (human) | | 5e-170 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38162912 | 38162913 | Human |
407346391 | GWAS995367_H | triglyceride measurement QTL GWAS995367 (human) | | 5e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 40556638 | 40556639 | Human |
407297235 | GWAS946211_H | schizophrenia QTL GWAS946211 (human) | | 0.000003 | schizophrenia | | 20 | 59678449 | 59678450 | Human |
407346385 | GWAS995361_H | triglyceride measurement QTL GWAS995361 (human) | | 3e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45950322 | 45950323 | Human |
407297233 | GWAS946209_H | schizophrenia QTL GWAS946209 (human) | | 6e-11 | schizophrenia | | 20 | 38797315 | 38797316 | Human |
407067860 | GWAS716836_H | N-acetylglutamate measurement QTL GWAS716836 (human) | | 6e-13 | N-acetylglutamate measurement | | 20 | 46640917 | 46640918 | Human |
406953174 | GWAS602150_H | Lewy body dementia, Lewy body dementia measurement QTL GWAS602150 (human) | | 0.000002 | Lewy body dementia, Lewy body dementia measurement | | 20 | 56679998 | 56679999 | Human |
407018714 | GWAS667690_H | body height QTL GWAS667690 (human) | | 3e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 36890036 | 36890037 | Human |
407346398 | GWAS995374_H | triglyceride measurement QTL GWAS995374 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 57538727 | 57538728 | Human |
407346397 | GWAS995373_H | triglyceride measurement QTL GWAS995373 (human) | | 2e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 52383088 | 52383089 | Human |
407346396 | GWAS995372_H | triglyceride measurement QTL GWAS995372 (human) | | 1e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 46967739 | 46967740 | Human |
407248090 | GWAS897066_H | birth weight QTL GWAS897066 (human) | | 4e-10 | birth weight | neonatal body weight (CMO:0002079) | 20 | 40544088 | 40544089 | Human |
407346395 | GWAS995371_H | triglyceride measurement QTL GWAS995371 (human) | | 2e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45966613 | 45966614 | Human |
407346394 | GWAS995370_H | triglyceride measurement QTL GWAS995370 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45903616 | 45903617 | Human |
407346393 | GWAS995369_H | triglyceride measurement QTL GWAS995369 (human) | | 1e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45601653 | 45601654 | Human |
407346392 | GWAS995368_H | triglyceride measurement QTL GWAS995368 (human) | | 3e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 41227440 | 41227441 | Human |
407313639 | GWAS962615_H | triglyceride measurement QTL GWAS962615 (human) | | 6e-17 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 57543502 | 57543503 | Human |
407313638 | GWAS962614_H | triglyceride measurement QTL GWAS962614 (human) | | 3e-10 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 52429770 | 52429771 | Human |
407313637 | GWAS962613_H | triglyceride measurement QTL GWAS962613 (human) | | 3e-19 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 46966072 | 46966073 | Human |
407313636 | GWAS962612_H | triglyceride measurement QTL GWAS962612 (human) | | 3e-17 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 41244128 | 41244129 | Human |
407198944 | GWAS847920_H | blood protein measurement QTL GWAS847920 (human) | | 1e-21 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 43450979 | 43450980 | Human |
407002340 | GWAS651316_H | nicotine dependence symptom count, depressive symptom measurement QTL GWAS651316 (human) | | 0.000008 | nicotine dependence symptom count, depressive symptom measurement | | 20 | 47768731 | 47768732 | Human |
407002341 | GWAS651317_H | vital capacity QTL GWAS651317 (human) | | 1e-09 | vital capacity | | 20 | 57749029 | 57749030 | Human |
406953194 | GWAS602170_H | emphysema imaging measurement QTL GWAS602170 (human) | | 0.0000005 | emphysema imaging measurement | | 20 | 57562984 | 57562985 | Human |
406920429 | GWAS569405_H | appendicular lean mass QTL GWAS569405 (human) | | 1e-11 | appendicular lean mass | | 20 | 36608799 | 36608800 | Human |
407198960 | GWAS847936_H | lipopolysaccharide-binding protein measurement QTL GWAS847936 (human) | | 4e-624 | lipopolysaccharide-binding protein measurement | | 20 | 38369011 | 38369012 | Human |
407297278 | GWAS946254_H | lipopolysaccharide-binding protein measurement QTL GWAS946254 (human) | | 9e-18 | lipopolysaccharide-binding protein measurement | | 20 | 38325279 | 38325280 | Human |
407297279 | GWAS946255_H | lipopolysaccharide-binding protein measurement QTL GWAS946255 (human) | | 8e-17 | lipopolysaccharide-binding protein measurement | | 20 | 38352660 | 38352661 | Human |
407297277 | GWAS946253_H | lipopolysaccharide-binding protein measurement QTL GWAS946253 (human) | | 6e-21 | lipopolysaccharide-binding protein measurement | | 20 | 38360648 | 38360649 | Human |
407297275 | GWAS946251_H | lipopolysaccharide-binding protein measurement QTL GWAS946251 (human) | | 4e-142 | lipopolysaccharide-binding protein measurement | | 20 | 38354411 | 38354412 | Human |
407084284 | GWAS733260_H | rheumatoid arthritis QTL GWAS733260 (human) | | 1e-09 | rheumatoid arthritis | | 20 | 46105671 | 46105672 | Human |
406920325 | GWAS569301_H | high density lipoprotein cholesterol measurement QTL GWAS569301 (human) | | 2e-22 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45925376 | 45925377 | Human |
407362700 | GWAS1011676_H | insomnia QTL GWAS1011676 (human) | | 3e-08 | insomnia | | 20 | 52620434 | 52620435 | Human |
407329932 | GWAS978908_H | creatinine measurement QTL GWAS978908 (human) | | 2e-08 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 58901754 | 58901755 | Human |
407362699 | GWAS1011675_H | insomnia QTL GWAS1011675 (human) | | 4e-09 | insomnia | | 20 | 52465795 | 52465796 | Human |
407411845 | GWAS1060821_H | response to calcium channel blocker QTL GWAS1060821 (human) | | 0.000006 | response to calcium channel blocker | | 20 | 46607483 | 46607484 | Human |
407362698 | GWAS1011674_H | insomnia QTL GWAS1011674 (human) | | 4e-11 | insomnia | | 20 | 52342914 | 52342915 | Human |
407362697 | GWAS1011673_H | insomnia QTL GWAS1011673 (human) | | 4e-09 | insomnia | | 20 | 52207060 | 52207061 | Human |
406953103 | GWAS602079_H | Lewy body dementia, Lewy body dementia measurement QTL GWAS602079 (human) | | 0.000003 | Lewy body dementia, Lewy body dementia measurement | | 20 | 56679998 | 56679999 | Human |
407035036 | GWAS684012_H | diastolic blood pressure QTL GWAS684012 (human) | | 3e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 48692260 | 48692261 | Human |
407035037 | GWAS684013_H | waist circumference QTL GWAS684013 (human) | | 1e-08 | waist circumference | waist circumference (CMO:0000242) | 20 | 52365406 | 52365407 | Human |
407018659 | GWAS667635_H | body height QTL GWAS667635 (human) | | 1e-09 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 44688014 | 44688015 | Human |
407297189 | GWAS946165_H | monocyte count QTL GWAS946165 (human) | | 6e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 20 | 50286497 | 50286498 | Human |
407264428 | GWAS913404_H | blood protein measurement QTL GWAS913404 (human) | | 8e-60 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 58961072 | 58961073 | Human |
407018665 | GWAS667641_H | body height QTL GWAS667641 (human) | | 3e-74 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 58896988 | 58896989 | Human |
407100591 | GWAS749567_H | erythrocyte count QTL GWAS749567 (human) | | 4e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 41085229 | 41085230 | Human |
407215287 | GWAS864263_H | Ischemic stroke, coronary artery disease QTL GWAS864263 (human) | | 0.000009 | Ischemic stroke, coronary artery disease | | 20 | 47913380 | 47913381 | Human |
407231677 | GWAS880653_H | monocyte percentage of leukocytes QTL GWAS880653 (human) | | 2e-58 | monocyte percentage of leukocytes | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 20 | 50270731 | 50270732 | Human |
407215295 | GWAS864271_H | creatinine measurement QTL GWAS864271 (human) | | 9e-11 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 62475466 | 62475467 | Human |
407231675 | GWAS880651_H | monocyte percentage of leukocytes QTL GWAS880651 (human) | | 1e-09 | monocyte percentage of leukocytes | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 20 | 39923465 | 39923466 | Human |
407215428 | GWAS864404_H | coronary aneurysm QTL GWAS864404 (human) | | 2e-08 | coronary aneurysm | | 20 | 43305980 | 43305981 | Human |
407166288 | GWAS815264_H | unipolar depression QTL GWAS815264 (human) | | 1e-08 | unipolar depression | | 20 | 48981960 | 48981961 | Human |
407412063 | GWAS1061039_H | high density lipoprotein cholesterol measurement QTL GWAS1061039 (human) | | 2e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 40404016 | 40404017 | Human |
407231833 | GWAS880809_H | bone density QTL GWAS880809 (human) | | 9e-77 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 56233434 | 56233435 | Human |
407346535 | GWAS995511_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS995511 (human) | | 1e-236 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45934368 | 45934369 | Human |
407297383 | GWAS946359_H | brain measurement QTL GWAS946359 (human) | | 1e-11 | brain measurement | brain measurement (CMO:0000911) | 20 | 39923436 | 39923437 | Human |
407346534 | GWAS995510_H | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS995510 (human) | | 4e-08 | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45904979 | 45904980 | Human |
407330149 | GWAS979125_H | triglyceride measurement QTL GWAS979125 (human) | | 9e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45907567 | 45907568 | Human |
407149931 | GWAS798907_H | platelet count QTL GWAS798907 (human) | | 4e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 20 | 59022916 | 59022917 | Human |
407297399 | GWAS946375_H | platelet measurement QTL GWAS946375 (human) | | 6e-28 | platelet measurement | platelet measurement (CMO:0000921) | 20 | 59019629 | 59019630 | Human |
407231857 | GWAS880833_H | bone density QTL GWAS880833 (human) | | 3e-17 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 56497937 | 56497938 | Human |
407379314 | GWAS1028290_H | blood protein measurement QTL GWAS1028290 (human) | | 4e-160 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 46011586 | 46011587 | Human |
407002370 | GWAS651346_H | pulse pressure measurement QTL GWAS651346 (human) | | 0.000005 | pulse pressure measurement | pulse pressure (CMO:0000292) | 20 | 44168718 | 44168719 | Human |
407330054 | GWAS979030_H | glucose measurement QTL GWAS979030 (human) | | 3e-09 | glucose measurement | blood glucose level (CMO:0000046) | 20 | 58821440 | 58821441 | Human |
406887685 | GWAS536661_H | body mass index QTL GWAS536661 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 54837311 | 54837312 | Human |
407297280 | GWAS946256_H | lipopolysaccharide-binding protein measurement QTL GWAS946256 (human) | | 4e-16 | lipopolysaccharide-binding protein measurement | | 20 | 38356929 | 38356930 | Human |
407411982 | GWAS1060958_H | total cholesterol measurement QTL GWAS1060958 (human) | | 1e-15 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41331702 | 41331703 | Human |
406887686 | GWAS536662_H | body mass index QTL GWAS536662 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 55803977 | 55803978 | Human |
407297281 | GWAS946257_H | lipopolysaccharide-binding protein measurement QTL GWAS946257 (human) | | 3e-11 | lipopolysaccharide-binding protein measurement | | 20 | 38161726 | 38161727 | Human |
407100683 | GWAS749659_H | phospholipids:total lipids ratio QTL GWAS749659 (human) | | 3e-69 | phospholipids:total lipids ratio | | 20 | 45947863 | 45947864 | Human |
407346445 | GWAS995421_H | cortical thickness QTL GWAS995421 (human) | | 3e-08 | cortical thickness | | 20 | 57751703 | 57751704 | Human |
406969615 | GWAS618591_H | triglyceride measurement, trait in response to hydrochlorothiazide QTL GWAS618591 (human) | | 0.000004 | triglyceride measurement, trait in response to hydrochlorothiazide | blood triglyceride level (CMO:0000118) | 20 | 47051863 | 47051864 | Human |
407395611 | GWAS1044587_H | educational attainment QTL GWAS1044587 (human) | | 6e-10 | educational attainment | | 20 | 46095666 | 46095667 | Human |
407231763 | GWAS880739_H | omega-6 polyunsaturated fatty acid measurement QTL GWAS880739 (human) | | 8e-14 | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
407002388 | GWAS651364_H | rheumatoid arthritis QTL GWAS651364 (human) | | 7e-09 | rheumatoid arthritis | | 20 | 59817947 | 59817948 | Human |
407411999 | GWAS1060975_H | diet measurement QTL GWAS1060975 (human) | | 2e-10 | diet measurement | food intake measurement (CMO:0000772) | 20 | 55782850 | 55782851 | Human |
407231775 | GWAS880751_H | blood protein measurement QTL GWAS880751 (human) | | 1e-83 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38350107 | 38350108 | Human |
407231774 | GWAS880750_H | blood protein measurement QTL GWAS880750 (human) | | 4e-13 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38304396 | 38304397 | Human |
407231777 | GWAS880753_H | blood protein measurement QTL GWAS880753 (human) | | 2e-146 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38292965 | 38292966 | Human |
407231776 | GWAS880752_H | blood protein measurement QTL GWAS880752 (human) | | 4e-143 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 38311185 | 38311186 | Human |
407149857 | GWAS798833_H | high density lipoprotein particle size measurement QTL GWAS798833 (human) | | 8e-13 | high density lipoprotein particle size measurement | blood high density lipoprotein particle diameter (CMO:0002692) | 20 | 45919331 | 45919332 | Human |
407067940 | GWAS716916_H | histidine measurement QTL GWAS716916 (human) | | 1e-09 | histidine measurement | blood amino acid measurement (CMO:0003730) | 20 | 40552430 | 40552431 | Human |
407199020 | GWAS847996_H | chitinase-3-like protein 2 measurement QTL GWAS847996 (human) | | 6e-14 | chitinase-3-like protein 2 measurement | | 20 | 38369011 | 38369012 | Human |
407133480 | GWAS782456_H | blood protein measurement QTL GWAS782456 (human) | | 1e-318 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 46145210 | 46145211 | Human |
407018796 | GWAS667772_H | body height QTL GWAS667772 (human) | | 4e-26 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 49249247 | 49249248 | Human |
407035186 | GWAS684162_H | phospholipids in HDL measurement QTL GWAS684162 (human) | | 8e-24 | phospholipids in HDL measurement | | 20 | 45923216 | 45923217 | Human |
407199028 | GWAS848004_H | monocyte count QTL GWAS848004 (human) | | 2e-23 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 20 | 50297833 | 50297834 | Human |
407035185 | GWAS684161_H | phospholipids in HDL measurement QTL GWAS684161 (human) | | 4e-11 | phospholipids in HDL measurement | | 20 | 44380341 | 44380342 | Human |
407231794 | GWAS880770_H | systolic blood pressure QTL GWAS880770 (human) | | 1e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 62475466 | 62475467 | Human |
407248326 | GWAS897302_H | type 2 diabetes mellitus QTL GWAS897302 (human) | | 0.000007 | type 2 diabetes mellitus | | 20 | 41203988 | 41203989 | Human |
407035330 | GWAS684306_H | waist-hip ratio QTL GWAS684306 (human) | | 0.000009 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 20 | 52365406 | 52365407 | Human |
407035328 | GWAS684304_H | waist-hip ratio QTL GWAS684304 (human) | | 2e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 20 | 52365406 | 52365407 | Human |
407412172 | GWAS1061148_H | low density lipoprotein cholesterol measurement QTL GWAS1061148 (human) | | 3e-12 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 45924256 | 45924257 | Human |
407346624 | GWAS995600_H | total cholesterol measurement QTL GWAS995600 (human) | | 2e-08 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40403451 | 40403452 | Human |
407346633 | GWAS995609_H | cortical thickness QTL GWAS995609 (human) | | 6e-11 | cortical thickness | | 20 | 62246124 | 62246125 | Human |
407150038 | GWAS799014_H | Duchenne muscular dystrophy, disease progression measurement QTL GWAS799014 (human) | | 0.000008 | Duchenne muscular dystrophy, disease progression measurement | disease progression measurement (CMO:0001110) | 20 | 50575367 | 50575368 | Human |
407215581 | GWAS864557_H | Ischemic stroke QTL GWAS864557 (human) | | 0.000003 | Ischemic stroke | | 20 | 42663082 | 42663083 | Human |
406986206 | GWAS635182_H | response to methotrexate, drug-induced liver injury QTL GWAS635182 (human) | | 0.000005 | response to methotrexate, drug-induced liver injury | | 20 | 54314787 | 54314788 | Human |
407264738 | GWAS913714_H | basal cell carcinoma QTL GWAS913714 (human) | | 3e-08 | basal cell carcinoma | | 20 | 39319655 | 39319656 | Human |
407330275 | GWAS979251_H | very low density lipoprotein cholesterol measurement, lipid measurement QTL GWAS979251 (human) | | 2e-10 | very low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 41284992 | 41284993 | Human |
407100903 | GWAS749879_H | erythrocyte count QTL GWAS749879 (human) | | 1e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 44031248 | 44031249 | Human |
407133664 | GWAS782640_H | total lipids in very large HDL measurement QTL GWAS782640 (human) | | 4e-287 | total lipids in very large HDL measurement | | 20 | 45923216 | 45923217 | Human |
406969829 | GWAS618805_H | diastolic blood pressure QTL GWAS618805 (human) | | 0.0000008 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 20 | 51492442 | 51492443 | Human |
407248362 | GWAS897338_H | pneumonia, COVID-19 QTL GWAS897338 (human) | | 0.000006 | pneumonia, COVID-19 | | 20 | 61111166 | 61111167 | Human |
406920686 | GWAS569662_H | diet measurement QTL GWAS569662 (human) | | 9e-09 | diet measurement | food intake measurement (CMO:0000772) | 20 | 44779731 | 44779732 | Human |
407068151 | GWAS717127_H | intelligence QTL GWAS717127 (human) | | 7e-12 | intelligence | | 20 | 49184292 | 49184293 | Human |
407395839 | GWAS1044815_H | COVID-19 QTL GWAS1044815 (human) | | 0.0000008 | COVID-19 | | 20 | 48178454 | 48178455 | Human |
407313918 | GWAS962894_H | testosterone measurement QTL GWAS962894 (human) | | 5e-12 | testosterone measurement | serum testosterone level (CMO:0000568) | 20 | 44411929 | 44411930 | Human |
406937080 | GWAS586056_H | basophil count QTL GWAS586056 (human) | | 8e-22 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 20 | 44891646 | 44891647 | Human |
407068152 | GWAS717128_H | intelligence QTL GWAS717128 (human) | | 3e-11 | intelligence | | 20 | 48816978 | 48816979 | Human |
406986237 | GWAS635213_H | triacylglycerol 58:8 measurement QTL GWAS635213 (human) | | 0.000001 | blood triglyceride amount (VT:0002644) | | 20 | 42063187 | 42063188 | Human |
407330296 | GWAS979272_H | Alzheimer disease, polygenic risk score QTL GWAS979272 (human) | | 0.0000003 | Alzheimer disease, polygenic risk score | | 20 | 56513348 | 56513349 | Human |
407199111 | GWAS848087_H | non-alcoholic fatty liver disease QTL GWAS848087 (human) | | 1e-10 | non-alcoholic fatty liver disease | | 20 | 46921850 | 46921851 | Human |
406887810 | GWAS536786_H | BMI-adjusted waist-hip ratio, physical activity measurement QTL GWAS536786 (human) | | 3e-08 | BMI-adjusted waist-hip ratio, physical activity measurement | voluntary body movement measurement (CMO:0000954) | 20 | 46930192 | 46930193 | Human |
407133583 | GWAS782559_H | triglyceride:HDL cholesterol ratio QTL GWAS782559 (human) | | 2e-88 | triglyceride:HDL cholesterol ratio | | 20 | 45923216 | 45923217 | Human |
406904203 | GWAS553179_H | diastolic blood pressure, systolic blood pressure QTL GWAS553179 (human) | | 3e-10 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 62432324 | 62432325 | Human |
407199112 | GWAS848088_H | non-alcoholic fatty liver disease QTL GWAS848088 (human) | | 3e-08 | non-alcoholic fatty liver disease | | 20 | 46978214 | 46978215 | Human |
406936975 | GWAS585951_H | basophil percentage of leukocytes QTL GWAS585951 (human) | | 1e-21 | basophil percentage of leukocytes | blood basophil count to total leukocyte count ratio (CMO:0000368) | 20 | 44891646 | 44891647 | Human |
407379352 | GWAS1028328_H | blood protein measurement QTL GWAS1028328 (human) | | 4e-121 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 46011586 | 46011587 | Human |
406953360 | GWAS602336_H | fasting blood glucose measurement QTL GWAS602336 (human) | | 5e-08 | fasting blood glucose measurement | blood glucose level (CMO:0000046) | 20 | 50213728 | 50213729 | Human |
407395730 | GWAS1044706_H | BMI-adjusted hip circumference QTL GWAS1044706 (human) | | 1e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 20 | 58891038 | 58891039 | Human |
407281053 | GWAS930029_H | vaginal microbiome measurement QTL GWAS930029 (human) | | 0.000004 | vaginal microbiome measurement | | 20 | 60953660 | 60953661 | Human |
407231896 | GWAS880872_H | blood protein measurement QTL GWAS880872 (human) | | 1e-15 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 45144527 | 45144528 | Human |
407297446 | GWAS946422_H | blood urea nitrogen measurement QTL GWAS946422 (human) | | 1e-08 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 20 | 58897119 | 58897120 | Human |
406920610 | GWAS569586_H | body height QTL GWAS569586 (human) | | 2e-20 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 58831332 | 58831334 | Human |
407313827 | GWAS962803_H | free cholesterol measurement QTL GWAS962803 (human) | | 5e-09 | free cholesterol measurement | blood cholesterol level (CMO:0002280) | 20 | 41049649 | 41049650 | Human |
407149984 | GWAS798960_H | apolipoprotein A 1 measurement QTL GWAS798960 (human) | | 1e-21 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 20 | 45917558 | 45917559 | Human |
407068071 | GWAS717047_H | heel bone mineral density QTL GWAS717047 (human) | | 1e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46976909 | 46976911 | Human |
407117229 | GWAS766205_H | high density lipoprotein cholesterol measurement QTL GWAS766205 (human) | | 2e-195 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407068073 | GWAS717049_H | alopecia QTL GWAS717049 (human) | | 2e-15 | cortical thickness | | 20 | 41203988 | 41203989 | Human |
406986153 | GWAS635129_H | diabetic nephropathy QTL GWAS635129 (human) | | 0.000006 | diabetic nephropathy | | 20 | 54129184 | 54129185 | Human |
407379365 | GWAS1028341_H | free cholesterol measurement, high density lipoprotein cholesterol measurement QTL GWAS1028341 (human) | | 2e-08 | free cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407166378 | GWAS815354_H | serum alanine aminotransferase measurement QTL GWAS815354 (human) | | 6e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 20 | 40550283 | 40550284 | Human |
407330216 | GWAS979192_H | very low density lipoprotein cholesterol measurement QTL GWAS979192 (human) | | 4e-10 | very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 41284992 | 41284993 | Human |
407117232 | GWAS766208_H | high density lipoprotein cholesterol measurement QTL GWAS766208 (human) | | 2e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 46100450 | 46100451 | Human |
407199153 | GWAS848129_H | gut microbiome measurement, bone density QTL GWAS848129 (human) | | 5e-08 | bone mineral mass (VT:0005007) | bone mineral density (CMO:0001226) | 20 | 51492704 | 51492705 | Human |
407117233 | GWAS766209_H | high density lipoprotein cholesterol measurement QTL GWAS766209 (human) | | 1e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47712230 | 47712231 | Human |
407035458 | GWAS684434_H | vital capacity QTL GWAS684434 (human) | | 3e-33 | vital capacity | | 20 | 49068783 | 49068784 | Human |
407068235 | GWAS717211_H | low density lipoprotein cholesterol measurement QTL GWAS717211 (human) | | 2e-11 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551796 | 40551797 | Human |
407150156 | GWAS799132_H | neutrophil count QTL GWAS799132 (human) | | 3e-17 | neutrophil quantity (VT:0000222) | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 44413724 | 44413725 | Human |
406937164 | GWAS586140_H | alkaline phosphatase measurement QTL GWAS586140 (human) | | 3e-08 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 20 | 57565383 | 57565384 | Human |
407199306 | GWAS848282_H | corneal resistance factor QTL GWAS848282 (human) | | 2e-13 | corneal resistance factor | | 20 | 41052547 | 41052548 | Human |
407051852 | GWAS700828_H | atrial fibrillation QTL GWAS700828 (human) | | 0.0000002 | atrial fibrillation | | 20 | 47796832 | 47796833 | Human |
407379547 | GWAS1028523_H | high density lipoprotein cholesterol measurement QTL GWAS1028523 (human) | | 8e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47713312 | 47713313 | Human |
407166547 | GWAS815523_H | unipolar depression QTL GWAS815523 (human) | | 1e-10 | unipolar depression | | 20 | 47215211 | 47215212 | Human |
406969947 | GWAS618923_H | antileukoproteinase measurement QTL GWAS618923 (human) | | 1e-30 | antileukoproteinase measurement | | 20 | 45107892 | 45107893 | Human |
407281244 | GWAS930220_H | cup-to-disc ratio measurement QTL GWAS930220 (human) | | 3e-13 | cup-to-disc ratio measurement | | 20 | 47168014 | 47168015 | Human |
407084638 | GWAS733614_H | low density lipoprotein cholesterol measurement, alcohol consumption measurement QTL GWAS733614 (human) | | 2e-15 | low density lipoprotein cholesterol measurement, alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 41278348 | 41278349 | Human |
407314009 | GWAS962985_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS962985 (human) | | 8e-182 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45934368 | 45934369 | Human |
407314008 | GWAS962984_H | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS962984 (human) | | 2e-09 | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45460393 | 45460394 | Human |
407330406 | GWAS979382_H | cortical thickness QTL GWAS979382 (human) | | 2e-25 | cortical thickness | | 20 | 53832397 | 53832398 | Human |
406986339 | GWAS635315_H | response to methotrexate, drug-induced liver injury QTL GWAS635315 (human) | | 0.000005 | response to methotrexate, drug-induced liver injury | | 20 | 54314926 | 54314927 | Human |
406986348 | GWAS635324_H | diabetic nephropathy QTL GWAS635324 (human) | | 0.000002 | diabetic nephropathy | | 20 | 36992576 | 36992577 | Human |
406920815 | GWAS569791_H | fatty acid measurement QTL GWAS569791 (human) | | 0.000005 | fatty acid measurement | | 20 | 59734005 | 59734006 | Human |
406904431 | GWAS553407_H | COVID-19 QTL GWAS553407 (human) | | 0.000009 | COVID-19 | | 20 | 55256526 | 55256527 | Human |
407412339 | GWAS1061315_H | total cholesterol measurement QTL GWAS1061315 (human) | | 1e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 40391591 | 40391592 | Human |
407412340 | GWAS1061316_H | total cholesterol measurement QTL GWAS1061316 (human) | | 2e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41095698 | 41095699 | Human |
407068285 | GWAS717261_H | metabolite measurement QTL GWAS717261 (human) | | 0.000006 | metabolite measurement | | 20 | 47687648 | 47687649 | Human |
407182851 | GWAS831827_H | language measurement QTL GWAS831827 (human) | | 0.000002 | language measurement | | 20 | 47645829 | 47645830 | Human |
407412238 | GWAS1061214_H | smoking initiation QTL GWAS1061214 (human) | | 1e-11 | smoking initiation | | 20 | 48273805 | 48273806 | Human |
407100932 | GWAS749908_H | FEV/FVC ratio, response to bronchodilator QTL GWAS749908 (human) | | 0.000003 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 58709873 | 58709874 | Human |
407395841 | GWAS1044817_H | COVID-19 QTL GWAS1044817 (human) | | 0.000003 | COVID-19 | | 20 | 48178454 | 48178455 | Human |
407068169 | GWAS717145_H | triglyceride measurement QTL GWAS717145 (human) | | 3e-12 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45925376 | 45925377 | Human |
407166474 | GWAS815450_H | serum alanine aminotransferase measurement QTL GWAS815450 (human) | | 2e-10 | serum alanine aminotransferase measurement | serum alanine aminotransferase activity level (CMO:0000575) | 20 | 40513876 | 40513877 | Human |
406953491 | GWAS602467_H | Moderate albuminuria QTL GWAS602467 (human) | | 0.000004 | Moderate albuminuria | | 20 | 42429482 | 42429483 | Human |
407117335 | GWAS766311_H | peptic ulcer disease QTL GWAS766311 (human) | | 6e-13 | peptic ulcer disease | | 20 | 58901835 | 58901836 | Human |
407117330 | GWAS766306_H | sexual dimorphism measurement QTL GWAS766306 (human) | | 6e-09 | sexual dimorphism measurement | | 20 | 36839310 | 36839311 | Human |
406969879 | GWAS618855_H | triglyceride measurement, C-reactive protein measurement QTL GWAS618855 (human) | | 2e-24 | triglyceride measurement, C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 20 | 45956781 | 45956782 | Human |
407232019 | GWAS880995_H | BMI-adjusted waist-hip ratio QTL GWAS880995 (human) | | 0.000006 | BMI-adjusted waist-hip ratio | | 20 | 53804492 | 53804493 | Human |
407133725 | GWAS782701_H | Dupuytren Contracture QTL GWAS782701 (human) | | 4e-09 | Dupuytren Contracture | | 20 | 39849763 | 39849764 | Human |
407166493 | GWAS815469_H | hemoglobin measurement QTL GWAS815469 (human) | | 2e-08 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 20 | 50476458 | 50476459 | Human |
407133726 | GWAS782702_H | Dupuytren Contracture QTL GWAS782702 (human) | | 3e-10 | Dupuytren Contracture | | 20 | 40423486 | 40423487 | Human |
407133727 | GWAS782703_H | Dupuytren Contracture QTL GWAS782703 (human) | | 3e-25 | Dupuytren Contracture | | 20 | 40488567 | 40488568 | Human |
407346727 | GWAS995703_H | urate measurement QTL GWAS995703 (human) | | 3e-22 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 58897119 | 58897120 | Human |
407346726 | GWAS995702_H | urate measurement QTL GWAS995702 (human) | | 3e-10 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 54115823 | 54115824 | Human |
407346725 | GWAS995701_H | urate measurement QTL GWAS995701 (human) | | 1e-11 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 41113644 | 41113645 | Human |
407133728 | GWAS782704_H | Dupuytren Contracture QTL GWAS782704 (human) | | 3e-11 | Dupuytren Contracture | | 20 | 40630687 | 40630688 | Human |
407133730 | GWAS782706_H | Dupuytren Contracture QTL GWAS782706 (human) | | 7e-22 | Dupuytren Contracture | | 20 | 40689878 | 40689879 | Human |
406887976 | GWAS536952_H | intelligence QTL GWAS536952 (human) | | 1e-08 | intelligence | | 20 | 49061486 | 49061487 | Human |
407264813 | GWAS913789_H | neuroimaging measurement QTL GWAS913789 (human) | | 1e-08 | neuroimaging measurement | | 20 | 46567099 | 46567100 | Human |
407395877 | GWAS1044853_H | low density lipoprotein cholesterol measurement QTL GWAS1044853 (human) | | 4e-55 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
406904365 | GWAS553341_H | depressive symptom measurement QTL GWAS553341 (human) | | 3e-09 | depressive symptom measurement | | 20 | 49154219 | 49154220 | Human |
407133737 | GWAS782713_H | Dupuytren Contracture QTL GWAS782713 (human) | | 3e-12 | Dupuytren Contracture | | 20 | 51567761 | 51567762 | Human |
406969902 | GWAS618878_H | protein measurement QTL GWAS618878 (human) | | 2e-09 | protein measurement | | 20 | 62002148 | 62002149 | Human |
406904373 | GWAS553349_H | depressive symptom measurement QTL GWAS553349 (human) | | 3e-08 | depressive symptom measurement | | 20 | 41341794 | 41341795 | Human |
406937146 | GWAS586122_H | basophil count QTL GWAS586122 (human) | | 8e-10 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 20 | 50533973 | 50533974 | Human |
406986302 | GWAS635278_H | triacylglycerol 58:9 measurement QTL GWAS635278 (human) | | 0.0000003 | blood triglyceride amount (VT:0002644) | | 20 | 42063187 | 42063188 | Human |
406937284 | GWAS586260_H | heel bone mineral density QTL GWAS586260 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 49567926 | 49567927 | Human |
406986442 | GWAS635418_H | intelligence QTL GWAS635418 (human) | | 5e-10 | intelligence | | 20 | 48806040 | 48806041 | Human |
407166665 | GWAS815641_H | acute myeloid leukemia QTL GWAS815641 (human) | | 0.0000002 | acute myeloid leukemia | | 20 | 40863404 | 40863405 | Human |
407215818 | GWAS864794_H | cognitive function measurement, self reported educational attainment QTL GWAS864794 (human) | | 5e-14 | cognitive function measurement, self reported educational attainment | | 20 | 48833526 | 48833527 | Human |
407084759 | GWAS733735_H | phospholipids in IDL measurement QTL GWAS733735 (human) | | 6e-31 | phospholipids in IDL measurement | blood intermediate density lipoprotein phospholipid level (CMO:0001574) | 20 | 40537052 | 40537053 | Human |
406970072 | GWAS619048_H | educational attainment QTL GWAS619048 (human) | | 5e-11 | educational attainment | | 20 | 61285560 | 61285561 | Human |
407412434 | GWAS1061410_H | low density lipoprotein cholesterol measurement QTL GWAS1061410 (human) | | 2e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 41331702 | 41331703 | Human |
407314140 | GWAS963116_H | blood phosphate measurement QTL GWAS963116 (human) | | 2e-22 | blood phosphate amount (VT:0001565) | blood phosphate level (CMO:0000504) | 20 | 41203988 | 41203989 | Human |
407330535 | GWAS979511_H | triglyceride measurement, very low density lipoprotein cholesterol measurement QTL GWAS979511 (human) | | 4e-30 | triglyceride measurement, very low density lipoprotein cholesterol measurement | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45947863 | 45947864 | Human |
407199461 | GWAS848437_H | HbA1c measurement QTL GWAS848437 (human) | | 8e-09 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 20 | 57415349 | 57415350 | Human |
407166702 | GWAS815678_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS815678 (human) | | 4e-08 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 40515646 | 40515647 | Human |
407412451 | GWAS1061427_H | triglyceride measurement QTL GWAS1061427 (human) | | 7e-117 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45923216 | 45923217 | Human |
407166703 | GWAS815679_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS815679 (human) | | 1e-162 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45931109 | 45931110 | Human |
407183081 | GWAS832057_H | triglyceride measurement QTL GWAS832057 (human) | | 0.0000002 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45947863 | 45947864 | Human |
407314155 | GWAS963131_H | glutarate (C5-DC) measurement QTL GWAS963131 (human) | | 1e-16 | glutarate (C5-DC) measurement | | 20 | 46608139 | 46608140 | Human |
407166697 | GWAS815673_H | platelet component distribution width QTL GWAS815673 (human) | | 6e-09 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 62485878 | 62485879 | Human |
407150326 | GWAS799302_H | Duchenne muscular dystrophy, disease progression measurement QTL GWAS799302 (human) | | 0.000001 | Duchenne muscular dystrophy, disease progression measurement | disease progression measurement (CMO:0001110) | 20 | 50575367 | 50575368 | Human |
407183103 | GWAS832079_H | calcium measurement QTL GWAS832079 (human) | | 6e-21 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 40782509 | 40782510 | Human |
407117567 | GWAS766543_H | duodenal ulcer QTL GWAS766543 (human) | | 1e-13 | duodenal ulcer | | 20 | 58896228 | 58896229 | Human |
406904572 | GWAS553548_H | COVID-19 QTL GWAS553548 (human) | | 0.000004 | COVID-19 | | 20 | 37426096 | 37426097 | Human |
407265016 | GWAS913992_H | lymphocyte count QTL GWAS913992 (human) | | 2e-27 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 20 | 46120612 | 46120613 | Human |
406920833 | GWAS569809_H | lean body mass QTL GWAS569809 (human) | | 0.0000001 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 20 | 52575100 | 52575101 | Human |
407297668 | GWAS946644_H | systemic lupus erythematosus QTL GWAS946644 (human) | | 1e-08 | systemic lupus erythematosus | | 20 | 46119308 | 46119309 | Human |
407297678 | GWAS946654_H | type 2 diabetes mellitus QTL GWAS946654 (human) | | 3e-15 | type 2 diabetes mellitus | | 20 | 44366172 | 44366173 | Human |
407297679 | GWAS946655_H | type 2 diabetes mellitus QTL GWAS946655 (human) | | 7e-10 | type 2 diabetes mellitus | | 20 | 46967739 | 46967740 | Human |
406937227 | GWAS586203_H | heel bone mineral density QTL GWAS586203 (human) | | 2e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46949739 | 46949740 | Human |
406937226 | GWAS586202_H | heel bone mineral density QTL GWAS586202 (human) | | 7e-45 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 41203988 | 41203989 | Human |
406904459 | GWAS553435_H | COVID-19 QTL GWAS553435 (human) | | 0.000008 | COVID-19 | | 20 | 56794071 | 56794072 | Human |
406937228 | GWAS586204_H | heel bone mineral density QTL GWAS586204 (human) | | 8e-39 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46975781 | 46975782 | Human |
406888080 | GWAS537056_H | DNA methylation QTL GWAS537056 (human) | | 5e-09 | DNA methylation | | 20 | 58833371 | 58833372 | Human |
406986387 | GWAS635363_H | intelligence QTL GWAS635363 (human) | | 6e-09 | intelligence | | 20 | 49115230 | 49115231 | Human |
406920852 | GWAS569828_H | risk-taking behaviour QTL GWAS569828 (human) | | 4e-10 | risk-taking behaviour | | 20 | 53005546 | 53005547 | Human |
407297680 | GWAS946656_H | type 2 diabetes mellitus QTL GWAS946656 (human) | | 2e-11 | type 2 diabetes mellitus | | 20 | 50215483 | 50215484 | Human |
406970013 | GWAS618989_H | pelvic organ prolapse QTL GWAS618989 (human) | | 0.000006 | pelvic organ prolapse | | 20 | 62317060 | 62317061 | Human |
407117476 | GWAS766452_H | total lipids in large HDL QTL GWAS766452 (human) | | 8e-10 | total lipids in large HDL | | 20 | 47712230 | 47712231 | Human |
407068322 | GWAS717298_H | birth weight QTL GWAS717298 (human) | | 9e-15 | birth weight | neonatal body weight (CMO:0002079) | 20 | 40525455 | 40525456 | Human |
407297701 | GWAS946677_H | body height QTL GWAS946677 (human) | | 0.000001 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 45812764 | 45812765 | Human |
407117474 | GWAS766450_H | total lipids in large HDL QTL GWAS766450 (human) | | 3e-192 | total lipids in large HDL | | 20 | 45923216 | 45923217 | Human |
406953638 | GWAS602614_H | appetite-regulating hormone measurement QTL GWAS602614 (human) | | 3e-13 | appetite-regulating hormone measurement | | 20 | 40263818 | 40263819 | Human |
407117475 | GWAS766451_H | total lipids in large HDL QTL GWAS766451 (human) | | 6e-11 | total lipids in large HDL | | 20 | 46100450 | 46100451 | Human |
407133865 | GWAS782841_H | high density lipoprotein cholesterol measurement QTL GWAS782841 (human) | | 7e-295 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407150257 | GWAS799233_H | suntan QTL GWAS799233 (human) | | 3e-38 | suntan | | 20 | 37337505 | 37337506 | Human |
407264955 | GWAS913931_H | basal cell carcinoma QTL GWAS913931 (human) | | 1e-08 | basal cell carcinoma | | 20 | 39319655 | 39319656 | Human |
406970046 | GWAS619022_H | C-reactive protein measurement QTL GWAS619022 (human) | | 2e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 20 | 62022567 | 62022568 | Human |
406937409 | GWAS586385_H | prostate carcinoma QTL GWAS586385 (human) | | 2e-09 | prostate carcinoma | | 20 | 57003244 | 57003245 | Human |
406937408 | GWAS586384_H | prostate carcinoma QTL GWAS586384 (human) | | 2e-28 | prostate carcinoma | | 20 | 53846869 | 53846870 | Human |
407150406 | GWAS799382_H | mean platelet volume QTL GWAS799382 (human) | | 4e-10 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 54078416 | 54078417 | Human |
407265093 | GWAS914069_H | sarcoidosis QTL GWAS914069 (human) | | 0.000008 | sarcoidosis | | 20 | 47795948 | 47795949 | Human |
407412545 | GWAS1061521_H | elafin measurement QTL GWAS1061521 (human) | | 3e-21 | elafin measurement | | 20 | 45235657 | 45235658 | Human |
407019336 | GWAS668312_H | depressive symptom measurement, response to antidepressant QTL GWAS668312 (human) | | 0.000002 | depressive symptom measurement, response to antidepressant | | 20 | 46033306 | 46033307 | Human |
407150408 | GWAS799384_H | mean platelet volume QTL GWAS799384 (human) | | 1e-22 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 59047403 | 59047404 | Human |
407379781 | GWAS1028757_H | balding measurement QTL GWAS1028757 (human) | | 1e-53 | balding measurement | coat/hair morphological measurement (CMO:0001807) | 20 | 56859627 | 56859628 | Human |
407232343 | GWAS881319_H | serum hepcidin measurement QTL GWAS881319 (human) | | 0.0000002 | serum hepcidin measurement | blood peptide hormone level (CMO:0000286) | 20 | 38268416 | 38268417 | Human |
407117649 | GWAS766625_H | phospholipids in large LDL measurement QTL GWAS766625 (human) | | 2e-30 | phospholipids in large LDL measurement | blood low density lipoprotein phospholipid level (CMO:0001568) | 20 | 40537052 | 40537053 | Human |
406888283 | GWAS537259_H | gut microbiome measurement QTL GWAS537259 (human) | | 0.0000007 | gut microbiome measurement | | 20 | 42783625 | 42783626 | Human |
406970205 | GWAS619181_H | self reported educational attainment QTL GWAS619181 (human) | | 3e-20 | self reported educational attainment | | 20 | 61257735 | 61257736 | Human |
407215963 | GWAS864939_H | metabolite measurement QTL GWAS864939 (human) | | 4e-20 | metabolite measurement | | 20 | 46557758 | 46557759 | Human |
407117676 | GWAS766652_H | alcohol consumption measurement QTL GWAS766652 (human) | | 1e-08 | alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 53071269 | 53071270 | Human |
407084907 | GWAS733883_H | post-operative acute kidney injury QTL GWAS733883 (human) | | 0.0000009 | post-operative acute kidney injury | | 20 | 60011599 | 60011600 | Human |
407347063 | GWAS996039_H | phospholipid measurement, high density lipoprotein cholesterol measurement QTL GWAS996039 (human) | | 2e-10 | phospholipid measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47713453 | 47713454 | Human |
407265141 | GWAS914117_H | human papilloma virus infection QTL GWAS914117 (human) | | 0.0000003 | human papilloma virus infection | | 20 | 44113618 | 44113619 | Human |
407412603 | GWAS1061579_H | triglyceride measurement QTL GWAS1061579 (human) | | 6e-190 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 45923216 | 45923217 | Human |
407215985 | GWAS864961_H | mean corpuscular volume QTL GWAS864961 (human) | | 6e-300 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 57416581 | 57416582 | Human |
407134065 | GWAS783041_H | schizophrenia QTL GWAS783041 (human) | | 0.0000001 | schizophrenia | | 20 | 49514091 | 49514092 | Human |
406937463 | GWAS586439_H | prostate carcinoma QTL GWAS586439 (human) | | 1e-13 | prostate carcinoma | | 20 | 62424681 | 62424682 | Human |
406953846 | GWAS602822_H | coiled-coil domain-containing protein 126 measurement QTL GWAS602822 (human) | | 3e-20 | coiled-coil domain-containing protein 126 measurement | | 20 | 45923216 | 45923217 | Human |
407199609 | GWAS848585_H | Alzheimer disease QTL GWAS848585 (human) | | 8e-17 | Alzheimer disease | | 20 | 56423488 | 56423489 | Human |
406904701 | GWAS553677_H | heart rate variability measurement QTL GWAS553677 (human) | | 0.000003 | heart rate variability measurement | heart rate variability (CMO:0002812) | 20 | 38211754 | 38211755 | Human |
407183111 | GWAS832087_H | calcium measurement QTL GWAS832087 (human) | | 4e-19 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 54154722 | 54154723 | Human |
407248645 | GWAS897621_H | saturated fatty acids measurement QTL GWAS897621 (human) | | 4e-11 | free cholesterol measurement, low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
406986501 | GWAS635477_H | FEV/FVC ratio QTL GWAS635477 (human) | | 0.000004 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 58088218 | 58088219 | Human |
407248650 | GWAS897626_H | brain measurement QTL GWAS897626 (human) | | 5e-18 | brain measurement | brain measurement (CMO:0000911) | 20 | 41615023 | 41615024 | Human |
407199497 | GWAS848473_H | thyroid peroxidase antibody measurement QTL GWAS848473 (human) | | 2e-09 | thyroid peroxidase antibody measurement | | 20 | 47657495 | 47657496 | Human |
407248651 | GWAS897627_H | brain measurement QTL GWAS897627 (human) | | 2e-09 | brain measurement | brain measurement (CMO:0000911) | 20 | 49105171 | 49105172 | Human |
407232276 | GWAS881252_H | reticulocyte count QTL GWAS881252 (human) | | 4e-16 | reticulocyte count | total reticulocyte count (CMO:0003020) | 20 | 53613491 | 53613492 | Human |
406953747 | GWAS602723_H | ras-related protein Rab-22A measurement QTL GWAS602723 (human) | | 9e-14 | ras-related protein Rab-22A measurement | | 20 | 58414213 | 58414214 | Human |
406953748 | GWAS602724_H | ras-related protein Rab-22A measurement QTL GWAS602724 (human) | | 2e-18 | ras-related protein Rab-22A measurement | | 20 | 58312100 | 58312101 | Human |
407265054 | GWAS914030_H | breast carcinoma QTL GWAS914030 (human) | | 0.000001 | breast carcinoma | | 20 | 50826118 | 50826119 | Human |
407101215 | GWAS750191_H | mathematical ability QTL GWAS750191 (human) | | 2e-09 | mathematical ability | | 20 | 47131444 | 47131445 | Human |
406986526 | GWAS635502_H | progression free survival, ovarian carcinoma QTL GWAS635502 (human) | | 0.000009 | progression free survival, ovarian carcinoma | survival measurement (CMO:0001021) | 20 | 47960104 | 47960105 | Human |
407101214 | GWAS750190_H | mathematical ability QTL GWAS750190 (human) | | 4e-08 | mathematical ability | | 20 | 46279305 | 46279306 | Human |
407101213 | GWAS750189_H | mathematical ability QTL GWAS750189 (human) | | 9e-12 | mathematical ability | | 20 | 45942124 | 45942125 | Human |
406904606 | GWAS553582_H | R-warfarin measurement QTL GWAS553582 (human) | | 0.00001 | R-warfarin measurement | | 20 | 53947711 | 53947712 | Human |
407101219 | GWAS750195_H | mathematical ability QTL GWAS750195 (human) | | 3e-10 | mathematical ability | | 20 | 52209807 | 52209808 | Human |
407101218 | GWAS750194_H | mathematical ability QTL GWAS750194 (human) | | 1e-08 | mathematical ability | | 20 | 50475559 | 50475560 | Human |
407101217 | GWAS750193_H | mathematical ability QTL GWAS750193 (human) | | 3e-11 | mathematical ability | | 20 | 49475527 | 49475528 | Human |
407183143 | GWAS832119_H | calcium measurement QTL GWAS832119 (human) | | 2e-10 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 54146645 | 54146646 | Human |
407183142 | GWAS832118_H | calcium measurement QTL GWAS832118 (human) | | 3e-10 | calcium measurement | blood calcium level (CMO:0000502) | 20 | 54102016 | 54102017 | Human |
407150370 | GWAS799346_H | unipolar depression, mood disorder QTL GWAS799346 (human) | | 2e-09 | unipolar depression, mood disorder | | 20 | 43256482 | 43256483 | Human |
407133997 | GWAS782973_H | high density lipoprotein cholesterol measurement QTL GWAS782973 (human) | | 1e-15 | blood lipid amount (VT:0003949) | red blood cell count (CMO:0000025) | 20 | 44413724 | 44413725 | Human |
406921011 | GWAS569987_H | triglyceride measurement QTL GWAS569987 (human) | | 6e-11 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 52619074 | 52619075 | Human |
406953782 | GWAS602758_H | vital capacity QTL GWAS602758 (human) | | 1e-08 | vital capacity | | 20 | 58857551 | 58857552 | Human |
406937403 | GWAS586379_H | prostate carcinoma QTL GWAS586379 (human) | | 3e-16 | prostate carcinoma | | 20 | 53570298 | 53570299 | Human |
407314237 | GWAS963213_H | low density lipoprotein cholesterol measurement QTL GWAS963213 (human) | | 7e-13 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 53918861 | 53918862 | Human |
407314236 | GWAS963212_H | low density lipoprotein cholesterol measurement QTL GWAS963212 (human) | | 1e-12 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 48966347 | 48966348 | Human |
406937402 | GWAS586378_H | prostate carcinoma QTL GWAS586378 (human) | | 6e-26 | prostate carcinoma | | 20 | 50947674 | 50947675 | Human |
407314234 | GWAS963210_H | low density lipoprotein cholesterol measurement QTL GWAS963210 (human) | | 7e-108 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 41126055 | 41126056 | Human |
407396151 | GWAS1045127_H | COVID-19, mortality QTL GWAS1045127 (human) | | 0.000005 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 20 | 49725752 | 49725753 | Human |
407068614 | GWAS717590_H | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio QTL GWAS717590 (human) | | 9e-57 | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | blood very low density lipoprotein cholesterol level (CMO:0000648) | 20 | 45923216 | 45923217 | Human |
407084998 | GWAS733974_H | low density lipoprotein particle size measurement QTL GWAS733974 (human) | | 2e-51 | low density lipoprotein particle size measurement | blood low density lipoprotein particle diameter (CMO:0002693) | 20 | 45923216 | 45923217 | Human |
407379904 | GWAS1028880_H | triglyceride measurement, alcohol consumption measurement QTL GWAS1028880 (human) | | 1e-43 | triglyceride measurement, alcohol consumption measurement | ethanol drink intake rate (CMO:0001407) | 20 | 45923216 | 45923217 | Human |
406986699 | GWAS635675_H | sex hormone-binding globulin measurement QTL GWAS635675 (human) | | 2e-17 | sex hormone-binding globulin measurement | | 20 | 41145523 | 41145524 | Human |
407052233 | GWAS701209_H | systolic blood pressure QTL GWAS701209 (human) | | 4e-23 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 20 | 59176062 | 59176063 | Human |
406921162 | GWAS570138_H | cancer QTL GWAS570138 (human) | | 0.0000006 | cancer | | 20 | 46007856 | 46007857 | Human |
406953938 | GWAS602914_H | self reported educational attainment QTL GWAS602914 (human) | | 8e-09 | self reported educational attainment | | 20 | 49206904 | 49206905 | Human |
407330771 | GWAS979747_H | Varicose veins QTL GWAS979747 (human) | | 7e-08 | Varicose veins | | 20 | 37933480 | 37933481 | Human |
407298002 | GWAS946978_H | type 2 diabetes mellitus QTL GWAS946978 (human) | | 1e-18 | type 2 diabetes mellitus | | 20 | 44366172 | 44366173 | Human |
407298003 | GWAS946979_H | type 2 diabetes mellitus QTL GWAS946979 (human) | | 1e-09 | type 2 diabetes mellitus | | 20 | 50215483 | 50215484 | Human |
407347153 | GWAS996129_H | urate measurement QTL GWAS996129 (human) | | 1e-13 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 58897119 | 58897120 | Human |
407347152 | GWAS996128_H | urate measurement QTL GWAS996128 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 44420045 | 44420046 | Human |
407330779 | GWAS979755_H | schizophrenia QTL GWAS979755 (human) | | 0.000001 | schizophrenia | | 20 | 42428631 | 42428632 | Human |
407019496 | GWAS668472_H | hippocampal atrophy QTL GWAS668472 (human) | | 0.000002 | hippocampal atrophy | | 20 | 37137934 | 37137935 | Human |
407232495 | GWAS881471_H | migraine disorder QTL GWAS881471 (human) | | 4e-08 | migraine disorder | | 20 | 47212407 | 47212408 | Human |
407019497 | GWAS668473_H | hippocampal atrophy QTL GWAS668473 (human) | | 0.000006 | hippocampal atrophy | | 20 | 37181380 | 37181381 | Human |
406904819 | GWAS553795_H | cystic fibrosis-related diabetes QTL GWAS553795 (human) | | 0.0000008 | cystic fibrosis-related diabetes | | 20 | 50214170 | 50214171 | Human |
407117808 | GWAS766784_H | peptic ulcer disease QTL GWAS766784 (human) | | 2e-14 | peptic ulcer disease | | 20 | 58890516 | 58890517 | Human |
407068660 | GWAS717636_H | high density lipoprotein cholesterol measurement QTL GWAS717636 (human) | | 9e-21 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45925376 | 45925377 | Human |
407298041 | GWAS947017_H | response to tenofovir, creatinine clearance measurement QTL GWAS947017 (human) | | 0.000006 | response to tenofovir, creatinine clearance measurement | creatinine clearance (CMO:0000765) | 20 | 48614297 | 48614298 | Human |
407330701 | GWAS979677_H | urate measurement QTL GWAS979677 (human) | | 4e-10 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 41113644 | 41113645 | Human |
407068562 | GWAS717538_H | heel bone mineral density QTL GWAS717538 (human) | | 7e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46976909 | 46976911 | Human |
407330709 | GWAS979685_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS979685 (human) | | 2e-36 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45947863 | 45947864 | Human |
407150486 | GWAS799462_H | type 2 diabetes mellitus QTL GWAS799462 (human) | | 0.000005 | type 2 diabetes mellitus | | 20 | 53554244 | 53554245 | Human |
407330708 | GWAS979684_H | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS979684 (human) | | 9e-13 | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45909845 | 45909846 | Human |
407183271 | GWAS832247_H | blood protein measurement QTL GWAS832247 (human) | | 2e-80 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 62345644 | 62345645 | Human |
406904739 | GWAS553715_H | cystic fibrosis associated meconium ileus QTL GWAS553715 (human) | | 0.0000001 | cystic fibrosis associated meconium ileus | | 20 | 50214170 | 50214171 | Human |
406904741 | GWAS553717_H | cystic fibrosis associated meconium ileus QTL GWAS553717 (human) | | 0.0000003 | cystic fibrosis-related diabetes | | 20 | 50215598 | 50215599 | Human |
406937511 | GWAS586487_H | suntan QTL GWAS586487 (human) | | 1e-44 | suntan | | 20 | 36923214 | 36923215 | Human |
406904742 | GWAS553718_H | cystic fibrosis associated meconium ileus QTL GWAS553718 (human) | | 0.0000002 | cystic fibrosis-related diabetes | | 20 | 50218524 | 50218525 | Human |
406937510 | GWAS586486_H | suntan QTL GWAS586486 (human) | | 2e-80 | suntan | | 20 | 36816725 | 36816726 | Human |
406904743 | GWAS553719_H | cystic fibrosis associated meconium ileus QTL GWAS553719 (human) | | 0.0000006 | cystic fibrosis-related diabetes | | 20 | 50218794 | 50218795 | Human |
406937512 | GWAS586488_H | suntan QTL GWAS586488 (human) | | 3e-56 | suntan | | 20 | 37164857 | 37164858 | Human |
406904747 | GWAS553723_H | cystic fibrosis associated meconium ileus QTL GWAS553723 (human) | | 0.0000005 | cystic fibrosis associated meconium ileus | | 20 | 50214170 | 50214171 | Human |
406904748 | GWAS553724_H | cystic fibrosis associated meconium ileus QTL GWAS553724 (human) | | 0.000001 | cystic fibrosis associated meconium ileus | | 20 | 50215598 | 50215599 | Human |
406904749 | GWAS553725_H | cystic fibrosis associated meconium ileus QTL GWAS553725 (human) | | 0.0000009 | cystic fibrosis associated meconium ileus | | 20 | 50218524 | 50218525 | Human |
407379877 | GWAS1028853_H | joint damage measurement QTL GWAS1028853 (human) | | 0.000004 | joint damage measurement | | 20 | 51925009 | 51925010 | Human |
406904750 | GWAS553726_H | cystic fibrosis associated meconium ileus QTL GWAS553726 (human) | | 0.000002 | cystic fibrosis associated meconium ileus | | 20 | 50218794 | 50218795 | Human |
407150516 | GWAS799492_H | apolipoprotein A 1 measurement QTL GWAS799492 (human) | | 1e-09 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 20 | 47847399 | 47847400 | Human |
406904756 | GWAS553732_H | cystic fibrosis-related diabetes QTL GWAS553732 (human) | | 0.0000003 | cystic fibrosis-related diabetes | | 20 | 50214170 | 50214171 | Human |
407150514 | GWAS799490_H | S-7-hydroxywarfarin measurement QTL GWAS799490 (human) | | 0.000002 | S-7-hydroxywarfarin measurement | | 20 | 53323282 | 53323283 | Human |
407101370 | GWAS750346_H | FEV/FVC ratio, response to bronchodilator QTL GWAS750346 (human) | | 0.000002 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 56880653 | 56880654 | Human |
407084984 | GWAS733960_H | triglycerides to total lipids in large HDL percentage QTL GWAS733960 (human) | | 3e-98 | triglycerides to total lipids in large HDL percentage | | 20 | 45923216 | 45923217 | Human |
407134143 | GWAS783119_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS783119 (human) | | 0.000004 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 20 | 62315753 | 62315754 | Human |
407130180 | GWAS779156_H | schizophrenia QTL GWAS779156 (human) | | 0.000005 | schizophrenia | | 20 | 38650612 | 38650613 | Human |
406966337 | GWAS615313_H | infant body height QTL GWAS615313 (human) | | 1e-09 | infant body height | body height (CMO:0000106) | 20 | 49265430 | 49265431 | Human |
407228484 | GWAS877460_H | leptin measurement QTL GWAS877460 (human) | | 0.0000007 | leptin measurement | blood leptin level (CMO:0000779) | 20 | 38704369 | 38704370 | Human |
406917186 | GWAS566162_H | basal cell carcinoma QTL GWAS566162 (human) | | 9e-39 | basal cell carcinoma | | 20 | 50776208 | 50776209 | Human |
407228481 | GWAS877457_H | BMI-adjusted leptin measurement QTL GWAS877457 (human) | | 0.000008 | BMI-adjusted leptin measurement | | 20 | 38704369 | 38704370 | Human |
407015494 | GWAS664470_H | Beta blocking agent use measurement QTL GWAS664470 (human) | | 1e-12 | Beta blocking agent use measurement | | 20 | 59160393 | 59160394 | Human |
407031879 | GWAS680855_H | cholesteryl ester measurement QTL GWAS680855 (human) | | 1e-14 | blood lipid amount (VT:0003949) | | 20 | 44380341 | 44380342 | Human |
407359567 | GWAS1008543_H | creatinine measurement QTL GWAS1008543 (human) | | 2e-08 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 38220605 | 38220606 | Human |
407031880 | GWAS680856_H | cholesteryl ester measurement QTL GWAS680856 (human) | | 7e-39 | blood lipid amount (VT:0003949) | | 20 | 45923216 | 45923217 | Human |
407277645 | GWAS926621_H | anti-thyroglobulin antibody measurement QTL GWAS926621 (human) | | 0.000002 | anti-thyroglobulin antibody measurement | | 20 | 54100528 | 54100529 | Human |
407162953 | GWAS811929_H | color vision disorder QTL GWAS811929 (human) | | 4e-08 | color vision disorder | | 20 | 62425241 | 62425242 | Human |
407162964 | GWAS811940_H | schizophrenia QTL GWAS811940 (human) | | 0.0000009 | schizophrenia | | 20 | 38718108 | 38718109 | Human |
407375960 | GWAS1024936_H | colorectal cancer, colorectal adenoma QTL GWAS1024936 (human) | | 8e-13 | colorectal cancer, colorectal adenoma | | 20 | 50438781 | 50438782 | Human |
407064657 | GWAS713633_H | hemorrhoid QTL GWAS713633 (human) | | 4e-08 | hemorrhoid | | 20 | 60423593 | 60423594 | Human |
407359570 | GWAS1008546_H | creatinine measurement QTL GWAS1008546 (human) | | 2e-17 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 57562839 | 57562840 | Human |
407359569 | GWAS1008545_H | creatinine measurement QTL GWAS1008545 (human) | | 4e-09 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 44406498 | 44406499 | Human |
407228498 | GWAS877474_H | Hepatic fibrosis QTL GWAS877474 (human) | | 0.000001 | Hepatic fibrosis | | 20 | 38759219 | 38759220 | Human |
407359568 | GWAS1008544_H | creatinine measurement QTL GWAS1008544 (human) | | 2e-10 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 40839341 | 40839342 | Human |
406999130 | GWAS648106_H | forced expiratory volume QTL GWAS648106 (human) | | 9e-10 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 20 | 52517381 | 52517382 | Human |
407081050 | GWAS730026_H | body mass index QTL GWAS730026 (human) | | 8e-32 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 52449315 | 52449316 | Human |
406917216 | GWAS566192_H | serum IgG glycosylation measurement QTL GWAS566192 (human) | | 0.0000003 | serum IgG glycosylation measurement | | 20 | 40842787 | 40842788 | Human |
407261287 | GWAS910263_H | total cortical area measurement QTL GWAS910263 (human) | | 5e-09 | total cortical area measurement | | 20 | 53833665 | 53833666 | Human |
407015520 | GWAS664496_H | Varicose veins QTL GWAS664496 (human) | | 1e-12 | Varicose veins | | 20 | 51538108 | 51538109 | Human |
407294060 | GWAS943036_H | blood protein measurement QTL GWAS943036 (human) | | 3e-13 | blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 59019629 | 59019630 | Human |
407179378 | GWAS828354_H | lipopolysaccharide-binding protein measurement QTL GWAS828354 (human) | | 3e-29 | lipopolysaccharide-binding protein measurement | | 20 | 38346109 | 38346110 | Human |
407294079 | GWAS943055_H | anti-thyroglobulin antibody measurement QTL GWAS943055 (human) | | 0.000009 | anti-thyroglobulin antibody measurement | | 20 | 38622111 | 38622112 | Human |
407048194 | GWAS697170_H | low density lipoprotein cholesterol measurement QTL GWAS697170 (human) | | 5e-18 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 41043978 | 41043979 | Human |
407244807 | GWAS893783_H | high density lipoprotein cholesterol measurement QTL GWAS893783 (human) | | 3e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 47711852 | 47711853 | Human |
407113735 | GWAS762711_H | mathematical ability QTL GWAS762711 (human) | | 2e-13 | mathematical ability | | 20 | 45936043 | 45936044 | Human |
407097349 | GWAS746325_H | kit ligand measurement QTL GWAS746325 (human) | | 3e-25 | kit ligand measurement | | 20 | 45916409 | 45916410 | Human |
407113740 | GWAS762716_H | mathematical ability QTL GWAS762716 (human) | | 2e-11 | mathematical ability | | 20 | 50475403 | 50475404 | Human |
407113741 | GWAS762717_H | mathematical ability QTL GWAS762717 (human) | | 2e-08 | mathematical ability | | 20 | 52209807 | 52209808 | Human |
407113736 | GWAS762712_H | mathematical ability QTL GWAS762712 (human) | | 4e-10 | mathematical ability | | 20 | 46052214 | 46052215 | Human |
407113737 | GWAS762713_H | mathematical ability QTL GWAS762713 (human) | | 1e-09 | mathematical ability | | 20 | 46279288 | 46279289 | Human |
407097357 | GWAS746333_H | tumor necrosis factor, receptor superfamily, member 5 measurement QTL GWAS746333 (human) | | 2e-121 | cytokine amount (VT:0008713) | | 20 | 46113425 | 46113426 | Human |
407113738 | GWAS762714_H | mathematical ability QTL GWAS762714 (human) | | 5e-09 | mathematical ability | | 20 | 47131444 | 47131445 | Human |
407113739 | GWAS762715_H | mathematical ability QTL GWAS762715 (human) | | 3e-10 | mathematical ability | | 20 | 49475527 | 49475528 | Human |
406982669 | GWAS631645_H | breast carcinoma QTL GWAS631645 (human) | | 0.0000005 | breast carcinoma | | 20 | 50346469 | 50346470 | Human |
407293975 | GWAS942951_H | Thrombocytopenia QTL GWAS942951 (human) | | 3e-31 | Thrombocytopenia | | 20 | 59019629 | 59019630 | Human |
406949906 | GWAS598882_H | junctional adhesion molecule-like measurement QTL GWAS598882 (human) | | 4e-15 | junctional adhesion molecule-like measurement | | 20 | 59022916 | 59022917 | Human |
406966298 | GWAS615274_H | hepatitis C virus infection, response to protease inhibitor, bilirubin measurement QTL GWAS615274 (human) | | 0.000001 | hepatitis C virus infection, response to protease inhibitor, bilirubin measurement | serum total bilirubin level (CMO:0000376) | 20 | 47205635 | 47205636 | Human |
407326747 | GWAS975723_H | beverage consumption measurement QTL GWAS975723 (human) | | 1e-09 | beverage consumption measurement | drink intake measurement (CMO:0000771) | 20 | 39649778 | 39649779 | Human |
407097379 | GWAS746355_H | free cholesterol to total lipids in large VLDL percentage QTL GWAS746355 (human) | | 3e-77 | free cholesterol to total lipids in large VLDL percentage | | 20 | 45947863 | 45947864 | Human |
407130148 | GWAS779124_H | triglyceride:HDL cholesterol ratio QTL GWAS779124 (human) | | 3e-11 | triglyceride:HDL cholesterol ratio | | 20 | 46970451 | 46970452 | Human |
407097383 | GWAS746359_H | total cholesterol measurement QTL GWAS746359 (human) | | 1e-09 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41043978 | 41043979 | Human |
406949929 | GWAS598905_H | BMI-adjusted waist-hip ratio QTL GWAS598905 (human) | | 6e-11 | BMI-adjusted waist-hip ratio | | 20 | 46930192 | 46930193 | Human |
407097386 | GWAS746362_H | total cholesterol measurement QTL GWAS746362 (human) | | 2e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41182635 | 41182636 | Human |
407031851 | GWAS680827_H | self reported educational attainment QTL GWAS680827 (human) | | 1e-09 | self reported educational attainment | | 20 | 42574318 | 42574319 | Human |
406949928 | GWAS598904_H | BMI-adjusted waist-hip ratio QTL GWAS598904 (human) | | 3e-10 | BMI-adjusted waist-hip ratio | | 20 | 46930192 | 46930193 | Human |
407097385 | GWAS746361_H | total cholesterol measurement QTL GWAS746361 (human) | | 7e-10 | BMI-adjusted waist-hip ratio | blood total cholesterol level (CMO:0000051) | 20 | 41182635 | 41182636 | Human |
407097384 | GWAS746360_H | total cholesterol measurement QTL GWAS746360 (human) | | 2e-10 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 20 | 41043978 | 41043979 | Human |
407228467 | GWAS877443_H | urate measurement QTL GWAS877443 (human) | | 0.000006 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 49667096 | 49667097 | Human |
407228466 | GWAS877442_H | urate measurement QTL GWAS877442 (human) | | 0.000006 | urate measurement | blood uric acid level (CMO:0000501) | 20 | 42605938 | 42605939 | Human |
407228479 | GWAS877455_H | BMI-adjusted leptin measurement QTL GWAS877455 (human) | | 0.0000002 | BMI-adjusted leptin measurement | | 20 | 38704369 | 38704370 | Human |
407392310 | GWAS1041286_H | creatinine measurement QTL GWAS1041286 (human) | | 4e-11 | creatinine measurement | blood creatinine measurement (CMO:0000767) | 20 | 58888417 | 58888418 | Human |
407179322 | GWAS828298_H | C-reactive protein measurement QTL GWAS828298 (human) | | 4e-17 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 20 | 40513876 | 40513877 | Human |
407015485 | GWAS664461_H | atypical femoral fracture, response to bisphosphonate QTL GWAS664461 (human) | | 0.000002 | atypical femoral fracture, response to bisphosphonate | | 20 | 62193854 | 62193855 | Human |
406966465 | GWAS615441_H | platelet component distribution width QTL GWAS615441 (human) | | 2e-09 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59014711 | 59014712 | Human |
406966467 | GWAS615443_H | platelet component distribution width QTL GWAS615443 (human) | | 3e-34 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59022396 | 59022397 | Human |
406999232 | GWAS648208_H | intelligence QTL GWAS648208 (human) | | 4e-08 | intelligence | | 20 | 59644708 | 59644709 | Human |
406966466 | GWAS615442_H | platelet component distribution width QTL GWAS615442 (human) | | 1e-13 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59021437 | 59021438 | Human |
407081152 | GWAS730128_H | total blood protein measurement QTL GWAS730128 (human) | | 2e-08 | total blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 62403468 | 62403469 | Human |
406933701 | GWAS582677_H | telomere length QTL GWAS582677 (human) | | 0.0000001 | telomere length | | 20 | 37106460 | 37106461 | Human |
406966469 | GWAS615445_H | platelet component distribution width QTL GWAS615445 (human) | | 8e-21 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59024287 | 59024288 | Human |
406966468 | GWAS615444_H | platelet component distribution width QTL GWAS615444 (human) | | 1e-134 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59023753 | 59023754 | Human |
407064773 | GWAS713749_H | malate measurement QTL GWAS713749 (human) | | 5e-14 | malate measurement | | 20 | 46607483 | 46607484 | Human |
406966470 | GWAS615446_H | platelet component distribution width QTL GWAS615446 (human) | | 2e-47 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59038885 | 59038886 | Human |
406966472 | GWAS615448_H | vaginal microbiome measurement QTL GWAS615448 (human) | | 0.000009 | vaginal microbiome measurement | | 20 | 61537105 | 61537106 | Human |
407392453 | GWAS1041429_H | BMI-adjusted waist-hip ratio QTL GWAS1041429 (human) | | 4e-16 | BMI-adjusted waist-hip ratio | | 20 | 46858178 | 46858179 | Human |
406917327 | GWAS566303_H | response to trauma exposure, nucleus accumbens volume QTL GWAS566303 (human) | | 6e-08 | response to trauma exposure, nucleus accumbens volume | brain morphological measurement (CMO:0000136) | 20 | 47989202 | 47989203 | Human |
407130327 | GWAS779303_H | gut microbiome measurement QTL GWAS779303 (human) | | 0.000007 | gut microbiome measurement | | 20 | 48130560 | 48130561 | Human |
407015639 | GWAS664615_H | Diuretic use measurement QTL GWAS664615 (human) | | 4e-09 | Diuretic use measurement | | 20 | 50398774 | 50398775 | Human |
407032021 | GWAS680997_H | inflammatory bowel disease QTL GWAS680997 (human) | | 8e-11 | inflammatory bowel disease | | 20 | 46111557 | 46111558 | Human |
406917345 | GWAS566321_H | triglyceride measurement QTL GWAS566321 (human) | | 6e-20 | very low density lipoprotein cholesterol measurement, lipid measurement | blood lipid measurement (CMO:0000050) | 20 | 45923216 | 45923217 | Human |
407032038 | GWAS681014_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS681014 (human) | | 2e-10 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 20 | 45986352 | 45986353 | Human |
407064809 | GWAS713785_H | vitamin D measurement QTL GWAS713785 (human) | | 2e-65 | vitamin D measurement | | 20 | 54125767 | 54125768 | Human |
407343340 | GWAS992316_H | sleep duration QTL GWAS992316 (human) | | 0.000009 | sleep duration | | 20 | 38549563 | 38549564 | Human |
407064808 | GWAS713784_H | vitamin D measurement QTL GWAS713784 (human) | | 4e-56 | vitamin D measurement | | 20 | 54120584 | 54120585 | Human |
407408868 | GWAS1057844_H | eye morphology measurement QTL GWAS1057844 (human) | | 2e-13 | eye morphology measurement | eye morphological measurement (CMO:0003080) | 20 | 38208894 | 38208895 | Human |
407277803 | GWAS926779_H | skin neoplasm QTL GWAS926779 (human) | | 4e-13 | skin neoplasm | | 20 | 50782470 | 50782471 | Human |
407310583 | GWAS959559_H | low density lipoprotein cholesterol measurement QTL GWAS959559 (human) | | 3e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40523275 | 40523276 | Human |
407310582 | GWAS959558_H | low density lipoprotein cholesterol measurement QTL GWAS959558 (human) | | 1e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40231350 | 40231351 | Human |
406999280 | GWAS648256_H | level of serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform in blood serum QTL GWAS648256 (human) | | 4e-16 | level of serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform in blood serum | | 20 | 38354411 | 38354412 | Human |
407326965 | GWAS975941_H | cortical surface area measurement QTL GWAS975941 (human) | | 2e-12 | cerebral cortex morphology trait (VT:0000788) | tibia-fibula cortical bone total cross-sectional area (CMO:0001721) | 20 | 41203988 | 41203989 | Human |
407408892 | GWAS1057868_H | unipolar depression QTL GWAS1057868 (human) | | 0.0000009 | unipolar depression | | 20 | 46095666 | 46095667 | Human |
407408882 | GWAS1057858_H | R-warfarin measurement QTL GWAS1057858 (human) | | 0.000004 | R-warfarin measurement | | 20 | 51802719 | 51802720 | Human |
407310585 | GWAS959561_H | low density lipoprotein cholesterol measurement QTL GWAS959561 (human) | | 2e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 41012331 | 41012332 | Human |
407310584 | GWAS959560_H | low density lipoprotein cholesterol measurement QTL GWAS959560 (human) | | 8e-10 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40697511 | 40697512 | Human |
407376008 | GWAS1024984_H | high density lipoprotein cholesterol measurement QTL GWAS1024984 (human) | | 1e-14 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood triglyceride level (CMO:0000118) | 20 | 45923216 | 45923217 | Human |
407163010 | GWAS811986_H | FEV/FVC ratio, response to bronchodilator QTL GWAS811986 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 46495583 | 46495584 | Human |
407376003 | GWAS1024979_H | prostate carcinoma QTL GWAS1024979 (human) | | 6e-18 | prostate carcinoma | | 20 | 53838666 | 53838667 | Human |
407261322 | GWAS910298_H | phospholipids:total lipids ratio QTL GWAS910298 (human) | | 6e-20 | phospholipids:total lipids ratio | | 20 | 45906012 | 45906013 | Human |
406950028 | GWAS599004_H | protein JTB measurement QTL GWAS599004 (human) | | 4e-16 | protein JTB measurement | | 20 | 45421276 | 45421277 | Human |
406933647 | GWAS582623_H | heel bone mineral density QTL GWAS582623 (human) | | 1e-49 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 41203988 | 41203989 | Human |
406933646 | GWAS582622_H | heel bone mineral density QTL GWAS582622 (human) | | 8e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 41049841 | 41049842 | Human |
406933649 | GWAS582625_H | heel bone mineral density QTL GWAS582625 (human) | | 5e-45 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 46975781 | 46975782 | Human |
406933650 | GWAS582626_H | heel bone mineral density QTL GWAS582626 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 20 | 47173269 | 47173270 | Human |
407146642 | GWAS795618_H | adenosine diphosphate measurement QTL GWAS795618 (human) | | 0.000004 | adenosine diphosphate measurement | | 20 | 56704289 | 56704290 | Human |
407130271 | GWAS779247_H | Alzheimer disease, age at onset QTL GWAS779247 (human) | | 0.0000006 | Alzheimer disease, age at onset | | 20 | 50382958 | 50382959 | Human |
407015583 | GWAS664559_H | Calcium channel blocker use measurement QTL GWAS664559 (human) | | 8e-12 | Calcium channel blocker use measurement | | 20 | 59160402 | 59160403 | Human |
406950049 | GWAS599025_H | body mass index QTL GWAS599025 (human) | | 2e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 20 | 52471323 | 52471324 | Human |
407130279 | GWAS779255_H | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement QTL GWAS779255 (human) | | 6e-60 | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407048360 | GWAS697336_H | neuroticism measurement, cognitive function measurement QTL GWAS697336 (human) | | 1e-08 | neuroticism measurement, cognitive function measurement | | 20 | 46073481 | 46073482 | Human |
407212213 | GWAS861189_H | low density lipoprotein cholesterol measurement QTL GWAS861189 (human) | | 6e-17 | blood lipid amount (VT:0003949) | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
407392440 | GWAS1041416_H | low density lipoprotein cholesterol measurement QTL GWAS1041416 (human) | | 6e-35 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 44413724 | 44413725 | Human |
407244978 | GWAS893954_H | sex hormone-binding globulin measurement QTL GWAS893954 (human) | | 0.0000001 | sex hormone-binding globulin measurement | | 20 | 46965656 | 46965657 | Human |
407244979 | GWAS893955_H | sex hormone-binding globulin measurement QTL GWAS893955 (human) | | 0.0000001 | sex hormone-binding globulin measurement | | 20 | 50924388 | 50924389 | Human |
407244976 | GWAS893952_H | sex hormone-binding globulin measurement QTL GWAS893952 (human) | | 6e-09 | sex hormone-binding globulin measurement | | 20 | 41241938 | 41241939 | Human |
406917303 | GWAS566279_H | otosclerosis QTL GWAS566279 (human) | | 1e-08 | otosclerosis | | 20 | 48723580 | 48723581 | Human |
407244977 | GWAS893953_H | sex hormone-binding globulin measurement QTL GWAS893953 (human) | | 4e-19 | sex hormone-binding globulin measurement | | 20 | 44411929 | 44411930 | Human |
407179453 | GWAS828429_H | low density lipoprotein cholesterol measurement QTL GWAS828429 (human) | | 3e-41 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 44413724 | 44413725 | Human |
407179452 | GWAS828428_H | low density lipoprotein cholesterol measurement QTL GWAS828428 (human) | | 3e-203 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
407244991 | GWAS893967_H | body fat percentage QTL GWAS893967 (human) | | 4e-13 | body fat percentage | body fat percentage (CMO:0000302) | 20 | 44424948 | 44424949 | Human |
406999227 | GWAS648203_H | intelligence QTL GWAS648203 (human) | | 3e-08 | intelligence | | 20 | 48816978 | 48816979 | Human |
407081151 | GWAS730127_H | total blood protein measurement QTL GWAS730127 (human) | | 5e-09 | total blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 58731640 | 58731641 | Human |
407081150 | GWAS730126_H | total blood protein measurement QTL GWAS730126 (human) | | 1e-08 | total blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 47651083 | 47651084 | Human |
407081149 | GWAS730125_H | total blood protein measurement QTL GWAS730125 (human) | | 6e-16 | total blood protein measurement | blood protein measurement (CMO:0000028) | 20 | 40320210 | 40320211 | Human |
406966463 | GWAS615439_H | platelet component distribution width QTL GWAS615439 (human) | | 1e-63 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 58995513 | 58995514 | Human |
407392439 | GWAS1041415_H | low density lipoprotein cholesterol measurement QTL GWAS1041415 (human) | | 2e-161 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40551182 | 40551183 | Human |
407163207 | GWAS812183_H | color vision disorder QTL GWAS812183 (human) | | 0.0000002 | color vision disorder | | 20 | 55198525 | 55198526 | Human |
407327041 | GWAS976017_H | uric acid measurement QTL GWAS976017 (human) | | 9e-10 | uric acid measurement | blood uric acid level (CMO:0000501) | 20 | 54088791 | 54088792 | Human |
407195979 | GWAS844955_H | body weight QTL GWAS844955 (human) | | 3e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 20 | 52532117 | 52532118 | Human |
407032146 | GWAS681122_H | insulin resistance QTL GWAS681122 (human) | | 0.0000003 | insulin resistance | | 20 | 44360627 | 44360628 | Human |
407359831 | GWAS1008807_H | erythrocyte count QTL GWAS1008807 (human) | | 1e-48 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 57416581 | 57416582 | Human |
407163218 | GWAS812194_H | schizophrenia QTL GWAS812194 (human) | | 8e-08 | schizophrenia | | 20 | 59678449 | 59678450 | Human |
407376208 | GWAS1025184_H | triglyceride measurement QTL GWAS1025184 (human) | | 8e-09 | triglyceride measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
406966621 | GWAS615597_H | glomerular filtration rate QTL GWAS615597 (human) | | 6e-15 | glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 20 | 61983579 | 61983580 | Human |
407376214 | GWAS1025190_H | high density lipoprotein cholesterol measurement QTL GWAS1025190 (human) | | 3e-09 | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 20 | 45923216 | 45923217 | Human |
407310680 | GWAS959656_H | low density lipoprotein cholesterol measurement QTL GWAS959656 (human) | | 4e-11 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40464833 | 40464834 | Human |
407359832 | GWAS1008808_H | erythrocyte count QTL GWAS1008808 (human) | | 8e-15 | erythrocyte count | red blood cell count (CMO:0000025) | 20 | 62455524 | 62455525 | Human |
407179621 | GWAS828597_H | body height QTL GWAS828597 (human) | | 0.000007 | body height (VT:0001253) | body height (CMO:0000106) | 20 | 41179129 | 41179130 | Human |
407196000 | GWAS844976_H | elafin measurement QTL GWAS844976 (human) | | 3e-14 | elafin measurement | | 20 | 45236168 | 45236169 | Human |
407245167 | GWAS894143_H | neutrophil-to-lymphocyte ratio QTL GWAS894143 (human) | | 8e-13 | neutrophil-to-lymphocyte ratio | | 20 | 59249846 | 59249847 | Human |
406983024 | GWAS632000_H | unipolar depression QTL GWAS632000 (human) | | 2e-14 | unipolar depression | | 20 | 46052214 | 46052215 | Human |
407376252 | GWAS1025228_H | colorectal cancer, colorectal adenoma QTL GWAS1025228 (human) | | 4e-11 | colorectal cancer, colorectal adenoma | | 20 | 50367160 | 50367161 | Human |
407376245 | GWAS1025221_H | colorectal cancer, colorectal adenoma QTL GWAS1025221 (human) | | 1e-26 | colorectal cancer, colorectal adenoma | | 20 | 62357358 | 62357359 | Human |
407277944 | GWAS926920_H | initial pursuit acceleration QTL GWAS926920 (human) | | 0.000001 | initial pursuit acceleration | | 20 | 55897540 | 55897541 | Human |
406966529 | GWAS615505_H | platelet component distribution width QTL GWAS615505 (human) | | 3e-49 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59039452 | 59039453 | Human |
407097602 | GWAS746578_H | cholesterol to total lipids in medium VLDL percentage QTL GWAS746578 (human) | | 7e-37 | cholesterol to total lipids in medium VLDL percentage | | 20 | 45961659 | 45961660 | Human |
407163142 | GWAS812118_H | FEV/FVC ratio, response to bronchodilator QTL GWAS812118 (human) | | 0.000005 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 20 | 44350931 | 44350932 | Human |
406966531 | GWAS615507_H | platelet component distribution width QTL GWAS615507 (human) | | 4e-87 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59098895 | 59098896 | Human |
406966530 | GWAS615506_H | platelet component distribution width QTL GWAS615506 (human) | | 5e-56 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59063624 | 59063625 | Human |
407195905 | GWAS844881_H | cardiac troponin T measurement QTL GWAS844881 (human) | | 0.000002 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 20 | 47114062 | 47114063 | Human |
406966533 | GWAS615509_H | platelet component distribution width QTL GWAS615509 (human) | | 8e-32 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59161308 | 59161309 | Human |
406966532 | GWAS615508_H | platelet component distribution width QTL GWAS615508 (human) | | 3e-61 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59133359 | 59133360 | Human |
406966535 | GWAS615511_H | platelet component distribution width QTL GWAS615511 (human) | | 3e-24 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59287932 | 59287933 | Human |
406966534 | GWAS615510_H | platelet component distribution width QTL GWAS615510 (human) | | 1e-09 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59210114 | 59210115 | Human |
406966536 | GWAS615512_H | platelet component distribution width QTL GWAS615512 (human) | | 2e-113 | platelet component distribution width | platelet distribution width (CMO:0001350) | 20 | 59291787 | 59291788 | Human |
407048462 | GWAS697438_H | prostate carcinoma QTL GWAS697438 (human) | | 5e-11 | prostate carcinoma | | 20 | 50911385 | 50911386 | Human |
407081229 | GWAS730205_H | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio QTL GWAS730205 (human) | | 6e-24 | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | blood low density lipoprotein cholesterol level (CMO:0000053) | 20 | 40537052 | 40537053 | Human |
407130391 | GWAS779367_H | triglyceride:HDL cholesterol ratio QTL GWAS779367 (human) | | 9e-09 | triglyceride:HDL cholesterol ratio | | 20 | 47712230 | 47712231 | Human |
407294225 | GWAS943201_H | vaginal microbiome measurement QTL GWAS943201 (human) | | 0.000003 | vaginal microbiome measurement | | 20 | 51059717 | 51059718 | Human |
407163164 | GWAS812140_H | mean platelet volume QTL GWAS812140 (human) | | 8e-27 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 58977406 | 58977407 | Human |
406982937 | GWAS631913_H | unipolar depression, mood disorder QTL GWAS631913 (human) | | 1e-11 | unipolar depression, mood disorder | | 20 | 46093017 | 46093018 | Human |
406999326 | GWAS648302_H | mean corpuscular volume QTL GWAS648302 (human) | | 4e-22 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 20 | 37047109 | 37047110 | Human |
406999327 | GWAS648303_H | mean corpuscular volume QTL GWAS648303 (human) | | 1e-27 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 44031796 | 44031797 | Human |
407032095 | GWAS681071_H | creatinine measurement, glomerular filtration rate QTL GWAS681071 (human) | | 9e-15 | creatinine measurement, glomerular filtration rate | glomerular filtration rate (CMO:0000490) | 20 | 54115823 | 54115824 | Human |
407163163 | GWAS812139_H | mean platelet volume QTL GWAS812139 (human) | | 2e-11 | mean platelet volume | mean platelet volume (CMO:0001348) | 20 | 57411745 | 57411746 | Human |
406999330 | GWAS648306_H | mean corpuscular volume QTL GWAS648306 (human) | | 5e-43 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 53605567 | 53605568 | Human |
407032099 | GWAS681075_H | phospholipids in very large HDL measurement QTL GWAS681075 (human) | | 3e-18 | phospholipids in very large HDL measurement | | 20 | 46080900 | 46080901 | Human |
406999331 | GWAS648307_H | mean corpuscular volume QTL GWAS648307 (human) | | 1e-11 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 56389305 | 56389306 | Human |
406999328 | GWAS648304_H | mean corpuscular volume QTL GWAS648304 (human) | | 1e-25 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 48820675 | 48820676 | Human |
406999329 | GWAS648305_H | mean corpuscular volume QTL GWAS648305 (human) | | 4e-30 | mean corpuscular volume | mean corpuscular volume (CMO:0000038) | 20 | 50470475 | 50470476 | Human |
407163168 | GWAS812144_H | immature platelet count QTL GWAS812144 (human) | | 4e-152 | immature platelet count | | 20 | 59022915 | 59022916 | Human |
407032103 | GWAS681079_H | phospholipids in very large HDL measurement QTL GWAS681079 (human) | | 2e-11 | phospholipids:total lipids ratio | | 20 | 45427070 | 45427071 | Human |
407163189 | GWAS812165_H | immature platelet count QTL GWAS812165 (human) | | 2e-41 | immature platelet count | | 20 | 59023753 | 59023754 | Human |
407163191 | GWAS812167_H | color vision disorder QTL GWAS812167 (human) | | 0.0000003 | color vision disorder | | 20 | 51903304 | 51903305 | Human |
407163198 | GWAS812174_H | color vision disorder QTL GWAS812174 (human) | | 0.000 |